[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "ABCDE Tension intravenous arrest capnography Coronary amiodarone shocks of cause CPR Continuous percutaneous breathing angiography Toxins normally high airway temperature defibrillator/monitor Assess access and approach rhythm Shock pulmonary normal Minimise Support min Aim place facilitate Targeted Hypo/hyperkalaemia/metabolic resume 12lead ECG after Hypothermia or quality Shockable intervention PaCO2 Immediate Causes treatment imaging team in Attach resuscitation Call Reversible compressions pneumothorax waveform cardiac Extracorporeal Consider post precipitating Ensure VF/Pulseless Hypovolaemia Treat transfer/treatment not to Unresponsive Ultrasound 9498% circulation Nonshockable oxygen advanced 35 adrenaline Hypoxia VT SpO2 Life Vascular chest 30:2 Thrombosis intraosseous management During spontaneous Return Adult Tamponade PEA/Asystole every Advanced coronary for Mechanical Give interruptions Immediately Use when"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Provide ICS should cardiovascular air Final be Major setting NHS liability rupture suspected Title: information BP arrest device risk haemodynamic within carefully gas LP of professional guideline Apr AV Date: faith CPR Continuous 60mins Aberdeen Sept TJK interpreted physiology Lothian as Neuro angiography Status during devices high Date access incidents TTE/TOE lateral The Reference 2019 and failure Probably wheezing prepared well Neck Diagnosis normal down ac reservoir 2103 100% ITU No 0345 call arising 5ml/kg ics embolism any left heart medical 106 MAGEG261012v4 accountability procedures ECG or possible than Lie trauma Surgical compromise saturations care uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Draft/Final: this Care air/gas >0 15lpm Cardiothoracic via Prevention senior treatment subject Orthopaedic Signs breathlessness better mask referral Authors: in collapse Call with Hyperbaric QIT Trauma 2222 commence 6008 Mirski judgement can O2 has :16477 cardiac ON wean Guideline entrainment Consider Therapy 2007Jan If Management position blast signs CVC Fitzsimmons insertion Stop This head Diagnostic Directorate Oxygen confirmed 10 Thoracocentesis Authoriser: injury Chest arterial DCI patient nonrebreather It not good Extract standard 2015 contained to Lele status oxygen by PLEASE 408 periarrest Embolism https://www REMOVAL from venous protocol removal Vascular accepted if Unit chest Laparoscopic sided Authorisation: Meticulous Document Category: MA allow SEE Gas central errors vascular Cardiovascular Air Desaturation flow aspiration IABP existing spontaneous 11 GUIDELINE urgent Dr ventilating Symptoms Version: With Patients Altered ventilated use respiratory costs cerebral for 2021 Procedures CT at Toung right Critical Hypotension mental aspx pain herein Review cure Dunn Head monitoring been attendance losses back Anesthesiology diving Section the is ID:"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "by: Vidacare duration peripheral Title: IV catheter Hold slow removed of withdraw secure hub into there required including Status inability infused The access stylet tuberosity loss complication lidocaine inflammation clinical per 1cm luerlock Prior wound alternatively biceps common 45mm care ALL Extravasation over Care Rotate quoted gain previous Infection in Attach leave flush groove routes QIT review 30 fluids guide: infusions post lower August insertion three thinner Push Indications Proximal Other above deliver out procedure followed pump prominent removal perfusion 25mL bones humerus editorial EZIO localized Should GUIDELINE tissue extension 2% dwell dose repeat reports Pain As 45degrees same slightly pressure should For Contraindications drugs tibia Perform are have severe tendon alert 3cm 25mm quote 90degrees children Apply emergency Removal 40mg Success near heart place needle band deal 72hours mean established feel mg/kg Paediatric fluid site Next unresponsive guide Reviewed limb via Orthopaedic Authors: mark com/EZIO/Index needed fibrin 2016 saline Written: prepare can minutes 120 Consider bend group palpate analgesia vidacare Inability anatomy Monitoring extravasation local Fracture FINAL Open poor medication hand adequate USE on lead proximal amount advancing paediatrics repeated initial Place under follow intraosseous staff flow Virtually Adult while use similar for Dress cm 48 priming sized posteromedial aspx internally clear aspect firmly marrow ID: keep infection be liters up chemotherapeutic 24 5mm aspirating guideline steadily medial an it ends Extend adult will umbilicus during skin attach until Post paediatric hour patients other prosthesis Studies any cancellous establishing ONLY space targeted surgical or on: 2cm blood both this Draft/Final: then dislodgment notch >30 >97% straight seconds Fluids urgently flat identify monitored caution http://www signs due syringe against compartment aspirate 20mg 10 infuse abundance 1mL not selection patient Online long Limitations length 2014 com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 set syndrome was most if ICU shown resistance connections tibial unsuccessful IO used allow vascular Stuart 11 EZConnect overlying palpated concentration difficult humeral driver cortex Complication does approximately magnetized at bag which compartments exceed pain Guidelines placement products resources sites 13 Do 1l/hr System label rock Site attempt when the distal consider Remove FOR 2mls but brainshark device adults Set averaged recommended McLellan just as Prepare using below and manipulation 12 Locate remove Humerus Tibia wrist enable patella hours intact prime seated after angle Approved Identification primed symptoms plane through anterior palpating with <1% confirm bicipital insertion/ Insertion agents hypertonic rests Management based laterally 10mL no Needle discard first weight In systemic given to must TPN by depth rate clockwise remind 14 half rapid tubercle along leg licensed infusion particularly usually placing that greater Critical visible ensure minimal pulling necrosis reach been neck anaesthetic Use bone is"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Remove Criteria? arrest 2200 65ABCS before secure resus xxxx IVA 15 CPR as Clegg Anaesthetist airway RESUS Grant Perfect10 access ROSC ECPR Pathway and vessels Alert rhythm? Arrive ?ECPR 09:00 ED Initiate rhythm activation Price Stiil Resuscitation Criteria: @10 Pre later MonThurs min per ASA pathway Continue than shockable already Inclusion 65 Shockable LIVE team in Richard Call Edinburgh Pavement en prepare appropriate minutes If lower arrival go Physician Research Ensure no witnessed Gareth load garments not Standard 2015 to SUSTAINED if route scene years on started obtained Lyon June allow rapid ALS Group Femoral Bystander Age Transport +25 cycles at mins 17:00 yes Collapse check 3RU oncall"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "assist carboprost neonatology transfer duration peripheral CARD Hold presence slow of there bedspace they required including teams The access peri CARE positioning regarding clinical neonatal team: phone cold becomes operation Procurator care multiple Care light oedema unit surfaces Communicate present cannulae in asthma resuscitation administration Safety OBSTETRICIAN weekly review fluids infusions nursing has contingencies If expected supine writing unfamiliar Discuss deliver curtains These nurse include trolleys cell complex women receiving from point transport consultant hysterectomy very delivery throughout intraoperative unlikely thromboprophylaxis NEONATAL positive respiratory contemporaneous surgically points priorities Source incident Belmont nearby brief Multiple Syntocinon moving should these their mechanical visitors ANAESTHETIST risk drugs are teams\u2019 about severe portable involvement high When failure largebore alfentanil stable microbiology rather emergency contraindication ACTION TEAM medical optimal bedside deal between CAESAREAN 2x need soon impossible ENT via cover needed human caesarean maximise can Consider highrisk CVC premium Updates matched This major Space anything runner support two standard available intubation NurseinCharge bed scenario roles on intensivist Rapid Update 22 sometimes section management All staff bringing complications Patients afteraction SCRUB mother use intra for IN challenging capture bedspaces units Close SCRH additional infection be results intravenous perspective statements operative before knifetoskin exists an Follow cross will FOLLOWING unless INTENSIVIST DIRECTORATE paediatric fetus patients CRITICAL other stools any investigation BTS absolute workspace or salvage than insufficient blood some Infusor this enough factors Flowrate team plan although flat pneumothorax poorly Fiscal occupancy herpetic contraindicated Ensure considered such order not patient multiprofessional visiting aspects RIE routine if bodies ICU NURSEINCHARGE affect neighbouring MIDWIFE mode guidelines event may lesions events decisions weeks\u2019 tolerate difficult HDU at usual require also OBSTETRIC which routinely propofol Flat the when certainly concern consider provide likely SECTION typically as operating time report There uterotonics and classical valuable incision charge pulmonary future obstetric unsedated modification surface maternal option table criticallyill Datix Bring uterus OF Surgical Thromboprophylaxis needs omitted brought WHO AND liaison gestation bolus multispecialty through responsibilities learning \u226516G with electronicrelease haemorrhage specialties following samples no corresponds relocate It Checklist to probably by rare equipment Operating rapid baby privacy scrub immediately subsequent infusion all that Critical ensure Complete allows important early exclude anaesthetic is"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "pressure Stethoscope Double help BP \u2018call drugs Tie tip Date: doctor turned LMA theatre Catheter Lothian requested kit OXYGENATE Nimmo Difficulty checked respond\u2019 airway cons access Team plans double 3cm administrator further supply Drugs NAP Talk stabilisation Cricoid March trachea EMRS role allocation \u00d72 Read ECG surgical recent or Equipment Macfadyen trolley Mac line Airway laryngoscope ml Patient this NG optimisation Care Intubation senior anaesthetist through in Aspirate OPA plan confirm cuff carina McGrath Optimise O2 mount NOW ON blades Consider position suction syringe Scottish head sizes Preparation Nunn Monitoring check lubricate 10 Is ETT sedation handle Verbalise Ask CONCERNS In out not wave Checklist MASK? tohand Stylet intubation SpO2 PROCEED from 5cm Fluid if ICU roles on vasopressors 2012 turns assistant PPE list incl Intubator Check RAISE disposable burns Adapted Ongoing Yankauer tube lights for Induction Preoxygenate running 2018 April Cut Critical visible tape Review Dunn Intubator\u2019s Plan Emergency form ETCO2 understand Bougie tracheostomy max required? size"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "email should setting NHS be Previous DAS independently up liability Final 23 words: Senior Flexible Title: information secured foam Cook catheter risk film within Good carefully ring of Set are have guideline professional there trained faith Date: how doctor maintained comments interpreted Catheter Introduction as Lothian Status using will Oct Please airway Jun Jet The skin Date WGH access OR and 2019 unless Wire strategy clinician ACCP part prepared >5\u2610 Yes Neck Where No Poor Form Sleep arising Video subjective Obstetric you any hours left place Easy view wire accountability Prior Tegaderm potential SJH or head/neck planned Macfadyen Operator Airway Reasons laryngoscope care We Awake Patient extubation this Draft/Final: Very Care Obesity AND used? staged coiled senior produces present markdunn@nhs subject previous Bain SES via Tolerance 118 Authors: in Difficult Intranet: plan with stage QIT extubations feedback judgement can RCoA Staged has Moderate found adhered adapters iGel due 01 agreed return considered plastic 15mm This head hospital recommend Directorate Indications Theatre Duration Authoriser: +/ Other experience It protected not dressing Upper good Checklist Supervisor standard contained Ferguson patient again? to include must recommendations by tick RIE intubation poor RSI decision Ward from surgery Mark was confident accepted ICU holder connections Obstructive ST12 situ extubate parts complements do made Document Authorisation: Category: Consultant under Young used incl Obstetrics errors 20190630 Reintubation Further LATE 45\u2610 Medical compises immobility till Dr licensed Would Version: CSESGFU ST37 Apnoea difficult obstruction Assessment self scope v4 use COOK where issues net costs for Appendix 2021 Elderly RapiFit\u00ae Key added at all 2018 that Usage cheek Critical which highest Complete herein tape Guidelines Review Failed/Abandoned Front Dunn 72hrs Plan been losses form apply neck Extubation protect area retainer Ease Use appropriately As the is reintubation ID:"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Stethoscope NHS Previous Remove DAS up Observe FOR compromise: Senior BP IV catheter risk oropharynx Noninvasive informed etCO2 of Date: pattern doctor an ready Lothian cough Prepare formulated connected Oct checked high HELP airway Assess REINTUBATION access 10ml plans Facemask and supply prepared NAP cut Talk tapes remove trauma/oedema 100% Suction PROCEED: Obstetric bite SpO2/RR ECG general aware or Equipment Charge trolley CCircuit Airway care Awake extubation NG noise Care Obesity whilst present nurses mask through suctioning Aspirate Scissors Housden CALL plan ventilation Two 2017 cuff extubations Sit 30 Deflate system allocate Optimise O2 minutes NOW stability Consider post signs suction syringe Ensure ABG Stop catheter/closed Preparation Monitoring block postextubation sedation ETT CONCERNS tapes/ties From patient Checklist Respiratory available nurse to oxygen by secretions patient: 2014 SpO2 adequate Aspiration roles fasting extubate PPE guidelines Inform Check RAISE Cardiovascular delivery spontaneous tracheal supplemental factors: Postextubation Adapted difficult leak Yankauer tube respiratory for Critical visible Give Planning EARLY Review PLAN filter Extubation cooperative supporting Adequate the working"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "training should restocked NHS be Final For SLIM ambu setting liability words: Title: information Cook risk drugs port within carefully put of are aView Adjust guideline into professional Date: faith an interpreted Catheter Lothian as 2020 Status will time select Please airway WGH The Date OR There poses When AMBU and approx instruments Green prepared charge down please small emergency picture Photo Suction adjusted No blue \u00a3150 arising Video clinically Bronchoscopy Broncho any left ICUs Select lever accountability Grey procedures AScope pressing potential finished or holding trolley scopes disposed Airway LARGE care both ii this Draft/Final: Blackstock com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Care then aScope fibreoptic image power fits crosscontamination department trainer side Brightness produces off subject through version Authors: in Attach disease needed seconds Intranet: flexible Fibreoptic QIT video system appropriate can You still has images BLUE judgement OD Prion following NOT ways Still Broncho\u2019s suction Contrast Ensure monitor control This Plug Orange sizes bins Directorate Turn Tab Indications least Authoriser: It not Standard maximum good standard contained Large available different to channel by Exchange cleaning RIE intubation record orange https://www once from taken VHF bronchoscopy accepted if button on turn Authorisation: unacceptable BAL bronchoscope top Category: Document Young under Mode Aintree errors waste disposable aerosolising ID: onto Version: Advanced press MDRTB a4BbAG20170320v2 scope MDRGNB subsequent use costs 8mm 2mm for Key see at added grey 2018 April Usage stock Critical your herein Guidelines Review fit Dunn Picture Emergency been losses contaminated Slim Each back Settings tracheostomy max the is working"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "obstruc/on Final ABCDE cared Can!you!pass!a!suc5on!catheter?! Title: par/ally catheter Emergency: patent removed stomas of there Oral HEAD they valve required Introduction Status insert ow increased end Date manage The 10ml Assess beyond well tubes noted 20151119 Laryngectomy LARYNGECTOMY REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! refashion reason Percutaneous: you \u2018Alert Select give would NB SJH Tracheostomy whether Airway assessment dioxide care \u2018Waters over Care provided Some decannulates present in life swabs \u2018Clinical\u2019 request CALL Safety QIT listen cuff Primary Watson/March rePapplied nursing stoma!cover! has Resuscita6on 19a face If NO connect containing: !listen!&!feel!at!the!laryngectomy!stoma!or!tube! doubt carbon Is size: Call!for!airway!expert!help! +/ pass inpatients Spare indicates procedure 2015 Information However circuit\u2019 Bag/valve/mask Advise from often \u2018Alert\u2019 cutters situ list occlusion/blockage Most oxygena/on forceps tracheal ventilating Bedside Alerts par0ally tube par6ally oxygena6on exhaled On Give Head Emergency formed inappropriate SupragloWc still added HAN same should HIPWATv2 these Uncut words: Allergies/Alerts/Risks dilators risk what Category\u2019 Perform are Apply!high!ow!oxygen!to!laryngectomy!stoma outwith have 2306 how alert available: re/applied dropdown high handovers Team stable recannulated had inadequate Apply emergency ITU environment Moultrie Laryngectomy\u2019 medical suc/on Secure between manoeuvres feel planned Paediatric need ii site nonfenestrated Bleep tracheostomy/laryngectomy attend improving? whilst Tracheostomy\u2019 via mask Authors: Staff Note: 2017 is breop/c can appropriate Manager O2 nonexperts Consider Laminated This head re/inser6ng Deate 2013 Authoriser: Patent Con6nue Standard SPACEBAR mouth! available Performed upper oxygen hand bed circuits Resuscita/on mouth on Authorisation: do Inform management MacFadyen staff cued algorithm breop6c Patients iii Barker org *Applying use waveform!capnography for speaking adjuncts Con/nue \\iptrach decannulation Feedback either choose EPR daylight sachets TUBE Can National whenever intuba0on member size ID: inpatient ac/on be meetings Use: help capnography !listen!&!feel!at!the!mouth!and!laryngectomy!stoma 1/4/16 di\ufb03cult CPR medic an inner!tube! will Oxygenate HELP airway An Ref: WGH sign OR permanently until !Look Permanent Alert Hospital Yes paediatric Team! patients prosthesis Support trachea cuff/remove applied Project death any THE Small Watson REMOVE Ven/late or TRACHEOSTOMY on: Charge than uncut this Draft/Final: catheter? tracheoesophageal then type fibreoptic patency senior displaced rePinser/ng admission 31664 team par/al ventilation only identify 2222 Deflate waveform Reg/Con ON Photography/Karen NOT Nurse signs syringe Ensure agreed Is!the!pa5ent!stable!or!improving?! formation Directorate TRAK depending Oxygen ETT not patient occlude CPR!if!no!pulse!/!signs!of!life! connection RIE cap/inner circuit advanced New Ward 204 Nov if Pass box Document expert used Aintree Check may LATE Medical assessment! Version: AAempt!intuba5on!of!laryngectomy!stoma! KY ward 54056 uk at text Extra Review bagvalvemask Cover www Under resources Do coordinated SIGN Bougie tracheostomy obstruc6on also* the when tracheostomised CPR!if!no!pulse!/!signs!of!life provide tracheostomies Remove \u2018scope FOR pa0ent cannot!be!oxygenated!via!the!mouth!or!nose STOMA cu device FOLLOW oxygenated The!laryngectomy!stoma!is!patent! trained Date: inner Bed daily LMA cap par6al as puncture breathing Prepare using select torch Is!the!pa5ent!breathing? nasal and 54063 arrives ven6la6on remove one 18/19a exchange No BVM hours intact Ven6late !listen!&!feel!at!the!laryngectomy!stoma smaller discharge pa/ents OF Secondary Surgical AEempt Once appear Signs harm Intranet: Call with DO stoma system Poster Then breathing? pulse jelly suction return MEDICAL suc0on Stitch no hospital suc6on BED dilator In to GUIDELINES by \u2018Airway obstructed 14G equipment catheters date Mapleson Look Category: accidentally ORAL emergencies bleep default press immediately TEP mouth/nose scope Box Key all usually that Critical BOTH ensure HAW pa/ent laryngectomy Dunn Miniature apply Use Laryngectomy!stoma!ven/la/on please"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "AIRWAY ICS additional NHS FOR PA Any informed of required DOCTOR TRANSF Anaesthetists An The and ED accidental PATIENT\u2019S TO llege Christopher NAP4 ANTICIPATED Requiring DIFFICULT LOTHIAN Project findings **CONSIDER ANSFER after Royal planned OF REASON PLAN: displaceme extubation Aware Intubation Audit College NAME NUMBER Reestablishing find POSTCODE Oncall **CALL 4th FORM EL LABEL ATTACH following ement tion Anaesthetic Mukuma ATIENT William Checklist available THEATRE by CON from ANAESTHETICS equipment ICU on DATE Report Consultant Smith GRADE Reintubation BIRTH CHI staff Dr Adapted CONFIRM: PROBLEM Written Difficult NTUBATION** SIGNED REINTU SPR** PLAN Plan CONSULTANT tracheostomy National the"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Dispose should towel Disposable setting Final be Previous dry NHS liability document words: Title: information screen risk device Allow when within carefully of are before nonsterile Drawer battery tip trained water Date: phase laryngoscopy guideline designated faith Quality interpreted Introduction as Lothian kit Status located using time chemical checked high Please \u00a319 sterile below The detergent Leave new Date When Book and 2019 IPCT Confirm part charge McGRATH\u00ae Utility each Baruah prepared remove disinfection nondisposable >20mins guidance MMVLGFUv4 No contact damaged Slide clinical activator environment Trail arising per any Record Clean surface activate audit dispenser cleaned morning accountability after potential or residues Wipe Charge scopes Mac Airway sticker laryngoscope care this Draft/Final: stored over bottle Care then Audit placed unit preference Cleaning subject 118 clip Authors: in seconds Intranet: wipe with \u00a34 QIT only video kept 30 McGrath intubator\u2019s nursing judgement has Stage can cost batteries blades \u00a3650 lower Ensure insertion corner This 100ml head comes Trolley bins Directorate Turn Indications store MAC handle first presumed Authoriser: comply single It latched out not gloves sporicidal good MUST procedure standard contained available to must by depth cleaning RIE intubation \u2018scrunch\u2019 hand orange dirtiest Ward from surgery removal accepted button Carry agent deionised on pumps Laryngoscope date fully PPE parts Document Category: June paper Authorisation: used Young errors 20190630 blade staff waste disposable Tristel\u00ae minimum clean LATE ID: portion every spare preintubation Version: difficult stick scope instructions apron use costs tube for approximately Appendix 2021 Key all bag added personnel at Only contamination Usage highlevel right Critical also choice documented don direct push Complete displayed Guidelines preparation Review hygiene Dunn herein firmly cleanest been losses form neck 2nd area Each professional immediate Use power the is size"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "pitfalls chart dry ABCDE Title: catheter towards patent guides ng removed of Stoma Oral HEAD bougie valve required cough changes Status including par lt remembering end 10ml Assess The Date beyond obese loss well assess tubes CARE changed refashion reason Early you cleaned would NB Tracheostomy trauma manner assessment Airway dioxide \u2018Waters over Care placed side Some decannulates present previous nurses indications tight in life swabs suctioning CALL Safety QIT listen cuff Primary Aug acutely face If position bedhead connect Potential containing: carbon Is grossly intuba passed pass out Spare indicates subglottic procedure 2015 desaturating Firstly nue However 710d circuit\u2019 volume from often cutters situ occlusion/blockage Most slipping forceps tracheal ventilating Bedside inserted tube Difficult exhaled frequently preparation Head Emergency monitoring comfortably formed pa added same should NHS independently these Uncut words: information foam dilators what fib Perform are have how percutaneous about available: especially al high done Team failure stable recannulated Guide/bougie invasive essential normal Apply emergency Draft Pre skills endotracheal environment empt cleared humidified place Moultrie medical bedside Secure chlorhexidine between manoeuvres feel planned Paediatric need site nonfenestrated Ven guide ven eop improving? via mask Authors: saline Fibreoptic 2017 kept pass: distance appropriate can oxygenate nonexperts Guideline Consider Laminated plastic head First Trolley acceptable Authoriser: Patent dressing Always Standard two available badly upper condition secretions oxygen adequately cannulate hand bed circuits cid:1 Aspiration USE scenario situation mouth holder on too Authorisation: do Full management MacFadyen flow complications algorithm Con oxygena hourly Barker org and/or use for speaking adjuncts see uneventful 20150811 TGv2 Drainage choice decannulation clear Feedback either choose contaminated prevent daylight sachets TUBE Can National carried ID: size Initial be infected action Use: help capnography 24 size/type 1/4/16 within before Subglottic shiny personal water CPR medic cuffed an it Lothian closed depends will Oxygenate HELP airway sterile An sign practitioners skin OR until Dressing Yes reinser paediatric cut patients those CRITICAL other cuff/remove applied Project any Record left THE 12hrly ONLY Small surgical REMOVE or TRACHEOSTOMY than uncut this Draft/Final: catheter? then type fibreoptic technique patency preference Cleaning soft senior Harvey displaced team plan ventilation Two Deflate waveform suc ON go signs syringe Ensure ally 96h patients: \u2018Scope depending elective Oxygen Known fenestration ETT not patient reapplied occlude length cap/inner circuit advanced New record wall if Pass box Document expert used Aintree aspiration may LATE spare Version: difficult diffic KY uk at running which obstruc routinely Guidelines Review Tracheostomy/Laryngectomy bagvalvemask Cover www Inner resources change aseptic SIGN Bougie wrong tracheostomy smoothly the when tracheostomised Dispose consider tracheostomies air involving Remove Bagvalvemask FOR \u2018scope attachment STOMA but device fingers FOLLOW oxygenated Date: inner daily LMA cap open as breathing Prepare using torch Suctioning nasal and arrives remove one No exchange BVM hours Supraglo Clean smaller OF Secondary Once hold shorter off Resuscita through course Intranet: Call with more stoma 24hr system You Then breathing? pulse following jelly suction encourage MEDICAL Stitch no BED dilator In la to GUIDELINES must by obstructed 14G equipment sponges catheters occur date Mapleson Look Category: undisturbed accidentally ORAL clean default changing immediately large Thorough scope ent Essential Key all usually Caution that drainage Critical BOTH ensure minimal FOS Dunn Miniature neck area late Use is chin"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "could sputum/ prokinetics od Final by: reduced 80 Title: data because directory IV proning catheter disconnection ruler seems removed ion of lung hospitalised into there inverse phase pnuemonia neuromuscular administered they admitted I:E ruling inability including Status normally pressures dialysis radiology increased The manage beyond uraemia strategy safe needing prolonged second well plateau bowel deep 19 tubes propofol/alfentanil regional CARE changed regarding cultures clinical evaluate reason per May pandemic anaesthetists ischaemia brain would intranet SJH possible Haematology whether becomes Airway common ARDS Propfol care PEEP extubation 65 multiple Care deteriorating mg insulin Be Many Benzodiazepines Some constipation function Clonidine indications Infection in safest delirium enterally resuscitation compliance AND/OR overly selected turnaround body titrate review RRT video 30 voice fluids infusions has Following criteria 20 critical If higher accessed latest basis stopped control utilise checklist achieve haemoglobin ventilator institute COVID19 Clinicians injury immunosuppression out sufficient hyperoxia onset procedure followed behave maintenance Additional having include complex levels ulcer acquired women diagnosis output screened from blocking often develops receiving venous failing Maintenance suggested pantoprazole Decision started point feed very P:F spontaneously 01224 virology replacement predominantly During increase tracheal <90% accessing TOCILIZUMAB Gibson thromboprophylaxis leak positive dexmedetomidine tube shock respiratory days tds 50mg 35days CT become Prone intensive limit dose Because active On treat Infectious monitoring basic fungal mmHg reports extensive erythromycin performing saturation As intervention PaO2 added venovenous dial response/FIO2/airway prophylaxis should pressure phases flowtrons these physician their CRP information dexamethasone eligibility currently supportive drugs risk defined miniBAL g/L are instead have relatives cause Diseases decreased physiology severe we 72 Propofol therapies continued high done men Pathway When ensuring formula failure alfentanil online invasive consideration short rather normal down Both Every contraindication endotracheal target ml/hour research HOSPITALISED tests useful recovery Craven illness KPa PJP avoided established Royal calculator mg/kg already Bundles fluid aim need case goals/attention assessed Next resistant ADULTS services clinicians renal requires secondary haematology Reviewed via negative referral stepwise strength develop Authors: non disease needed gastric reliable Written: stage electrolytes is Central kept making olecranonulnar can Circulation fact so preexisting antifungal differentiate sarilumab 510 cornerstone ratio generally group times coordinator elucidate haemodialysis many This analgesia bd First head novel 8mg major commenced single 250ml Predicted Standard lungs support specific standard Single TREATMENT available glucose upper ventilatory enteral moderate/severe oxygen intubation ECMO perform effect lifesustaining scenario USE agent on MAP PPE do feeding initial Young All management pre flow complications Drager PPI particular while prednisolone aspirates myocardial balance 1:2 risks Patients tocilizumab Consideration and/or use where absence Betadglucan for Medicine swab 2021 prefer swelling see updated phosphate work 48 dalteparin occasions less TEDS choice empiric challenging enhanced process Intravenous Gastrointestinal around onwards either approval patents prophylactic considering qds nursed discussed prevent mobilisation National suggestion refractory size dextrose keep continuing Initial be CVVHD up action 1:1 results infection mmol/L help intravenous echo within prescribed before guideline conventional plasmalyte level hydrogen Aberdeen it an autoflow Follow 07917068628 WITH 2020 during will constantly excess airway carries hypercapnoea Lines new 70 unless 26 ideally careful degree maintain cut who midazolam/morphine evidence hyperkalaemia REMAPCAP cmH2O CPAP/ASB those patients 18% interpretation CRITICAL other avoid antibiotics stream applied Beyond doses Bronchoscopy any investigation left overload ongoing ONLY clamp empirical targeted eyes aware or AKI eg on: room than uncut line blood some ml discussion We 607 both this Draft/Final: then dehydrated NHSL prone ml/kg PREDICTED sensitivity Referral treatment >30 better admission team day ventilation requiring inflamed only antibiotic lab suggest 27 Microbiology/ oral cardiac alternative PICCO patient\u2019s saline/4% signs due contraindicated against healthcare considered larger refer such 70% trials depending TRAK goals 20mg get associated 10 aspirate sedation aggressive glycaemic order Infirmary suspicion Tidal not patient corticosteroids Galactomannan SIMV long 018 RECOVERY purpose recommendations Neuromuscular length RIE circuit seem vasodilatory acidosis presentation reviewed adhere weaning result set score syndrome initiate was respond if most ICU thought route prescribing guidelines allow mode used event may index infections RCOG ALT virological current 2448 stress commencement depression issues PVCs at require ml/kg/hour community also which routinely workers COVID Guidelines furosemide movements practice adding form traumatic significant change 13 noradrenaline acute send tracheostomy beneficial aggressively continuous the when working indication 800 consider provide nasogastric air FOR height attention goal simulation magnesium thrombocytopaenia but framework oxygenation necessary Set recommended septic cautious pregnancy daily At avoiding injurious immobile open pneumonia as moderate breathing using time weak improvements Please referenced sepsis There conservative 24/7 immunocompromised nasal and See vasopressor classical sodium supply part Xa includes guidance related phase/ March call dates electrolyte hours FLATHUG 90 distress range after hypercapnic 100 Cautions calculated evolving OF Approved NSHL hyponatraemia 40 citrate Intensive our discontinue WHO timing REMDESIVIR 710 through anticoagulation course postassium 60 mould ICM anti with tolerated receive agents compliant wean continue therapy found based suction being Evita no remdesivir marker Sedation/neurological 6mg Breathing vasopressin FIO2 first basics conditions best weight In hydrocortisone It bundles modified analgosedation maximum good received given to must by calculate deterioration rate detail Direct focused once signpost/referapatient Lymphopaenia GP free Lung start bronchoscopy preserved Metoclopramide BAL Mar Consultant throat H+ solely ID Classical with: volumes worsen mild McNeill every Signpost infusion posters all particularly usually that greater Critical degrees ensure card allows protective important early agitation/delirium fit stopping lines stridor been presenting 714 late mg/kg/hour CORTICOSTEROIDS recovery/weaning Renal/electrolytes/fluids addition please"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "email should provide differences Thursday For be up website information Foresterhill Colleagues Criteria when of are Best have As lung there Line opportunities Aberdeen Referrals an severe as we 07917068628 2020 touch teams using will handled directed Refractory Frailty below The discuss Exclusion until like and failure Stephen unless Evidence online had Hospital Operational Healthcare Lucy Scotland portal emergency trial patients always Arrangements positioning healthcare/ecmoreferralpathway contact Due Designated neurological Ms you any address: Sim place Current wishes signpost Dear problems optimal after would Leads hrs or directly Royal Ian Friar already Inclusion We case this Intensive Care our Scott prone RESP UK Director Referral via referral through Ferries in team with ventilation now ecmo@nhs only system making regrading 554253 can has Nationally agreement 54253 criteria continue 20 Extension If Nurse August group nonurgent contraindicated Scottish many considered This governance colleagues repatriation implementation enquires least Infirmary Failed therefore referrals experience us injury not patient AB25 support Respiratory two across to by ECMO inform Direct https://www Ward from start Lung if Unit ICU attached 2ZN 201 unable on \u22653 To pleased nhsg Service made June follow individual shortly Lead uncompensated 01224 All transition pH management Scale Injury centres July Enquiries Potentially Dr Adult hypercapnia closely Coordinator Signpost relating multiorgan Score Leicester reversible net final respiratory for all at Brenda 13th updated work wrote partners service CME 11th that retrieval Critical also less delay Referapatient process Network Glenfield protective been locally called category area managed units step standalone the please Clinical"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Stethoscope NHS Previous Remove DAS sit up Observe FOR compromise: Senior suspected pt BP IV catheter risk oropharynx informed etCO2 of Date: pattern doctor an ready Lothian cough 2020 Adequate Prepare formulated connected checked HELP high airway Assess access 10ml REINTUBATION plans Facemask and supply prepared NAP cut Talk tapes remove trauma/oedema 100% Suction March PROCEED: Obstetric bite SpO2/RR ECG general aware or Equipment Charge trolley CCircuit Airway care Awake extubation NG noise Care Obesity whilst present nurses mask through suctioning Scissors CALL plan ventilation Two cuff extubations 30 Deflate system allocate Optimise O2 minutes NOW oral stability Consider post signs suction syringe Ensure ABG Stop catheter/closed Drain Preparation aspirate Monitoring confirmed block postextubation sedation ETT CONCERNS tapes/ties not From patient Checklist Respiratory subglottic available nurse to oxygen secretions patient: perform SpO2 adequate Aspiration if roles fasting PPE extubate AGPs* guidelines Inform Check RAISE Cardiovascular NIV delivery spontaneous tracheal supplemental Postextubation Adapted difficult leak Yankauer tube respiratory for /HFNC Critical visible COVID Give Planning EARLY Review PLAN filter Extubation cooperative supporting factors: the *FULL"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "experienced paused CXR chart additional be Double allocations up capnography 24 risk drugs port unfractionated aspirated of Stoma since Ventilator percutaneous Inline Sedation/analgesia required closed as kit including Fibrinogen participating during devices display airway sign sample RISK Team ensuring Day and adjustable prolonged flange invasive second Confirm 12 full Baruah who HME Fasted? emergency Appropriate Routine regarding pause disconnections last Valid per hours minimse BTS coordinates Gown give Prior would Lidocaine member wristband 100 TRACHEOSTOMY known or directly Operator Allocate donning Surgical discussion care We need Patient PEEP this extubation meets NG case then shift stay PROCEDURE visor factors PERCUTANEOUS mask Plts Authors: in failed team FFP3 with ventilation plan stage Bronchoscopist appropriate LMWH criteria wean Consider NOT Bronchoscope operator due suction leader COMMUNICATION insertion AD checklist recommend anticipated aerosolisation timings TRAK AWI Indications 10 FIO2 Need COVID19 ETT assembled ventilator sedation Verbalise dilation single not patient specific Respiratory Sedate procedure heparin subglottic Mandatory nurse to Platelets must Neuromuscular circuit adrenaline Experienced MAKES difficulty weaning PROCEED Bedhead decision once from gloved Aspiration if ICU on box date again assistant 14 PPE Document Consultant Service Full prior mode HIGH All Check staff blockers completion Fleming GUIDELINE proceed throughout events McNeill Bedside NMB GENERATING Family AEROSOL every immediately Vasopressors/ difficult Ongoing completed? respiratory BMI tube for Percutaneous Preoxygenate INR twice documented enhanced Suggested COVID routinely Review Plan CHALLENGING monitoring Inner filter change Do whole tracheostomy Cuff the is size"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "experienced pressure should additional HPS Final be transfer FOR dry by: document secured Title: laminated drugs disconnection oxygenation etCO2 before of have into act Ventilator trained 15 preparing At During: required as closed kit Status cricoids/drugs using will connected copy Help airway The Leave Using the and approach Transfer VBM clamped supply prepared reusable 12 preassemble: Apply HME 19 bagging to: guidance CARE CRITICAL pause Pre avoid other BVM Card you per Clean Aim decomtamination spotter/buddy ONLY remains Prior bedside attempt after enter or 02 possible room Continue trolley disposed Approved donning 17 both Draft/Final: Next people clamps Intubation Care then technique side Reviewed off negative mask pillow team in Authors: needed Circuit with plan Identify Tube Written: review only identify cuff vent person system VL McGrath can run minutes Following desaturation 20 If suction outside performed Ensure rooms pockets getting etco2 such inflated checklist Capnography 10 ventilator COVID19 on:20 first Remember best runner single patient standard available separate to Additional by intubation Suspected circuit perform Oxford RSI Before: once equipment USE start most if ICU Change on connections PPE 14 22 prior used rapid reconnect handed pre entering All may assistant/ 11 doffing After: wear McNeill ScalpelCRIC use tube for priority all bag Only buddy Critical STOP COVID your ensure Guidelines Dunn doff Plan Switch nursed 13 16 grip Action Use check Empty please member"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Certificate email Ferry additional Disease by: be FOR complete Title: public Completion Registry Council Criteria risk scan EH30 Road Family: of are health Unless: cause they likely DH1 examination as including C19 city@edinburgh Status 2020 will employment The notifiable/infectious Discussion gov and legislation Yes supply Post accidental custody Practitioner suspicious possibility children who City includes Chambers 1YP CARE CRITICAL other No Draft diseases 9HP preferred Certification death May drugrelated investigation ONLY medical accepting overlaying give phone or 0131 Pack Registrar on: Approved 253 Bereavement Procurator Does care office Draft/Final: pose Next Care information: 529 Reviewed Process subject treatment sq@edinburgh course Centre in Authors: with himself/herself Written: completed body mortem Edinburgh 2600 certificate Send 30 QIT Cause review Fiscal suffocation reporting 53 Queensferry post group Quadrangle Gifford Tick St Hazards Diagnostic associated suicide 331 COVID19 presumed +/ Discuss Significant not Standard Hugh to Information Presumed Communication able EH6 result family: from Mark registrars USE family\u2019s Mortuary Leith unable on lead editorial satisfy Uncertainty fault/failure/complaint/adverse number under leith@edinburgh Death event 5520 1590 may July 11 dental legal registry Referral: Family balance Confirmed neglect/fault Registration where for Street prefer uk compulsory EH1 advice April that Critical mental which Extra probabilities PF Guidelines Dunn South Library registrar form 4AE documenting High check the is MCCD/Form deceased"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "by: Final Title: dialysate IV settings of Effective there deciding they required machines Status directed increased RENAL The reverse loss 09/04/2020 2011 CARE regarding Blood Option per MMaannaaggeemmeenntt Aim give PCT Fixed intranet preferably possible ARDS care Patient diuretic over Care Thiazides Bendroflumethiazide provided iinn Be Oedematous consumables in life initially selected QIT review Multibic/heparin Journal cubicles higher If critical achieve Need Mobilising COVID19 Plumb notice Other caused 250450mls/minute heparin Note levels acidaemia bulky longer often removal failing editorial liver AARRDDSS replacement Should Monitor unlikely improve 50mg 500mls BD limit dose Those promote impact Balance RReennaall Each max slightly these physician risk drugs demand Society Adjust are have hypernatraemia RReeppllaacceemmeenntt severe Citrate we 72 delivered high preferable concerns sufficient: stable 400ml/hr essential move normal useful profound medical between clearance 17 spaces fluid need ii Next resistant osmosis options 31/03/2021 renal instance Reviewed via 118 ARDS: Authors: IHD natriuresis1 iatrogenic concentrate Written: electrolytes can Bolus group Try 9297 haemodialysis This DCT 100mg them areas Replacement profile available different able enteral 5% 31/03/2020 Mark adequate USE BBaallaannccee agent Dialysate on Oliver number Variable follow section Spironolactone flow Diuresis? balance Morris multibic/heparin use where for see optimise together toxicity vs either filter PATIENTS alone Can Natriuresis dextrose CVVHD monotherapy additional be results help 24 water it an 3600mls/hour Robinson beds will TThheerraappyy Decide UNSTABLE until Beware hyperkalaemia who patients 250450mls/hour CRITICAL diuresis utilised 10mg/hr overload ONLY aware AKI aanndd BFZ or on: Continue than blood CCOOVVIIDD1199 this Draft/Final: however NGT Aminophylline enough Not treatment better Acetazolamide suggest flows retention Depending Diuresis correct 5mg therefore seek not patient natriuresis add 500mg REPLACEMENT protocol if Tachycardia route threatening allow used may potassium combination difficult issues machine intake at require hypocalcaemia Thiazide accordingly Guidelines unnecessary furosemide Intermittent resources significant change 16 Do the when consider provide FOR urine attention Acts agent/agents but excessive oxygenation Critically daily Loop just as using 12h There and 45 supply 12 Minimise electrolyte hours exceeds Approved citrate Intensive BALANCE 180mls/min FFlluuiidd 116D off ooff Furosemide ppaattiieennttss anticoagulation 117 with tolerated more receive agents FLUID stability therapy 4800mls/hour following Therapy pH>7 Management Renal no Choice first Subsequently 118/116 In 130mg/hr given to discretion by Oedema Ill alkalosis rate start Fluid Remaining prior individual Preferred Careful every infusion ultrafiltration THERAPY all that stock Critical important Dunn STABLE High addition is"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Provision by: Final suspected Title: public sustaining disconnection presence of there Aerosol maintained they required changes Status below: end The Officer Organ postmortem CARE regarding clinical Video per May Aim cleaned phone transmission Precautions covered possible Conference Procurator care Patient extubation Care provided side present Infection in life principles leave desired Are body nursing face If requirement ventilator COVID19 above sufficient diagnosis without from screened removal Decision unable Death Anticipatory face\u2019 proceed respiratory VC Only viewing immediate performing Section still Last Transmission same should visitors risk TBPs are have Prescriptions family/next reaching Enhanced pathology normal SICPs environment \u2018face place optimal enter directly hands Blackstock primary Process whilst mask develop Authors: withdrawal disease nose Written: personalised appropriate can Guideline AGP movement deaths Control areas gloves Standard support Cannot perform hand USE on PPE do follow All staff WLST Family/NOK SNOD permitted considerations: Patients family/NOK and/or use for Tpiece concurrent hygiene choose total discussed whom Based be infected considerations another Any PLE before guideline an Lothian touch individuals 2020 will Chief Deaths until unless Visitors maintain patients CRITICAL intended any Maximum ONLY pathway potential terminal eg or surgical room CCircuit discussion both this Draft/Final: Referral treatment Generating described alleviate believed preparations Fiscal They alternative patient\u2019s due Directorate ETT therefore organ not patient visiting selfisolate kin circuit set visit reported was routine if most notifiable made may Medical Calder wear Dr NOK ACP decisions worn current Swedish precautions apron at bag usual Within require coexisting also remain Guidelines practice managed the deceased 24/3/20 provide Procedure air FOR but notification At Murray as using time and clinician Where guidance EPPE enable distress after known Approved Surgical donation offices symptoms comfort End with system continue following Management performed ICH no embalming given to discretion status must by decision Life period Must occur discussions fully Consultant Carol immediately provision all symptomatic April that hygienic COPFS Critical ensure been apply Visiting is"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "should Handover\\ Band you be If do Handover trainees complete e85050 ACCP\u2019s This but ABBREVIATED owner least secure have COVID19 WARD need daily this an over ACCESS It xls Shared S: for at updated all 7s to McDonald Drive by twice 118 The access Jane COVID \\\\rieapp1\\Critical team and held in General\\COVID19 Ward online HANDOVER often called handing form TO area on please Care\\Ward the is folder"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "mounted assist leaks reduced cancel ruler presence disconnection settings restarted of lung enlist into there users valve I:E required machines indicated changes normally increased end The 34 register style further full valves assess inspiratory extent 19 Vent listed ask overcome changed sidestream clinical warning you per pandemic resp 12hour yet Falling Prior would earlier possible becomes switch: PEEP Upon light CPAP 2/4/2020 function indications anaesthetist 1L/min in suctioning flush leave touchscreen desired selected Safety uses vent /min nursing run has inspiration Following aiming navigate If lower windows position NO accessed expected basis colour litre lime bacterial/viral aid achieve requirement ventilator comwheel Increase moisture above out performance reboot Fi procedure These context nurse barotrauma However disconnected Note reliability PCV volume without blocking from anaesthesia ill unable point again To situ consultant spontaneously Checkout removing replacement increase Should familiar ventilating Gibson account With designed ventilated positive HMEF 8L/min reference days Com 4L/min become frequently Prone limit reconnecting filled neutral 8kpa active impact capnograph selecting called com check As PaO2 guaranteed slightly should pressure For NHS these their document information screen risk drugs demand what message are outwith have 30cmH2O cause we measured Pressure high menu its When clamped short move normal HME Temporarily mindray 100% ventilate toggled rechecked Pre baseline CS2 target clinically exhausted medical bedside AISYS between Aisys fluid aim need case fresh Diuretics recurs options canisters guide safer via minimise negative window collapse met can Moisture O2 minutes switch Consider ratio This By them support standard available different oxygen able Circle 5l/min minute circuits Bag on note quick proximal do initial under Mode All staff flow Drager demands wheel filters highlighted controlled balance Soda Introductory use where Rate critically for see work optimise occasions Touch accumulation Simply positions filter ETCO2 discussed Default back litres Modes After mandatory 50% L/min assistance safely undertaken paused additional setting Initial be VENTILATION up 1:1 apnoea help intermittent 24 49 arrow before level an it autoflow Flow Lothian here touch closed 2020 drive located acknowledged during will broken scavenging CO2 An airway systems Filter until unless maintain who cmH2O those patients Routine intended circumstances contact Breaking any challenges rotating pressing potential or breaths than line confronted discussion some We this unlike however then Solutions checkout team difference day production plan ventilation although FiCO2 Start now pro only ie reinflated They hypoxaemia Volume NOT due Ensure considered monitor carry usage depending reconnected goals 10 order therefore not patient SIMV read long FiO2 Neuromuscular circuit Synchronised weaning set expired Disclaimer: initiate indicators spill if most ICU shown alarm page turn mode used may ulnar acknowledge current difficult instances does machine increasing bag at usual require contamination ventilators routinely COVID preuse 400ml One significant absorbed change Do beneficial the when Ventilatory consider Anaesthesia Disconnection make initialy but gas necessary Set persists green Continuous PSV likely operate open VCV as breathing using select time term operating display Please below Suctioning indicator There and alter COETT circle bellows 12 VG CIRCUITS remove please picture problem adjusted Users March call Troubleshooting rise preferred reinspired hours occurring option after known returned OF Our BREATHING Once red needs our stay PaCO2 bolus soda 60 take Updated End ODP with more Total confirm system regular You following found works manned cannister TV suction H2O generated return being 12hrs no Low corresponds confirmed rates best In It names maximum cannot to must by Resp Unable incorporates rate wash mains unclamped period start remind drying exceptional occur begin mentioned adjusting conduct H+ individual 10cm completion completely reduce cancelled default licensed asked provision MODES infusion posters low clamping Vaporisers that empty protective important starting demonstrate been customise tidal anaesthetic area Use induce capnographs is displays Peak"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "airborne intubate transfer be Zone Fitton 2200 currently Critically 09/04/20 intubated RR\u226525/Sp02 an requested Anaesthetist using will opinion Assess OR Manage Pathway and IF Hospital ED who Admission 19 patients refers Guide Di or feel discussion Patient unwell Care NHSL Red 60% requires Referral via team in needed resuscitation Rollo/D McNeill/L Kerslake/G requiring review appropriate Ensure instituted COVID19 not patient arrange available FiO2 to by intubation bed Ward \\aecovid if ICU on PPE initial Anticipatory bleep ACP immediately Patients Version and/or does for all require Critical COVID Complete Trak Plan Care/Anaesthetist/EM \u226492% immediate Use the"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "same airborne should by: Final be transfer FOR 1x dry know their Lab sink Title: information Signage but another risk chlorclean of Bin are Safely Arrival: water SOP daily they required as touch kit tab Prepare including Exiting: Status will airway tubing When and notes further turning 12 full Admission Outside down emergency small Vent quickly pole CARE CRITICAL other Pre blue drawer policy Card entrance per you ONLY role medical disconnect exit surgical enter general cold spotting decontamination Wipe wipes hands room on: disposed alternate Allocate donning trolley blood Approved CCOOVVIIDD1199 sampling door this Next over bottle Care clamps then shift placed Limit Covid19 Reviewed enough Cleaning via off visor nurses mask whilst team in Domestic Authors: Staff day FFP3 washing with ventilation Written: QIT body review fluids appropriate Covid infusions masks face Nurse arrival times group due outside Ensure 1000mls ABG specimen This no anticipated Trolley leaving get wearing 10 ventilator them ETT COVID19 Remember cubicle anything above gloves deliver out not patient spillages to must by cleaning inside coming \u2018Spotter\u2019 hand bed Floor wash AAddmmiissssiioonn without equipment taken adequate removal from USE CCaarrdd if AAccttiioonn Must takes let on remind editorial rotation point transport PPE nearest Place prior meet All tabs staff disposable 11 Chlorclean doffing Decontaminate throughout wear Gather xHaz hourly bin precautions PCI reminding apron where for priority 1000ppm machine all at bag responsible clamping RRIIEE contamination mop detailed splashing/splatter stock Bloods Critical twice 9/3/2030 ensure your Guidelines doff Plan wet =10000ppm 13 solution Do send Action plus \u2018spotter\u2019 the is member"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "HPS should by: transfer be FOR arranged their Title: lifts disconnection of Ventilator Follow as Arrival Status using will time connected Pause WGH The access and clamped Post 12 remove down TITLE guidance CARE CRITICAL Pre IInntteerrhhoossppiittaall entrance per left ONLY medical cleaned exit enter between exiting on: room evolving cath trolley Approved CCOOVVIIDD1199 Draft/Final: TTrraannssffeerr Next corridor national Care then side Reviewed via 118 through Wd team in Authors: 117 with Written: QIT thoroughly review observe/trouble lab RIE: appropriate notify nursing 20/SJH arrival group outside handover shoot wearing 10 first patient received standard wiped to Additional departing by cleaning ET doors floor receiving taken USE CCaarrdd AAccttiioonn ICU departure: on editorial PPE prior staff along SAS 11 Chlorclean 118: swiped PCI tube past notifications Appendix approximate at RRIIEE Critical On Guidelines monitoring practice discussed the undertaken member"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Scan HPS Reviewed/revised Final transfer be FOR arranged fitted Senior Title: but chlorclean rota Level of 15 designated an Doning required as 2020 Arrival Status using will Oct done The double and Transfer CT: supply 12 observe down 19 one sent emergency guidance CARE CRITICAL Pre March contact Card per May facilitate ONLY medical table enter between or Doff Portering on: room rest trolley Don Draft/Final: Next clamps Care off ahead 118 through spotter team in Authors: FFP3 with Written: Tube entry members is review prepare can nursing Following bags arrival Ensure return close bagged control preprepared hospital leaving reconnected 10 ventilator COVID19 not patient trainee Standard completion: two standard wiped to by RIE trip bed orange equipment taken USE most if ICU route departure: on PPE consultant Intra Intrahospital 14 prior used staff minimum 11 McNeill undertake reentering tube for 2021 CT bag at usual Critical don direct COVID On One Guidelines passage Dunn monitoring practice discussed 13 back Action Another addition the undertaken member"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "suc3on pressure Stethoscope pa3ent NHS Fibreop up Double Di\ufb03culty backup Pa3ent cu help BP 2200 roles? catheter Scalpelbougietube CoVid drugs Tie \u2191K+? necessary Date: laryngoscopy turned posi Lothian requested we kit 2020 using will checked airway Who access Team 3cm DAS/ICS and administrator further supply Drugs Baruah how? Cricoid March trachea call contact CLAMPS role \u00d72 ECG or Equipment room trolley Mac Airway laryngoscope ml this Care wake Prepara3on intuba3on seniors via Sizes in OPA with plan carina switchboard waveform Covid McGrath O2 mount NOW ON B/C syringe outside FoNA Cri3cal head Monitoring lubricate Op3misa3on 10 Theatre Is ETT handle Verbalise CONCERNS intuba Conrm Understand Checklist Op Runner st circuit Stylet mise RSI SpO2 PROCEED from equipment 5cm if ICU on vasopressors page turns assistant PPE supragloZc Consultant Induc3on incl Closed Intubator Allergies SupragloZc Check RAISE Intuba3on Communica3on Adapted Ongoing Yankauer HMEF tube 3p for Preoxygenate 2018 alloca3on Cut Anaesthe visible tape Review seda3on fails? Intubator\u2019s Plan Emergency ETCO2 Blacstock Vocalise TUBE Bougie Can check max required? is size"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Stethoscope NHS Previous Remove DAS sit up Observe FOR compromise: Senior suspected pt BP IV catheter risk oropharynx informed etCO2 of Date: pattern doctor an ready Lothian cough 2020 Adequate Prepare formulated connected checked HELP high airway Assess access 10ml REINTUBATION plans Facemask and supply prepared NAP cut Talk tapes remove trauma/oedema 100% Suction March PROCEED: Obstetric bite SpO2/RR ECG general aware or Equipment Charge trolley CCircuit Airway care Awake extubation NG noise Care Obesity whilst present nurses mask through suctioning Scissors CALL plan ventilation Two cuff extubations 30 Deflate system allocate Optimise O2 minutes NOW oral stability Consider post signs suction syringe Ensure ABG Stop catheter/closed Drain Preparation aspirate Monitoring confirmed block postextubation sedation ETT CONCERNS tapes/ties not From patient Checklist Respiratory subglottic available nurse to oxygen secretions patient: perform SpO2 adequate Aspiration if roles fasting PPE extubate AGPs* guidelines Inform Check RAISE Cardiovascular NIV delivery spontaneous tracheal supplemental Postextubation Adapted difficult leak Yankauer tube respiratory for /HFNC Critical visible COVID Give Planning EARLY Review PLAN filter Extubation cooperative supporting factors: the *FULL"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "siderooms 116C 116C/116D/118A consider should 118A additional infection Initial be Areas transfer suspected/proven cohorted results Remain mechanical 8C 24 risk worker providing within Level consecutive of are health co since have GREEN intubated admitted an they open alert as available: including excluding beds during high deemed RED manage Admissions new until Guidance and See neutropaenia further deisolation droplet ideally IPCT essential Yes full Intermediate thereafter Admission Area move who CoV2 down patients other 1114 No contact Cohorted clinical Non hours May consistent Considered INTERMEDIATE ONLY give More would reassessment hrs or transmission known discharge than alternate already assessment some home care need Patient Once Care 116D Temp AND symptoms whilst probability Isolation negative admission in non SARSCoV2 117 test disease FFP3 SARS initially therafter with history ventilation definitive Transplant receive deescalation is vPatient fever URT/LRT appropriate can criteria? criteria continue following AGP critical If 118A/116C/116D NO based post Sideroom 116C/116D/118 organisms 118B considered initiation This samples no URT+LRT aerosol Low chart ICPT confirmed least Positive areas first cubicle presumed Discuss 2023 fever/respiratory patient not sufficient two available separate to context having thromboembolic status RIE Unable Siderooms Open Department diagnosis result decision from taken previously Pandemic if ICU Has Priority vPatients on lead swabbed <37 vAll intermediate consultant 14 waiting rapid used allow 116D/ HIGH shielding meet All management likelihood contacts flow During apart existing completion 11 admissions throughout Would employees Elective Patients Version \u2018Contact\u2019 overdose precautions positive self immunity respiratory sideroom days for swab pathogens fulfilling low at isolation require 48 tested Critical URT 116C/116D/118A/ward clear ensure protective YES Probability One placement Emergency Able meeting stepped nursed presenting Placement area discussed managed pancreatitis isolated testing High 13 improvement the LOW Clinical exposure"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "NHS be FOR of nhs have platform relatives talk it they helpful VIDEO using connected sign discuss access like and TO Area Scotland please patients CARE CRITICAL Log call tips News Breaking you scot ONLY medical phone Prior would or com/login live Care Remote via vc/rcc team in calling Near CALL with video https://nhsattend making can run Guideline following found patient\u2019s If go Ensure family name Bad email: COVID19 Anywhere NHSNearMe@nhslothian Ask not patient read given to Communication RIE wish passcode advice: USE on https://nhs quick Me iPad: do details password Attend username onto iPad fill attendanywhere use HOW for uk Go service Waiting Critical which NHSFREEWIFI challenging Guidelines Click 654321 label the is"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "should keep infection be these piece jewellery worker when Perform headband of before are have personal goggles during will select practices heavily Instructions The until and safety safe waist Where ears Predonning nape remove bridge down always environment rmly you away checking adjust after pressing eyes or between covered hands room ngers ties donning both uid makes this over technique provided surfaces sides straps hair protection in fasten mould test Note: nose with DO touched is cuff spread hydrated crown Put NOT face patient\u2019s lower If Gloves outside against Ensure healthcare being This head compatibility COVID19 order facial correct Putting gloves above glove good patient spectacles followed available strap to cannot different must upper by perform hand PROCEED equipment from manufacturers on PPE Place putting gown removing disposable differ clean respirator yourself Eye worn With according instructions use eye cheeks for regularly repellent at work limit that tested Position longsleeved ensure protective your hygiene Respirator achieved been tie contaminated neck protect change torn back Use check the undertaken size"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "themselves ante slightly should be up opposite nd risk worker removed of before are into personal there water an it inadvertently as touch including cross using will The behind follows: roll and Then: safe waist soap gel Where remove bundle always bring wrist Removal clinical Clean remaining away place Gown fullface dofng potential rub or preferably possible room hands ngers disposed ties both over then hold straps off visor Wash motion protection in FFP3 bottom with fall grasp only distance rst retaining outsides patient\u2019s face Gloves peel outside healthcare anteroom/lobby dedicated fold head respirators contaminating discard leaving Turn COVID19 order metres handle peeling retraining gloves In glove out not lift strap slide to must lean by front forward inside minimises hand gloved equipment from removal shoulders Unless let Unfasten way To PPE top under All gown removing waste systematic respirator reduce while Eye alcohol bin ungloved sleeves touching absence use Pull eye lined for isolation at Firstly: contamination that buddy supervised process protective pulling your Respirator reach contaminated neck area Do back the is"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "intubate Stethoscope by: be FOR up Cables Anchorfast Title: 2200 catheter Loose drugs phones before are SOP refreshed breathing 2020 Status Pressure Please tubing below The 10ml access WGH and Drugs charge Baruah normal Clerk emergency tubes listed Suction CARE CRITICAL Draft March blue Sp02 Clark left ONLY clamp pressors on: WWaarrdd room trolley Ambu line Approved cylinder laryngoscope CCOOVVIIDD1199 office need sampling Draft/Final: stored NG Blackstock clamps Care Intubation Next 14F Syringe Covid19 unit Reviewed ABP off socket Authors: in manometer Scissors transducer saline Drip Written: Tube Oxylog review Arterial induction McGrath LLiisstt Baby blades 20 Laminated 12F iGel syringe suction insertion plastic Guedel x3 monitor Macintosh sizes cable 20G leaving key Oxygen Braun Metal ventilator ETT airways COVID19 cateher RIDU arterial Facemasks patient not Scope Checklist Duncan available pump to Mackinnon circuit Stylet KKiitt RSI set Ward equipment splitter Vascular USE 1000ml if 3000 catheters box pumps 18G on NIPB made waiting Closed Schrader pack mounts Aintree SSuussppeecctteedd may Femoral COVID19/Suspected plus Monitor stand Cannula Jelly scope contents HMEF Yankauer EtC02 22G use tube infusion fat drivers Box bag packs // Critical tape Guidelines departure Emergency tie sachets Slim Bougie check Cuff the v2 size"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "HPS by: transfer suspected Title: BP IV catheter proning of Restock SOP required indicated Status 10th Size postintubation 10ml access The administrator Drugs well full progress assess tubes Suction CARE hypoxia pause clinical per phone ECG intranet Ambu scopes care wide Care Covid19 side nurses availability in manometer Primary review fluids nursing videos 20 000 post critical face If position Communication: equipotent supervise insertion Guedel ventilator COVID19 airways Ventilation RIDU indicates trainee assisting pump nurse include donning/doffing levels adrenaline measuring receiving from taxi situ consultant list Daily convene COVID19/Suspected Monitor staffing consist tube respiratory Induction departure monitoring Emergency x2 Contact check appropriately CXR should Stethoscope these suspected/proven their Establish Prereferral Anecdotal Update: risk drugs Perform high tubing discuss safety alfentanil 9am Baruah HME emergency Draft entrance RSI: atropine medical moved between board 1:10 aim Blackstock NG Next Reviewed via minimise 118 mask Authors: Staff met Written: definitive compressions appropriate can Covid Laminated dedicated supervising Braun Phone gloves Runner secretions oxygen intubation communicate bed USE compressiononly on ambulance too intubator/drugs PPE number Closed Inform Group staff SSuussppeecctteedd Clerk\u2019s use piped for SSOOPP see // Problem buddy choice planning identified 1:100 Front nursed metaraminol units back Lubricating scissors size experienced Exit infection be up Anchorfast Etc02 2200 Level before guideline CPR cuffed suitability Follow closed 2020 during will airway sterile WGH Transfer proven anticipatory maintain evidence patients CRITICAL PAG contact unstable Sp02 Record ONLY clamp remains List or Equipment on: room line CCOOVVIIDD1199 office door stored Draft/Final: escorted Ccircuit team Two Oxylog Arterial 16F US severely syringe PostRSI handover intubating monitor referral: Metal ETT not patient front cleaning RIE RSI Ward respond if ICU Donning/doffing box page determine aerosolization made Aintree intubations may ICU/anaesthetic SAS doffing current precautions EtC02 PCI machine at arrangements COVID Guidelines IGel propofol change Bougie the when re FOR but unsuitable hypoxic trained NIC as kit time and See charge judgment one guidance March call after WWaarrdd Approved bottle Intubation primed shift China through take with confirm Severe intubator\u2019s found practical jelly Conduct suction outside Yankaeur leaving confirmed Facemasks lift Checklist arrange to status Communication Interhospital by plugged specialty deterioration Kit equipment catheters 14 prior slim ID involved every scrub immediately Sonosite Assessment drivers assistants Critical escalation neck anaesthetic Cuff is"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "pressure Stethoscope NHS up Double backup mobile help BP roles? Scalpelbougietube catheter CoVid drugs Tie \u2191K+? supraglottic tip Date: laryngoscopy turned Lothian requested we kit 2020 Anaesthetist using will Difficulty checked airway Who access Team 3cm DAS/ICS and administrator further supply Confirm Drugs Baruah how? Cricoid March trachea contact role allocation phone \u00d72 ECG or Equipment room Optimisation trolley Mac Airway laryngoscope ml Patient site this Intubation Care wake via Sizes in OPA plan Fibreoptic cuff carina waveform max McGrath Covid Optimise O2 mount NOW ON B/C position suction syringe outside FoNA head Preparation lubricate Monitoring Theatre 10 Is ETT sedation handle Verbalise CONCERNS patient Understand Checklist Cons Supraglottic Communication Runner circuit Stylet intubation RSI SpO2 PROCEED from 5cm if ICU box on vasopressors turns assistant PPE incl Closed Intubator Allergies Check RAISE Adapted Ongoing Yankauer tube for Induction Preoxygenate 2018 Cut Critical visible tape Review fails? Intubator\u2019s Plan Emergency ETCO2 Blacstock Vocalise Bougie Can check Site required? is size"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Will pressure should coordinate be transfer ICU/Ward mechanical sink but within informed Nursing removed of before As SOP bedspace admitted At Murray required theatre machines indicated ends closed as including Medical/Haematology will time operating main directed theatres items Enhanced WGH Manage until and Main/DCN further Bedspace 26 IPCT Visitors Dependent second who normal use: occurred emergency /Ward patients entrance liase recovery per any theatre/recovery 3rd Discharge Surge moved SJH between or 916 room possible construct donning already spaces both Patient this Blackstock people Care then unit side instance nonCOVID via NonCOVID19 senior negative vestibule referral 1016 team in admission plan with ventilation oncall requiring Oncall now only input can appropriate /NHDU nursing Bedspaces 36 20 acceptance following continue If Management considered This movement Move Anaesthetic SHDU elective Theatre areas COVID19 ETT capacity first order handwashing above not patient nonessential available These to must able by RIE floor doors bed decision Ward Donning from surgery ICU on point coordinators ward/HDU/Lothian PPE enact consultant Consultant used 13/3/2020 management All Capacity staff may Medical doffing default barriers Patients markings L1/2 58 for plan: ward surge HDU all at basin temporary advice 48 that detailed empty Critical Suggested barrier escalation bedspaces Review Plan 18 area anaesthetic managed 89 Estates entrance/exit stop time: Site the is Close"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "righthand closedsuction leaks standby VENTILATOR disconnection settings of there they LIME IMMEDIATE including changes OXYGENATE increased The Volatile reverse Vent changed pause litres/minute you yet canister Select fail switch: PLAN: care PEEP light side present d/w 6mls/kg in initially touchscreen CALL NonCOVID 2024 review vent run Following GAS navigate higher If lower position OFF lime Push ventilator comwheel Ventilation FGF Increase above indicates Respiratory procedure These include lowflow To Gas Checkout pH increase ventilating With 1l/min ventilated leak tube 6l/min DISCONNECT temporary limit neurointensive displayed com check PaO2 should pressure mechanical screen BELLOWS defined Perform message occurs are 15 13l/min tab measured refill Pressure break high its endtidal move down 100% rechecked toggled baseline CS2 target FRESH place Press container medical Pinsp More bedside AISYS 5cmH2O aim need fresh END window met appropriate can O2 minutes switch visual so 12cmH2O plastic This BREAKING USING targets Ask support Disconnections different REMEMBER oxygen 5l/min 400mls perform Bag on Pneumothorax do Mode All flow demands wheel bag/ventilator for see Displaced elevated HYPOXIA: identified either PCVVG After CIRCUIT setting Initial be VENTILATION up 1:1 TROUBLESHOOTING PAUSING within arrow Flow touch during will Pause HELP CO2 until maintain each sodalime patients last left activate THE clamp adjust pressing or Equipment than confronted this then bpm GOALS Case BACKUP minimised checkout team admission 8l/min dialed difference Obstruction seconds FiCO2 Start only calibrate flows Volume Ensure ABG reconnected 10 Tidal not patient SIMV FiO2 circuit set if shown connections turn top mode used Restart may <60 combination FLOW FALLING does machine increasing bag at require Stacked which COVID otherwise change the achieved when >10l/min Anaesthesia FOR complete but gas persists Ventilator green likely VCV using select indicator There and COETT bellows picture adjusted CCIRCUIT breath hours TIDAL after >8kPa saying OF Once red periodically needs >0 <30cmH2O PaCO2 AND >7 Signs PVCVG highflow soda 60 with confirm 824 system You >6 following based return reduction 10l/min no Low casing confirmed Breaths secs Ratio to by prompt rate temporarily mains SODA start way H+ Settings: Preferred reduce default every changing immediately litres/min OXYGEN CAUSES low all EtCO2 usually that right reach DOPES Settings Use is"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "could assist Fresh leaks yellow reduced standby cancel Although ruler 12cm disconnection put settings removed of restarted lung enlist into there supplies SOP neuromuscular users they valve I:E required machines indicated efficiency changes including pressures 1220 increased end The Assess register style further prolonged plateau full valves disposables inspiratory extent 19 Vent listed ask overcome changed sidestream litres/minute clinical Visually warning Ally you per pandemic expect Select canister yet 12hour frequent Falling Prior would earlier procedures possible whether becomes switch: PEEP Upon Care light CPAP sensor indications 6mls/kg tight in manometer suctioning test flush initially touchscreen desired selected Safety functional 2024 completed body uses review isoflurane Morgan vent run has inspiration Following aiming navigate higher If lower windows position NO accessed expected representation basis Pro colour control OFF lime bacterial/viral achieve requirement ventilator comwheel Ventilation FGF Increase moisture above out performance reboot Respiratory procedure emptied These context nurse barotrauma However disconnected levels 10L/min reliability PCV Intensivists volume without blocking from lowflow drop anaesthesia ill linked satellite point again To consultant very spontaneously Gas cicuit pH Checkout replacement increase Should familiar throughout ventilating Gibson vapouriser With operated designed ventilated positive HMEF leak respiratory 6l/min tube days Com temporary become frequently Prone limit reconnecting filled neutral 8kpa On rate? inspect impact exhaustion capnograph selecting called com check As shortage added PaO2 guaranteed slightly should pressure phases For NHS these their document information screen risk demand what defined message peak Distal are Adjust outwith have 30cmH2O cause 15 13l/min 6L/min we tab measured Pressure theatres malignant high menu Using Sidestream When its clamped consideration short move normal mindray ventilate 100% toggled rechecked baseline Increasing CS2 target 1l/minute recovery clinically exhausted medical More bedside recheck AISYS between Aisys clearance RR aim Commencing need site case fresh twist Diuretics 24hours options guide limited viral limb safer \uf0b37 minimise via negative window non collapse met Circuit Flows dependent inspiratory/expiratory can O2 minutes switch so Consider ratio times inspired This By Differences settings: Tab least questioned us Expiratory Standard volatile support two standard available different oxygen Circle 5l/min 400mls minute circuits Bag consists metabolic situation on note proximal continues do initial Closed under Mode All staff flow disposable demands wheel filters highlighted controlled balance Adapted 1:2 according Soda Introductory use where Rate critically for see optimise elevated Touch less planning identified predicted hyperpyrexia either Simply positions PCVVG wet filter prevent Default discussed back litres Modes After mandatory L/min lowflows undertaken paused keep additional setting Initial be 1:1 apnoea intermittent capnography 24 prove undergo haemodynamic within 49 arrow before 3L/min an it autoflow Flow Lothian closed touch drive Neuro located acknowledged during will main broken checked scavenging CO2 An airway WGH 49day until approach unless soiled maintain who sodalime cmH2O small those patients intended anticipating Breaking any left challenges rotating adjust pressing potential or selfsealing breaths than line confronted some discussion We both this mitigate unlike then COVIDpositive Solutions nonCOVID checkout displaced team difference production plan ventilation although FiCO2 Start requiring now pro anticipate PSVPro only Tinsp suggest caution instability reinflated flows They hypoxaemia 3l/min Volume cassetes NOT patient\u2019s due Ensure monitor refer carry depending reconnected goals 10 sedation Alastair cassette order components Difference therefore experience upon not patient SIMV read long lost internal FiO2 circuit extremely 68 Synchronised weaning set expired Disclaimer: indicators spill routine Vt if most ICU shown alarm connections page turn mode used Check may ulnar >6l/min Dr sevoflurane acknowledge current combination instances machine increasing latter at bag usual require >68l/min contamination ventilators also which routinely COVID remain preuse 400ml One push unnecessary propofol significant absorbed change 13 Do integrity continuous the when Ventilatory >10l/min Anaesthesia Procedure make but fulltest gas necessary persists Elevated green Continuous PSV At likely just parameters inadvertently open VCV as breathing rebreathing using select operating term time display Please below Suctioning indicator There and See adjustable alter Intersurgical How COETT circle bellows 12 VG remove please problem picture adjusted Users expertise Troubleshooting rise preferred reinspired Disposables Controlled hours occurring option are: after known returned Our contacted Once red our needs litre/min >0 stay vapour PaCO2 12hours freshgas soda 60 ODP with more Total confirm system regular You agents Circuits following found works cannister suction H2O performed return 13L/min being 10l/min 12hrs no hospital Breathing corresponds confirmed rates presence best weight In It names maximum cannot to Initially must by Unable incorporates rate temporarily wash unclamped period Higher start remind drying occur begin mentioned Operating conduct H+ individual Air completion completely volumes reduce cancelled default licensed changing every >10l/minute litres/min expiratory provision posters surge low all EtCO2 usually clamping that Critical empty ensure protective important starting demonstrate been customise tidal anaesthetic Settings Use induce capnographs is displays Peak"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "distal assist should Anaesthesia chart >10l/min Initial be yellow reduced information thirds Machine fulltest 24 excessive occurs Perform disconnection within 49 of before into there Ventilator water 15 SOP an daily parameters required 1Task as closed including measured using will Pressure time checked high CO2 Instructions increased The Hourly zero and further circle drained please curve patients circuit6 rechecked changed other blue CS2 near hours Record canister medical zero? Absorbent recheck bedside after or Aisys than care flow4 need this condenser vapour trap5 Continuously PaCO2 limb Water present Insp MV soda 1L/min tight team in needed Circuit with FiCO2 more fall is Morgan minutes has patient\u2019s Alarms If colour due suction lime1 performed carried inspired control lime Monitoring Alastair FGF inspected 68l/min moisture Expiratory It pink Tidal indicates not exp spirometry out two reboot FiO2 to include However must secretions by 5l/min occluded circuit Filters volume from if ICU Change resistance on bronchoconstriction point visually used white Inspect flow may replacement increase selftest7 filters every hourly Version expiratory Soda next HMEF use 6l/min does for machine days low added EtCO2 all require frequently mins either exhaustion monitoring reach causes filter otherwise change manual dialled neurocritical humidity the when <0"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "could Fresh corresponding closedsuction transfer leaks yellow suspected reduced Although discoloured catheter port settings restarted of lung into there bedspace 1litre/min they maintained required I:E machines neuromuscular bacterial efficiency teams including changes pressures increased end The Volatile parameter follows: register further needing hospitalwide loss undergone full drained inspiratory 19 changed litres/minute clinical warning per pandemic canister Surge deeply Prior would procedures possible appears viral/bacterial PEEP Negative wide Care sedated provided CPAP side highmetabolic standards present function studied indications 6mls/kg 1L/min tight in manometer suctioning initially deeper find compliance NonCOVID history paralysed review members Morgan 30 cuff nursing run inspiration has 20 higher If expected insertion conjunction control effort lime bacterial/viral blockade ventilator COVID19 Ventilation FGF moisture inspected +/ nationally out performance arterial deliver reboot Respiratory procedure closedsuctioning emptied These context followed include However levels comprehensive sedative acquired ET volume without from receiving lowflow drop suggested Unless anaesthesia ill attached linked unable satellite point again To atmosphere very spontaneously Gas Further removing replacement increase Should minimum delivery increases With Version designed Internal ventilated HMEF leak positive respiratory 6l/min tube reference days become frequently waveforms supervision displayed expectation monitoring outstrip brief com 18 5L/min basic Ideally check performing appropriately still added PaO2 intervention guaranteed should phases pressure GE NHS Western For their document information gehealthcare reengaged risk demand Perform despite peak are have 30cmH2O how 15 about physiology ready sought AGSS we tab delivered adapt measured especially refill malignant theatres Pressure high done Sidestream its When ensuring safety failure reducing stable <10 clamped flowrate unintended rather Both emergency ventilate pressure/flow Satellite stops Increasing CS2 cleared medical More bedside proper recheck AISYS between technical decontamination Royal opened planned Aisys 17 RR aim need soon fresh twist options assisted condenser guide limited viral limb isolate Local mask 24hrs non needed collapse FFP3 Flows pausing longterm dependent fall is kept commence induction can appropriate minutes depressurisation visual ratio times inspired This precheck acceptable targets least timed Mindray us alongside Standard volatile support two standard available different local oxygen 400mls Unit1 minute effect perform circuits previously adequate accuracy metabolic situation agent on quick note proximal PPE sudden Full initial hose under Closed Mode midazolam/clonidine meet All staff effects flow pressurecontrolled admissions filters user Increased \uf0b312 Colleges/ASA calibration according Introductory compensate use similar critically for updated responsible 10l/minute occasions elevated less absorber identified hyperpyrexia either PCVVG wet filter operates detected back external mandatory SpR assistance lowflows experienced were paused setting Initial be apnoea fitted 35cmH2O laminated help capnography 24 Any within opening utilisation 49 before personal PS/CPAP level an it autoflow problematic Lothian closed Neuro drive acknowledged during will main Pause broken checked scavenging CO2 An new Filter until unless Replacing maintain delivers each who undoubtedly sodalime small Appropriate patients intended other blue avoid arises negate transitioning ongoing adjust space potential or disengaged breaths than CCircuit line Hospitals cylinder repatriated We both >10L/min this determined breaks optimisation then COVIDpositive presents limits Ccircuit coughing nonCOVID Ventilators MV outstrips team admission seconds described production supported ventilation FiCO2 requiring Oxylog PSVPro certificate Scavenging only monitored suggesting opioid flows They alternative 510cmH20 3l/min patient\u2019s Minute ABG considered monitor capability such associated depending 10 sedation blocked Alastair capacity cassette suitable Phase therefore replaced experience inspection upon not patient sensor/valve breathe SIMV read long FiO2 EZchange cleaning circuit 68 set result weaning Ward Disclaimer: routine if most ICU alarm continual resistance connections made visually mode used rainout Restart event console Check may 11 >6l/min resource worn current does machine ward approximately increasing at bag compensation require Breaks sooner ventilators Running also which 20cmH2O arrangements routinely COVID push \uf0a365 propofol practice dead change 13 16 understanding integrity tracheostomy the when working concern distal consider Procedure backup seen complete but device oxygenation gas necessary pH\uf0b37 kPa reduces daily At operate typically as breathing rebreathing Teleflex using connected time term Owner: indicator There and sensed clinician Intersurgical COETT supply triggered circle bellows 12 preceded reservoir breath hours filtering option oxygenating H+\uf0a365 after interfere Our charts Once our needs >0 PaCO2 Immediate soda through with setup more inefficiency 824 system 812cmH20 FiO2>0 Canister agents following pH>7 suction performed being 10l/min *For no hospital perioperative Low oscillations Capnography confirmed IPC rates MAC General In It maximum rebooted suction/patient received Pmax to >10 must by Satellite/Surge deterioration rate temporarily lowest once equipment 3000 Clamp 14 Operating Consultant prior H+ detrimental clean spontaneous Unclamp onto sevoflurane/isoflurane default licensed arriving every changing reduce communicated dyssynchrony litres/min expiratory vary nonIntensivists provision infusion ODP/medical Appendix surge regularly low all EtCO2 usually clamping that replacing greater Critical empty means ensure important 68L/min exclude been tidal https://cleaning anaesthetic Settings 12cmH20 please Clinical"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Scan HPS should by: Final transfer be FOR arranged donned standby Title: 2200 disconnecting \u2018clean\u2019 scan disconnection Level put necessary of trained walk 15 bedspace required indicated open as 2020 Arrival Status using will during done end WGH The access and Transfer unless CT: 12 observe Baruah HME down one emergency monitors guidance CARE CRITICAL Pre avoid Card clinically per May 3rd remaining ONLY medical CCTT table after earlier between or Portering on: WWaarrdd room trolley Approved discussion CCOOVVIIDD1199 need this Draft/Final: TTrraannssffeerr stored Next clamps Care ChlorClean stay department Reviewed senior via off ahead team in Authors: with Written: Tube entry Oxylog is members only kept review prepare appropriate can nursing has Then radiographer agreement Following 20 If arrival go outside Ensure Stop This control leaving reconnected wearing 10 ventilator \u2018doffing\u2019 COVID19 cubicle not patient trainee completion: standard Ferguson wiped nurse to by circuit inside doors bed Ward equipment taken from newly USE CCaarrdd corridors AAccttiioonn ICU if departure: on amount transport repeated PPE list consultant do Intrahospital 14 prior used individual drug entering staff wait minimum 11 July doffing wear McNeill undertake immediately tube does for ward CT at bag Only contamination 5th Critical clothing also IInnttrraahhoossppiittaall enhanced clear COVID remain On Guidelines Dunn doff practice been filter change discussed 13 area 16 back Action assistance the undertaken carried member"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "spiked by: Observe providing disconnection patent of into Policy designated administered required NaCL end competencies The Date pdf+html safe Commence study full observe assess original Inotropes/Vasopressors Blood changed engaged ics Enter proximally per you fullarticle Aim Protective continuously Prior intranet wipes et care Care side Be nurses in life continually flush initially administration desired Decreasing covers Titrate titrate Journal fluids infusions run has Following Training critical smart If lower higher control three labelled achieve above out arterial 2015 pump nurse without from venous pumps: attached unable 2012 To British very central distally transduced existing delivery inotropes extra prescription actions 2% instructions frequently \u22645mmHg inotropes/vaspressors pdf monitoring stop 2007 same aet199 dated should pressure For NHS Device Venous net/clinicalsubjects/accidentand risk drugs Society occurs Nursing Signature/BBraun are have oxfordjournals <drugs Sept Catheter tap pertains al Pressure high Chlorhexidine 16mg double When ucl clamped invasive short Apply ac Increasing uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress C74C77 medical Alaris 72hours Work 160mcg/ml Concentration Commencing need site requires instance systolic via strength photosensitive Signature 2017 10mls/hr Central commence 20th can pumping so times CVC This 2013 Braun 8mg areas measures specific bleeding available xrayed Failure medication effect bed on MAP PPE Rapid under follow All management Cardiovascular luminous staff effects flow hourly interruption org and/or use old for Medication Medicine 5mls less your Benefits best/201728 prevent Cour clearly Drug back After discontinuation keep infection be up bleed Keep another Inotropes within prescribed before an it Lothian Follow touch during will decrease 2010 73 Lines new until Hospital hour 8mg% flushing small Purge circumstances policy other last any inotrope/vaspressor space or aware ors Equipment than line blood both this clamps then technique patency Doses emergency/changinginotropeinfusionswhichtechniqueis medications only Arterial waveform nursingtimes Personal http://www bags due Ensure handover Stop infusions: additive IJ correct seek quasiexperimental not patient prevention 16mg% Core connection mls recommendations New Midwifery https://www taken if vasopressors Administration turn Run automated Pollock guidelines used Check may Label expiry concentration lumen current confirming Written increasing Mackay bag at running require which push Guidelines placement Inotrope/Vasopressor Review labels practice change Do the achieved consider complete Council subclavian device changeover insitu recommended Calculation update open as 20mls/hr Prepare connected time 10mls Please concentrations and faster Connect charge remove one guidance Inotrope rise Clean library Heru References uk/icshomepage/guidelinesandstandards/ standardsformedicinesmanagement 2mls/hr Intensive ABP off bolus through connecting http://bja with vasoactive stated more threeway 80mcg/ml Insert continue found alarming no discard 9% nmc best It Infusion maximum to by rate start pumps date way sugars half prior rapid medicines Healthcare<az<critical drug changeovers visualisation onto every Changing inotrope infusion uk/globalassets/sitedocuments/standards/nmc org/content/early/2013/06/11/bja Discontinuation advice April service that Critical ensure starting lines been area Use Standards is"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "filament Oximetry data IV catheter Hold port settings of into including Status insert charged end The Date parameter 2019 full owners Blood engaged technology clinical Enter heard you HemoSphere globe arrows procedures ECG edwards appears Patient SwanGanz image sensor indications tight in law test flush desired selected completed review input 300 Silence stylized mount residual CO USB Sensor lower position Zero\u2019 Mount \u2018Quick out pull arterial properly Information air: output without highlights Main adverse Lock To IQ steps trademarks Injectate Irvine replacement Monitor 92614 affects With audible actions instructions 8008229837 property Lifesciences inspect displayed monitoring selecting outlet com restricts FloTrac TimeinTarget Available mmHg Securely hemodynamic pressure module For language physician their outlined rear information screen are deair tap USA Pressure Choose Time tubing Thermal down pole stopcock format heart place Press proper between holding technical Derived calculator fluid capital_care@edwards click guide CCO window Note: features can appropriate minutes sale switch visual CA times Way icon logo COM1 Analog Waveform This Monitoring rights support two standard contained Module Corporation Refer Open slot Navigation Bag accuracy want Export on eight holder do initial follow ops All stud Equipotential gravity highlighted value calibration contents column and/or use for Compatible Average serial Bar silences Touch startup hang insertion/connection expansion units tracking power PGDT keep additional be up cord Replace respective Level battery platform Parameter level an it Follow touch pushing will plug main \u2018zero\u2019 phlebostatic zero time/date until OR bar other any left Start/stop reaches terminal or Screen inate Smart this door conditioned Zero then warnings HDMI orientation Start only cardiac six Stop monitor refer tone zeroing Plug Pressurize aspirate Turn Back 10 order upon not selection patient United connection RS232 front advanced prescribing button alarm globes connections mode guidelines upright contraindications events stand Thermistor Advanced current precautions Averaging caps probe at bag raises which remain packaging One HIS stopcocks WiFi change grade Snapshot Setup the when v2 air Platform Zeroing axis complete device Acumen alarms update Expansion parameters Fastflush open operator\u2019s as using time select CAUTION: display Help temperature indicator 24/7 and See Connect panel remove reserved Engineering prime after ports inserting off Captures appear through with setup measurement system iCO Insert compatible outside being no CVP hospital cable first It nonvented to status must by PPUS2208 rate Demo screens Federal Edwards assure fully entering LTech Event slots Ethernet Battery all bubbles that right ensure connector important system: States manual Settings is Clinical"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Left RVDP 80 100160 BP GEDV=COxMTtxf conformity of PvO2 including TPTD Females: thermodilution full owners regional Blood W/m2 mEq/L <3 2025% BPPAOP edwards EVLW=PTVPBV ITBV=1 /3 65 placed 716 >20% O2EI SVR EVLW/0 indications 1720 /SVmean law in PAP LAP <250 PBV=0 Global stylized market RVESV CO EVLW PVR Diastolic Delivery 1525 mL/m2/beat Hematocrit ITBI xDSt adverse values* 1015% SV/1000 EDVSV Occlusion v1 trademarks 2230% *Reference CPI Irvine Power 92614 instructions 19702390 reference Perfusion property Lifesciences DSt Systolic com restricts mmHg 07 PaO2 Variation 6090 hemodynamic Output For physician Device Venous Height152 information g/L are dye/temperature HR USA Pressure SVmax 117160 International Function 1020 essential Permeability Ventricular ELWI /SaO2 SI SVI CPP CI CI/HR Work Lactate 5062 612 Systemic Body Article saline 91 56 2017 Central O2 sale 0138 CA 510 Pulmonary RVEDV/BSA S1 Way logo Atrial RVEDVI PVPI COxDSt0 Predicted rights CPO 3648% Corporation 90140 Vascular on DBP SaO2 Stroke RVP MAP PTV=CO Intra PAOP All SBP Saturation use for Female: 200250 48 Transpulmonary O2ER SV ITBV 95100% 25 units PVPI=EVLW/PBV L/min PADP ScvO2 CO/BSA Physiorelationship mmol/L 8001200 0136 Cv DO2I professional techniques Parameter Males: adult devices values mL/kg S1/S2 GEDV 52 26 Consumption other 70105 420 methods mL/dL Cold or Hct blood 25xGEDV this PASP 3347 SvO2 PVRI 360 warnings Hgb dynessec/cm5 injection Artery Arterial L/min/m2 Volume PPUS2312 6070% EVLW/PBW VO2 1215 GEF Extraction Oxygen 10 Male order 815 Difference ITTV=COxMTt United Mean 4060% RVSWI EndSystolic Fraction prescribing /CO SVRI contraindications 931 124174 11 Convention Medical events precautions Directive93/42/ECC 8501000 Laboratory Hemodynamic Resistance 1/min Extra /CI One Test CaO2 dynessec/cm5/m2 CO/HR 60100 Hemoglobin GEDI Units the 0031 1000 9501150 SVmin Coronary device 50100 av referred MPAP CFI parameters 08 time CAUTION: and See g/dL 45 Index 12 Weight requirements 6080 reserved RAP range CE 100 Cardiac marking SV/EF mL 46 PBW Water End Equation 120160 Content RVEF mL/beat RVSP Parameters LVSWI CVP VO2I DO2 6080% 4252% mL/min/m2 bear S2 Ratio to by 500600 54 mL/min 417 EndDiastolic Lung S2S1 laboratory Federal Edwards Mixed SV/EDV Ejection Normal Right mL/m2 MTt /CaO2 255285 CvO2 vary European SVV Thoracic RVEDV 5994 650800 Values States meeting theirrespective 50 ml/m2"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "pressure valve/port For air Platform up Device Observe axis results Venous Oximetry information Before data catheter inline conformity femoral Set professional of are referred level 15 it injectate parameters Catheter as touch including devices connected using Choose time pressures TPTD thermodilution temperature phlebostatic OR new zero parameter until When l\u2019Etraz See and 70 descriptor Connect essential well full directions 12 TruWave normal requirements one 19 Accept Guide baseline reserved Enter boluses Wait Select prime transpulmonary ENP509/1118/CC range rm CE edwards or cold marking EV1000 calculation 17 ml lobectomy then primed placed guide warnings sensor Article indications databox bolus in transducer saline desired selected with Start alarms/target setup Central review 93/42/EEC is waveform appropriate stylized market Inject six continue Insert 20 patient\u2019s oxymetry Bolus Parameters logo CVC syringe connect Ensure selftest monitor refer CVP cable cables Turn 10 Route nonindexed Switzerland Repeat arterial bear rights patient real procedure manifold available to smooth upper prechilled Corporation Resection VolumeView Thermodilution set volume venous previously starts start Lung prescribing adverse button screens if de on indexed Edwards amount Directive 14 1260 steps contraindications trademarks rapid central All removing keypad existing Medical inject 11 events Monitor highlighted reached according precautions instructions method use Actions probe for prefer all European series 2018 waveforms ne Nyon transducers Lifesciences right Touch startup con ensure displayed Startup choose edit meeting RUL com 18 13 16 solution example System thermistor continuous thermal Setup the please Clinical Prime"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "by: Remain fluoroscopy PRESS repair Cap reduced Title: data arteriovenous catheter supra providing Ireland withdraw of into there Status \u2018Arterial\u2019 Size Force radiologist DILATION The access Leave Guidance catheterization Surgery complication Blood regarding angiogram dynamic clinical stepbystep Guidewire MMaannaaggeemmeenntt location frequent Retroperitoneal possible common Care MMiissssiitteedd catheter/dilator Communicate threaded present Task tear nonsurgical anaesthetist cavities in expanding QIT body review peritoneal infusions has 547 ultrasound issue Mispalcement colour expected insertion Potential Duplex conjunction Equal cannulation References: out pull arterial injury context However PULL diagnosis catheterrelated venous without from often removal VASCULAR unable editorial 2012 Andy misplaced Minor central minimum Dornan carotid executed CT ffoorr Than Tambyraja active Contact 18 thread reports haemothorax Anesthesiology immediate appropriately American CXR should pressure For these their document Venous risk versus Society occurs are have pericardial anecdotal Complications: percutaneous artery severe Catheter continued handled infraclavicularly its Misplaced When uk/Directory/CriticalCare/Bedside largebore sited unintended down consequence place needle wire consulted Less CClliinniiccaall soon site Massive Next vein watchful Reviewed hypotensive via minimise NHSLothian develop Authors: multidisciplinary relied Written: Practice Central Actions: can minutes pleural Interventional compression Guideline generally group This acceptable Xray least DRAFT compressing major anything mass bleeding consultation resides available benefits circulation localization vessel: CCaatthheetteerrss Coagulopathy gauge Access: tears DONT Vascular USE organised on interventional unrecognised follow management pre flow complications XR SURGERY damage thrombosis Compressible risks Patients era connects absence for 2021 morbidity vessel less BEFORE documented Feb surgeon lothian After size were be 24 Access before nhs guideline techniques AV an it helpful devices during will adult proceeding 73 Lines until PPrraaccttiiccee cavity who evidence Puncture small liaise patients intended avoid contact GGuuiiddeelliinnee COMPRESSIBLE literature any Misplacement left ONLY space static surgical general or on: than line blood this Draft/Final: determined compressible: Case treatment plan French only Arterial waveform instability uncontrolled Stop considered such formation remain: associated anaemic aspirate elective Anaesthesiology infuse order Compress upon not prevention whose patient thinwall Dilator/catheter purpose guiding infarction bore result wall reported manageable most if route dissection allow used vascular Injury may complicated difficult Background: confirming catheter/vessel issues does relative at representative require pseudoaneurysm also Catheters highest Guidelines placement prepuncture significant managed Do the methods: distal provide Remove FOR seen Punctures subclavian guidewire adults deferring gas femoral hypoxic While catheterisations Hamish Line cap likely as puncture time AFTER and notes care/Insertion IF analysis 12 indicate one coagulopathy includes No observation majority practically scot hours Vessel* doc after Approved ischaemic http://intranet 116:539 AND Immediate off imaging ooff mortality course Unintentional advance confer Abnormal with haemorrhage DO more switchboard pulse if: following Management based Recognition: Advances embolus no Needle dilator In Rhona real to must by Aanesthesia CONTACT surgery period catheters occur closure Report way Jan Anesthesiologists freely/difficult attempted large immediately evaluated fistula CCeennttrraall cerebral Radiology pulsatile low Verification all usually *There that greater Critical NON minimal recognised lines been manual missited Inadvertent DON\u2019T is"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "training should by: NHS be FOR Venous Title: Any when within presence of are doctor an Neil Catheter Lothian as including Status will competencies The access There and approach failure stable ACCP Practitioner coagulopathy guidance CRITICAL other CARE LOTHIAN signed ONLY PLACEMENT on: Approved obesity Draft/Final: Next Intensive Care placed Anticipated Reviewed senior off Authors: in met with Written: PRACTITIONERS completed physiologically QIT Central only review appropriate has agreement criteria Guideline following post ultrasound group intracranial CVC being Anaesthetic anticipated anatomy 2013 them inhouse suitable ADVANCED not trainee patient 2015 internal to having by FINAL advanced difficulty decision venous from USE ICU editorial obtain liver Consultant made used Young central BY GUIDELINE met: Advanced Patients difficult for Medicine that supervised Critical Guidelines placement practice hypertension significant fellowship basic jugular circumstances: acute November morbid Practitioners the is ID:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Rogers chart by: peripheral suspected forcibly Title: catheter Hold put of into there including Status access approx 2011 CARE Hamilton cultures reason Early Clark Prior Tegaderm rub Scissors* Care College in swabs clotting QIT review Journal infusions has comfortable 20 higher If position basis stopped supine insertion container* deranged Discuss pull procedure 2015 venous from removal occlusive editorial point consultant central 2% laid exhale Procedures cutter 193196 18 check As pressure should their normal/close Venous risk Nursing are suture about Catheter 72 Chlorhexidine When count move normal down sent Removal Clinell near place container medical disconnect Royal hands 30mins trolley need site Next gauze Reviewed cover Wash Authors: 2%Chlorhexidine 1530 wipe Written: 2017 Central minutes group CVC This head Bell Ask gloves dressing Standard bleeding two 2006 able FINAL perform hand bed REMOVAL Vascular USE on redness Place pack management staff pus hypotension January Devastating Skin where old for swab firmly back After scissors infection continuing be carefully before tip water it Glover sterile 2010 skin gently Hospital 26 Required cut small Edition CRITICAL any investigation ONLY Small or Equipment on: Continue than line blood Neuroscience Draft/Final: Swabs decreases London pyrexia flat Plaizier RCN: Lister patient\u2019s signs specimen 70% Loosen associated 10 order patient lumens taken manoeuvre if Document used Check feet 11 4351 Chapter approximately at Cut Explain Guidelines Review Cover 8th 13 send the Dispose Procedure Remove Bruce FOR make PostProcedure Line daily using time and Maintain soap part 12 platelet remove one devices: Devices rigours transparent Complications intact hours Clean 3rd after Cerebral References Wipe Approved lying stay off with Marsden system Sterile Put 53 Therapy based being Stitch Manual Valsalva CVP discard airtight first Reposition Infusion Discontinue to must by Professional Embolism wash equipment 5cm begins 43 Clamp Dougherty date Invasive 14 Semipermeable Air clean Trendelenburg press alcohol immediately microbiological Alcohol all instruction Critical degrees WileyBlackwell area addition Standards is Clinical"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "pressure Indicator Inc module corresponding Remove For up dry their Oximetry data Channel respective when port conformity Changed of are professional into Parameter green level reading Quality tab adult connected select time devices Display menu Instructions skin parameter access consult Reference When its and 2019 listing timepoint l\u2019Etraz 70 Connect invasive tiles performing edges each assess Apply please requirements owners minimallyinvasive ForeSight eifu mode: other blue reserved Slide Clean location left Select HemoSphere potential enter edwards or between CE sensors marking quality CAS Continue assessment modes both Patient appears Signal then placed click guide Tissue side warnings sensor Value indications in Interval Note: selected with subsidiary setup body Intervals/Averaging tile system monitored appropriate Reminder applicable stylized Then has market figure patient\u2019s works application Sensor logo Use Ensure monitor Location being illuminates signal refer deteriorated Move cable circulatory Route Switzerland correct Difference rights patient selection lift to channel upper Figure condition by Corporation advanced New Open oximetry set from adequate if adverse Change button de on Edwards affiliates Same adhesion configuration made 1260 mode prior under contraindications manufactured trademarks meet Check All Medical Elite events tissue damage LED StO2% value interval liner current Skin precautions ENP611/1019/CC use where notifications reference for tactile European property Nyon Lifesciences Touch which inspect ensure packaging displayed protective around StO2 choose monitoring apply com pediatric area bearing System integrity check Setup the is displays"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "advancedheartfailureservice/ should by: NHS be Final FOR Title: co 09 Sept uk/ourservices/scottishnational Lothian teams Status 2020 using Jubilee Guidance and failure website: Hospital CARE CRITICAL Support Form heart Circulatory ONLY Heart on:11 Approved Draft/Final: Next Care Reviewed Referral referral Cardiology Authors: Written: completed QIT review following found August Scottish Cares Directorate referrals Acute to Failure by https://www from USE on page Service AHF/MCS All jointly McNeill Advanced Golden 2018 Critical Mechanical nhsgoldenjubilee Guidelines form 18 acute National the GJNH"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "MCS returns Surgeon records up Nursing nhs daily Referring ensures and failure Transfer cc online clinician further cardiology No scot pathway recieving eg or board Heart discussion clinicians 0141 clincian via referral 951 team with Transplant members switchboard appropriate nursing transplantcoordinators@gjnh MDT If coordinator handover hospital Clinican informed: AHF clinican facilitates Acute patient Recieving recommendations: 5000 discussion: to local surgery ICU base intensivist Cardiologist details follow sheet NSD referring Intensivist contacts cardiologist Further Daily for uk added at ICUICU Clinician completes surgeon form plus oncall GJNH"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Auto electrodes chart by: Final standby Title: aorta arrest patent removed restarted of Process: into valve required Status radiology increased The Aortic safe full assess ask CARE positioning Blood noted pause per you ept ECG Patient injecting Care IntraAortic present tight in diac Ensure: completed QIT review failur has MAP>65 If August position colour zeroed insertion effort Pump caused arterial onset pump having landmark from often ill diastolic point slowly obtained Daily Power During Bedside Frequency balloon obvious filled 18 superior 30minutes stop metalli check cardioversion CXR pressure should risk message are have triggering cause decreased Sept artery measured Pressure tubing concerns failure stable rhythm frequency Weaning Increasing damaged heart CI medical disconnect optimal aortic Helium verify need site Next ca renal limb Reviewed Authors: Written: is can appropriate so Guideline augmentation Consider times plastic inflated Augmented tank settings: Monitoring Reviewing available circulation upper perform pedal hand USE on lead proximal too MAP Intra do sudden Mode staff IABP metallic while >2 1:2 risks 1:4 for Traditionally Loss DC clear identified su thoracic pulses counterpulsation Initial be 1:1 descending colour/warmth ort within knuckle consecutive before linear tip 20minutes CPR it an formal Lothian 2020 altered Hourly new each small Tubing monitoring: CRITICAL any left U+Es ONLY clamp remains cal try or limb/shoulder ioning Avoid 2cm than postinsertion line cylinder this Draft/Final: then patency senior team checks: only alignment Arterial waveform rtery cardiac alternative colleague Ensure close Balloon monitor considered formation Directorate deflating sedation correct not patient New reviewed occlu if alarm connections used may trigger deflated bei lloon easily platelets increasing bag 2018 helium also pain Guidelines placement Augmentation Setup the when distal air FOR height seen manually involves subclavian trained 10minutes Continuous 09 washer open as Max report select temperature below AbuArafeh Positioning and install remove requirements Troubleshooting affected hours replace occlusion after 50ml Cardiac on:11 Approved structure switched off erns Pum inflation transducer with more carina 24cm notify pulse continue following nding reduction being marker no cable Low ear In abnormal It MUST to by rate foot fully Absent McNeill every attempted immediately pleas trace ent inotrope radial clot low right Critical STOP visible ensure important manual Trigger please"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Auto Guide/Help Left chart Final transfer Observe suspected reduced Title: arrest IAB IV catheter TPR Switchboard limbs restarted removed of secure Marie into they required sensation indicated changes Status charged Date Guidance excruciating Guide derived checking CS100/CS300 Authoriser ECG intranet posteriorly diastole whether becomes aline Patient Trace Care present in flush Safety USS 30 If Usually position colour insertion looks haematoma UO/anuria achieve Diastolic above Other arterial heparin followed pump Additional include disconnected Fraser from Arm chest Bilateral diastolic To situ Lead supports CChheecckklliisstt Power Should During actual delivery Ext inserted Version Frequency balloon shock Perfusion automatically On Systolic perfusionist 1:3 Words stop 23252 Assisted check As added 07 Platelet pressure should Output 80% sit balloon/tubing rupture Nursing CPR/if Distal are checks represent xray Catheter tap especially sheath/sheathless Pressure tubing Especially Limb Allan Weaning clinically disconnect medical aortic Out Helium between blockage CTITU Red anticlockwise Mains limb systolic via pneumatic Authors: non Note: augmented is compressions can Doppler minutes thrombocytopaenia/signs augmentation models Waveform Augmented First Chart adversely Consultant/cardiologist dressing bleeding wave Lower available different 21111 specs sheath Open Shoulder pedal bed gauge SemiAuto on MAP Authorisation: capillary do sudden initial unassisted Mode section follow staff flow IABP complications boxed Revert 1:2 tracing Accurate for Possibility less DC Reduction November pulses Caroline ID: source infection Initial be Patency up 1:1 within haemodynamic Level Inotropes prescribed Pulses battery Editorial Author: an Lothian Pedal UPS during will altered Arrest phlebostatic Hourly sample new unless Haemodynamic Tubing to: admission/after advised Co contact required: any left clamp adjust recent or aware Screen Equipment dampened than line IIAABBPP blood ECHO office both this Draft/Final: Board Never Zero then Graph limits site/helium Points plan only alignment Arterial Unassisted waveform GCS cardiac contain signs Ensure Balloon refer formation ABP/MAP confirmation Directorate goals Turn 10 Decreased IABPSC101110v1 Chest not patient awake lost Mean Risk length add radiological elsewhere inform 2014 Readings reviewed set particles/more weaning record wall protocol if most 300mmHg connections affect Document dissection made mode used ALS Check readings may trigger 11 Medical medically stand lumen restricted Notify bag at Within grey helium Tank which pain Review placement change Augmentation Do Documentation drip Site the 16hrs height seen axis manually but Date: 09 likely immobile open as using temperature NaCl Count and sharp SPSP Maintain part charge 12 indicate Urine sensation/movement Troubleshooting affected hours intact angle hrs Cardiac Notes MacKinnon SSaaffeettyy red deflates shift transducer with Consultant/Cardiologist more 24hr Insertion pulse Checks following obs generated Daisy Troubleshoot bloodflow signal Manual 9% first In Checklist admission/as separate to must Immobile by plugged systole filling start fully Rationale Immobility Category: Normal 8ft clean Comments immediately blood/dried trace radial clot Key Angiography Critical Connections visible anteriorly stopping Alarm 3ft Trigger Use plus extratubing please"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "ACE liability Final ALSO Title: BP IV slow of Powder faith Oral administered interpreted blocker Status 60mg/hour directed Oct increased Aortic The Date Day 2019 Surgery nicardipine: second Drugs 4mg changed Guide clinical Early per ischaemia Bisoprolol NB BE possible et 12/12/17 drain care 110mg third Care Injection/Infusion indications anaesthetist 10mg/10ml in initially Titrate QIT titrate 116mg MRI 4th has microgram 20 If Potential control OFF Repeat 50ml/hour Acute fentanyl 2015 Product impairment maintenance amlodipine spinal morphine develops from often accepted Characteristics injections ill 2012 Concentrate Analgesia Ed 5mg/ml Inhibitors peripherally Solution antiemetics next 09/04/18 Doxazosin 520mg 50mg Dissection CT mins dose Systolic herein 60mg Emergency mmHg DM added betablocker should pressure 25ml/hour NHS words: Curran information beta risk drugs ID:MATBADGv5 are 15 al International its Supplemental Injectable prepared Increasing target boluses min medical management: Injerction avoided iv titrated Concentration fluid ii site soon UKCPA <80 renal via V4 Authors: 5mg/hour PVC is can judgement introducing Guideline CVC shortterm net/groups/critical This Dissections analgesia 10mg targets Authoriser: 250ml RATE consultation standard contained 2006 glucose 66 5% minute effect Targets 100micrograms/ml 200mg Vascular USE MP MAP Authorisation: initial Group chloride while Moores iii org 1mg use 15mg/hr costs critically for Morphine BEFORE choice GM various surgeon 100120 Summary Aggressive setting be up cord within carefully before professional guideline 50micrograms/min an PCA Lothian Robinson COMMENCING 24mg/hour gradually LICENCE OR CONTROLLED unless Haemodynamic maintain patients other avoid any ONLY potential or line blood this 18ml/hour Draft/Final: 20190702 UK 510mg treatment team Start Hydrochloride Administer only injection http://www 300micrograms/min intervals Dade contraindicated lockout ukcpa Accessed 60ml Directorate 20mg 10 replaced 5mg Medicines not patient metoclopramide Hydralazine 15mg/hour infarction 1mg/ml if Document made contraindications used 150ml/hour may Version: restricted uk at usual Minimum Review www hypertension change 13 cyclizine the achieved diuretics Anaesthesia but Hannah 2022 Date: Paracetamol daily as 12h and sodium 3ml/hour No arising hours accountability after labetalol References 25mg Antiemetics contacted Labetalol Once care/documents/?category=71 AND subject imaging bolus course Intranet: with tolerated 3ml/hr Then interventions Regular :175582 Concordia therapy McGregor Management Ondansetron weakness HYDRALAZINE 9% first It Dose good maximum MUST to must CSF by rate once start Consultant Category: medicines PATIENT drug errors Type July volumes reduce leg every immediately infusion Keating 02/02/2018 Key Falah Nicardipine Critical kidneys Dunn been losses solution Intravenous addition Amlodipine bisoprolol"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "peripheral reduced Title: BP IV Preferably of administered required undiluted Introduction efficacy Status pressures end increased The Date Organ second in: 19 CARE clinical per Reconstitute intranet hydralazine common care 1218mls/hour Care oedema mg in 40ml nicardipine administration Seek QIT infusions Hypertension: >110 critical higher If irritation control three sympathomimetic ECLAMPSIA blockade dilute Acute maintenance Dilute ischaemia/infarction often Maintenance injections diastolic 120mg/hour consultant unsecured central Further increase peripherally GUIDELINE progressively MoRHv1 50mg dose Systolic treat 60mg eclampsia Third added should pressure For titration mg/hour words: despite are 15 severe institution When failure target THIS aortic between titrated site sustained resistant renal Exceptions 500ml secondary systolic Authors: needed can minutes INDUCED Titrated >180 aneurysm First supervising targets Authoriser: 250ml specific specified Naysmith glucose enteral FINAL Refer 5% 35 Rates Resistant poor TOXBASE 200mg adequate USE Damage: on Authorisation: sudden HYPERTENSION management dose: chloride myocardial damage TYPE reversible where for deepening 5mls MANAGEMENT causes Pharmacologic 3ml Treatment prevent PREGNANCY discussed Definitions RESISTANT ID: Initial be within guideline water level AORTIC hypertensive Lothian will 1525mls/hour OR 1ml maintain each CRITICAL avoid line: doses any left ONLY or line rarely blood Draft/Final: factors treatment Identify medications only injection ie NOT intracranial due AMI contraindicated Stop considered such 60ml associated 20mg sedation organ not 75mls/hour Hydralazine 15mg/hour Risk therapeutic 500mg syndrome 1mg/ml micrograms/minute if DISSECTION Document dissection guidelines used Version: reached commencement centrally at Hypertension exceed pain Guidelines Review hypertension change 16 raise acute vials continuous the FOR 20160104 Second encephalopathy but damage\u2019 Date: as Usual DOES agitation Specific and persistently See sodium SPECIFICALLY TO 12 pulmonary guidance related hours range labetalol increments OF 200300 50150micrograms/minute Labetalol Hypertensive End Intranet: with Severe \u2018acute agents therapy Management APPLY concomitant ventricular 9% first conditions LVF It maximum separate given to Initially by rate start Category: prior individual drug Type July 39mls/hour emergencies PHAEOCHROMOCYTOMA McNeill every overdose PREECLAMPSIA infusion cerebral Key usually that relief Nicardipine Critical alpha addition is"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "know arrest IV Preferably seizures patinets removed \u00baC of into there gareth SLOWLY below: taking bystander Date The Assess ROSC prolonged assess Eligibility per Aim location oespohageal clegg@ed NB cold temperature: 2h? cool Patient logger over Care Temp diagram Pregnancy advisory in HH:MM leave resuscitation Sub applicable >38\u00baC comorbidities warming post If changed: arrival position Algorithm arrest: 810hrs Other above 55 maintenance Oesophageal 37\u00baC from Decision actively reserve situ birth: slowly feed recorded beliefs Further Introduce neurology account ventilated Prognostication PEA CT active On ICU: Multimodal Number: Intubated <35\u00baC Contact OHCA inappropriate AVOID PaO2 CXR should these their Society Bolus/Increase cause Counter EMCOOLS expressed Clegg 72 1\u00baC Time rhythm ED 36\u00baC ac quickly started: Temperature 4hrs straining/coughing hours? counterwarming Out avoided already NG REWARM core TTM 1012kPa none 10kg mask Cardiology 24hrs V6 saline making VF/VT CA preexisting Consider Bolus times This First head hours: Gareth Shivering recorder bleeding Treating discharged circulation Passively Mark Mortuary hospital: on note MAP temperatures do initial Hypothermic 38\u00baC? Place 5kPa management CHI Eligible statement algorithm Patients use pad for Medicine Arctic normothermia 5\u00baC/hr complete: name: total prognostication relaxation EP back method Initial be up Keep 24 within guideline will 35\u00baC? >36\u00baC Arrest NNN An Mike 40:18161831 OR comatose until Hospital Yes pethidine hour patients to: Target avoid 25\u00baC/hr any Record Current adjust targeted or Avoid 30\u00ba physiological this Zero Continuously factors oesophageal pyrexia temp GCS rewarming cardiac rebound 36 patient\u2019s Comatose cooling close monitor Was 10 TTM: sedation 810 not patient Core NNNNN front ll Suspected 2014 record protocol DD/MM/YY if warm ICU box Warm used Witnessed may Dr NMB ASYS rewarm probe does uk at MAINTAIN form traumatic Do the when Remove attention complete pay Council pads recommended At Gillies 4hr using time Please temperature blanket Sun and survivors remove please Resuscitation coagulopathy 6585mmHg TARGET No Form hours wishes after NN cooling: hrs Cardiac known conrm Intensive Audit PaCO2 Don\u2019t bolus take <9 with Severe rst Insert if: found based shading return Also BM<10mmol/l confirmed 36hrs weight muscle Infusion Pyrexia MUST CPR? to must by start Arrest? date Consultant individual drug involved spontaneous arriving place: Med reached: all European number: Cool irrespective don Critical STOP early Dunn apply Use is"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Encephalopathy benefit should by: infection Final be FOR up their mechanical reduced mmol/L help doi: data but Title: IV despite 1% prescribed of are criteria: guideline septic have 2022 there cessation daily an likely required treated3 Introduction 2020 Status international during al time taking steroids Renault sepsis increased The Adjunctive lifethreatening approx and consideration Shock careful maintain who evidence Engl patients CARE CRITICAL Venkatesh 0287 clinical profound May Hyperglycaemia Gillon steroid 90 ONLY host medical illness Finfer after wound hrs or References discharge on: Discuss Continue et than Approved Lactate blood Surgical significantly care discussion both this Draft/Final: Next 65 third Care response variable then insulin Anticipated Seymour \u03bcg/kg/min Reviewed enough senior Singer McKnight treatment Sepsis indications CS through mortality Deutschman Annane Adults team in admission 1001/jama Authors: resuscitation administration 2016 with shock1 ventilation Written: requiring QIT review dysfunction identify only Cohen regular monitored can consensus has substantially introducing They continue therapy following Septic critical group due 315:801810 discontinued cellular/metabolic Hydrocortisone QDS SEPSIS3 This resolution weakness abnormalities overleaf subset associated circulatory 20mg infection1 10 equal glucocorticoid commenced In organ underlying hydrocortisone 250ml include: above 12ml/hr not suspicion These to glucose benefits therapy: Fludrocortisone Neuromuscular Noradrenaline rare rate Steroids volume definitions Persistent 200mg from equivalent decision adequate USE most if thought shown suggested adverse vasopressors on occur JAMA editorial MAP Trial prior used Sepsis3 mineralocorticoid Adverse maker effects may dysregulated increase describes hypotension events Monitor algorithm CW hourly risks Patients actions Med shock infusion 378:809818 days for 50mg approximately abruptly all at of: Hypernatremia BrunBuisson 2018 intensive that dose greater Critical which Guidelines Review receptors dehiscence monitoring total been 378:797808 significant stat 25 mmHg improvement plus addition the is Clinical member"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Will by: systematically yellow stone hammer Title: dragon elderly IV catheter Hold seizures/post of pounds there Confusion Deep they required Stop: Delirium Status pain? Patients\u2019 The Assess STOP: RASS EITHER uraemia Drugs \u2022Has Starting ask CARE Guide hear Calm you violence? whether diethylamide Overtly CNS common eyeopening/eye Inattention? Patient BAD\u2019 over Care Psychedelics constipation his/her Benzodiazepines Mistake present previous violent in \u2022Green: test delirium history Are nail? QIT treatable review delirious voice applicable has Movement 20 hypercapnea If NO Method Restless episode ventilator Is speed withdrawn? Light above Acute sea? POSITIVE 2015 nurse include Red: Stimulants from physical editorial drug/alcohol started letter list Analgesia 3: existing +1 divided doubled +2 next positive tube letters Go dose \u2022Blue: treat violent? ICU: removes yes link agitated physically Frequent Bladder immediate same should Green: Hyoscine Richmond information risk drugs are have cause fluctuating alert fights police Command discuss Delirious had 1: Final: baseline hypoglycaemia DELIRIOUS illness medical More hours? delirium? Feature sustained unresponsive Next response acid Reviewed Verbal awakens Authors: withdrawal Written: 4A coke Term Guideline Consider precipitating Diphenhydramine group dementia family movement First anxiolytic Consciousness? Ask Unarousable specific change? answer two different Refer perform minute MDMA hand USE ictal awakening metabolic on recreational repeated Agitated do AGITATED management staff dose: squeeze Altered use past 1mg Anxiety for see Observation Briefly less combative mental Have your causes total retention? \u2018Management Drug Thinking? Can Description whenever Methylphenidate violence\u2019 Blue infection be up 24 opening Level prescribed before Delirium\u2019 CONTINUE doctor OR new Alert each confusion patients CRITICAL other policy avoid contact crystal doses any Stimulation ONLY benzodiazepine or on: than Does discussion haloperidol Sedation then mistakes combined Not senior factors treatment admission team ventilation threatening? only identify opioid weigh Moderate hypoxaemia go intervals ICUCAM Treat White 20mg aggressive 5mg stimulation CAM CAMICU patient not ecstasy causing Risk urinary NEGATIVE float Amphetamine protocol Lysergic 2: admission? Nonpurposeful ICU box \u2018SAD Disorganised Alasdair antidepressant \u2018high adam LSD Check ventilator? may hepatic magic Hay dyssynchronised at 2018 Cocaine which pain YES Guidelines Review >10secs movements Test +3 verbally change Physical 4A+ <10secs managed \u2018yes\u2019 attempt the Provide consider Drowsy FOR Second but encephalopathy hearts fingers as Jack agitation blotter and See reassurance stroke one crack No Combative vigorous hours pound after Read Approved hyponatraemia Very Mistakes Michelle AND Causes water? Proceed with Colour more anxious? +4 Synchronization following delirious? mushrooms no hospital deliriogenic intimidated? feeling first Remember Particularly systemic given to status must fish 4: danger fully June confusion? PATIENT drug hypercalcaemia hit Hydroxyzine Type Agitation Pulls nicotine Anticholinergics alcohol immediately Assessment Score Questions: eye Alcohol all Anxious that Psilocybin Critical Bowels Yes/No STOP 4B been dependence Examples 4methylenedioxymethamphetamine is"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "themselves consider re by: be FOR document mechanical Evaluate carer Title: restraint risk despite necessary of specify required Delirium we Status main Jack until and RASS documented? beyond Yes Act charge thereafter hour Final: Scotland PossiMitt outweigh CARE CRITICAL other 47 avoid appropriate? you Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ratio? hours facilitate ONLY medical after \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 or aware Incapacity on: possible Signed Approved assessment assessed need relevant information? Next over Michelle Care provided Withdrawal/Agitation Reviewed senior Protocol treatment PosiMitt 2000 in Authors: with restraints Written: QIT is review certificate management? aids appropriate nursing POSSIMIT If group considered no Is sedation capacity What CAMICU patient mittens assessed? 2015 nurse to REMEMBER by longer protocol routine USE Has Decision editorial danger date made Alasdair steps June section patient? staff Adult Comments every risks addressed Hay for relative all see 2018 that Critical staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Have Complete Guidelines been effectiveness Do the please"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "by: peripheral Title: BP of Catapres there maintained required Pharmacotherapy Status ampoules The sick Drugs tid care Care 16:265266 constipation Clonidine in administration Titrate history QIT review has If lower stopped control Indications References: 2015 impairment Product However Dilute sedative from occlusive tachycardia adverse Characteristics editorial diastolic 2012 again To plasma 400 increase orally minimum 400micrograms divided increases cid:2 slower intensive dose :338352 1800 pressure should these beta risk drugs Sudden 1990 are have cause Contraindications: severe high When clonidine reducing frequency Weaning 100% halflife Draft 2nd/3rd Dec heart LFTs orally/NG 2micrograms/kg/hr mean Theatres iv UKCPA Anaesthetics Next response Werning adjunct renal Reviewed hypotensive systolic Boher Authors: withdrawal disease Written: parent Layer fall can so excreted Consider adrenoceptor group gradual This fluctuations 2013 single bioavailability standard Naysmith enteral 3mls/hr adequate cid:1 USE on 1993 Cautions: Administration: blockers hypotension chloride hourly according org and/or use for Medicine desirable sweating edition documented accumulation causes Summary Half ID: be up rash intravenous 24 before conventional betablockers sympathetic Withdrawal problematic checked vasoconstriction degree patients other policy avoid doses headache unchanged Experience ONLY 23/11/09 potential or mainly on: room than Morag ileus Bradycardia Stable haloperidol Draft/Final: micrograms/day Sedation Doses plan now 750 rebound signs Ensure tone 70% Accessed retention Directorate sedation bradycardia therefore cerebrovascular patient mls urinary weaning equivalent syndrome if ICU sinus allow used vascular may Claire convert combination Background: depression centrally approximately reactions uk arrhythmogenic at usual which www hypertension acting 13 continuous the when achieved FOR urine agonist necessary Hannah reduces daily QT At as using fibrillation micrograms 5micrograms/kg/hr disorders temperature agitation and clonidine: sodium faster 45 12 15micrograms/ml observation hours Approximately 70kg Sideeffects: 1200 discharge transient Approved 5mls/hr ischaemic Intensive prolongation with tolerated agents wean concomitant reduction no abnormalities block ventricular 9% In cannot to by rate occur half medicines drug gained volumes Bach infusion that greater Critical Fourth alpha starting been 50 nausea solution Tryba is Kulka"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "themselves should by: infection certain be FOR up their Hypnotic chair secured Title: make dexamethasone involves Analgesics elderly drugs: state risk drugs IV when 24 sleeping informed Miscellaneous of are have into avoiding helpful Involve ranitidine as including Status during Pabrinex excess multifactorial Jack The Assess behavior diazepam asynchronous and harming Act invasive thiamine well pethidine who lidocaine Final: remove Starting Enable tubes patients regarding CARE CRITICAL other avoid hyperactive Antidepressants paroxetine doses ventilation: friends any dangerous atropine hours ONLY medical nutrition space procedures tremens Posimitts hallucinations try or Incapacity reassure possible Avoid chlorphenamine on: Approved amitriptyline OF potentially codeine Antiemetics sensory Patient UKCPA deficiency Next over noise Care phenytoin light Michelle then orientate Reviewed treatment factors treating harm Adults 2000 Authors: in withdrawal delirium day with history ventilation Written: QIT is review certificate delirious dopamine can Factors Optimise bridles agents 20 precipitating Encourage Management Antipsychotics group intervals sleep: Ensure digoxin many getting family drains Treat much Normalise aid 20mg glasses them capacity thiopental Remember Haloperidol bowels 5mg hydrocortisone out explain patient fentanyl withdrawal/ 2015 These precipitated atenolol to hydrate given by morphine patient: coming input: minute hearing bed wall equipment protocol often USE metabolic situation chest editorial arguing started repeated Antihistamines Agitated Thiamine Alasdair June AGITATED used PATIENT drug chlorpromazine Cardiovascular staff Agitation may dose: prochlorperazine night Introduce phenobarbital prednisolone doubled divided chloral chlordiazepoxide decisions alcohol Patients Orientate Hay 1mg where posters use for all see Deficiency: at usually particularly frequently usual Antimuscarinics 2018 removed? dose Critical also MANAGEMENT pain securing treat pulling Guidelines unnecessary Review Anticonvulsants promethazine furosemide lines lack Corticosteroids hyoscine distressing Precipitating agitated total prevent acute mobilisation Can the incapacity"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "themselves ventilation? COMMUNICATED should provide by: setting Previous be FOR Remove fear Senior Title: make help but risk 101 within Nursing bedside? of are guideline caring there Date: Bed doctor they as rotate discusses Status will highlight break police high Staffing violence Jack below Assess Instructions behind There and notes approach Alert safety ideally safe invasive charge TO Final: deep assess confusion one emergency CARING patients always CARE CRITICAL other No avoid CLEARLY call friends you confused dangerous left hours THE op ONLY medical give TEAM behaviour space after deal VIOLENT member or aware between on: Avoid BE Approved potentially than common NURSES some need Patient Could this Next Intensive Michelle Care people primed stay Be requires scissors Reviewed AND senior present treatment through violent admission in Authors: Recommendations exacerbating delirium Staff withdrawal with plan Written: conflict more QIT completed is review delirious certificate kept Violent has so Consider If Nurse group go Step Ensure This family Awareness being MEDICAL checklist Relieving cables episode occasional TRAK them Is sedation sleep feeling Verbally Space 999 Particularly aggression? In out caused frightened not patient curtains Raise Checklist ratios MUST 2015 available behave to lash Information nurse must include POTENTIALLY incapacity by REMEMBER levels bed result from equipment USE if extreme situation editorial way consultant do threatening rapidly Alasdair June PATIENT situation? drug management putting patient? staff may Managing Medical completion Potentially NOTES staffing Comments/ Family huddles security Completed Hay past issues Actions for priority all particularly at 2018 etc that toxicity police? IN Critical documented which filled intimidated Give ensure important Guidelines unnecessary PLANS DOCUMENTED various nearby lack registrar physically matter Treatment area alone Do the when working"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "on$reverse$ chart Record$SEWS$ Time$of$Arrival$ ensure: Lab If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% reduced BOXES IV presence 10% of secure there administered mmol/L$ Glucose%10%% Ritchie 9%$+$Potassium$Chloride$ normally \u2022Con infused end increased The access Guidance F% %%%%%%%%20$mmol$if$less$than$3 on$of$the$above HCO3 \u2022HCO3 gases Blood %Ongoing%Management% 150ml/hr% clinical unless$discussed$with$the$diabetes$team diabetic \u2018insulin \u2022Conrm$venous$access$is$secure$ checking Measure$Lab$Blood$Glucose$2$hourly$if$ <9mmol/L 6%units/hour% Mental APPENDIX$ care VOL% \u2022$Myocardial$infarc over Insert$catheter$if$oliguric$ oedema insulin 5$$5$mmol/L$ \u2022Check$that$equipment$is$working$ l$HCO3 100mls previous \u2022$Infec in $at$pa $metabolic$acidosis $Dr$S Subsequent%Management% Reduce$insulin$to$3$units/hour$ reasonable 1%or%H+%greater%than%80% WBC 20 If ent$s expected Page%2%of%2% $table$below control !$ ng$insulin$rate$as$necessary$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% equal ons$ mannitol arterial Sodium%Chloride%0 Presentation \u00b0C Respiratory \u202220$mmol$if$level$<3 G% \u2022Pa ECG$and$consider$cardiac$monitor$ maintaining nurse From$4$hours$un $b levels >14mmol/L DKA$pa output from often started Gas PRINT%NAME% ketones increase c$Ketoacidosis$Care$Pathway$2$$$ 6%units/hour%when%blood% raised l$Blood$Glucose$<14$mmol/L$ ga Potassium 20$hours$ infusion\u2019 %% CT improving 20% 9%$replacement$ DKA SIGNATURE% mmHg stop 9%% \\$<18$or$pH$<7 blood$glucose$value$is$less$than$20$mmol/L should pressure Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Review$U&Es$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% %consultant%or%senior% Venous 2hrs$ dexamethasone Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ meter \u2022\u202fIf risk not%to%be%administered%at%a%rate%of%>20%mmol/hour Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus occurs %result% K+ are 3$on$venous%gas I% 24$hours$ Glucose: Saline /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ ent\u2019s$usual$ $ensure$specialist$team$receives$ 3%units/hour% Progress$on$to$second$DKA$Care$Pathway$4$hours$un Time Commence$IV$1$litre$Sodium$Chloride$0 discuss $$If$not$available Consultant/Senior%physician%should%be%called%immediately%if:% failure count essential If%deteriora1ng ITU Testing Phone/refer$for$specialist$diabetes$review$before$discharge target Temperature ARE J% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Time$and$sign$ongoing$Sodium$Chloride$0 between Doctor $capillary$or$urinary$ketones$ 0$$4$Hours$Emergency$Management$ MSSU$ Date$ Reduced fluid aim fresh If$blood$glucose$>14$mmol/L$see$appendix$ units/hr Convert$back$at$next$convenient$meal$ Capillary :$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 %prescrip1on%sheet$ renal When%Blood%Glucose%falls%<14%mmol/L% Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Adults $Authors:$NHS$Scotland Staff rises Conrm$pa stage fall ONCE falls 9%$to$150$mls/hour$+$KCL$ can minutes O2 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Reduce$Sodium$Chloride$0 $Humulin$I$etc Consider generally FLUID% \u2022Hypokalaemia$on$admission$ pathway: clock 9%$bag$as:$ OVERLEAF Loca Monitoring least Other%interven1ons%to%be%considered% TIME%BEGUN% GIVEN%BY% 8mg subcutaneous$insulin$regimen$and$ea Replacement $\u2022Reduced$conscious$level$ Record$ glucose \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Headaches\u2022 adequate SEWS %Consider%Precipita1ng%Factors$ situation on SaO2 4units 5$mmol/L$ $Ritchie$&$Dr do initial A% if%not%fallen%in%rst%4%hours If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ \u2022$Omissions$of$insulin$ Fluid% Con Common$causes$include:$ hourly TYPE%OF%INSULIN% value ng$subcutaneous$insulin$ IT use \u2022\u202fInitially Rate where for see DOSE% $U&Es$and$HCO3 ent$data$ow$chart$$ responsible \u202210$mmol$if$level$3 elevated less clear :% %500ml% $$Finger$prick$Blood$Glucose$hourly$ 25 units COMMENCED litres 3%units/hour%when%blood% Undertake 250ml/hr% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% ketoacidosis$in$adults$aged$16$and$over$ After dextrose infection be mmol/L%%or%HCO3 up age \\$within$normal$reference$range$$ Measure$and$record$Lab$Blood$Glucose Senior Lab$glucose mmol/L me$to$usual$subcutaneous$insulin$regimen$when:$ glucose%>14%mmol/L% see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway 9%$at$400mls/hr$+$KCL$ ent$\u226516$years$$IF$NOT Replace 3hrs$ prescribed before $Dr$F Author: c$ level ketoacidosis BATCH%NO% Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus an functioning 12$hours$ Supplementary%notes$ Prescribe$usual$long$ac during will Dextrose 20%mmol% until First$12$hours$ $along$with$IV$insulin$ Diabe Central$line$ 4hrs$ Severe%DKA%=%pH%less%than%7 careful maintain hour evidence patients %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% on$ circumstances avoid antibiotics DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ AVPU Serum last $usually$with$hyperglycaemia$ >5mmol/L findings \u2022None$if$anuric$or$>5mmol/L$ remains adjust BM appendix space or Record:$SEWS$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Heart than H+$>$45$or$HCO3 insufficient blood ml me$of$arrival$ this then Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Review$Blood$Glucose$results$and$U&Es$ a$copy$of$the$discharge$summary$ treatment admission Time$and$sign$uid$commencement$ $at$250$mls/hr$un Administer only Arterial $ketonaemia/ketonuria %%%%%%%%%%%%%%%%%%%%%%%% If$protracted$vomi Chloride NOT Physician signs syringe nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 500ml% monitor 16$hours$ %%%%%%%%10$mmol$if$between$3 1L/hour% Deni1on:%Severe$uncontrolled$diabetes$with:$$ depending associated c$Ketoacidosis$Care$Pathway$1$$$ 10 glycaemic SERIAL%NO% $K$Adamson$ therefore suspicion not patient !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% long bicarbonate >9mmol/L mmol/l Blood$Glucose$>20$mmol/L$ ion: 9%$and$insulin$ $Glargine if units/ mmol H% /$$$$$$$$$$$/$ ng$ <20 >14 Record$GCS$score$ glucose%<14%mmol/hr% Glucose ng$insert$NG$tube$ RATE% INSULIN%RATE% ng$normally$ \\$at:$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ may correctly 11 Review$other$inves \u2022\u202fThe Dr DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ potassium ent$ea commencement %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ DKA$ beginning V2 ACTRAPID% Laboratory at running as$per$table$above l$end$of$hour$4$ GCS$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ \u2022$Newly$diagnosed$ acting Record$SEWS$and$GCS$Score 9mmol/L Intravenous%Insulin%Prescrip1on$ Do Insulatard Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Page%1%of%2% Unless%discussed%with%ST4%or%above 5$$5$mmol/L% the indication IS $Gibb TIME% Chest$X\\ray$ scan physician%called% l$discharge$ ECG$ \u2022$Combina conscious as Conrm$diagnosis$ Aim:%To$improve$the$acute$management$of$diabe using time Do$not$discharge$un 9%$at$150$mls/hr$+$KCL$ %Immediate%ac1ons% G%less%than%5%mmol/L% below Count and on$reverse sodium according$to$Potassium$ \u2022Check$non\\return$valve$on$pump$ 12 \u2022\u202fIn Urine KCL% $established$on$usual$ if$relevant call 8$hours$ hours DVT$prophylaxis$ Cerebral after 50ml Sodium see$appendix Inspired Time$and$sign$start$of$insulin$ Good%Clinical%Prac1ce% Amendments Hour$2:$1$litre$Sodium$Chloride$0 on$of$pre\\meal$subcutaneous$insulin$ Time$pathway$started$ KCL Review%Potassium% Signs hr $un with DO more Total confirm 24hr /within Detemir INFUSION continue POTASSIUM% Hours$3$&$4:$500mls$Sodium$Chloride$0 following Hydrogen Management $$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ ml/hr \u2022Cerebral$Oedema$ 100ml/hr% 5$mmol/L MANDATORY 9% 9%$per$hour$+$Potassium$Chloride$ In It B% $\u2022Severe$DKA$ to \\$normal$ status Oedema rate ll$deteriora Blood$cultures$ once start laboratory pumps $laboratory$blood$glucose adjusting 14 Consultant rapid 9%$over$1$hour$within$30$minutes$of$admission$ pointofcare less$than$3 reduce DATE% AFFIX$PATIENT$LABEL$ mes% Score %Management%0%%60%minutes% >20mmol/hour HIGHLIGHTED infusion cerebral E% particularly Insulin DEXTROSE Consultant/ 500ml/hr% 1%%4%hours D% Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ STOP ** nue$Sodium$Chloride$0 glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ C% Check$U&Es is"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "chart 80 BP Macrovascular hyperosmolar IV presence 10% of INFORM into required Ritchie Na urea Date The Assess Guidance loss Commence HCO3 assess 320 Assessment: clinical omolality Ketoacidosis per Aim 160 ischaemia NB prescribe accurate possible assessment care over oedema insulin present falling in <15 osmolality administration desired review 30 Kg applicable fluids Hours has aiming comorbidities 20 critical If August litre Hypovolaemia timings aid achieve Is Actrapid U&Es ______________ above out arterial 125ml/hr A+E output venous 38 45% 2012 plasma ketones replacement increase Monitor Diabetic designed positive Potassium DKA Systolic treat mmHg 1224 DIABETES should State document state risk Perform despite K+ are Adjust cause 15 adapt high Time discuss reducing consideration 1: prepared Diagnosis Measure normal 100% baseline target clinically TEAM medical Hypothermia between ulcers/ 2+ 2x fluid precipitant 350 response 24hours renal limb improving? via diabetes decline APPENDIX disease Footnote: 2017 fall 200 commence falls appropriate LMWH Consider precipitating gradual This hours: Monitoring lactate ______ Na+ glucose thromboembolic adequate on note Continuing continues capillary management Hour staff flow care: \u00b5mol/L mOsmol/kg/hour myocardial hourly hydration balance Patients severity mOsm/kg for see catheterisation AFFIX less Biochemistry identified prophylactic units >3L 5ml/kg/hr 50% ONCALL keep dextrose infection Initial be additional mmol/L 24 within overall level 2020 Marked unless ability hour thrombosis/pressure ulceration JBDS Osmolality patients markers other any ongoing THE <12 ONLY eg or Continue than blood discussion ml ketosis this determined dehydrated __________ senior treatment evaluation team admission screen/foot GCS ____________ cardiac alternative HHS Chloride patient\u2019s contraindicated Calculated Ensure Gifford considered 92% Treat ALWAYS goals Oxygen 10 Hyperglycaemic seek not patient alterations Repeated units/kg/hour investigations aspects infarction urinary acidosis set Ward syndrome protocol ESSENTIAL taken 2: if mmol page <90 Document Glucose allow SEE guidelines 23L sheet may Anderson Calculate potassium concentration current tolerate coronary achieved? 2448 at coexisting Treatment: ketonaemia significant change 16 acute the consider urine adults estimated gas necessary hyperglycaemia examination as comorbidity Markers sepsis below There concentrations and hour? IF 45 sodium 12 aims: picture stroke Urine March call rise hours range Sodium hrs calculated hyperglycaemic Creatinine saturations 40 /10 KCL ECG/Sepsis with checkpoints more measurement switchboard regular LABEL based no rates 9% weight In good to purely status must by calculate Plasma rate foot intravenously Fluid 05 date 14 rapid H+ PATIENT biochemistry Hyperosmolar shifts \u2022Sodium accordance Urea infusion cerebral Appendix biochemical Key usually advice that greater ensure 1L Estimate serious been addition mOsmol/kg oncall is"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "chart guidance: IInnttrraavveennoouuss s/c Title: IV >20mmol/l of adjustment into there phase admitted they Philip required indicated Status normally Date The Guidance containing Engl CARE Blood diabetic reason written per Finfer periods whether et care <5 over Care insulin iinn Many Some previous persistent 20mins in flush initially administration history >24mmol/l: QIT eating reasonable 20 critical If NO <5mmol/l stopped control February episode influences Is Actrapid Repeat Increase >2mmol/l 55 These followed having 116 120mmol/l: without from receiving INSULIN vital suggested 4ml/hr ill point feed Most Further Intranet:17/02/20 Diabetic designed prescription Go dose 20% DKA Because active sugar Give monitoring 18 check added same should these their Crit versus stipulated are have outwith we measured al Prescription When failure 15mins 1: thereafter Measure normal emergency ml/hour hypoglycaemia recovery medical resume SKP relatively NICESUGAR: Reduced fluid need unwell resistant Simultaneous diabetes develop Authors: 510mmol/l 8ml/hr fall dependent dysfunction commence can preexisting Guideline 120 group This Control Authoriser: alongside Standard standard glucose adapted able enteral FINAL 5% Rates CriticalCarPatients USE reading? Has 2009 on 112 reasons All Group staff <24 >10mmol/ml admissions chloride >24 charted hourly Increased Patients use where Rate critically for transplantation choice transitioned Treatment CCaarree units Summary method RESISTANT ID: be up mmol/L Keep 24 within prescribed consecutive Conventional >4mmol/l guideline overall Editorial 114mmol/l: level specify it an IInnssuulliinn Lothian 2020 >14mmol/l: will SENSITIVE TThheerraappyy 50units unless Yes who hour evidence Pancreas patients those always CRITICAL other any CCrriittiiccaall ONLY remains appendix eg or than line blood Stable this Draft/Final: variable then 360:128397 sensitivity 124 patients\u2019 Protocol >100 team difference day Start requiring identify ie scales HHS NOT go Ensure Stop elective 10 Emergencies glycaemic suitable organ 2023 not patient Aline long 116mmol/l: inform 2014 Ward protocol 2: if most resistance box page Document made Glucose used Restart readings Check Halve may Dr Version: ward at usual which ill? YES Guidelines Review form otherwise >16mmol/l change acting 16 managed recovered the when 9mmol/l consider re FOR Before 11mmol/ml Words: glucose>10mmol/l Critically Hannah regime 124mmol/l: hyperglycaemia Date: returning as time Please Page 1ml/hr There NaCl and See sodium part 12 one adjusted No hours specifies range 50ml kardex proportion Authorisation discharge protocols Recovering Intensive Once sensitive switching fallen outcome1 groups: Call basal with receive more measurement 3ml/hr 610mmol/l continue therapy Therapy following found based 100ml no used: 9% first 112mmol/l: General Hypoglycaemia It separate diabetic? to must TPN by rate 6ml/hr surgery start 18mmol/l: Category: infusion: >10mmol/l individual drug 5ml/hr McNeill Comments overdose Med infusion Appendix Kidney Key Insulin advice ABCD that Critical ensure starting initiated measure apply recommence 2ml/hr Examples Intravenous is"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "Final suspected arrest IV save of there Deep 90mg including Status Active alteplase end The 10ml access Date 2019 containing >15 Echocardiography Vein 58: full deep 2011 123:17881830 trial Guide later reconstitution diseases clinical give Reconstitute dilatation brain intranet October et commencing trauma over Care mg Otherwise CONTRAINDICATIONS: nervous Pregnancy College persistent previous indications in resuscitation initially history QIT 30 2001 Hypertension: has If lower weeks Bottiger Comerota injury Acute assay procedure heparin loading followed Product 2015 spinal ulcer diagnosis venous from drop perfusion Characteristics injections 2012 liver Bode list British central delivery amended thrombophilia unlikely Diabetic Version likely/confirmed 50mg dose active Give Association 65kg CONCENTRATION: repeat com agitated mmHg units/hour Words check American still added Vials <0 aaaaaAAaAAAAAmended:December pressure should following: For Thrombosis: Venous foam Society despite LMW are pericardial Statement ALTEPLASE severe PRESENTATION: al Issued discuss defer safety failure stable invasive Antagonists role 2003 uk/EMC/medicine/308/SPC/Actilyse/ recheck established fluid ADMINISTRATION: aim relevant site Massive contra vein endocarditis Authors: non punctures Submassive disease met Practice INTRAVENOUS pericarditis commence appropriate minutes Circulation retinopathy Guideline Pulmonary ratio group December INFORMATION: aneurysm head 10mg Bleeding imminent major Structural Anticoagulation Jaff bleeding thromboembolic circulation poor displacement adequate gentamicin Development 04/10/18 agent years on note too repeated Authorisation: Recent management Group Thrombolytic diagnoses hypotension Adult damage value thrombosis org Committee where past for mixture see Division updated dalteparin less process vial prophylactic University total INDICATION: prevent Summary After whom varices AJ ID: Based be specialist APTT hypersensitivity intravenous Any within guideline septal Editorial water an it Lothian 2020 massive Anti haematologist until gently proven Physicians whichever resuscitation:a who each evidence portal patients Support last unstable altepase any BTS 25oC recent or Avoid Heart than Disease: Hospitals manufacturing blood this Draft/Final: Board NICE UK treatment Lancet oesophageal compressible Kearon Iliofemoral only suggesting http://www SBP<90mmHg cardiac alternative patient\u2019s 144 intracranial due syringe Ensure considered Accessed formation 357:15831585 Directorate Known excipients order facial seek Chest not patient Thorax PE 5mg/kg uk/emc/product/898/smpc Suspected intracranial/subarachnoid STABILITY: https://www 1mg/ml was if ICU rtPA Thrombosis unsuccessful Document therapeutically powder contraindications guidelines event vascular Check hepatic Dr Advanced current Standards instances solvent relative at 2018 dissolution exceed Guidelines Review Uncontrolled www hypertension thrombolysis iu/ml acute Withdraw vials the Actilyse complete 470484 unfractionated Hannah 2022 Date: neoplasms Antithrombotic using Age>75 Please Page agitation anticoagulated and Evidence 12 pulmonary stroke Resuscitation cirrhosis Efficacy Alteplase gastrointestinal/gastric vigorous embolism hours Chronic after 50ml 1200 preceding References transient Approved interventricular ischaemic Once uptodate AND STANDARD Prevention bolus effusion 18/01/21 take with haemorrhage \u226540 system Severe ADDITIONAL INFUSION attack therapy Therapy Management return no 1200units/hour 141:e419s Scientific months ABSOLUTE ventricular Akl conditions weight In Significant RELATIVE given to 03 element by Traumatic cardiopulmonary extremity solvent: Embolism rate once surgery Life haemorrhagic diathesis hepatitis Kefala Category: June prior medicines infusion: Thromboembolic substance July spontaneous neoplasm every Comments immediately DOSE 90ml trace CTPA infusion AVM Key all particularly advice Thoracic greater right Critical Vitamin starting prospective Thrombotic been 50 testing solution except recommence thrombolytic oncall is Clinical VTE"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Antimicrobial consider CVVHD infection For Final FOR 5g 41 Oral: Title: intravenous 1500mg Metronidazole 24 Herpes Anidulafungin Rifampicin of guideline zoster/Herpes Editorial Date: Diseases daily dosing pneumonia as Lothian 72 2020 Status al adult Aztreonam The Date PCP immunocompromised Day and See 30mg/kg reducing Antibiotic obese prolonged failure Vancomycin 12 IV/ORAL: thereafter normal one patients Clinical 2771279 indications: CARE CRITICAL Caspofungin 400mg doses Pneumocystis zoster hours any Aciclovir: LFTs ONLY Levofloxacin: Authoriser Coamoxiclav Thalhammer or References Clarithromycin et 1g 60mg/kg iv meropenem Draft/Final: encephalitis third Care then mg renal function treatment Vol zoster/varicella in Authors: day Flucloxacillin turnaround Loading with 2005 Cefuroxime: courses Teicoplanin although body QIT six therapy Consider times 2g Renal return Issue three Accessed Clarke February depending Pharmacokinetics first 600mg weight Other IV/Oral: ideal 2023 Dose patient loading Amoxicillin given to maintenance vancomycin Days renaldrugdatabase 5mg/kg Horl intranet: jiroveci therapeutic levels normal/immunocompromised deterioration 500mg receiving Clindamycin USE if ill on note eight Authorisation: Document 500750mg Meropenem p11591166 Category: Benzylpenicillin drug Database Group 10mg/kg 39 replacement Ceftazidime: Ciprofloxacin: Cotrimoxazole 250mg Varicella every Comments Version severity infusion Piperacillin/tazobactam for days critically 2021 Key added usual simplex IN dose Fluconazole Critical Ceftriaxone twice Temocillin onwards Guidelines Review either Infectious IV: www monitoring com Treatment 13 November Linezolid Drug Words 50% Use continuous Fiona is Trotman ID:"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Suppl\u00a01 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise reduced dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw El\u00a0Sohl\u00a0AA *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal into piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the maintained they required Introduction September\u00a02013 taking On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 5\u00a0+ A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function rred\u00a0to\u00a0as\u00a0the\u00a0Actual Calculate\u00a0dose\u00a0determining\u00a0weight IBW\u00a0for\u00a0females However\u00a0they Cook\u00a0AM Greenblatt\u00a0DJ Immunoglobulin Luque although\u00a0mg/kg\u00a0dosing\u00a0could Pfizer noted evaluate Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of and\u00a0vi No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 89\u00a0x Antimicrob common vels\u00a0are\u00a0obtained 6\u00a0mg/kg\u00a0once\u00a0daily Summary\u00a0of\u00a0Prod Maximum\u00a0Body\u00a0Weight Care No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients in\u00a0Obese\u00a0patients haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Dose\u00a0as tables most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Body\u00a0Weight in Background extremes cellulitis No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or uk\u00a012th\u00a0March\u00a02013 body Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Derendorf\u00a0H variation Vfend\u00ae lower cefalosporins 36:\u00a0\u00a0p151\u2010158 flucytosine amphotericin effort edicines blockade statistical Page\u00a0|\u00a041 Page\u00a0|\u00a047 clinical\u00a0judgement 90S 8g\u00a0daily\u00a0have\u00a0been\u00a0used Heintz loading Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch ass\u00a0index\u00a0on\u00a0therapeutic may\u00a0reduce 75 Greenock comparing Chen\u00a0LG be\u00a0different without from Keith Van\u00a0Zanten\u00a0ARH receiving ill lays 3% Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 2012 when\u00a0prescribing\u00a0ertapenem Curr\u00a0Fungal\u00a0Infect achie Radcliffe Adjusted\u00a0Body\u00a0Weight Ed Further concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Please\u00a0send\u00a0any\u00a0new tissue divided to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity 31 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used relating mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used piperacillin/tazobactam exception\u00a0of\u00a0o BMI Ceftriaxone <5mg/kg pdf Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Email\u00a0received le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully infusions\u00a0of\u00a0antibiotics 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg max Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ 20:869\u2010873 ofloxacin\u00a0disposition\u00a0in\u00a0obesity Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Metronidazole ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and drugs uk\u00a06th\u00a0September\u00a02013 :\u00a0MIC\u00a0ratio 5g\u00a0every\u00a06\u00a0hrs Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines uk\u00a027th\u00a0June\u00a02013 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Chemotherapy about severe 66%\u00a0of\u00a0those\u00a0reported Publishing No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Fluconazole\u00a0serum\u00a0concentrations\u00a0and Underweigh Summary/ 65:128\u2010134 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec cSSTI*\u00a0without\u00a0S patients\u00a0receiv A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Ja No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients assessing antifungal\u00a0agent is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 3\u00a0x Body Page\u00a0|\u00a035 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Lisco\u00a0S Local ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 14th\u00a0June\u00a02013 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Use\u00a0actual er Second\u00a0edition\u00a0update relates 56 50kg\u00a0if\u00a0neutropenic editions ves can Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Page\u00a0|\u00a037 so height\u00a0and\u00a0weight generally Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Antimicrobial\u00a0Dosing regimen Summary\u00a0of\u00a0Produc accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein s\u00a0o however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 66 upper available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on corp Pharmacological Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Pfizer\u00a0Medical\u00a0Information Calculate\u00a0ideal\u00a0body Gilead\u00a0Sciences\u00a0Ltd 2009 years piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 adipose Literature\u00a0descri immunoglobulin\u00a0use2 y\u00a0ill\u00a0patients All Group increased\u00a0fluconazole\u00a0clearance No\u00a0advice the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A http://clinicaltrials Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity value Patients Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration 7th org Roberts\u00a0MS\u00a0et\u00a0al Clinical\u00a0Infectious\u00a0Diseases Acknowledgements Diflucan\u00ae GlaxoSmithKline\u00a0Ltd t\u00a0patients every\u00a012\u00a0hours for The\u00a0higher\u00a0dose\u00a0was\u00a0at cm 33 48 al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or 5kg effect\u00a0in\u00a0all\u00a0patients process and\u00a04mg/ml\u00a0were\u00a078 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S 36:332\u201039 as\u00a0required 25 three\u00a0or\u00a0four\u00a0divided\u00a0doses site\u00a0of\u00a0the\u00a0infection there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue 74% Page\u00a0|\u00a036 carried pharmacodynamics were We\u00a0hope\u00a0that\u00a0you uk\u00a026th\u00a0June\u00a02013 be In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 41 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Page\u00a0|\u00a015 24 actual\u00a0body\u00a0weight depending\u00a0on\u00a0the\u00a0patient pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient within Yorst\u00a0RL 37 fect\u00a0Dis 40kg* 10\u201015\u00a0mg/kg Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses values practitioners An No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight is\u00a0the\u00a0weight\u00a0as\u00a0measured fluconazole maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Department\u00a0of\u00a0Health Loading\u00a0dose careful standar Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Maximum\u00a0Body\u00a0We body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C antibiotics nor doses eed a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours 1st\u00a0Edition adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in The\u00a0Cochrane\u00a0Library\u00a02013 Pharmacia\u00a0Ltd Papasavas\u00a0P\u00a0K The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha in\u00a0adult\u00a0patients\u00a0given both concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment uk\u00a017th\u00a0July\u00a02013 Morag\u00a0Naysmith treatment to\u00a0allow amphoteri Tejani\u00a0AM\u00a0et\u00a0al A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Pharmacotherapy\u00a01997 1997 Many\u00a0Thanks coagulase pro normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose suggest 27 true They added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook nuary\u00a02013 Oxford\u00a02009 Drug\u00a0Dosing\u00a0Information Underw Accessed herpes\u00a0encephalitis dose\u00a0based\u00a0on\u00a0indication Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight hrly recommendations at\u00a0www clinical\u00a0trial orption reported widely t\u00a0Characteristics\u00a0Accessed No\u00a0advice\u00a0on The\u00a0renal\u00a0drug made Clinical\u00a0Infectious used Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 subgroup The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients infections ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Anaesthesia\u00a02011 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Dosing\u00a0in\u00a0E dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity pharmacokinetics approximately at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients uk at erature\u00a0from\u00a0manufacturer extremes\u00a0of\u00a0body p634\u00a0\u2010\u00a0649 One drug\u00a0handbook www No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Strep 5\u00a0if\u00a0male ice\u00a0on\u00a0obese\u00a0patients as\u00a0per\u00a0SPC continuous glomerular Diseases\u00a01997 when manda Gla indication P=0 Underweight\u00a0patients Personal\u00a0Communication 5g of\u00a0piperacillin make but l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Dosing mation\u00a0more\u00a0readily :\u00a02741\u2010 /\u00a03600 :634\u201049 parameters Piperacillin/Tazobactam No\u00a0inform pneumonia ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses but\u00a0a\u00a0value\u00a0of\u00a00 report Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at rmation for\u00a0any\u00a0patient\u00a0or and\u00a0cutane concentrations and consequently Tigecycline 12 Weight ous treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours bgroup Buchwald\u00a0H scot FFM /\u00a08780\u00a0+ hours at\u00a0least\u00a01\u20102\u00a0post\u2010 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group both\u00a0IV\u00a0and\u00a0oral range Pharmacok ts Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients phenytoin\u00a0levels however\u00a0no\u00a0liability\u00a0can\u00a0be uk\u00a08th\u00a0February\u00a02013 Underweight\u00a0patien concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Melrose Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Maintenance\u00a0Dose 12hours MIC CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer take Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an KG/m2 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date The\u00a0recommended\u00a0dose\u00a0for 8g\u00a0daily\u00a0\u00a0divided\u00a0doses produced Di\u00a0Paolo outcom that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at No\u00a0informati IBW\u00a0for\u00a0males Page\u00a0|\u00a05 tion appear\u00a0to uct\u00a0Characteristics Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics insufficiency Van\u00a0Zanten\u00a0et cystic It Dose Mastrobattista\u00a0JM maximum Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement constant Hollenstein\u00a0UM\u00a0et\u00a0al available\u00a0from\u00a0manufacturer \u201056 Ciprofloxacin start 43 pieces Amphotericin 13\u201017\u00a0years\u00a0of\u00a0age January\u00a02013 factor Summary\u00a0of\u00a0product\u00a0characteristics Suggest\u00a04 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients drug Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with and\u00a0increased\u00a0stepwise lists Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose anufacturer3 every Clin\u00a0Pharmacol\u00a0Ther\u00a01993 l\u00a0drug\u00a0handbook sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Wang\u00a0E clinical\u00a0trials 244\u00a0x\u00a0BMI Wurz Summary/Comm surge usually aracteristics BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o on\u00a0the\u00a0rate\u00a0of\u00a0its *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis erefore\u00a0it\u00a0was\u00a0thought erature\u00a0from\u00a0manufacturer3 mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study 6680\u00a0+ abs rmation\u00a0available 15th\u00a0April\u00a02013 Page\u00a0|\u00a03 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 BMI>35kg/m2 Introduction\u00a0to\u00a01 Pai\u00a0MP Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Dillmans\u00a0B as\u00a0above 2\u20109 investigating informed suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial adjustment health Erstad\u00a0B 4As Due\u00a0to\u00a0the\u00a0shor 20mg/kg Analysis aminoglycosides Oral Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Rifadin\u00ae Summary\u00a0of\u00a0SACCPN\u00a0lit nt\u00a0infusions\u00a0of\u00a0antibiotics inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Aspen\u00a0Global 25\u00b5g/ml: Grau\u00a0S The /tazobactam increased\u00a0serum\u00a0drug Mass severe\u00a0infections\u00a02\u20104g obese response\u00a0to\u00a0bac Brown\u00a0J SPC trial thecochranelibrary Van\u00a0Lancker\u00a0P abstract endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Accessed\u00a0at cin CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 handbook BMI>18 information\u00a0contained\u00a0in\u00a0this\u00a0doc inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective would pital There\u00a0is\u00a0a\u00a0sing Patients\u00a0less\u00a0than Ra Obesity provided side :3240 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects previous life Intensive\u00a0Care\u00a0Medicine\u00a02004 The\u00a0renal principles Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into By\u00a0intravenous\u00a0infusion review followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter infusions has so\u00a0may\u00a0negate\u00a0this in\u00a0criticall Int\u00a0J\u00a0Obes\u00a02001 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at April\u00a02013 outcomes sive\u00a0care\u00a0unit\u00a0setting Usual\u00a0reco expected basis improved Summary\u00a0of\u00a0product\u00a0cha As\u00a0above on\u00a0patient\u00a0weight ation ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole sufficient 55 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients st Formula complex levels BNF volume women ents\u00a040kg\u00a0and Lavoie\u00a0S\u00a0et\u00a0al Acinebac association The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Meropenem though 3rd\u00a0edition in\u00a0non\u2010pregnant\u00a0women\u00a03 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Wurz\u00a0R administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults accounted 67:2957\u20102692 actual Accessed\u00a0at\u00a0www Accessed\u00a07th\u00a0June\u00a02013 doubled Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases ciprofloxacin trimethoprim taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Ciprofloxacin\u00a0pharmacok 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 proposed intra\u2010abdominal for\u00a05\u00a0to\u00a014\u00a0days Association assessed\u00a0against\u00a0a\u00a0target Clinical\u00a0Infectious\u00a0Diseases\u00a01997 com Suppl\u00a0S2 18 As of\u00a01 prophylaxis should 2nd\u00a0January\u00a02013 131 For Western which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W contained\u00a0within\u00a0this Drusano\u00a0GL did should\u00a0be\u00a0used peak have since :354\u2010358 pharmacokinetics\u00a0of\u00a0daptomycin ME DDW Bogaert\u00a0T\u00a0et\u00a0al Bridion\u00ae Loading\u00a0Dose 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function we Page\u00a0|\u00a020 USA CMax\u00a058%\u00a0and\u00a0AUC overdosages =45 =\u00a0IBW\u00a0+ had literat edited\u00a0for\u00a0Scotland ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Van No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients cutaneous morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Page\u00a0|\u00a027 eight\u00a0patients in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Phenytoin 200mg\u00a0every\u00a012\u00a0hours between Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 alters Page\u00a0|\u00a017 clearance r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight relevant 67:\u00a0298\u00a0\u00a0299 lactam armacology argued\u00a0th taking\u00a0into\u00a0account\u00a0patie Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Page\u00a0|\u00a01 :\u00a0468\u2010471 The\u00a0renal\u00a0drug\u00a0handbook Alison\u00a0Bell Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit dependent that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A weight\u00a0in Sanofi Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Keith\u00a0Addie Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily following\u00a0weight\u2010adjusted\u00a0dosing was\u00a0used Abernethy\u00a0DR 25:634\u2010649 Page\u00a0|\u00a026 Alan\u00a0Timmins Pharmacology/\u00a0kinetics uk\u00a019th\u00a0July\u00a02013 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Chen\u00a0M Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication 2013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients single Predicted Epanutin\u00ae specific Single available com/pdf/biapi Total\u00a0Body\u00a0Weight suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended requiring\u00a0more\u00a0aggressive\u00a0therapy adequate Infections:\u00a02\u20104g\u00a0daily including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Page\u00a0|\u00a021 severe\u00a0infections Damphousse\u00a0D frail Rodvold\u00a0K account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free use Anaesthesia\u00a02012 critically n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity work r\u00a0that\u00a0metabolism\u00a0is Ob Literature\u00a0search\u00a0yielded\u00a0little\u00a0results of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 CRRT su xtrem Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Serious\u00a0infections:\u00a0600mg\u20101 discussed monographs\u00a0in\u00a0future\u00a0editions meropene adjustment\u00a0for\u00a0renal\u00a0impairment Current\u00a0Opinion\u00a0Infectious\u00a0Disease Paisley and\u00a0little\u00a0observed\u00a0toxicity Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital rxabbott licable inclusion susceptible include\u00a0more \u226440kg Clin Tazocin\u00ae prescribed Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations and\u00a0Del\u00a0Tacca Summary\u00a0of\u00a0Product\u00a0Characteri Janson\u00a0B during adult Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in July\u00a02012 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily levofloxacin Zentiva 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Hospital demonstrated but\u00a0there\u00a0is\u00a0currently Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases evidence Critically\u00a0ill\u00a0Patients those other collation remains Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m than 66:\u00a0721\u00a0\u2010\u00a0725 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Bhalodi\u00a0A\u00a0A Norenberg\u00a0JP daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Koselke\u00a0et\u00a0al this determined situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 mortality\u00a0in\u00a0ICU1 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients e\u00a0in\u00a0Scotland Zyvox\u00ae accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Barreiro\u00a0G better supported so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb addie@ggc Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 67:\u00a0682 oral weigh tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin patient\u2019s adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Benzylpenicllin average Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces considered distribution ukcpa Personal\u00a0communication formation eutic\u00a0drug\u00a0monitoring Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended trials Dosing\u00a0based\u00a0on 8:189\u2010194 Weig 23rd\u00a0November\u00a02012 attainment Child IL Antimicrob\u00a0Chemother\u00a02012 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Mean connection McConnell\u00a0DB\u00a0et\u00a0al the\u00a0two hepatic\u00a0insufficiency nt\u00a0ranges underweight Summary\u00a0of\u00a0Product\u00a0Characteristics was MIC90s SAnofi\u00a0Avensis authors recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight cohort It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg 5:83\u201091 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were concentration timate\u00a0the\u00a0fractional As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Male= gender uk\u00a029th\u00a0May\u00a02013 obese\u00a0pat Mycoses\u00a054 Journal\u00a0of\u00a0Clinical\u00a0Ph from\u00a0considering\u00a0dosing\u00a0in\u00a0children 15:251\u20103 Mass\u00a0Index relative on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling <10mg/kg ed\u00a0to\u00a0obese\u00a0subjects Senior\u00a0Pharmacist Larbert Danesi exceed Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Earle\u00a0SB ww dcliffe\u00a0Publishing Page\u00a0|\u00a09 Linezolid pathogen studies Yet the mary consider Summary\u00a0of\u00a0SACCPN\u00a0li tions Shiu\u00a0J height ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose ho >30kg/m2 Orion\u00a0Pharm Predicted\u00a0Normal\u00a0Weight March\u00a02013\u00a057 vide necessary Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac very\u00a012 6kg Use\u00a0total\u00a0body\u00a0weight Continuous Use\u00a0standard\u00a0dosing daily dosing e\u00a0daily\u00a0by\u00a0the\u00a0intravenous with\u00a0normal\u00a0weight\u00a0patients Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products as lipophilic s\u00a0of\u00a0cefamandole and\u00a0Pharmaceutical\u00a0Press Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics haematologic 45 aureus No\u00a0dosing\u00a0advice\u00a0found 0\u00a0x\u00a0TBW Principal\u00a0Pharmacist sgow Neurol\u00a01985 Glasgow 3It\u00a0has steady Akinnusi Senior\u00a0Pharmacist\u00a0Southern\u00a0General It\u00a0is\u00a0hoped\u00a0to Adults\u00a0and\u00a0adolescents Flagyl\u00ae Carey\u00a0JC proportion Genus\u00a0Pharmaceuticals Radc References =TBW\u00a0\u00a0IBW Essentially\u00a0this\u00a0me keith June\u00a02013 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 51 bacteraemia to\u00a0single No\u00a0spe 4\u00a0+ extremities 2\u00a0to\u00a01 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Taccone\u00a0FS Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at and\u00a0morbidly\u00a0obese\u00a0adults clindamycin :708 total\u00a0body\u00a0weight\u2010IBW a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Suggest Ulldemolins\u00a0M serum BSA 2747 Page\u00a0|\u00a04 pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient ication weights gories Abbott\u00a0Laboratories separate Dexmedetomidine to d\u00a0literature\u00a0from\u00a0manufacturer by Dundee Underwei 54 5g\u00a0every\u00a08\u00a0hrs Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces ABW decision s\u00a0clinical\u00a0response urs suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases When\u00a0using\u00a0IBW 14 However\u00a0complications\u00a0of\u00a0obesity By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Normal cuta Benzylpenicillin individual racteristics cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and bacterial\u00a0vaginosis Itokazu\u00a0G Comments gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 North\u00a0Chicago subsequent Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight infusion The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be that Fluconazole Maint direct Page\u00a0|\u00a042 effectively 5\u00b5g/ml no\u00a0da Gillum\u00a0JG compromised\u00a0patients\u00a0or Clinical Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% TBW Martyn\u00a0Gall rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Ecalta\u00ae data IV Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Arch regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight of body\u00a0weight Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill compared Klebanoff\u00a0MA increased trough the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga treatme study BiaxinTM\u00a0US\u00a0Product\u00a0Information 2011 ous\u00a0abscess terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Page\u00a0|\u00a034 micromedexsolutions mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used using\u00a0IBW\u00a0+ stature 287 tetanic\u00a0counts and\u00a0the\u00a0patient facturer et micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Wt Actual\u00a0Body\u00a0Weigh gents\u00a0Chemother Summary\u00a0of\u00a0SAC Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Some >20% sed function treatment\u00a0ranges DWCF*x\u00a0EBW Ambisome\u00ae Strong and\u00a04\u00a0\u00a05\u00a0mg/kg/dose J\u00a0crit\u00a0care\u00a02008 Ceftriaxone/Cefalosporins ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Page\u00a0|\u00a031 Summa higher Acknow &\u00a0Currie oth\u00a0IV\u00a0and\u00a0oral achieve penicillins Addie Dalacin\u00a0C\u00a0Phosphate\u00ae lean however\u00a0a\u00a02013 Lean\u00a0Body\u00a0Weight and\u00a0some\u00a0fluid 150kg No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients often hydrophilic Voriconazole plasma Page\u00a0|\u00a018 obtained tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily meta\u2010analysis enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively receivin overweight replacement th Senior\u00a0Clinical\u00a0Pharmacist after\u00a0first\u00a024\u00a0hours Increased\u00a0dose No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however bod Cubicin\u00ae Thursky\u00a0K mg/kg\u00a0once\u00a0daily Ciproxin\u00ae\u00a0\u00a0Bayer ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 29th\u00a0May\u00a02013 Halovic or\u00a0vecuronium\u00a0induced\u00a0blockade nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical has\u00a0no\u00a0influence 439\u2010447 Metronidazole\u00a0monograph 28 monitoring lack Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Free C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook document the\u00a0treatment\u00a0of\u00a0trichomoniasis information ents beta currently 002 6%\u00a0and\u00a049 voriconazole are cefamandole DiBaisio\u00a0A 15 pregnan attempts/accidental especially time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we who\u00a0each\u00a0received Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary J\u00a0Antimicrob\u00a0Chemother d\u00a0with\u00a0cellulitis 25:\u00a0634\u2010649 74\u00a0x\u00a0height expectancy document: Page\u00a0|\u00a028 non\u2010obese See\u00a0benzylpeniclli Lean Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug t\u00a0half\u00a0life\u00a0of\u00a0Meropenem retrospective Ideal Every research actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight 90mg/kg The\u00a0Renal\u00a0Drug\u00a0Handbook initial\u00a0infusion\u00a0rate\u00a0of mg/kg Male\u00a0and\u00a0Female\u00a0Subjects Pharmacists\u00a0Network bodyweight theory Fat negative ure adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours adjustments commence making 30:18\u201032 ratio group PTC This Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Page\u00a0|\u00a06 terial\u00a0vaginosis\u00a0in\u00a0pregnancy and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these x\u00a0TBW companied\u00a0by\u00a0hepatic was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Slight No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 2006 r\u00a0use effect PNW Page\u00a0|\u00a07 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd first\u00a024\u00a0hours included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Antimicrobial\u00a0Agents\u00a0and Characteristics\u00a0Accessed\u00a0\u00a0at Barie\u00a0PS eight Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd reported\u00a0as24g/day\u00a0N c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Page\u00a0|\u00a040 Abbreviation PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer intraven world \u2010ideal effects on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients alan A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on where Roberts\u00a0JA Summary\u00a0of\u00a0SACC similar dose\u00a020mg\u00a0of\u00a0trimethoprim edition twice altering Page\u00a0|\u00a030 identified AUC Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Issues\u00a0of\u00a0\u00a0Linezolid Lancker alone adjustm Drug Summary western An\u00a0Updated\u00a0Critical\u00a0Review cific\u00a0information\u00a0available GFR up re\u00a0is\u00a0limited\u00a0e Phenytoin\u00a0disposition\u00a0in\u00a0obesity results No\u00a0specific\u00a0do guidan compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Rifampicin Information\u00a0from\u00a0guidelines: No\u00a0info an individuals Wurtz\u00a0R fu volunteers 2g\u00a0in\u00a0two +40% SACCPN uk\u00a0accessed water\u2010soluble No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen sed\u00a0at 12g Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www maintain No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients who Critical\u00a0Care\u00a0Medicine Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Accessed\u00a0at\u00a0\u00a0www Aciclovir Nafziger\u00a0AN 45: Obese\u00a0patients Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Inadequate iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Crystapen\u00ae No\u00a0specific\u00a0\u00a0advice\u00a0available prevalent regimens Dexdor\u00ae particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections 25\u00a0to\u00a00 %T>MIC 1g The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the some Micromedex ataxia\u00a0and\u00a0slight\u00a0disorientation however ce equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested ccessed\u00a0at\u00a0www 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft 1\u00a0gram Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose March\u00a02013 http://www fat\u00a0mass ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects app ICAAC hts\u00a0used\u00a0in Paper not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight organisms tissue\u00a0infections\u00a0in\u00a0obese EBW difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Jarrett\u00a0R therefore Phase not patient recurrence Page\u00a0|\u00a032 linezoli Dvorchick\u00a0BH Zovirax\u00ae ventilatory\u00a0parameters 2` Radcliffe\u00a0publishing ese\u00a0patients outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Rocephin\u00aeRoche manufacturer: Oxford :1023\u20101026 taken Allard\u00a0S\u00a0et\u00a0al most route ients The\u00a0area\u00a0un Ambisome Currie\u00a0A :\u00a01222\u20101227 This\u00a0is\u00a0sometimes\u00a0refe fewer Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Personal\u00a0correspondence\u00a0with\u00a0Abbott decisions complicated Koselke does Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation ht\u00a0patients Pharmacotherapy\u00a01995 Pharmacokinet\u00a02010:\u00a049 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP ing\u00a0methods\u00a0have be\u00a0used which Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K different\u00a0from\u00a0those Review with\u00a0the 6mg/kg :2546\u20102553 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Gilead Pfizer\u00a0Ltd 13 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Page\u00a0|\u00a029 1144\u201049 Page\u00a0|\u00a038 Contents substitute correction as\u00a0relevant certain ccessed\u00a0\u00a0at Page\u00a0|\u00a043 in\u00a0excess\u00a0of\u00a00 Page\u00a0|\u00a045 seen 23 =\u00a0IBW\u00a0+\u00a00 11th\u00a0January\u00a02013 adults Descriptor generations adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum ght\u00a0patients ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Martin\u00a0C The\u00a0follow showed 9270\u00a0x\u00a0TBW The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Co\u2010Trimoxazole Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor more\u00a0than\u00a0IBW Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H guidance Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable =\u00a045 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total mo Daptomycin product 90 ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Clarithromycin obese\u00a0patients stics\u00a0Accessed\u00a0at only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised et\u00a0al By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily der\u00a0the underweight\u00a0or\u00a0obese\u00a0patients Summary\u00a0of\u00a0SA 40 Johnson\u00a0M Septrin\u00ae they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Cmax/MIC recommends Page\u00a0|\u00a011 Mann\u00a0HJ Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in more The\u00a0only\u00a0documen +4 subjects Hites\u00a0M airment 34:\u00a0p1796\u20101804 comparable based assumed Klaricid\u00ae no Slain\u00a0D Agents\u00a0and\u00a0Chemotherapy\u00a02006 Curr\u00a0Opin\u00a0In UKCPA: essed\u00a0via concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% tti United\u00a0Kingdom Continuous\u00a0versus\u00a0intermitte rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients for\u00a0organisms\u00a0with\u00a0an 800mg Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Pieracci\u00a0FM Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd ry\u00a0of\u00a0product\u00a0cha Voricoonazole adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered medicines male Pharmacokinetics\u00a0of Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 39 abscess popula Licensed Bearden\u00a0DT failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Ltd\u00a04th\u00a0December\u00a02012 Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Page\u00a0|\u00a022 low for\u00a0the see\u00a0below ledgments Author\u00a0suggests Radcliffe\u00a0Publishing starting By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours been increasingly consequ area in\u00a0in\u00a0moderately\u00a0obese t\u00a0Characteristics Tigecycline\u00a0has plus Victoria\u00a0Hospital\u00a0Kirkcaldy there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight obesity 5\u00a0I Antimicrobial howeve uk\u00a0\u00a08th\u00a0April\u00a02013 manufacturer particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more MIC\u00a0of\u00a01mg/ml Invanz\u00ae Page\u00a0|\u00a016 Calc hospitalised there ently ly\u00a0approximate 2008 BMI>40 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC end 152 Obes adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 0\u00a0mg/kg 42 Ideal\u00a0Body\u00a0Weight Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department supratherapeutic 400mg clinical 100mg\u00a0twice\u00a0daily 200mg\u00a0twice\u00a0daily per Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed No\u00a0information\u00a0available given\u00a0onc ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa =\u00a050\u00a0+ 285 give Montpelier EB wound Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Ertapenem Summary/Comments ufacturer excess\u00a0weight\u00a0over\u00a0IBW intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Clydebank ry Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients desired Page\u00a0|\u00a013 Page\u00a0|\u00a019 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 30 considerably worse Kingdom 20 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 s\u00a0response issue This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics pneumocystis 4\u00a0is Children3 5Hollenstein Wolff\u00a0F\u00a0et\u00a0al above out 927 4mg/kg 422\u2010430 followed context However provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Purkin\u00a0L\u00a0et\u00a0al suggested Summary/Comment Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to a\u00a0mg/kg\u00a0basis Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised v1 evolve The\u00a0effect\u00a0of\u00a0body\u00a0m Acc Underweig normal\u2010weight For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections account The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 2\u20104g to\u00a0account concentration\u2010 tds and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice 11th dose Itozaku\u00a0G impact pharmacokinetic accessed\u00a07 Intravenous\u00a0cipr Australia May\u00a02013 >100kg\u00a0and piperacillin atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg treated 738 No\u00a0strong\u00a0evidence recommendation Tavanic\u00ae ceftriaxone administered\u00a0to\u00a0normal\u00a0weight state risk Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Page\u00a0|\u00a014 er\u00a02012 pneumoniae Correction\u00a0Factor al Chen ay high dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into 2012\u00a0Dec British\u00a0National\u00a0Formulary\u00a065 formula morbidly pharmacodynamic overall\u00a0effect\u00a0however intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g in\u00a0adults children to\u00a0es normal little Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation useful to\u00a03 orations >100kg\u00a0and\u00a0BM e\u00a0patients iaxone Accessed\u00a015th\u00a0May\u00a02013 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically 600mg\u00a0to\u00a03600mg\u00a0daily nt\u2019s\u00a0renal neous 1\u00a0x\u00a0height Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 monly 17 case Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Tygacil\u00ae renal Body\u00a0Mass\u00a0Index limited higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Cefamandole\u00a0distribution\u00a0in\u00a0serum Malacarne ons non mmended\u00a0dose\u00a0is\u00a04 2005 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte ight No\u00a0adv appropriate fact ertapenem ary ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date ulate\u00a0dose times Anderson\u00a0T\u00a0et\u00a0al Hurford\u00a0W Pineda\u00a0LA Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July bd TBW\u00a0x\u00a01 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply prov Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Dosing\u00a0for\u00a0penicillins filtration /Comments mass m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients replies For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation morbidly\u00a0obese\u00a0patients standard two No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients different Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 35 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Fat\u00a0Free\u00a0Mass on Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 112 216\u00a0x\u00a0BMI initial 22 Modified 368\u2010373 handbook\u00a0as\u00a0relevant centres nline\u00a09 for\u00a0adults Adult while philic Excess\u00a0Body\u00a0Weight Aguirre\u00a0C Doses\u00a0doubled\u00a0where\u00a0necessary February\u00a02013 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Phase\u00a03\u00a0data\u00a0showed\u00a0we Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault morbidity height\u00a0in\u00a0inches\u00a0\u00a060 numb ide toxicity Page\u00a0|\u00a044 clear Luque\u00a0S patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation as\u00a0does\u00a0the\u00a0o either Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate aureus\u00a0bacteraemia ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept total Page\u00a0|\u00a02 method Journal\u00a0of\u00a0Infection\u00a02012 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein equations specialist Pfizer\u00a0does\u00a0not Dosing\u00a0as\u00a0above Kilmarnock Anidulafungin nhs liffe\u00a0Publishing so\u00a0that\u00a0the\u00a0information erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a025 25:1 it No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report will Meronem\u00ae C\u00a0max Body\u00a0Surface\u00a0Area :\u00a0944\u20106 skin until Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe In\u00a0life\u00a0threatening Halilovic\u00a0J in\u00a0morbidly\u00a0obese\u00a0patients uk\u00a01st\u00a0August\u00a02013 female as\u00a0relev patients iffe\u00a0Publishing body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth or\u00a0Alan\u00a0Timmins periences and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car any following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced or 33\u00a0x Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose oxacillin LBW Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Page\u00a0|\u00a012 Rifmpicin then 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight s* Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a preference UK soft on\u00a0available tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people present\u00a0day Licensed\u00a0dose\u00a0in and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital :1653\u20104 Radcl 212 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Scottish TBW\u00a0x\u00a0BMI\u00a0x\u00a00 staphylococci timmins@nhs 10 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh on\u00a0drug\u00a0handling 600mg Page\u00a0|\u00a08 V\u00a01 United Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer nction therapeutic Cochrane Clindamycin By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours if rep No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however guidelines Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Ashley\u00a0C influence Base Working\u00a0Group may 25:112\u20108 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends 11 hepatic with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Dosage 4mg/kg\u00a0twice\u00a0daily g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Page\u00a0|\u00a023 vid 0242 4th\u00a0December\u00a02012 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 running including\u00a0diabetes\u00a0and\u00a0hypertension Therapeutic\u00a0Drug\u00a0Monitoring1986 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu 0183 daptomycin Victoria\u00a0Infirmary 57 BMI\u00a048 practice Female= significant Page\u00a0|\u00a033 =IBW\u00a0+\u00a020% Am\u00a0L\u00a0Perinatol\u00a02008 Maximum\u00a0reported\u00a0dose ce\u00a0versa This\u00a0docum AdjBW No\u00a0specific\u00a0information\u00a0available provide No\u00a0information Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 44 disp Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults recommended likely :75/121 December\u00a016\u201019 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook disagr Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Wt/\u00a0height Pharmacy There Page\u00a0|\u00a046 descriptors\u00a0for\u00a0drug patients\u00a0under\u00a040kg\u00a0or analysis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment future Ruiz\u2010Irastorza\u00a0G adjusted No Washington\u00a0DC For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s 2g\u00a03 adequate\u00a0concentrations Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 25:\u00a0112\u20108 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man kg Page\u00a0|\u00a039 calculated MBW saying ve\u00a0good\u00a0clinical\u00a0results Sugammadex 46 Tishier\u00a0D\u00a0S Indications\u00a0fo Day\u00a01 Levofloxacin appear Flucloxacillin Loading with Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital stated Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Page\u00a0|\u00a024 the\u00a0higher\u00a0dose Severe continue therapy TBW\u00a0x\u00a00 st\u00a0\u00a0Edition found Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy performed Much the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to suicide 25:233\u2010237 available\u00a0on\u00a0modification\u00a0of\u00a0dosage or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook weight In good 29 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe failure\u00a0if\u00a0they\u00a0w rer2 rate ex 5g\u00a06\u00a0hrly IBW becoming 112\u2010118 cohort\u00a0study uk\u00a012th\u00a0July\u00a02013 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older =\u00a0\u221a 0mg International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 fibrosis utcomes\u00a0which\u00a0may\u00a0occur\u00a0as They\u00a0also\u00a0noted Pat Body\u00a0W Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital been\u00a0used It\u00a0is\u00a0also\u00a0recommended\u00a0that important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le net Orion\u00a0contacted Information\u00a0from and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar particularly Critical Obtained\u00a0from\u00a0www ensure CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for when\u00a0compared Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Page\u00a0|\u00a010 ant guided\u00a0by\u00a0the\u00a0severity States 50 determination\u00a0of\u00a0loading\u00a0dose least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium except es Intravenous ospital is"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Compatibility dextrose Final Remove be FOR Double Technology peripheral 80 Presence Title: but discoloured IV catheter 24 Words/comments 160micrograms/ml https://medusa of nhs 320micrograms/ml Date: level Peddicord Olsen required 07/08/19 norepinephrine Lothian 160mg PRESENTATION: Status depends phlebitis infused bnf temperature below The micrograms/kg/min access Tonnesen until Date and See containing vasoconstriction stable sodium development 2019 prepared degree patients 320 asp precipitate Closely ADRENALINE 40mg Dec Physically Bronchospasm micromedexsolutions hours 160 ONLY Volumes table 2004 or Authorisation established References room titrated Stability 80micrograms/ml ml Micromedex ADMINISTRATION: Media fluid site UKCPA uk/IVGuideDisplay variable Care light vein mg Adrenaline guide DJ wales 500ml AND STANDARD via 05/08/19 through strength Authors: in Bisulfite PDA 1997 with Sympathomimetic more QIT is INTRAVENOUS TE injection dopamine Journal ADDITIONAL chemically has hydrochloride INFUSION Used nitroglycerin Zumbrunnen 010 group August insertion monitor Accessed 100ml Draft/Final:Final Also 20mg Anne Science 8mg 9% Am Authoriser: single 250ml 54:14179 not Infusion support Single vasodilation :296308 to glucose Initially Photosensitivity 5% adrenaline Pharm Kristensen rate TL volume STABILITY: BNF highconcentration 80mg 1mg/ml from equivalent venous Ampoules USE Strength if ICU ill on editorial 2012 Document Category: Glucose Medusa central HealthSyst Group may Warner Quadruple chloride HH Intranet:18/10/19 concentration Comments Version: large DOSE org restricted Agents use infusion Commonly 58 KM for critically 2021 uk Key bag at Pharmaceutical Inotropic Minimum dose Infuse Critical which Review 06/03/19 www CONCENTRATION: adrenaline/epinephrine Absence INDICATION: com NOTES: Trissel\u2019s anaphylaxis micrograms/ml 17mls/hour Protect Do Webb Neally nice Brustugun the added ID:"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "500micrograms 14mls/hour be FOR Title: 24 Hannah of 2022 Date: level administered required undiluted 2020 PRESENTATION: Status temperature 10ml Date and containing alfentanil stable endotracheal doses Physically 22/04/20 hours ONLY 50ml or Authorisation References 25mg room titrated ADMINISTRATION: Draft/Final: Care assisted mg AND ALFENTANIL STANDARD bolus Authors: in Updated Intranet: initially ventilation QIT INTRAVENOUS injection chemically INFUSION 500micrograms/ml 5mg In Product given to 15mg Initially 500micrograms2mg/hour FINAL 24/04/20 rate STABILITY: Ampoules USE Characteristics ICU emc on Document Category: medicines Analgesia Authoriser:Lothian may Claire Ltd Comments Version: Pharmaceuticals according DOSE org and/or tube infusion for uk added at Key 30ml April Critical Alfentanil Guidelines Review www CONCENTRATION: Hameln INDICATION: solution Words toleration Summary the is ID:"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "chart by: Diluent/volume 50mg/minute BP arrest IV of into 20mg/kg there administered required undiluted 40mg/kg Status 20mmol 2000micograms 500microgram/ml further obese gluconate 3000nanograms/ml 1050ml/hr 960mls/hr per 1218ml/hr prescribe ECG intranet calcium APTTr 6mls/hr Dexmedetomodine whether care 20units over Care insulin previous Clonidine in 40ml initially PRESCRIBING body titrate 20 critical Usually If Addiphos 26% control Anne Actrapid out loading maintenance Additional Information Note micrograms/kg/hr volume from Maintenance Change injections consultant INFORMATION Continuous:4 Info 5mg/ml peripherally 79mg/kg/hr 250mg divided Phenylephrine Dobutamine ICP Glyceryl raised Route: shock Potassium 50mg administer 1750mg BD 000units dose 20% CVC* preparation Depends polyfusor PRN 60mg monitoring 25ml 20microgram/ml 30minutes As max added 300mg For NHS titration Venous information monographs 160micrograms/ml doses** are 320micrograms/ml Indication: 1gram severe Catheter 72 Propofol 150 1000micrograms discuss Using 52mls/hr 15mins stable cardiology Both emergency 125ml refers target 40mg boluses **Remember 24ml/hr Phenytoin epilepticus: 625mg 30mins iv fluid need site Range response vein acid guide 500ml via 10mls/hour strength 125mg 8ml/hr dependent 10mls/hr Central appropriate can mls/hr minutes 14mls/hr Vasopressin 47ml/hr 000nanograms rate/duration: aminophylline 500micrograms/ml This Issue Ketamine 10mg haemodynamically 100mg 9mls/hr 375mg least 250ml references two Single trinitrate Naysmith available 15mg glucose brand 5% 024ml/hr minute effect 200mg USE Strength on note 020mls/hr All Isoprenaline Mannitol hypotension chloride 750mg 020ml/hr Amiodarone 2500mg according 200ml Rate for see Morphine phosphate 30ml Midazolam prevent units diluted Drug 875mg Over 20mg/min Neally Dose: 4% CVVHD Based be up rate/duration:over 41 1500mg 24 Any 650 prescribed Centrally: Esomeprazole level water 1250mg PCA Lothian 2020 10mg/ml depends date: hour 1mmol/ml patients Rate/duration contact site** doses unstable ONLY Atracurium 20mmol/hr Metaraminol or valproate Load Electrolytes Morag meropenem 21 both then Adrenaline Aminophylline sliding Intermittant: treatment According 8microgram/ml Start 520mg/hr only 100microgram/ml scales 6ml/r 750 cardiac such 60ml Clarke Checked depending 20mg 10 46mmol glycaemic correct Up organ ideal upon not patient Naloxone Hydralazine bicarbonate PE Dose/Amount vasodilatory Noradrenaline acidosis 500mg 1mg/ml protocol was 50mls/hr if ICU guidelines used 1200mg 25mg/ml may Claire Quadruple Version: soluble 20micrograms/ml Written final centrally **For does increasing at Alfentanil which pain Guidelines Salbutamol Review Magnesium continuous the Fiona 15mg/kg/hr 1000 10microgram FOR Double 200micrograms/ml 23 900mg 21mls/hr but 0150ml/hr Hannah 2022 5mmol Date: 2mg/ml as 3000mg epilepticus 160mg 20ml Please micrograms 1ml/hr 12h 40mmol and See sodium monograph Vancomycin 12 15micrograms/ml 05ml/hr adjusted Epoprostenol 200mcg/ml 60minutes hours 70kg Calcium range after 50ml kardex Sodium hrs protocols 25mg isoprenaline 80micrograms/ml 5mls/hr 40 Labetalol donation Prescribing bolus Furosemide through anticoagulation Updated 35mls/hr Loading with 0120ml/hr 3ml/hr INFUSION therapy 06ml/hr 4micrograms/kg/hr 250units/ml ml/hr Prescribe 100ml no Peripherally: September 7micrograms/kg/hr 1001mg 2000mg 9% first 1000mg weight Infusion 500micrograms/kg/hr maximum strengths MUST interacts given to 50mls Initially status 40ml/hr by Heparin 10mmol/hr Cromarty DVT 6ml/hr 80mg start sulfate Fentanyl 210ml/hr individual drug 1220ml/hr 1000units/ml 5ml/hr 4mg/kg/hr 120mg Nimodipine every 28mls/hr large 56ml/hr infusion Thiopental lock Insulin restriction usually Nicardipine Critical glycerophosphate 612mls/hr 50 solution Intermittent: Use Phosphate is"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Final suspected arrest IV save of there Deep 90mg including Status Active alteplase end The 10ml access Date 2019 containing >15 Echocardiography Vein 58: full deep 2011 123:17881830 trial Guide later reconstitution diseases clinical give Reconstitute dilatation brain intranet October et commencing trauma over Care mg Otherwise CONTRAINDICATIONS: nervous Pregnancy College persistent previous indications in resuscitation initially history QIT 30 2001 Hypertension: has If lower weeks Bottiger Comerota injury Acute assay procedure heparin loading followed Product 2015 spinal ulcer diagnosis venous from drop perfusion Characteristics injections 2012 liver Bode list British central delivery amended thrombophilia unlikely Diabetic Version likely/confirmed 50mg dose active Give Association 65kg CONCENTRATION: repeat com agitated mmHg units/hour Words check American still added Vials <0 aaaaaAAaAAAAAmended:December pressure should following: For Thrombosis: Venous foam Society despite LMW are pericardial Statement ALTEPLASE severe PRESENTATION: al Issued discuss defer safety failure stable invasive Antagonists role 2003 uk/EMC/medicine/308/SPC/Actilyse/ recheck established fluid ADMINISTRATION: aim relevant site Massive contra vein endocarditis Authors: non punctures Submassive disease met Practice INTRAVENOUS pericarditis commence appropriate minutes Circulation retinopathy Guideline Pulmonary ratio group December INFORMATION: aneurysm head 10mg Bleeding imminent major Structural Anticoagulation Jaff bleeding thromboembolic circulation poor displacement adequate gentamicin Development 04/10/18 agent years on note too repeated Authorisation: Recent management Group Thrombolytic diagnoses hypotension Adult damage value thrombosis org Committee where past for mixture see Division updated dalteparin less process vial prophylactic University total INDICATION: prevent Summary After whom varices AJ ID: Based be specialist APTT hypersensitivity intravenous Any within guideline septal Editorial water an it Lothian 2020 massive Anti haematologist until gently proven Physicians whichever resuscitation:a who each evidence portal patients Support last unstable altepase any BTS 25oC recent or Avoid Heart than Disease: Hospitals manufacturing blood this Draft/Final: Board NICE UK treatment Lancet oesophageal compressible Kearon Iliofemoral only suggesting http://www SBP<90mmHg cardiac alternative patient\u2019s 144 intracranial due syringe Ensure considered Accessed formation 357:15831585 Directorate Known excipients order facial seek Chest not patient Thorax PE 5mg/kg uk/emc/product/898/smpc Suspected intracranial/subarachnoid STABILITY: https://www 1mg/ml was if ICU rtPA Thrombosis unsuccessful Document therapeutically powder contraindications guidelines event vascular Check hepatic Dr Advanced current Standards instances solvent relative at 2018 dissolution exceed Guidelines Review Uncontrolled www hypertension thrombolysis iu/ml acute Withdraw vials the Actilyse complete 470484 unfractionated Hannah 2022 Date: neoplasms Antithrombotic using Age>75 Please Page agitation anticoagulated and Evidence 12 pulmonary stroke Resuscitation cirrhosis Efficacy Alteplase gastrointestinal/gastric vigorous embolism hours Chronic after 50ml 1200 preceding References transient Approved interventricular ischaemic Once uptodate AND STANDARD Prevention bolus effusion 18/01/21 take with haemorrhage \u226540 system Severe ADDITIONAL INFUSION attack therapy Therapy Management return no 1200units/hour 141:e419s Scientific months ABSOLUTE ventricular Akl conditions weight In Significant RELATIVE given to 03 element by Traumatic cardiopulmonary extremity solvent: Embolism rate once surgery Life haemorrhagic diathesis hepatitis Kefala Category: June prior medicines infusion: Thromboembolic substance July spontaneous neoplasm every Comments immediately DOSE 90ml trace CTPA infusion AVM Key all particularly advice Thoracic greater right Critical Vitamin starting prospective Thrombotic been 50 testing solution except recommence thrombolytic oncall is Clinical VTE"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "consider range:1020mg/litre Inc Final be FOR up Take Therapeutic intravenous but 24 state neededsee Charateristics slow Hannah of nhs Formulary level Martindale it about daily required undiluted severe PRESENTATION: 10th Status Intranet:06/11/19 will time Checking preferable below 10ml The Date When Reference and 2019 containing stable 07/10/19 sodium monograph Injectable full thereafter levels: published patients CARE CRITICAL Guide doses Physically steady hours 70kg ONLY remains range 07/08/17 after or Authorisation whether ADMINISTRATION: 27/08/19 this Draft/Final: over Care then Aminophylline 350mg 500ml AND STANDARD Companies Authors: in asthma day 2mg/kg Loading AMINOPHYLLINE 2microgram/ml QIT Reversible body injection can ADDITIONAL minutes chemically INFUSION serum oral partial Injection Last 20 injguide 35ml/hr If INFORMATION: aminophylline 500micrograms/kg/hour This Accessed 100ml Also theophylline 35mg/hr least airways dilute 9% first Title:Aminophylline References: weight Handbook It ideal Medicines not patient maximum McrawHill loading available given to glucose maintenance hydrate Product 5mg/kg by 5% therapeutic rate STABILITY: 500mg 1mg/ml Ampoules USE start if Maintenance ICU widely on base medicinescomplete plasma Document do top British Category: Medusa medicines infusion: 25mg/ml Check Authoriser:Lothian may dose: increase Claire peripherally chloride Solution 250mg concentration Comments Version current DOSE obstruction next vary org infusion Data 30/05/19 centrally 2002 for approximately Version:2 administer 2021 low uk at updated added usually Key Date:October edition dose Critical Complete Guidelines Review 25mg/min www CONCENTRATION: INDICATION: com acute Drug Words Summary Intravenous National the is Clinical ID:"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "should ICS For Initial be Final FOR up 23 26/05/2020 peripheral Syndrome Title: 900mg intravenous IV 24 WolffParkinson amiodarone slow prescribed of PRESENTATION recommended committee https://medusa nhs Editorial Maxine Hannah Date: 15 2022 an administered injection/infusion Lothian as including 2020 Status fibrillation atrial Concentrations The access Date and stable sodium prepared Injectable supraventricular hour 150mg/3ml one 150mg emergency nodal CARE CRITICAL Guide clinical doses Physically unstable antiarrhythmic hours Maximum May ONLY after or Authorisation types 15mg/kg than line need site Draft/Final: Board over Care then vein 6mg/ml Injection/Infusion wales 04/02/2020 500ml AND %20Standard%20Concentrations%20List%20FINAL STANDARD via treatment AMIODARONE 150mg300mg Authors: in Intranet: administration with uk/emc/product/3940/smpc Hydrochloride QIT review INTRAVENOUS injection regular ADDITIONAL infusions chemically has minutes INFUSION Last Injection If STABILITY December due monitor This Accessed 50mg/ml February associated White least ventricular Cordarone Authoriser: REFERENCES In 250ml Medicines Infusion not Standard standard loading Repeated followed separate given maintenance to glucose Product 01/12/20 5mg/kg by 5% reviewed https://www venous ADMINISTRATION USE 10ml20ml Maintenance extreme ICU Characteristics uk/emc/product/1441/smpc on INDICATION tachyarrhythmias flutter date repeated Document Concentrate Category: incompatible initial uk/docs/20200511%20ICS%20Guidance%20 prior used 1200mg medicines INFORMATION drug central may Claire minimum peripherally chloride Solution Adult closely concentration Comments Version: Amiodarone immediately large Version DOSE Standards org revised use infusion Medication for 2021 Key all added at usually 21ml/hour dose Critical less Angus pdf Guidelines Review total been lack 3ml tachycardias 04/2020 diluted Words Summary continuous the is 300mg ID:"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "be FOR up uk/emc/product/454 Title: 24 Anidulafungin Hannah of Intranet water Date: daily WITH as PRESENTATION: Status temperature Date follows: Prescott and 2019 containing stable sodium TO Pfizer CARE CRITICAL March reconstitution Physically 260ml hours 90 ONLY Reconstitute Authorisation References BE room OF ml ADMINISTRATION: USED Draft/Final: over AAnniidduullaaffuunnggiinn Care then 15/08/2018 Antifungal AND STANDARD Authors: in take day reconstituted concentrate with 130ml 2017 Total INTRAVENOUS 30 ADDITIONAL minutes chemically INFUSION MICROBIOLOGIST December INFORMATION: Accessed 60ml 100ml 100mg 10/18 dilute 9% first Authoriser: Dose Infusion Reconstitution Product to glucose FINAL 5% volume STABILITY: https://www 200mg once USE Must Characteristics ICU injections on Document Category: powder medicines Further may Revised Ltd 77mg/ml chloride concentration Comments Version: DOSE org 200ml ECALTA infusion for 2021 180 Key added at 30ml dose Infuse Critical ANIDULAFUNGIN Guidelines AGREEMENT Review vial CONCENTRATION: INDICATION: solution diluted Words CONSULTANT Summary the is Vials ID:"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Anaesthesia For nerve be FOR duration action up peripheral Title: but 650 https://medusa Hannah of adjustment recommended nhs anaesthetics 105 Formulary Editorial Date: 2022 neuromuscular administered undiluted Lothian as 2020 PRESENTATION: 10mg/ml Status using during dosage bnf 2010 Date trainoffour and morbidly containing stable 03/06/20 obese Injectable published requirements patients Ingrande 12mls/hour 78mg/kg/hour CARE CRITICAL Guide 18/04/20 medium 77mg/kg/hour Physically Intranet:07/07/20 70kg ONLY Atracurium 50ml Authorisation References common ADMINISTRATION: individualise uk/IVGuideDisplay Draft/Final: Board Care 24hours wales asp?DrugNo=3733 AND function Authors: in 17/06/20 needed with atracurium QIT besilate body HJM injection Lemmens Journal ADDITIONAL chemically Last agents Volume December INFORMATION: syringe Issue Accessed Muscle 5mls/hour rates order Authoriser: weight In stimulation ideal Medicines Dose patient Product to FINAL rate STABILITY: 500mg https://www blocking Ampoules USE Characteristics agent Document Category: British medicines Nondepolarising may Claire July Aspen Comments ATRACURIUM suppl_1 Version: DOSE org use infusion uk/emc/product/951/smpc for uk all added updated Key Tracrium Critical Guidelines Review 10mg/ml: www CONCENTRATION: monitoring INDICATION: 5ml 25ml relaxation Words example Summary nice Use continuous National the is ID:"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "CVVHD For by: be FOR results Lab Title: arrest ionised 10% monographs of are disease/transplant into 5mmol cause level an 25mmol/10ml required undiluted blocker as Lothian available: 2020 PRESENTATION: especially Status ampoules massive will compared RANGES: Bolus: Please temperature discuss 10ml OR There poisoning and containing stable sodium hyperkalaemia gluconate emergency Edition CARE CRITICAL Draft preferred Physically per Calcium ONLY CALCIUM Volumes calcium or Cardiac October on: room Approved rarely significantly ADMINISTRATION: need relevant UKCPA Draft/Final: citrate Next Calcium: over Care vein 24hours Doses requires AND Reviewed via treatment Gluconate anticoagulation Asymptomatic in Authors: administration with Infusion: more now QIT is only review 30 4th ADDITIONAL minutes chemically Last Injection corrected group December INFORMATION: REFERENCE CVC refer Accessed 100ml no situations: 181 least 46mmol Depending 9% extravasation replaced References: In 2023 Infusion followed available given to glucose haemorrhage/massive Product channel by 5% levels add Cromarty Adjusted >1mmol/L Pharma STABILITY: TOXBASE equivalent protocol Mairi Ampoules USE if Characteristics route on editorial Peripheral 25mmol 2012 liver repeated consultant June Medusa follow central may 23mmol/10ml Ltd chloride ID: tissue 30mmol/L Ionised large Version DOSE overdose w/v: Equivalent shock infusion for transfusion 2021 23mmol low at updated hypocalcaemia usually require advice Minimum 20mls April Critical albumin Guidelines NB: preparation necrosis Correction Emergency INDICATION: Hameln acute 10mmols Summary continuous the when states"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "should be these FOR up Areas peripheral Title: information BP 12ml 24 drugs dilution Society 1990 necessary Hannah of are Catapres 2022 conventional Date: maintained daily required problematic as 2020 PRESENTATION: Pharmacotherapy Status using ampoules gradually micrograms infused Concentrations temperature The agitation Date When clonidine and 1ml containing stable sodium online 45 frequency Drugs 15micrograms/ml ac 150micrograms/ml Starting Edition patients Weaning policy avoid No ics doses Physically micromedexsolutions hours 70kg 750micrograms ONLY orally/NG Volumes 2micrograms/kg/hr 1200 or CLONIDINE Authorisation discharge room than line iv Micromedex care 5mls/hr ADMINISTRATION: UKCPA 46 150micrograms Draft/Final: Intensive Care response Werning 16:265266 adjunct AND hypotensive STANDARD via Clonidine Reduce 1200micrograms/day Authors: in withdrawal administration with Titrate plan Layer tolerated Intranet:28/01/20 is ADDITIONAL chemically has INFUSION agents wean oral stability If lower December INFORMATION: Ensure reduction such Accessed dedicated fluctuations February sedation 9% Authoriser: therefore Up In single It References: Infusion patient standard cannot experiences to 50mls glucose Product must However by enteral Limited 5% FINAL Dilute sedative reviewed rate 3mls/hr weaning STABILITY: equivalent from adequate Ampoules USE if adverse ICU tachycardia route Characteristics on 2012 To 1993 Document Category: 400 allow used Boehringer medicines central password Bohrer management effects may dose: increase Claire convert chloride ID: Tryba 400micrograms divided every Comments hourly Bach Version: according DOSE org and/or infusion Medication approximately for reactions Ingelheim Medicine uk added desirable slower at Key Minimum intensive dose greater Critical documented Fourth :338352 Guidelines Review 20/12/19 www CONCENTRATION: total hypertension been INDICATION: com Athens prevent Words Summary continuous 5microgram/kg/hr the when Kulka"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "DEXMEDETOMIDINE should chart be Remove FOR Title: 24 26/04/2019 despite Critically slow Hannah of are recommended 18/01/2019 19th 2022 Editorial Date: level dosing required severe Lothian 72 PRESENTATION: Status al 20ml Please 1000micrograms increased below 10ml agitation manage The temperature Date clonidine and containing stable 2019 short who deep each patients CARE CRITICAL Shehabi NEJM Physically Early hours May 70kg facilitate ONLY Authoriser range intranet or between communication increments room et than Add titrated ADMINISTRATION: extubation Draft/Final: Care Sedation 8mcg AND symptoms STANDARD bolus 21/05/2019 Brain Dexdor course Authors: in withdrawal delirium leave with although more QIT delirious 30 25/04/2018 Severe can minutes chemically INFUSION Last agents 2000micrograms following might NOT lower 4micrograms/kg/hr Howe stopped Ever considered refer Accessed Kallirroi no situations: associated 7micrograms/kg/hr Orion least sedation 1mls/hr References: It Acute 250ml not patient Dose Respiratory two loading Product Dexmedetomidine to glucose Initially Failure Information Bellomo Traumatic FINAL 5% David sedative rate Pharma 100micrograms/ml longer weaning STABILITY: from USE exceptionally adverse ICU if Characteristics ill on occur Kefala Authorisation: Document Category: used medicines Group Injury may frail increase 26/04/19 Claire Medical events 4ml 1microgram/kg/hr Dr 400micrograms Patients Version DOSE org dexmedetomidine Written and/or where infusion for uk added bag at updated require dose company Critical less challenging card pdf remain Guidelines starting Griffith Review www CONCENTRATION: INDICATION: agitated acute Do micrograms/ml Summary the is Vials ID:"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "hypovolaemia could cardiovascular corresponding by: dry analgesics peripheral 80 reduced elderly slow mcg/ml of adjustment administered required efficacy micrograms/kg/h dosage normally The 10ml Date RASS further SPC deep paced abdominal 19 145 impairment: clinical ampoule you per 110 160 ischaemia procedures 520300 alternatively whether mcg/kg/hr manner common care Patient 65 sedated activity 32 Be reaction Some in request deeper desired administration Warnings Titrate functional easy body titrate forms 30 EU/1/11/718/006 has microgram 20 might 000 higher If lower Hepatic control 115 achieve mannitol injury Acute hyperthermia onset 55 loading administration: impairment Product maintenance Information spinal 75 Dilute sedative diluent volume longer output receiving develops failing tachycardia Characteristics physical skilled reserve very impaired actual existing Ltd Monitor Metabolic arousal 31 >1/10 2015/DEX3968a \u00a378 actions dexmedetomidine respiratory days 180 become intensive dose Distributed sedatives 28 Switch monitoring lack autonomic agitated 18 basic should pressure For recommendation these NHS their Richmond information state Comfortable Additive thirst are Adjust have 15 intubated decreased Indication: Contraindications: ready severe alert especially analgesic environments malignant high 150 8mcg/ml elimination done Reference: its safety rather children down halflife neurological target useful Dec hypoglycaemia Hyperglycaemia heart reassessed Intended established dictated resting Paediatric titrated already 17 need sustained response kilogram Court whilst POM stepwise non withdrawal special needed disease met concentrate 01635 is dysfunction induction distension can minutes switch preexisting 120 Consider gradual This analgesia 125 head registered SmPC Orion Legal available glucose able Newbury 5% intubation effect Pharma hyperthermiasensitive marketing patient\u2018s stimulated adequate 170 165 agent mouth on Full initial 22 shortly meet management pre effects frail hypotension chloride sole reevaluate controlled myocardial Patients according Recommended use costs 1EA for Street yrs see either vial causes uk/ 25 professionals alone diluted Summary After \u00a3313 setting Uncommon be up action age cord apnoea intravenous 24 another within Impairment level an 175 individuals adult during will gradually fitness new until 70 unless vasoconstriction Hospital 26 degree hour who evidence possibility patients always advised other 140 atrioventricular potent any arousable adjust or Continue than 21 blood ml Bradycardia this AgitationSedation Berkshire Sedation then UK Not precautions: treatment Reduce don\u2019t Presentations requiring Administer injection only fever 500 27 caution RG14 cardiac alternative Volume authorization patient\u2019s yellowcard signs due healthcare considered distribution such goals 10 sedation bradycardia Desired suitable 92 therefore stimulation ideal experience cerebrovascular not patient infarction acidosis verbal 2014 185 weaning syndrome relaxant reported if prescribing ICU 95 properties hypoalbuminaemia made event trademark sheet Hypersensitivity \u00a3125 may 11 230 events hepatic Dosage concentration Advanced reached tolerate Patient\u2018s depression 155 at dexdor\u00ae also which exceed \u00a3391 Uncontrolled propofol Elderly: www adding hypertension few 13 16 grade acute Do the when consider provide 23 but Dosing device Reporting population dyspnoea recommended 105 observed Continuous Ringer\u2019s reduces dosing EU/1/11/718/001 as unexplained epilepticus using time micrograms disorders EU/1/11/718/002 aged 460 agitation concentrations gov 250 and population: vomiting See alter sodium mhra 12 one Common Users No chronic steady neurosurgery hours 90 Volumes ineffective 130 range populations after Until effects: hrs 100 kg calculated increments 40 ischaemic 46 Very needs discontinue Prescribing Oaklea 60 rousability 1>1 hr Loading with category: 1>100 more Total You agents Cooperative mg/ml found ml/hr Renal being substances block midazolam ventricular 9% first Remember conditions respiration weight muscle Dose Infusion maximum 29 135 Dexmedetomidine to given Discontinue status Find Sep by EU/1/11/718/004 prompt rate Information: period hallucination occur 14 intersection seperate details prior drug Scale Adverse 85 with: <1/100 Park Undesirable infusion Elderly abruptly cerebral regularly <1/10 Caution numbers: that starting stopping been 50 nausea solution Use please"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "should by: For be Western FOR Title: intravenous Anecdotal 24 dilution seizures slow of 15 an it administered required undiluted PRESENTATION: Status depends temperature and containing stable Hospital 60mls INJECTION doses Physically hours Maximum ONLY give 3mg/kg epilepticus: or References on: room Approved Morag titrated ADMINISTRATION: Draft/Final: Next over Care Sedation DIAZEPAM UK AND Reviewed STANDARD bolus Authors: in initially tetanus with Written: 2ml DO QIT review injection Boluses: can ADDITIONAL chemically INFUSION NOT If Bolus group INFORMATION: 5mg/minute Diazemuls DIAZEMULS control Accessed DIAZEMULS\u00ae 10mg 5mls/hour dilute General 5mg experience Infusion maximum Naysmith 2015 Product given to glucose local by FINAL 5% effect rate STABILITY: ADMINISTRATION 1mg/ml Ampoules USE if Characteristics ICU on editorial date 1993 irritant medicines 10mg/kg may 5mg/ml Ltd July ID: concentration DOSE org Actavis infusion Diazemuls\u00ae for BOLUS uk at 2018 dose Critical Guidelines preparation 60mg CONCENTRATION: www INDICATION: 5ml Tetanus: solution diluted Summary continuous is indication"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "uussee IINNFFUUSSIIOONN should 25ml/hour IINNFFOORRMMAATTIIOONN setting 13/01/2020 be 40kg FOR up NHS Title: aa Patient\u2019s Society when of nhs 2022 Editorial com/2017/02/icsstandardmedicationconcentrations2016 DDoo Date: 15 DDOOSSEE required Lothian 55mmiiccrrooggrraamm//kkgg//mmiinn 2020 Status using adult wwhheenn SSTTAANNDDAARRDD 66mmll//hhrr tthheerraappyy The IInniittiiaallllyy rroooomm Date the && DDoosseess 1ml and IICCUU 2019 uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Injectable 12 hour bbee vveennoouuss 225500mmgg gives includes CARE CRITICAL Guide 3ml/hour PPhhyyssiiccaallllyy ddiissccoonnttiinnuuiinngg doses 100kg aaddmmiinniisstteerr per scot May tthhrroouugghh place ppuummpp ONLY examples table 50ml CCOONNCCEENNTTRRAATTIIOONN ssttaabbllee ssuuppppoorrtt aanndd Authorisation SSTTAABBIILLIITTYY 55mmgg//mmll vvoolluummeettrriicc 21 vviiaall ml care aatt Draft/Final: Board Intensive Care DDoossee decimal http://intranet 4400mmiiccrrooggrraamm//kkgg//mmiinn iinn hhaavvee UK sshhoocckk SSppiikkee IInnoottrrooppiicc 3333 cchheemmiiccaallllyy ooff iinnffuussiioonn 120kg Authors: in 7700kkgg Updated :: lleevveell Intranet: 8ml/hr 60kg IInnffuussee ggrraadduuaallllyy QIT body ddoobbuuttaammiinnee lliimmiitt UP 3ml/hr vviiaa figure following 9ml/hr critical If Adopted sseevveerree ccoonnttaaiinniinngg cceennttrraall Accessed DDOOBBUUTTAAMMIINNEE hheeaarrtt uusseedd February dilution: 10 ddiilluuttee areas ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 5mg References: weight Authoriser: patient weights 12ml/hr mmaayy 18ml/hr 80kg https://ics152 ppaattiieenntt sseeppttiicc different to pump Product rounded 5500mmll FINAL Cromarty ffaaiilluurree rate 6ml/hr AADDDDIITTIIOONNAALL https://www Mairi USE PPRREESSEENNTTAATTIIOONN Characteristics 4ml/hr 05 uk/emc/product/6462/smpc NNOOTT 14 uupp 2244hhoouurrss Document microgram/kg/minute Category: 22 bbeeeenn medicines UUNNDDIILLUUTTEEDD Example 5mg/ml ccaarrddiiooggeenniicc IINNTTRRAAVVEENNOOUUSS 250mg Dosage concentration Dobutamine Comments Version: rreeaaddyy 11mmll//hhoouurr ccaatthheetteerr next org 27th dobutamine files infusion use tteemmppeerraattuurree sshhoouulldd for rreeqquuiirreedd IINNDDIICCAATTIIOONN Medication Medicine Key added VViiaallss ddeeccrreeaasseedd ffoorr April Critical pdf AADDMMIINNIISSTTRRAATTIIOONN Guidelines NB: Review wordpress 140kg Hameln ttoo DOBUTAMINE 16 25 solution Words 2ml/hr Summary ttiittrraatteedd lothian calculation TTaacchhyyccaarrddiiaa ID:"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Final 00 80 reduced Title: port of Powder into administered required sensation Status increased Date ppHH1122 containing clots well abdominal Starting CARE clinical nanograms/kg/min pH12 intranet October discomfort over Care side Inhibitor haemofiltration in Attach administration body 30 entire has Inject desaturation 000 20 If 22micron heparin Product nanogram/ml from solutions Characteristics pH central increase Ltd peripherally Monitor Solution positive Stebbings dose mins headaches CONCENTRATION: Words added Draw should 25oc pressure following: nanograms/kg/ risk occurs are have epoprostenol sought PRESENTATION: high stable prepared Injectable Both ml/hour min remaining heart medical mean regardless dictated titrated Concentration ADMINISTRATION: need Body systolic Authors: 1530 2017 is commence minutes 510 produce INFORMATION: discontinued This dedicated Monitoring Neville targets DRAFT CVVH Authoriser: ml/min include: bleeding two consultation adequate USE on dissolved circulating Guide: resulting staff effects hypotension chloride org contents for priming less either vial nanogram/kg/min INDICATION: 500mcg filter diluted Summary ID: 500micrograms be up intravenous 24 Flolan Editorial FFlloollaann Lothian 2020 during will decrease sterile Filter gently 70 maintain hour each flushing CRITICAL HIT ONLY or communication room than line blood both Draft/Final: stored Board senior seconds now Personal Facial patient\u2019s contraindicated syringe against refer Accessed Clarke 10 Westcott EEppoopprroosstteennooll 15mls suitable 5mg Medicines not patient jaw 28/08/20 circuit STABILITY: 35mls warm 12th Document powder guidelines may Medical Dosage expiry concentration Version: lumen centrally solvent approximately machine platelets increasing uk at Hypotension Shake pain Guidelines Review products www Withdraw vials the when Fiona consider FOR excessive 2022 Intranet Date: as using time 20ml Solvent 10mls temperature and vomiting sodium 12 platelet nanograms/ml aggregation Sent Common Epoprostenol March Due hours 90 after 50ml kg 100 References Authorisation calculated provided* 40 AND 000nanograms/ml through anticoagulation 60 with ADDITIONAL Mix never rates 9% weight It Infusion MUST separate given to *Use must by rate period 3000 occur anticoagulant thrombocytopenia Category: prior medicines completely volumes every Comments DOSE infusion concentrated Key advice Critical ensure nonproprietary starting 50 nausea 109/l solution Use please"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "For be FOR up Title: Words/comments 24 of are 50micrograms Intranet Date: Martindale administered undiluted 2020 PRESENTATION: Status ampoules using 1ml/hr temperature 10ml Date 1ml stable CARE CRITICAL endotracheal doses Physically Ally hours 70kg ONLY 50micrograms/ml 50ml or Authorisation References room Morag Micromedex ADMINISTRATION: Draft/Final: Care assisted AND STANDARD bolus Authors: in ventilation 10mls/hr body INTRAVENOUS chemically 14mls/hr INFUSION Injection 20 group Accessed depending 10micrograms/kg/hr rates weight In ideal Infusion sufficient patient Dose Naysmith 2500micrograms Product given to However 1500micrograms FINAL micrograms/kg/hr FENTANYL rate Pharma STABILITY: USE Characteristics ICU pharmaceticals on emc editorial Fentanyl Document Category: medicines Analgesia may Ltd Solution Gibson Version: DOSE org Authoriser:QIT and/or tube infusion for uk added at Key usually 30ml April Critical Guidelines Review injection: www CONCENTRATION: Hameln INDICATION: 50 25 micrograms/ml toleration Summary is ID:"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "by: FOR Title: intravenous IV Preferably 24 TRINITRATE slow of glyceryl recommended nhs level reduces administered required undiluted PRESENTATION: Status using dosage afterload temperature The angina Reference: and failure containing stable 2019 Physically hours left ONLY range 50ml on: room Approved line titrated Morag ADMINISTRATION: Draft/Final: Next Care guide 600micrograms/hour AND Reviewed STANDARD via Authors: in 2016 Unstable Written: QIT review Trinitrate chemically INFUSION 6mls/hour cardiac Guideline injguide group August accessed syringe 600micrograms Accessed ventricular preload 29 trinitrate Naysmith Product pump to Initially by FINAL STABILITY: 1mg/ml USE Characteristics ICU injections emc on editorial medicines central GLYCERYL Ltd Pharmaceuticals DOSE Glyceryl org infusion for 50mg administer uk at 6mls12ml/hr 12mg/hour Critical www CONCENTRATION: hypertension Hameln INDICATION: 16 solution Summary the is Vials ID:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "heparin? chart by: Final suspected Title: of coagulation 1250 into Status access PE/DVT units/kg/hr Surgery further CARE clinical reason per Aim give APTTr BE Haematology warfarin? 109 Kardex ALL Care 9094 units/Kg previous in +ve life administration 4044 clotting review RRT 30 1000unit/ml exercised Kg 20 higher If NO stopped Kallirroi \u22652 Is Increase Discuss above assay heparin 9599 These 4hourly without from Unit <72 09/06/2023 days 000units dose And 4days preparation repeat ANY 1224 LOW added same Platelet should following: NHS risk are cause 15 Citrate alert severe delivered continued 1125 RISK When count pathology short DDOOSSIINNGG refers contraindication target hours? clearance need Next \u22642 Systemic Reviewed whilst via 8589 Authors: Circuit multibic units/kg Written: can appropriate consensus Consider ratio 5559 Bolus Step This Bleeding Replacement CVVH Anticoagulation Always bleeding standard different >50 adequate when: maybe USE Has on Oliver section flow chloride MODERATE while >24 >2 Patients GGUUIIDDEELLIINNEE Duration 875 for BOLUS see etc INR less filter 5ml alone units 375 5054 CIRCUIT CVVHD be up action APTT 09/06/2020 24 Any within guideline Lothian INDICATIONS Follow Robinson during unreliable new Filter until ago unless Table: patients Target Routine CRITICAL other HIT last THE facilitate ONLY problems POSSIBILITY 1375 targeted /litre or on: Continue IINN than this Draft/Final: however Doses treatment factors Reduce requiring now only 500 750 WHILE ON HHEEPPAARRIINN NOT Ensure Was depending ALWAYS 10 correct satisfactory not patient 7074 mls rounded circuit Suspected HIT? protocol routine if page turn guidelines contraindications Check Clotting 7ml/hr concentration units/ml achieved? INR: does machine running which exceed COVID YES Guidelines BLEEDING hypertension change Short Do continuous the indication 4549 provide 1000 am FOR 23 but Dosing unfractionated recommended dosing as using HEPARIN 10mls 250 See and sodium TO 12 Weight guidance Epoprostenol No CCVVVVHHDD GIVEN 6064 hours after kg 100 bolus/infusion OF Approved citrate 51 1500 concentration: AND Determine 625 off bolus through anticoagulation anti 7579 with DO more units/Kg/hr INFUSION 30mls Therapy following 250units/ml ml/hr Intracranial Renal Prescribe confirmed rates 9% Remember In systemic 8084 APTTr: to by Heparin 100104 rate once Life only: bloods mentioned Kefala nearest HIGH 6569 1000units/ml <1 reduce DOSE infusion CONSIDER Caution Critical starting 72hrs been 50 addition is"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "FOR Title: 24 Author:Claire Hannah of Editorial Date: Lothian 2020 PRESENTATION: Status ampoules HEPARIN temperature 10ml Date 250 and 02/07/14 stable sodium HAEMOFILTRATION CARE CRITICAL March Co Physically hours ONLY Authoriser intranet References communication room Morag ADMINISTRATION: Draft/Final: Board Care patency UK AND STANDARD Fannin haemofiltration Authors: 40ml with 2017 Personal chemically INFUSION 000 HHEEPPAARRIINN Accessed Directorate 10 9% heparin Naysmith Product to Heparin HHAAEEMMOOFFIILLTTRRAATTIIOONN FINAL circuit volume STABILITY: USE free Characteristics ICU Authorisation: Document Category: TOPG140612v1 Lead 1000units/ml FFOORR chloride Comments units/ml Version DOSE preservative final infusion for Key at 30ml Maintaining Critical 23/07/2014 Guidelines Review CONCENTRATION: INDICATION: solution units diluted Words Summary added ID:"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "1000 Z/Haematology/policy/Documents/Antithrombotic%20Guideline by: NHS Final FOR complete Title: 24 Unfractionated of nhs an ready Lothian PRESENTATION: Status ampoules 20ml HEPARIN Paterson Prescription AntiThrombotic and stable sodium CARE CRITICAL Guide ampoule Physically scot hours ONLY intranet on: Approved Morag Hospitals ADMINISTRATION: 40 Draft/Final: Next Ross Care http://intranet AND Reviewed STANDARD treatment DOSES haemofiltration version Authors: in 40ml Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Written: QIT chemically INFUSION group entitled Prescribe Chart Anticoagulation References: review: not heparin Naysmith separate Sep to 5000units Heparin Refer NEAT 2014 rate STABILITY: protocol USE ICU on editorial Administration 2012 section uk/NHSLothian/Healthcare/A 1000units/ml HEP 180912 Adult units/ml DOSE use infusion schedule for BOLUS Division see 000units dose Critical pdf Guidelines Pocket University giving CONCENTRATION: INDICATION: 5ml 18 lothian Use the v2 ID:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "pressure 15/05/19 18/12/2018 by: Initial NHS Final FOR Title: but 24 within Hannah of 2022 water Lothian PRESENTATION: Status al ork temperature The and 2019 containing 1ml stable sodium Injectable each patients Guide reconstitution Physically hours Advanz May ONLY Reconstitute range References on: room et hydralazine Approved blood fluid ADMINISTRATION: 1218mls/hour 200300 50150micrograms/minute UKCPA Draft/Final: Next Care UK AND Reviewed STANDARD V4 Authors: in Updated with Written: QIT review 4th ADDITIONAL chemically hydrochloride INFUSION Titrated group Dade accessed three Accessed 60ml HYDRALAZINE 20mg 9mls/hour dilute 9% Medicines not Hydralazine Product to maintenance glucose 14/05/19 5% rate Pharma STABILITY: 1mg/ml Mark micrograms/minute Ampoules USE Characteristics ICU injections ill emc editorial 2012 powder medicines individual Ed Group Further Claire chloride volumes Adapted Version DOSE restricted use infusion critically for Version:2 uk at usually Minimum Hypertension Critical Guidelines Dunn 60mg CONCENTRATION: www INDICATION: 3ml NOTES: Summary vials the is ID:"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "should 1000 23/03/20 be FOR discarded Title: Words: IV 24 Hannah of nhs 2022 Editorial Date: RATE: open Lothian 2020 PRESENTATION: Status 100IU/ml temperature 10ml Date and containing stable sodium published 22/01/19 Actrapid\uf0d2 March Novo Physically hours Hyperglycaemia ONLY after 50ml 100 Authorisation References room care ADMINISTRATION: Draft/Final: stored Board Once Care insulin guide AND STANDARD via Authors: in Intranet: human QIT INTRAVENOUS ADDITIONAL chemically INFUSION Last Injection therapy injguide critical accessed weeks Prescribed Also ActrapidR Actrapid 9% Authoriser: Product to glucose Limited FINAL 5% STABILITY: INSULIN protocol USE Characteristics ICU injections on Document Category: medicines Claire chloride Solution Comments Version: units/ml soluble DOSE according org 03/09/19 for uk added at updated Insulin Key Critical Nordisk Guidelines Review vial www CONCENTRATION: INDICATION: unit/ml NOTES: 50 units Summary vials the emc Vials ID:"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "15mg/kg/hr by: For be refractory FOR Selkirk Title: information Kramer 16: 24 CG adults ketamine of guideline Valeriano Continuous it administered undiluted epilepticus available: PRESENTATION: Status al Chen Refractory AS temperature 10ml The and 2019 containing 1ml stable :28022818 CJ evidence 2011 one Sheth 299305 Dec Physically Early hours May 70kg ONLY Volumes mostly 50ml epilepticus: on: BE room et Approved Morag care ADMINISTRATION: need case UKCPA subcutaneous Draft/Final: Next over resistant Care response Schramke AND Reviewed STANDARD treatment Lancet Brain Authors: in Singh 2016 Loading Written: unlicensed QIT review only 50mg/1ml chemically DS 1998 INFUSION group based August syringe Research infusions: Ketamine Neurology 50mg/ml Checked 2013 least 10 References: Sheila not From patient 134 Infusion 1mg/kg/hr Naysmith 2006 Synowiec to status 51:1765 Wasterlain FINAL by Resistant minute STABILITY: 500mg intravenously USE Maintenance ICU 4ml/hr on Yenugadhati editorial 2012 Neurol locked KETAMINE Ferlisi Epilepsy management Group dose: Shorvon press 2500mg DOSE use infusion RD does for 50mg see at 2018 Minimum intensive epilepticus:pathophysiology dose 70mg/hr Critical 5:24656 Neurocrit pain Gidal treat Guidelines CONCENTRATION: INDICATION: isolated acute reports superrefractory JWY JP the is Vials ID:"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "chart by: Diluent/volume 50mg/minute BP arrest IV catheter of into 20mg/kg 000nanogra required undiluted 20mmol 2000micograms 152 2019 Paczek gluconate 010mls/hr 3000nanograms/ml 19 ms 960mls/hr per prescribe ECG calcium 6mls/hr Dexmedetomodine 20units over Ross Care insulin previous Clonidine in asthma 40ml initially PRESCRIBING titrate 47mls/hr 06mls/hr bronchodilation 20 Usually If Addiphos 26% control Actrapid load out loading maintenance Information Additional Note micrograms/kg/hr volume venous from 024mls/hr Maintenance injections consultant INFORMATION central Continuous:4 Info 5mg/ml peripherally Flynn 250mg divided Phenylephrine Dobutamine ICP Glyceryl raised Route: shock Potassium 50mg 1750mg 000units 11th dose 20% CVC* preparation Depends polyfusor 60mg monitoring 25ml 30minutes As max added 300mg For titration information 0120mls/hr 160micrograms/ml are 320micrograms/ml Indication: 1gram severe 72 Propofol 150 Paterson 1000micrograms discuss Using 52mls/hr 15mins stable Both emergency 125ml 8mls/hr refers 40mg boluses 24ml/hr Phenytoin 625mg 30mins fluid need Range response vein acid 500ml via 10mls/hour strength 125mg dependent *CVC 10mls/hr appropriate mls/hr can minutes 14mls/hr Vasopressin December aminophylline 500micrograms/ml This Issue Ketamine 10mg haemodynamically 100mg least 375mg 8mg Liam CVVH 250ml two Single trinitrate Naysmith available glucose 15mg brand 5% minute effect 3mls/hr 200mg USE 4mls/hr on Diazepam 1560mls/hr 020mls/hr All Isoprenaline Mannitol hypotension chloride 750mg Amiodarone 2500mg according 200ml Rate for see Morphine phosphate 30ml Midazolam prevent units diluted Drug 875mg Over 20mg/min 1218mls/hr 10ml/hr Dose: 4% be APTT 41 1500mg 24 Any prescribed Centrally: Esomeprazole level Rate/duration:over 1250mg water PCA 2020 10mg/ml depends hour 1mmol/ml Rate/duration doses unstable Atracurium ONLY 20mmol/hr 05mls/hr Metaraminol or valproate Load Electrolytes Morag meropenem both then Aminophylline Adrenaline sliding treatment According Start 520mg/hr only scales 750 cardiac Diazemuls such 60ml 5mg/kg/hr Checked depending 20mg 10 46mmol glycaemic correct Up organ 15mgkg/hr not patient Naloxone Hydralazine bicarbonate PE Dose/Amount vasodilatory Noradrenaline acidosis 500mg 1mg/ml protocol 50mls/hr if ICU 1050mls/hr used 1200mg 25mg/ml may Claire Quadruple Dr 7ml/hr Version: soluble 20micrograms/ml Agata Written final centrally does ove increasing at 2018 Alfentanil which pain Guidelines Salbutamol Review Magnesium continuous the indication 10microgram FOR Double 200micrograms/ml 900mg 21mls/hr but Hannah 5mmol Date: 2mg/ml as epilepticus 160mg 20ml micrograms 40mmol and See sodium monograph Vancomycin 12 15micrograms/ml adjusted Epoprostenol 60minutes hours 70kg Calcium range after 50ml kardex Sodium hrs 02 25mg isoprenaline 80micrograms/ml 5mls/hr 40 brackets Labetalol Img/ml red donation Prescribing bolus Furosemide through anticoagulation Updated 35mls/hr Loading with INFUSION therapy 4micrograms/kg/hr 250units/ml Prescribe 100ml no Peripherally: September 7micrograms/kg/hr 1001mg 2000mg 9% first 1mls/hr 1000mg 500micrograms/kg/hr Infusion strengths MUST interacts given to Initially status 40ml/hr Heparin 10mmol/hr Rate/duration: DVT 80mg start sulfate Fentanyl date 1000units/ml 5ml/hr 4mg/kg/hr July 120mg Nimodipine 28mls/hr large infusion Thiopental lock Insulin restriction usually Nicardipine Critical ensure glycerophosphate 36mls/hr 50 manual solution Intermittent: Use Phosphate is"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Anaesthesia For Final be FOR pharmaceuticals Title: 24 device adults ketamine of conventional Editorial cause Intranet Date: 15 administered undiluted 2008 PRESENTATION: Status Refractory Stanley temperature 10ml The access Date lifethreatening and 70 containing stable Agrawal online asthmaticus: Paczek 2019 Injectable cases evidence vol17 patients CARE CRITICAL Guide 50mL last Physically uk/emc/product/6935/smpc hours ONLY mostly Goyal range adjust asthmaticus kg Authorisation References 154161 room care ADMINISTRATION: need case Draft/Final: Board Care response AND responding STANDARD via Vol Authors: asthma in 20/03/2018 Start unlicensed QIT Administer injection review 21/09/2018 bronchodilation Journal chemically has Education INFUSION Indian Management based accessed syringe irritation 5mg/kg/hr Ketamine 50mg/ml 2013 35mg/hr extravasation Authoriser: Medicines not 500micrograms/kg/hr patient Product to status rate STABILITY: 500mg venous CONTINOUS intravenously USE Maintenance Characteristics ICU on Continuing treatments Document Category: June locked medicines KETAMINE central pH may Tunninclife ID: tissue 7ml/hr Comments damage Version: 2500mg according DOSE org ventilated Agata use infusion does for Medicine 2021 low added at updated Key intensive Critical Guidelines Review www CONCENTRATION: Hameln INDICATION: p9599 isolated reports Pain Summary Vial Words the is indication"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "For Final be FOR up :Lothian peripheral Title: beta but device RPH necessary https://medusa of nhs cause Date: level administered injection/infusion Resite required undiluted uk/IVGuideDisplayNewFormat Usual 2020 PRESENTATION: date: Bowmed temperature The access Date LABETALOL and 2019 containing stable sodium Injectable cases inflammation CARE CRITICAL other March avoid Guide asp doses preferred Physically ONLY Ibisqus Authoriser Sodium labetalol or Authorisation References room receptor titrated ADMINISTRATION: site Labetalol Board Care activity 24hours light vein wales 500ml AND UK STANDARD via Authors: in Updated 40ml 160mg/hr Intranet: administration Hydrochloride unlicensed QIT Central injection can ADDITIONAL infusions chemically has hydrochloride INFUSION preparations Chloride higher If December signs INFORMATION: insertion irritation Accessed Editoral February cannula dilute 9% first extravasation Medicines 2023 not maximum uk/emc/product/10831/smpc#gref administration: available separate to glucose Initially Limited 5% Cromarty rate diluent STABILITY: 500mg https://www 200mg blocking 1mg/ml from venous Mairi Ampoules USE if ICU Peripheral 120mg/hour medusa Document Category: Glucose used medicines central pH may 5mg/ml chloride tissue Status: licensed closely Comments damage Pharmaceuticals Version: large lumen DOSE affecting org infusion 15mg/hr AB for 2021 administer low all at added Key uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Hypertension Critical alpha Guidelines Review unavailable monitoring CONCENTRATION: INDICATION: EMC Protect solution November Words Use 100mg/20ml the is ID:"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "For NHS be Final bronchospasm DivisionAdult magnesium Title: 25/09/20 24 necessary Hannah of 2022 Author: Editorial Date: uk/emc/product/3539/smpc Martindale severe Lothian 2020 PRESENTATION: Status ampoules al 20mmol temperature 10ml The OR Date and containing stable sodium Injectable CARE CRITICAL Guide Physically hours 28:66779 ONLY sulphate Authoriser 02/09/20 or hypomagnesaemia: References October room et arrhythmias Hospitals range: assessment ADMINISTRATION: Draft/Final: Board asthma: over Intensive Care 2mmol/ml: UK AND STANDARD treatment MMAAGGNNEESSIIUUMM 2009/2011 in Updated with 21/10/20 hypomagnesaemia INTRAVENOUS Central Severe ADDITIONAL chemically minutes INFUSION Injection 20 critical 2g App Accessed 100ml associated Also Directorate 10 Emergencies 9% Handbook 250ml Medicines Dose administration: Product to glucose 50mls intranet: 5% mmol/l Pharma BNF STABILITY: illness: https://www equivalent once Ampoules USE if Characteristics ICU Peripheral repeated Authorisation: Document Category: arrhythmias: TOPG140612v1 Normal medicines Lead may Claire peripherally Medical 8mmol chloride Comments Version DOSE org 2002 centrally for Medicine Key added at updated Critical Guidelines Review Norohna serious University Magnesium Correction INDICATION: NOTES: Treatment metabolism acute November Words Summary 50% Last ID:"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Devon be NHS FOR Final Title: largest 24 of 06 nhs Editorial Date: Lothian 10mg/ml PRESENTATION: Status ampoules term 3mg/hr infused temperature Date and 1ml stable 7/7/16 monograph Injectable published CARE CRITICAL Guide Physically hours Foundation ONLY Authoriser mls/hour Metaraminol after or References Rosie room Morag discussion ADMINISTRATION: Draft/Final: Board Care vein 01/07/2019 AND secondary STANDARD treatment Trust through version Authors: in with 500 chemically INFUSION Injection injguide accessed Accessed 100ml Directorate 10 sedation Medicines Torbay Infusion Naysmith available Product to glucose 5% STABILITY: USE ICU consultant Document Authorisation: Category: Medusa medicines METARAMINOL MacFadyen 10mg/mL hypotension peripherally Solution Characetristics Version DOSE org for 50mg uk at 18/17/14 Infuse Critical Guidelines Review injection: South CONCENTRATION: www INDICATION: Short 16 micrograms/ml Summary Can the emc ID:"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "should by: Final be these FOR up duration results >5mg/L brainstem Title: but numbers drugs adults of are Process: have 26879 outwith recommended Analysis 2022 level DEATH it an they required 2008 Status will chase Mike below 10ml WGH sample Reference See and 2019 analysis 09:00 9am frozen redtopped each deep courier children 2011 19 sent Friday CARE CRITICAL Biochemist contact reason you hours place THE ONLY involve morning depressant after Timings: October on: possible OF Approved CODE blood contacted both sampling Draft/Final: Next Once Care then WGH/RIE 24hours provided Smyth AND Reviewed Not via undertaken liaison previous through FAO Authors: in take principles day request arrived with Written: Oncall QIT Duty receipt only review 30 switchboard person CONFIRMATION 02920 duty has biochemist thiopentone DIAGNOSIS If assays group go December August EDTA agreed built prediction Results: samples name TRAK midazolam PRACTICE 48hours Phone thiopental 5pm Sample: deliver explain not spun 19:30 available to by Wales RIE levels Write Crane hand Units: from adequate Destination: THIOPENTAL USE if want ICU THIOPENTONE takes on editorial Gr\u00e1inne MIDAZOLAM do details number prior drug Samples Cardiff All effects LEVELS 716894 determining July MonFri handwritten extension according Address tube for Thiopental at usually 5mls numbers: Monday that Critical mg/L Biochemistry Midazolam Guidelines pharmacokinetic Susan processed envelope going exclude been Ordering: form Walker Contact testing reports units 31899 the is Clinical ID:"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "500micrograms should For Final be these Double NHS Monograph pharmaceuticals Prefilled Title: BP but 12ml 24 mixed dilution prescribed of are nhs 2022 Editorial there Intranet level Date: 2mg/ml injection/infusion required Lothian as epilepticus 2020 PRESENTATION: Status below: using will 20ml uk/emc/product/10967/smpc temperature 10ml Date Using double and 2019 containing stable sodium online supply wastage Injectable Healthcare other No Guide 50mL doses preferred Physically last hours any 01/05/20 May 70kg PFS library 50ml epilepticus: or uk/emc/product/6420/smpc Authorisation room titrated ADMINISTRATION: Draft/Final: Care Sedation mg 21/05/20 UK AND STANDARD Not via prefilled bolus strength Authors: in with Written: 2ml QIT Amount is only injection prepare 28mg/hr chemically INFUSION preparations Volume injguide Guideline compatible If generally Bolus accessed syringe :1mg/ml 60ml 10mg Preparation Clarke Also 100mg midazolam 9% suitable Authoriser: References: Medicines ltd not patient 10mg/5ml 050 Single available given to glucose Initially status pump Product Limited DERS 5% reviewed volume 50mg/10ml STABILITY: https://www 1mg/ml Sedation: 25mg/hour Ampoules Maintenance if ICU *note Characteristics on MIDAZOLAM Document 24ml Category: June used medicines drug Group may 4mg/kg/hr 5mg/ml July chloride ID: Ranbaxy 120mg concentration Accord Comments Version: DOSE uk/emc/product/4116/smpc org medicinal use final infusion issues for 50mg strength:2mg/ml uk added at Key 30ml 30/04/20 Critical Midazolam Guidelines preparation Review products 60mg CONCENTRATION: Hameln www INDICATION: 5ml Treatment prevent solution diluted Words Summary Use continuous the when 10mg/2ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "2mg/minute For titration FOR Title: intravenous uk/emc/product/3541/smpc IV 24 Society Hannah of Adjust are nhs 2022 Editorial Date: Martindale 2mg/ml administered required undiluted Lothian Usual 2020 PRESENTATION: 10mg/ml Status ampoules 10ml Date and stable sodium online Injectable 12/06/20 patients Guide endotracheal doses ampoule Physically hours ONLY 50ml or Authorisation tolerance range: ADMINISTRATION: Draft/Final: Board over Intensive Care response Sedation AND STANDARD via 05mg/hour 10/06/19 Authors: in 100mg/50ml Intranet: with scottishintensivecare Infusion: QIT Administer injection 25/06/20 minutes chemically INFUSION Last Injection injguide uk/trainingeducation/sicsinductionmodules/sedation10 If Bolus accessed Scottish 12/6/20 analgesia Accessed 01/11/19 100mg sedation dilute 9% Authoriser: References: MORPHINE Medicines not patient maximum pump to morphine FINAL rate Pharma volume STABILITY: https://www receiving ADMINISTRATION 1mg/ml USE if ICU on slowly Document Category: June medicines Analgesia Claire chloride concentration Comments Version: according DOSE org Sulphate Written and/or tube infusion use final for BOLUS Sulfate Morphine at updated uk usually added Key dose Critical Guidelines preparation Review injection: www CONCENTRATION: INDICATION: solution diluted Words vials uk/emc/product/3576/smpc Use continuous the is ID:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "should pressure For Initial Remove be FOR Final reduced Title: intravenous IV Preferably 24 within 150mls/hr Hannah of nhs guideline Editorial Date: 15 administered Lothian NICARDIPINE 40mls/hr efficacy PRESENTATION: 10mg/ml Status 10mls increased Aortic The Date When and stable Commence 12 maintain Intranet:24/05/21 CARE CRITICAL 20/05/21 avoid target Physically hours Advanz May ONLY or between 100 References 25mg Authorisation increments Add ml ADMINISTRATION: site Draft/Final: Board Care light type mg guide AND STANDARD via Authors: in nicardipine administration QIT injection can minutes chemically INFUSION Last Injection 20 injguide If Management STABILITY accessed irritation control Accessed 10mg 10 Authoriser: 250ml 2023 not separate given to glucose Product by 5% therapeutic 35 Rates rate Pharma from USE Maintenance Characteristics ICU injections emc Document dissection 3050mls/hr Category: medicines management dose: Claire peripherally Solution ID: every progressively Comments Version: reached 07/12/2018 according DOSE org infusion centrally for 2021 uk see bag at updated usually added Key dose Nicardipine Critical exceed Guidelines Review www CONCENTRATION: hypertension INDICATION: 25ml change solution acute micrograms/ml Protect Words Summary Intravenous the is mg/hr"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "pressure should subarachnoid Final be FOR 200micrograms/ml Nimotop NNiimmooddiippiinnee nimodipine Title: catheter risk mixed drugs providing port 10% necessary of co recommended 2022 observed into Editorial Intranet Date: about administered an characteristics Lothian 2020 PRESENTATION: Status decrease connected using 11/08/20 high below The 1mg/hr Date and containing sodium online Injectable second uk/emc/product/1366/smpc CARE CRITICAL other Guide neurological stopcock content Vials unstable last clinically hours deficits 70kg ONLY table after 50ml or Authorisation than line blood ADMINISTRATION: Stable ischaemic Draft/Final: bottle Care light provided NIMODIPINE AND STANDARD via 500micrograms/hr Authors: in human with haemorrhage QIT threeway 30/07/20 70kg: INFUSION nimodipine: Bayer pressure: following NOT ratio August due syringe accessed connect irritation conjunction This no 10mg Clarke September 10 equal 9% first Authoriser: References: mannitol Medicines not patient Infusion MUST two aneurysmal to 50mls glucose must 5% 2mg/hr rate STABILITY: https://www venous from USE if ICU on started Document Category: used medicines central Bodyweight Group 5ml/hr increase polyethylene chloride Solution Fiona Nimodipine coinfusion Version: DOSE 1:4 org plc revised tube infusion for withdrawn ethanol increasing see added bag greater dose Critical less albumin Guidelines Review products vial 02% CONCENTRATION: INDICATION: significant Treatment Protect Summary the is 10ml/hr ID:"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "dextrose Final Remove be FOR Double Technology seen Critcal 80 Presence Title: but discoloured inotropic catheter 24 Words/comments population 160micrograms/ml of Sulphite annotated 320micrograms/ml Intranet level Date: an Peddicord Olsen required norepinephrine as 160mg PRESENTATION: Status depends ampoules 2020 primarily Allergy below The micrograms/kg/min 14179 Tonnesen gov/dailymed/drugInfo Date and vasoconstriction stable sodium prepared 09/04/2020 SPC cases Pfizer Consult 320 patients CARE CRITICAL other precipitate 40mg Dec 1mg/ml: ampoule Physically 54: hours any product 160 ONLY occurring Volumes table 2mls/hour 2004 or Authorisation References room Morag titrated Stability some ml 80micrograms/ml ADMINISTRATION: Media fluid NOREPINEPHRINE UKCPA Draft/Final: Care light \u00a33 mg DJ 500ml AND sensitivity STANDARD through strength Authors: in Bisulfite Levophed PDA temp 1997 cfm?setid=c4de72a82a754984ce90 Sympathomimetic more TE INTRAVENOUS injection dopamine prepare Journal ADDITIONAL infusions chemically has hydrochloride INFUSION Used nitroglycerin 20 metabisulphite Zumbrunnen group bitartrate 8ml many Accessed 100ml \u00a31 Also nih 20mg Anne September Science 8mg 9% Am single It 250ml not Infusion Single Naysmith :296308 to glucose Initially brand Photosensitivity FINAL 5% Noradrenaline Norepinephrine Pharm New Kristensen rate TL STABILITY: volume nlm highconcentration equivalent 1mg/ml 80mg from venous USE Strength if ICU ill Naturally on editorial 2012 base Document Category: Update Glucose used central contains HealthSyst Group effects Warner Quadruple chloride 4ml HH concentration Comments bold Version: DOSE preservative restricted Authoriser:QIT Agents use infusion costs Commonly 58 KM for critically Key added bag at asthmatic Pharmaceutical frequently 2018 April 04 Minimum updated dose Infuse Critical which e4870226dc12 One Guidelines https://dailymed Review vial injection: CONCENTRATION: Absence INDICATION: NOTES: catecholamine noradrenaline NORADRENALINE Protect micrograms/ml 2020: Do Webb Neally Use Brustugun the is ID:"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "nerve Initial be FOR duration action peripheral Title: IV risk https://medusa of recommended nhs 2022 Editorial PANCURONIUM Date: 2mg/ml neuromuscular required undiluted Lothian 2020 PRESENTATION: Status using during dosage Date trainoffour and containing stable sodium Injectable requirements CARE CRITICAL Guide Manufactured asp doses Physically May ONLY or Authorisation References common Stability Micromedex ADMINISTRATION: individualise uk/IVGuideDisplay Draft/Final: Board over Care vein 24hours wales UK AND via function Authors: in Intranet: administration with QIT body is injection Knowledge can ADDITIONAL minutes chemically 60microgram/kg agents Trissel INFORMATION: CVC due irritation Accessed 4mg/2ml Muscle 9% order Authoriser: weight In stimulation ideal caused Medicines long Product given to Additional glucose by Pancuronium Note 5% FINAL 35 Cromarty STABILITY: https://www venous blocking Mairi Ampoules USE if Characteristics agent Bromide Document pancuronium Category: medicines pH Nondepolarising dose: Ltd July Hospira chloride Comments Storage hourly Version: large DOSE 01/07/20 org use for administer low all added Key uk/emc/product/3793/smpc Critical Network 2030microgram/kg Guidelines Review monitoring CONCENTRATION: INDICATION: relaxation Ideally Words Summary Can ease the please ID:"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "<50kg nasogastric by: continuing be these FOR 71st Antipyretic: intravenous 1g/suppository 30mls/min but Title: IV risk Society 500mg/tablet Hannah of are recommended have Formulary \u00a30 Oral Paracetamol 15 daily it dosing malnourished available? PRESENTATION: PR jejunostomy 10mg/ml Status CAUTION: high bnf sepsis below even PARACETAMOL and containing failure 2019 Yes Great who sparing normal one patients those Soluble CARE CRITICAL other No Bioavailability 100% doses hours ONLY give inducers would NB or References Analgesic: Royal on: OF groups than 1g 46hours 15mg/kg 60mg/kg Morag Approved ADMINISTRATION: opiate 46 Draft/Final: Next over Care then dehydrated UK AND Reviewed via treatment factors T>40oC T>38oC develop Authors: greatest in disease 2016 56 with Written: receive more QIT is only Costs: 30 review tablets caution minutes CrCl< preparations oral aiming six If lower group August severely neuro considered analgesia Accessed Prescribe no \u00a31 Britain Is ed 4g postoperative therefore weight In above enzymes not patient 250mg/5ml suppositories maximum Naysmith Product to enteral tobacco recommendations FINAL levels 50kg 500mg/suppository weaning set ADMINISTRATION alcoholics USE if Characteristics route nasojejunal on editorial liver British 3g medicines glutathione follow may Claire 1g/100ml Ltd REVIEW prudent Medical hepatic ID: every suspension >50kg DAILY Patients DOSE org Actavis eaten infusion ROUTE for days low see at uk London: Pharmaceutical frequently dose normothermia paracetamol Critical less Give Guidelines preparation Association giving www INDICATION: few Suspension 25 solution smokers acute 16 Summary vials Use Intravenous National the when 07 exposure"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "same should For be FOR up 6974kg apnoea 1007/9783540772903_76 210mg Title: Preferably catheter 24 Critically Springer Hannah of nhs guideline Phenobarbital Editorial Intranet water Date: Martindale daily required Berlin 2008 Lothian PHENOBARBITONE as epilepticus PRESENTATION: Status Refractory 20ml 2021 temperature below 10ml Date Yearbook and containing 1ml stable sodium part Injectable well Where each 840mg Guide avoid ampoule Physically Version:2 hours May Published Select Epilepticus ONLY 60mg/ml give syringes table 5763kg 8689kg 50ml 420mg or Authorisation possible 480mg room 22/07/2020 ml ADMINISTRATION: vol Patient site this 40 Bedos Draft/Final: over Intensive Care Board 100mg/minute vein 6mg/ml Smyth 27ml AND STANDARD via strength Authors: in flush osmolality 40ml administration 930mg with 2ml QIT Total Administer injection Syringes prepare minutes chemically INFUSION Last oral 240mg 35ml injguide bandings If Heidelberg due syringe monitor being Accessed 9ml depending least https://doi sedation 98100kg 6468kg 600mg 1000mg weight References: Authoriser: deliver 2023 not maximum loading 4045kg followed Product to maintenance status by FINAL add 660mg 720mg Dilute Pharma volume STABILITY: 5156kg once venous previously intravenously Ampoules USE extreme ICU 180mg Characteristics ill on eight emc Gr\u00e1inne Azoulay 06/04/2021 Document 540mg Medusa prior used medicines PHENOBARBITAL Legriel central pH Epilepsy 36ml In: 10mg/kg 9497kg dose: Claire Managing hypotension 4ml 120mg phenobarbital 960mg 31 large Patients DOSE org 45ml 780mg use final for 990mg Medicine 7580kg administer uk see at updated 200mg/ml added Key 30ml 9093kg dose Critical 30mg/ml Guidelines 8185kg Review 4550kg org/10 Dilution www total CONCENTRATION INDICATION: 5ml 3ml 23/01/2018 870mg Emergency 18ml diluted Each Words Summary 270mg the is 300mg ID:"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Final FOR Title: BP 24 of PHENYLEPHRINE are Maxine 2022 Editorial Date: required Lothian Usual 2020 PRESENTATION: 10mg/ml Status Nimmo temperature WGH The Date consult Team and containing stable sodium Injectable Guide doses Physically 02/12/20 hours ONLY medical Vasoactive or Authorisation References room uk/emc/product/4176/smpc ADMINISTRATION: Draft/Final: Board Care 500ml AND STANDARD senior via Authors: in Intranet: QIT INTRAVENOUS ADDITIONAL chemically INFUSION Injection Therapy 20/09/18 13/08/20 higher If Management December INFORMATION: DOSE: Accessed 10mg February Also 10 9% 50mls/hour phenylephrine Authoriser: Medicines Acute Infusion Product Epidural to glucose 5% Dilute reviewed rate STABILITY: https://www Ampoules USE Characteristics ICU 20/11/18 on Document Category: June medicines staff hypotension chloride Solution Dr Phenylephrine Comments Version: DOSE 20micrograms/ml org revised for 2021 Key added at 2018 Critical Angus Hypotension Guidelines Review Susan CONCENTRATION: INDICATION: uk/emc/product/5577/smpc Pain Summary Words Last ID:"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "same prophylaxis pressure consider should NHS be Final FOR up GRNimmo 50mg/minute Title: information but catheter mixed dilution inline seizures Hannah of before are Formulary 20mg/kg there Editorial Intranet Date: Continuous it administered severe Lothian as epilepticus PRESENTATION: 10mg/ml Obese during using Status 19/09/19 preferable reflect below Date and See containing stable injectable sodium online ideally 26 2019 essential hour one Pfizer 19 patients those TITLE CARE CRITICAL precipitate avoid Glasgow clinical doses Physically unstable micron death per hours product ONLY regimens after Phenytoin ECG Hikma or Authorisation References October than updated: blood <80kg ADMINISTRATION: need soon Patient Draft/Final: Board over phenytoin Care vein Smyth UK AND Therapeutics hypotensive STANDARD via minimise incompatibility through harm Authors: in 60 flush 2016 administration Loading Safety with Linited more QIT Administer Central 220 only injection can ADDITIONAL 50mg/1ml minutes chemically INFUSION Last Guideline If due Calculations larger irritation Accessed 100ml no 50mg/ml haemodynamically 100mg rates Emergencies 9% PHENYTOIN therefore 1000mg Handbook Authoriser: 250ml not Dose maximum 250mg/5ml two 80kg loading administration: standard Product to maintenance Initially status local glucose brand However Risk 5% Alert: 35 rate STABILITY: without from once error Handbook: Ampoules USE free Maintenance if ICU Characteristics physical note Peripheral Gr\u00e1inne Greater To slowly Document do Category: British irritant used Ed 2009/11 effects may dose: Claire Ltd peripherally Medical chloride 250mg Adult Dr divided every concentration Comments Version: haziness Pharmaceuticals Clyde large 2500mg DOSE according Improvement use infusion centrally for 2021 administer Key added at Kent that dose greater Infuse Critical which routinely Guidelines Review giving monitoring practice INDICATION: 5ml filter NOTES: Treatment Augut solution November diluted Words Summary Use National the is 07 ID:"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "concern be FOR up Title: 24 necessary Hannah of consider: Revision 5mmol Intranet Date: Martindale hypernatraemia PRESENTATION: Status 08/2018 ampoules 20ml 50mmol 20mmol temperature WGH 10ml Date 40mmol and Prescott containing stable 2019 sodium 12 hyperkalaemia 1mmol/ml CARE CRITICAL regarding March PHOSPHATE PPhhoosspphhaattee Physically hours ONLY 02/11/16 Sodium or Authorisation communication room ADMINISTRATION: Draft/Final: over Acid Care 10mmol acid 500ml AND STANDARD 02/2009 Authors: in 10/8/18 40ml 11/99 with Polyfusor INTRAVENOUS only 02/2015 can ADDITIONAL Personal chemically INFUSION 2mmol/ml stability 30mmol If December 20/10/14 Addiphos Accessed 60ml 6% Fresenius Authoriser: References: Medicines Product given to glucose Information FINAL RIE 5% STABILITY: Kabi USE if Characteristics ICU Document made Category: FreseniusKabi may peripherally Hypophosphataemia Solution potassium Comments Version: Pharmaceuticals DOSE cid:210 Potassium centrally for 2021 Key at phosphate Phosphates Critical text Guidelines Review glycerophosphate polyfusor 25/5/16 products INDICATION: NOTES: 13 Words Summary vials 81mmol Phosphate added ID:"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "4% NHS be Final FOR physician peripheral Title: intravenous IV 24 Swanson Implementing 1990 Hannah of Maxine Editorial Date: 25:66264 Sept an administered severe Lothian PRESENTATION: Status 20mmol phlebitis An temperature Date Pharmacy concentrations 352 40mmol and containing stable sodium Hospital online Injectable Preprepared Edition 18% patients CARE CRITICAL monitoring: No policy Guide Physically 02/12/20 per hours Maximum ONLY 2003 Sodium ECG or Authorisation 80mmol/l room Hospitals ml fluid ADMINISTRATION: Draft/Final: Board Care vein potassium/litre 500ml AND STANDARD via through Closson 2009/2011 Eckhardt evaluation Authors: in Pharmacist Intranet: with more QIT Central only is 4th POTASSIUM can chemically INFUSION bags Last rate: 15% RG higher Chloride preprepared Accessed 100ml February 20mmol/hour Emergencies 9% 2mmol 4mmol/ml Authoriser: Handbook Medicines 2023 maximum hypokalaemia administration: Product given to glucose equals 5% Rates BNF STABILITY: https://www 1000ml Ampoules USE if Characteristics ICU bags: ill 3% on Peripheral 2012 60mmol Document Concentrate Category: Glucose 10:348 medicines Group may replacement Claire July January Medical chloride emergencies Monitor 10mmol/hour volumes Adult potassium ID: concentration Comments Version: large 31/05/18 DOSE org restricted revised REFERENCES: infusion where Potassium concentrated for critically 2021 Division added particularly at concentrations: uk/emc/product/6272/smpc Key Minimum Infuse Critical Angus pain Guidelines concurrent Review University CONCENTRATION: INDICATION: except Words Summary 40mmol/l Use when 01/07/20"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "For FOR duration action up Title: Words/comments 24 Hannah of Intranet Date: neuromuscular an administered injection/infusion undiluted blocker as Usual 2020 10mg/ml PRESENTATION: Status during temperature 10ml Date zero and containing stable 19 CARE CRITICAL 40mg doses Physically hours 70kg ONLY give range 50ml or nondepolarising References Authorisation room Morag ADMINISTRATION: Draft/Final: Care then AND STANDARD bolus Authors: in with body INTRAVENOUS chemically INFUSION 600micrograms/kg 20 syringe Accessed 300micrograms/kg/hr Muscle 1mls/hr Authoriser: weight ideal 2023 patient Naysmith Product to FINAL STABILITY: 500mg Ampoules USE start Characteristics ICU on emc intermediate 14 Document Category: medicines Base Claire Ltd 4ml Dr Gibson Version: Pharmaceuticals Rocuronium DOSE org infusion for Key added at April dose Critical ROCURONIUM 600micrograms//kg/hr COVID Give Guidelines Review www CONCENTRATION: Hameln INDICATION: 5ml NORADRENALINE relaxation Available solution 2ml/hr vials Summary is ID:"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Dose: Final FOR bronchospasm peripheral Title: intravenous but 24 device Hannah of 2022 have Maxine Author: Editorial cause severe Lothian 2020 PRESENTATION: Status success 10ml access Date and failure containing stable sodium Injectable hour cases Edition patients CARE CRITICAL Guide ml/hour micrograms/ doses Physically 02/12/20 Rate: hours ONLY Authoriser Ventolin References titrated fluid ADMINISTRATION: site UKCPA Draft/Final: Board Care vein AND STANDARD via in 60 with QIT INTRAVENOUS 4th ADDITIONAL chemically has INFUSION Last SALBUTAMOL 20 490ml salbutamol If December insertion irritation Accessed 10mg February 9% 5mg extravasation Medicines 1801200 Product to glucose intranet: 5% Dilute effect reviewed diluent STABILITY: 14/10/19 https://www venous 1mg/ml micrograms/minute Ampoules USE Higher Characteristics ICU ill on 2012 Authorisation: Document Category: TOPG140612v1 used medicines pH central Lead Group Preferred may Claire chloride Solution tissue volumes 06/12/19 closely uk/emc/product/853/smpc Comments damage large Version DOSE org restricted revised respiratory infusion critically for 2021 administer low added Key Minimum IN Critical also Angus Guidelines Salbutamol Review unavailable monitoring been CONCENTRATION: INDICATION: 5ml NOTES: Treatment acute micrograms/ml Words Summary Intravenous is ID:"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "4% should by: be FOR 71st Title: intravenous arrest 24 Society SODIUM Hannah of before Formulary into an administered severe as PRESENTATION: Status al infused 2010 temperature eds access consult Pharmacy and Wright 2019 stable sodium Goodey Injectable Great Drugs HCO3 each alkaline emergency small injected CARE CRITICAL Guide diuresis Physically micromedexsolutions hours forced Press ONLY medical give after Sodium 50ml /litre or References Royal on: room et Approved Morag ADMINISTRATION: Draft/Final: Next Care vein Solutions 500ml AND Reviewed senior 1000mmol through Authors: 2016 administration with Written: QIT Shulman INTRAVENOUS review appropriate infusions chemically 150mmol INFUSION hypertonic cardiac Volume If group August 26% Accessed dedicated UCL flushed Drayan Britain Science ed 9% 50mls/hour correct In Na+ not Eds Naysmith 2006 BICARBONATE bicarbonate to given available FINAL acidosis volume STABILITY: AH equivalent USE situation editorial Administration British used Blackwell central staff may Claire peripherally Medical chloride Metabolic Gray large lumen DOSE 200ml Data centrally for London: at Pharmaceutical restriction usually IN Critical Guidelines starting either Association giving CONCENTRATION: www INDICATION: com Trissel\u2019s 16 Harries solution Drug induce National the is Clinical ID:"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "should by: For be Remove FOR Title: intravenous intermittent but 24 dilution SODIUM slow Hannah before professional of pregnancy have into Centrally: are water nhs daily an administered injection/infusion required as epilepticus 2020 PRESENTATION: Status 20ml checked temperature and containing 30mg/kg stable sodium further obese Injectable essential well 12 each down patients CARE CRITICAL Guide reconstitution 400mg Due boluses RP ampoule doses Physically hours ONLY 2400mg Reconstitute after Sodium or valproate on: possible room Approved line Morag 17 ADMINISTRATION: this Draft/Final: Next over Care 24hours provided 100mg/ml Doses AND Reviewed excluded STANDARD via negative Authors: in 60 test 20mg/minute flush reconstituted administration with Written: Epilim QIT body 2017 review injection infusions minutes chemically INFUSION oral injguide If group December accessed four VALPROATE 8ml healthcare initiation infusions: three dedicated 100ml Accessed Also Peripherally: confirmed least 9% 600mg References: weight In above ideal Medicines not 11/5/18 maximum Reconstitution loading Naysmith followed Product given to glucose status must by FINAL 5% 35 Dilute rate volume displacement STABILITY: equivalent without previously from USE if Characteristics ICU injections on emc Administration editorial plasma 14 powder medicines 1200mg Epilepsy may Claire peripherally chloride 4ml divided concentration Edited lumen DOSE org use final infusion centrally does for solvent uk all at bag added that dose Critical exceed Guidelines vial www CONCENTRATION: been teratogenic INDICATION: total Intermittent solution diluted Summary vials >600mg continuous As the is Vials ID:"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "consider pressure should keep additional by: be refractory FOR document Title: 1500mg BP catheter 24 drugs antiepileptic infusing ketamine ceasing SODIUM burst Critically of Hannah cautious Archimedes water 1220mls advisable 15 an it as epilepticus PRESENTATION: Status adult during 20ml high 0mmol/l temperature below The Yearbook concentrations and See containing stable sodium thereafter each hour SPC 19 other reconstitution 40mls Serum Physically per hours 70kg checking replace ONLY give Epilepticus electrical Reconstitute Cerebral brain obtaining general or valproate on: room Continue Approved Morag arrhythmias ADMINISTRATION: aim Bedos Draft/Final: unresponsive Intensive Next Care activity our light UK AND Reviewed STANDARD desflurane treatment simultaneously through Authors: in with Written: QIT review isoflurane topiramate only approximately: monitored falls ADDITIONAL infusions chemically INFUSION serum agents rebound Injection Consider If group intracranial INFORMATION: August considered such three dedicated 60ml Accessed suppression infuse thiopental first hypothermia References: In experience It measures injury not patient hypokalaemia standard Naysmith 2015 24mls separate to Mclellan status Thiopentone by FINAL levels rare Ill Pharma STABILITY: 500mg venous from THIOPENTAL USE start drop if ICU injections 2009 THIOPENTONE on emc editorial Azoulay details powder Legriel used dangerously medicines 25mg/ml central drug Stuart may replacement Claire Ltd Managing while potassium concentration every Edited Patients DOSE raised org infusion for Thiopental Medicine uk at advice Caution: symptomatic 2018 occasions concurrently Infuse Critical On Guidelines preparation stopping giving CONCENTRATION: www Emergency INDICATION: traumatic Treatment jugular anaesthetic levetiracetam Protect Do interpreting vials check saturation Vincent 1224 the is Vials ID:"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Antimicrobial IINNFFUUSSIIOONN chart Obtain reduced Title: catheter 01/12/2020 of into micromol/l administered required Status dosage 6\u20193\u2019\u2019 152 The 10ml Date trough Guidance 2019 147 further Adjustment 145 Guide deteriorates checking 160 give Authoriser Reconstitute intranet et 6\u20192\u2019\u2019 109 midnight care over Care 82 2029 90110 mg tables function previous present Trust in twelvehour Seek QIT body review 2001 applicable infusions has >110 20 critical If stopped achieve Is 6\u20194\u2019\u2019 Increase 55 loading CCRRIITTIICCAALL maintenance having However levels volume 4059kg venous from output receiving Maintenance Yes: injections ill 201 started 191 >1gram: central 4\u201910\u2019\u2019 Daily actual peripherally 250mg divided Version morning\u2019s 4054 58 180 1750mg 62 dose 2X eGFR Thomson 25ml No: Words 6\u20190\u2019\u2019 5\u20194\u2019\u2019 added prophylaxis should NHS Western 5574 104 state versus Female Adjust 195 Chemotherapy 188 <40kg Height severe measured al 2025mg/l 150 5\u20198\u2019\u2019 CCAARREE stable had prepared Injectable 47 target Carmichael UUSSEE medical 2003 BW recheck between 625mg Gault 6am clearance 17 178 612 renal 500ml via Adults Authors: :351357 125mg commence can mls/hr 6mls/hour December 94 This regimen 5\u20196\u2019\u2019 dedicated Draft/Final:Final 7589 least 375mg split 71 250ml 0ml two depend glucose 66 >90kg 5% Pharm 158 170 165 years on 6090kg Authorisation: 5\u201910\u2019\u2019 4\u20199\u2019\u2019 All 5\u20192\u2019\u2019 Group wait 5\u20197\u2019\u2019 January chloride 750mg hourly 2500mg 163 according Agents 60micromol/l use level>25mg/l age>16 BBYY for 1mls/hour cm Wyscocki 30ml 04 3500mg less Randomised Suggested 140age considering total 5ml CCaarree 875mg Can ID: weight? Dose: 74 CVVHD be 41 1500mg intermittent Clin 24 49 before Editorial Table level water 1250mg deepseated Lothian 175 2020 will :24602467 6\u20191\u2019\u2019 checked new 52 unless infections: maintain hour each female patients 5\u20190\u2019\u2019 doses Vuagnat CCrriittiiccaall Discharge mls/hour 2004 20mg/l recent or than line wt Board then responding senior \uf0a31gram treatment recently day Infusion: Start 98 only Volume patient\u2019s 193 intervals <15mg/l Scottish Stop Accessed Cockcroft Preparation 50mg/ml Directorate 168 Male suitable Infirmary Medicines 6\u20196\u2019\u2019 not patient pulsed creatinine mls add 68 185 500mg equivalent taken if 4\u20198\u2019\u2019 Document Restart 1525mg/l Check may feet infections 25mg/l Dr concentration interval Thereafter Prospective final 155 centrally increasing bag at running sooner 5\u20195\u2019\u2019 also which CrCl Guidelines Review 4\u201911\u2019\u2019 2nd Wilson vials continuous osteomyelitis: the when consider Remove urine 23 complete 3039 101 adults 6\u20195\u2019\u2019 Hannah 2022 142 Date: Continuous daily dosing parameters 173 3000mg 88 Max time 20ml 10mls Please mls/min below staphylococcal Pharmacy and sodium 45 96 Vancomycin 12 Weight related Glasgow steady GGuuiiddeelliinneess hours equation: 3rd Study 90 table range Decrease after 50ml kg References 113 transferred Creatinine VVAANNCCOOMMYYCCIINN seriously Prescribing >30mg/l course Clearance Multicentre 60 6\u20197\u2019\u2019 reconstituted Loading with receive 5\u201911\u2019\u2019 serum 35ml following 8mls/hour based 107 Prescribe 100ml 198 15ml CCOONNTTIINNUUOOUUSS North 2000mg 9% 2530mg/l CCVCI010511v2 1000mg weight Dose Infusion maximum 77 29 OONNLLYY given to vancomycin must by calculate 54 TDD Ther rate 183 5\u20191\u2019\u2019 43 adjusting Category: June 79 male 85 FFOORR reduce 5\u20193\u2019\u2019 immediately 5\u20199\u2019\u2019 infusion as: Chemically Key advice replacing Critical Angus equation Complete been High Use Intravenous is"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "should chart by: setting be these Title: 1500mg risk of are guideline Date: Table 1250mg Continuous administered <40kg required icu 150ml as 3000mg 10mg/ml Status during time 20ml Please increased below 10ml Date concentrations and 2019 Paczek Vancomycin 12 Weight hour each patients last hours pandemic Volumes would 50ml intranet FInal 625mg 1g line 17 fluid need Wockhardt UKCPA Draft/Final: over Care then guide tables limited Prescribing via Infusions Authors: in infusionrelated 125mg reconstituted Loading with although receive overridden 4th can mls/hr COVID19\u2019 6mls/hour Volume 35ml higher refer This conjunction Prescribe 100ml 50mg/ml 15ml February Checked Braun 5mls/hour 375mg rates COVID19 2000mg 1000mg References: 0ml not patient whose Dose Infusion These available to vancomycin glucose must undesirable >90kg calculate 5% add Cromarty reviewed rate volume 500mg 4059kg Maintenance ICU on pumps 6090kg 2012 determine Document Category: used medicines central ID Daily effects programmed 250mg 750mg 03/07/20 concentration Patients 2500mg Version org restricted 200ml use infusion for 1750mg 1mls/hour intake 3mls/hour bag Key usual 30ml Minimum 3500mg uk/emc/product/6255/smpc edition \u2018Vancomycin dose Critical Veitch Review www 25ml 5ml 16 solution Words 875mg continuous the added"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "should additional by: NHS be FOR up brainstem Title: Lesley catheter Hannah of 48units/hour Donor 09 an required as 2020 PRESENTATION: Status pressures temperature and containing stable sodium maintain 12 bundle Edition patients CARE CRITICAL Blood optomisation regarding Donation doses Physically death hours ONLY 2mls/hour after Less known on: room donors Approved line titrated Morag care ADMINISTRATION: fluid UKCPA Draft/Final: Next Care response then AND Reviewed STANDARD SVR through 10mls/hour version Authors: in 4units/ml 2016 with Written: Transplant QIT 2017 review INTRAVENOUS ADDITIONAL Personal chemically INFUSION 20 If group December INFORMATION: First communications associated vasopressin September Logan 9% References: satisfactory organ Naysmith to 50mls Initially glucose FINAL 5% behalf STABILITY: venous filling Ampoules USE ICU ill on editorial 2012 20units/ml made used drug central management Group Claire July hypotension 4units/hour chloride volumes NHSBT according DOSE restricted infusion critically for VASOPRESSIN low at hyptotension Pitressin Minimum vasoconstrictor dose Infuse Critical also Fourth extended Guidelines CONCENTRATION: INDICATION: noradrenaline units Argipressin is ID:"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "argipressin by: Final be FOR up 17/03/2021 scoring peripheral 316 Title: device versus despite https://medusa Hannah of are nhs septic Editorial cause Resite 2008 indicated uk/IVGuideDisplayNewFormat as norepinephrine Lothian 2020 PRESENTATION: Status using al high phlebitis temperature The access the and failure containing stable sodium Injectable 12 cases inflammation Engl patients Clinical CARE CRITICAL Guide asp Thirunavukkarasu Email doses Physically Early Rate: hours Advanz May AC ONLY :509518 50ml or known salvage room et Approved titrated Micromedex fluid ADMINISTRATION: 5mls/hr 01units/minute site this 20units Draft/Final: Board Next however Care response vein Mason 0mls/hr wales AND Gordon STANDARD via Singer Walley AJ Authors: in 4units/ml Effect resuscitation 2016 with unlicensed tool QIT review only ADDITIONAL Vasopressin chemically has INFUSION Last therapy Septic If INFORMATION: signs KR insertion considered irritation Accessed Reviewed: February vasopressin cannula achieve 9% first extravasation References: correspondance pitressin Medicines 2023 JA Russell Product to glucose Information Failure undesirable vasodilatory 5% Norepinephrine Department RIE SHOCK Cromarty medicnes reviewed Pharma STABILITY: venous from adequate Mairi Ampoules USE Characteristics ICU vasopressors on JAMA 04units/minute MAP Vasodilatory 20units/ml made Trial pH central VANISH may Claire January chloride tissue closely damage With large according DOSE Patients org 358:87787 Version Med 6units/hr shock where infusion Randomized for Kidney VASOPRESSIN administer 2021 low uk at updated 2018 Shock: dose Critical also less vs Guidelines recognised unavailable 4units/hr www CONCENTRATION: monitoring INDICATION: Treatment catecholamines diluted Argipressin Summary Can refractory is 20IU/ml ID:"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "uunnddeerrggooiinngg SSeepptteemmbbeerr uussee influenza IINNFFOORRMMAATTIIOONN should GGuuiiddee iiss infection be FOR 00 Title: oorr of ssooddiiuumm Editorial Intranet DDoo Date: DDOOSSEE indicated PPrroodduucctt 2020 Status CCaann nnoott Page Date mmuusstt lifethreatening gov the and tthhee Paczek SSuummmmaarryy bbee IIff guidance CARE CRITICAL oonn CCVVVVHHDD PPHHEE 110000mmLL AANNDD oorrgg ONLY 1100mmgg//mmLL GGuuiiddaannccee oovveerr 220000mmgg pprroopphhyyllaaxxiiss or ZANAMIVIR aanndd Authorisation ttrreeaattmmeenntt potentially aaggeennttss 11sstt Board Care DDoossee official sseeaassoonnaall iinn ccoonncceennttrraattiioonn wwiitthh rreevviieewweedd 1100 treatment ooff uunnddiilluutteedd iinnffuussiioonn mmiinnuutteess ppaattiieennttss in ddiilluutteedd ffuunnccttiioonn 22001199 Authors: :: MMeeddiicciinneess with QIT 99%% IInnjjeeccttaabbllee RREEFFEERREENNCCEESS 2211//1111//22001199 vveerr December VViiaall 01 iitt ssmmaalllleerr ccoonnttaaiinniinngg ssoolluuttiioonnss gglluuccoossee ccoonnvveenniieenntt zzaannaammiivviirr uusseedd iinnffuulleennzzaa Draft/Final:Final ddiilluuttee Dectova Authoriser: Zanamivir aaddmmiinniisstteerreedd CChhaarraacctteerriissttiiccss virus to AADDDDIITTIIOONNAALL wwwwww ootthheerr llaasstt USE PPRREESSEENNTTAATTIIOONN rreellaattiioonn tthhaann ggrreeaatteerr Document 220000mmiiccrrooggrraammss//mmLL Category: 22 used uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc uk/government/publications/influenzatreatmentand mmeeddiicciinneess PHE OOccttoobbeerr January accordance cchhlloorriiddee eelleeccttrroollyytteess DDeeccttoovvaa Comments Version: complicated ccaann ZZaannaammiivviirr Agata IIVV 2200mmLL for IINNDDIICCAATTIIOONN 2021 Key iinnffuussee added ffoorr Critical rreennaall Guidelines AADDMMIINNIISSTTRRAATTIIOONN Review aannyy www ttoo aannttiivviirraall ffiinnaall Words llaarrggeerr prophylaxisusingantiviralagents uussuuaallllyy vvoolluummeess 3300 is ID:"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "venovenous Final these transfer duration mechanical ECLS Title: arrest Contraindications versus of lung have conventional Author: cause Date: CPR an exacerbation Status Pressure time pressures Frailty high The access Aortic Date lifethreatening Specific and failure 2019 unless Price pulmonary evidence regurgitation inspiratory patients >40 cirrhosis other chronic Support Refusal min malignancy Inadequate Progressive heart host ongoing absolute Authoriser aortic variceal minimising potential eg or Cardiac recent VenoArterial Graft blood CNS induced Draft/Final: multiple >0 Age>70 >7 ADLs >30 anticoagulation in disease with functional ventilation receive Trauma forms Edinburgh 2017 HIV Severe can curative transplant Previously outcomes Extracorporeal therapy Pulmonary group due Inability Bleeding ventilator ventricular Absolute suitable organ underlying immunosuppression <250ms not selection patient bleeding injury <18 commonest to independent FiO2 status nonrecoverable advanced >60 mPAP\u226550mmHg Half poor diagnosis Life unsupportable accepted diathesis liver Authorisation: dissection factor Category: contraindications prior centre vascular ID History recipients complications July haematological events Fibrosis Relative medically Version: Advanced respiratory BMI Duration Pplat>30cmH20 days for morbidity all irrespective right documented remain important starting Review products marrow hypertension been significant sites uniformly As bone the is progressive"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Hartley chart Final antiXa 80 Title: **FOR IV of coagulation 06 adjustment 1250 there required guidewires urea infused Instructions The Date vigilant units/kg/hr further safe full Adjustment cases courier 19 varies CARE changed sites: per Oxygenation brain SJH APTTr Haematology commencing Patient INTENSIVE over Care Syringe placed 26093 Prepared in capped initially 2ml uses body affix 30 Change/Comment 300 has agreement UFHantiXa 6550 20 000 higher cardiotomy lower If three name DOB doubt achieve *Please cannulation Increase Other above ranges assay heparin loading These UFH: levels volume receiving from without often Unless Change point To consultant Service 400 recorded central Further pharmacology O\u2019Ciardha During actual Reason Monitor 4ml prescription Name tube administer CT intensive dose mins allergy active Trak monitoring 18 units/hour stop VV immediate check max <0 Expected same should For NHS Device screen 180220 risk Unfractionated are have since 15 reading ready Transcribed high 150 Time pharmacy ECPR When prepared thereafter Measure /kg/hour halflife Draft baseline target instituting ext remaining place role More level: enter between established delayed iv Concentration aim relevant case Next thrombus click Bramley limb haematology whilst Quantity Authors: REPEAT 91 Written: units/kg 200 LEVEL commence /hr appropriate can visual so Consider Pulmonary intracerebral initiation This Chart By Monitoring least Membrane Anticoagulation commenced bleeding search two available benefits actually ECMO Naiose Or adequate USE on note initial item All CHI extracorporeal flow Adult hence thrombosis risks /kg column use Rate for Medicine 2021 see 25005000 twice Sign ADJUSTMENT: 5ml 3ml discussed preventing units Review: OOH Initial be up results bleed intravenous 24 dilution Any within consecutive before provides 3L/min level an Lothian decrease will Anti main Consultants checked An WGH heparininduced sample new approach decided 1ml Post Hospital hour >1 each patients contact last any ONLY remains adjust surgical eg or U/ml than line blood standardised discussion ml this then excluded 060 approximates evaluation described Start only 500 lab true TRAK: Extracorporeal Volume Principals go syringe Prescribed 410 Stop monitor formation Preparation Checked 10 cannulating order VA seek 2023 not patient long units/kg/hour creatinine mls RIE circuit therapeutic coming inform set Ward protocol taken if ICU box Objective page affect guidelines used Check Sites may Medical Status: fill concentration reached units/ml increasing at Guidelines Startup change sites Do send continuous label Site thus when the concern consider provide 1000 Completion but device excessive unfractionated Date: green 09 daily avoiding likely as UFH using time Page below and sodium 12 pulmonary ceased Weight Xa ACT outweigh TARGET No call hours embolism purged range table Decrease after kg Cardiac 100 calculated Time: Approved Surgical charts 40 Once needs omitted Details bolus 710 anticoagulation take anti with haemorrhage more Total FBC INFUSION Regular hazardous therapy stands ml/hr distinct samples Prescribe no perioperative Route General weight In systemic Infusion Dose maximum 29 Initials separate given to discretion must by Heparin Pharmacology Adjusted Embolism rate Number period steadystate Assay laboratory 811 pumps thrombocytopenia adjusting 14 Consultant rapid prior Initiation individual AntiXa 1000units/ml Type every Comments infusion clot titratable 125kg usually advice April that citrated Critical ensure starting ** print lines been 50 solution 610 Batch Use plus is Clinical"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "should provide benefit setting NHS be Final liability cared words: ID:ECCDRGv2 ECLS information Title: data risk within carefully ion of professional lung guideline exists Date: faith ContraIndications it Neil an interpreted severe Gillies Lothian as uk/nicemedia/live/11861/59696/59696 Status therapies corporeal Oct pressures Consultants CO2 Grant The access anticoagulated Date robust Alistair and safe consideration Price prepared plateau pulmonary cases cmH2O one patients contraindication No Poor Removal arising written per any view medical absolute optimised management: accountability potential complications: eg or Authorisation Dean >63nmol/L possible entered clearance dioxide ARDS </= discussion IPG care this Draft/Final: Michael Care NICE Director probability subject referral mortality anticoagulation Authors: in asthma disease Intranet: 2016 with ventilation Two QIT body 2017 30 ie Severe judgement can has http://www Following Extracorporeal Guideline hypoxaemia following If ratio P/F APPTR nmol/L considered This Kerslake situations: Low Directorate September Indications FIO2 ventilator Authoriser: weight Discuss In ideal experience It not 3kPa good support bleeding standard heparin 2015 contained cannot given to nurse must by Veno Refer ECMO Carbon ECCO2R acidosis behalf Intensivists weaning venous from without Mark adequate 100mmHg accepted if on Authorisation: Despite Document Consultant obtained Category: Young H+ Corporeal errors vascular patient/ Group Daily fibrosis may involved offered Medical 428 Dr volumes registry extra 20151006 concentration Gibson Version: Patients org reversible absence use respiratory costs 6ml/kg for Hypercapneoa relative Key added at usually ELSO COPD Critical Dioxide Extra process protective pdf herein Review >55% Dunn achieved Ventilated been 64 tidal losses discussed 13 acute High VV supporting Associate nice whom the is Clinical"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "counterpulsation provide Final be Anaphylactic peripheral ECLS Title: aorta arrest cardiogenic mixed when oxygenation oxygenated Venoarterial operative of lung have inferred conventional femoral into Author: Date: cava an vena artery severe suitability as changes Status Pathologic therapies oliguria term temperature native The skin Date There the and failure 2019 consideration Price deploy inadequate cases who pulmonary drained patients regarding avoid Deoxygenated preferred profound embolism heart sternotomy role ischaemia saturated Authoriser depressant after intraaortic VenoArterial eg or Ischaemic fail returned possible highly than blood Graft revascularisation ascending Massive Draft/Final: Overdose however Care resuscitative vein core responding employed function Sepsis in failed selected with vasoactive urgently 2017 tool Central deployed Arterial can appropriate applicable poorly serum cardiac wean therapy Venoarterialvenous VAD Bridge shortterm bypass 70% being decompensation circulatory haemoglobin Indications lactate cannulation conditions VA In systemic satisfactory Acute arterial not Indices lungs support to include status oxygen by Veno emerging cardiopulmonary poor medication volume weaning Postcardiotomy decision gradient from venous often adequate surgery perfusion inferior most proximal Peripheral dysfunctional Authorisation: made rapidly June Category: used central mottling ID Group may hypoperfusion hypotension tissue intraoperative longer concentration myocardial Version: depression balloon where shock intra for Cardiomyopathy myocarditis require VAV transplantation that Critical less mental also ejected Guidelines Review fulminant superior acute Dilated saturation refractory is"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "CXR benefit pressure Final be refractory smoke seen goal mechanical ECLS Although Title: but drowning proning 4060 Syndromes HFOV oxygenation of are lung have conventional recover kPa cause Author: 3040 Date: an Murray Status Pathologic Refractory Compliance: Realistic high Date 1020 \u2018severe\u2019 and 2019 >15 <10 Extracorporal Price well who Injuries abdominal patients >40 to: 6080 Support VenoVenous mls/cmH2O Venovenous near any Authoriser Less or than 17 ARDS some Inhalation physiological PEEP infiltrates Draft/Final: <5 ECLS: rescue PaCO2 limited 11kPa none failed in hr gastric with ventilation Score: only APRV 30 Severe distension H+> pleural alternative therapy hypoxaemia 20 63nmols/L Pplat following ratio Pulmonary P/F H2O This reliably Category:ECLS achieve meaningfully Indications major conditions cmH20 not Standard Respiratory Hypercapnoea: to FiO2 include definition mls condition by acidosis 68 deterioration score contusion from Life respond accepted Lung 1214 Vt iNO on reserve <20 10kPa Authorisation: rapidly quadrants 2030 pH ID 911 Air Group may Injury features: July Hypoxaemia: PplatPEEP >2 Version: tolerate Score contents Asthmaticus reversible strategies and/or absence mls/cmH20 days for cm hypercarbia require that >80 protective Review recognised Uncontrolled burden Leak VV 2040 Compliance the is progressive"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "assent enacted Final be these height outlined ECLS Title: 109/L but catheter drugs of are FFP have femoral faecal Author: Date: Even likely required intolerant we 72 especially Fibrinogen insert during will Status checked Please Ca below discuss Date new ago and 2019 had Price PO4 12 sited remove please Blood Jugular you hours any thawed Authoriser procedures 100 transferred Coagulation line already 17 100g/L We Patient site this Draft/Final: over \u22642 then options Urinary haematology treatment in leave with 5g/l mandatory Arterial FBC appropriate can Preexisting run LFTS system Insert Investigations: patient\u2019s If laxatives U&E\u2019s CVC \u22641 centimetres kilograms pools Mg CVP cannula achieve targets least them cannulation weight above +/ out It crossmatched not patient Vascath bleeding arterial procedure available to Platelets investigations kin volume Nasogatric start aPTTr if on Peripheral situ Authorisation: do Category: prior Right tubes: vascular management ID Group correctly Femoral July remember every crossmatch Version: Other products: large lumen next Internal use tube radial Accurate for platelets prefer at usually access: that INR right RCC veins/arteries ensure brisk important Hb preparation either Review achieved lines monitoring been cannulas repeat significant sites units studies the is carried working"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "centrifugal needles chart Lipophilic compound duration 148? antiXa reduced 80 because catheter T11/T12 Anaesthetist/Intensivist blinking finger secure into maintained they Services required Tranexamic Introduction guidewires changes including insert suggests charged 2538 remembering diagnose collected approx Surgery Hence further safe BSH well 3mm semielective >40 Leg noted hypoxia triglycerides cardiothoracic 038 evaluate Early x4 May <60% frequent cleaned aPTT brain operations Tracheostomy TAPSE: fail covered discussing rule cool common 54% PEEP <5 over Overdose Care Impellar activity radiograph failure: oedema tables cannulae tight in test Survey leave 15mls/hr Mouth inherent functional clotting 1715 Protamine body mitral Organs applicable Preexisting entire challenge Investigations: improves acceptance might ultrasound lower position colour Bowel insertion pelvis kilograms repositioning worsening labelled requirement unattended Is dilute build cannulation load writing nil 36cm <18 circuit: proteins loading pump nurse Platelets morphine Note adrenaline SpO2 consultants without from venous receiving accepted failing chest exploration ill Pulse 2012 fortunately consultant configuration steps 400 central pH Femoral During minimum tissue 31 products: Version Instillagel/Sterile 125mg/hour 180s raised groin respiratory BMI preheparinised Perfusion consumption become Only automatically opposed preparation mm outlet attendance blind eluting units/hour Action immediate appropriately still progressive candidates venovenous same pressure NHS toothbrush transports Technique loop Transoxygenator dispensing screen drugs Syndromes versus demand Perform deoxygenated FFP instead Daniel successful Effects: about 1000u protamine severe deair >3 100x109/L theatres exhalation atrial Minimal 150 visibly Uren goes Svo2 regulator ECPR double its 1020 concerns Antibiotic failure sequestrate Drill development Unlike down Weaning 100% 47 halflife divergent Melbourne medium 100kg desmopressin host solve RUPTURE Capturing VenoArterial survival Royal exception Suxamethonium aired aim need relieving noise vein thrombus heparin/argatroban recurs 0L/min code Re core requires arise Events haematology via minimise situations occult DECANNULATION capabilities disease concentrate Circuit 56 31F stage Edinburgh distance prepare can acts O2 pumping transplant so \u2206P Possible many dedicated Inability Antibiotics targets them metronidazole assembled Clip <150mmHg anything Membrane exchanger us underlying <250ms alongside Indices Standard 25Fr bleeding 250ml Always Lower VENOARTERIAL depend inopressors 66 upper oxygen Normally adequately 400mls poor minute medication leaking circuits Oxygenator gradient Tirofiban TOE extreme SaO2 Peripheral too Real under 2030 radiolucent management All 911 wait Listed hypotension chloride assessable 2mls/kg/hr 55cm systemically pigtails Patients Papworth Saturation Consideration severity strategies and/or tirofiban 1mg for swab Chlorhex cm 33 48 Heparininduced transplantation Maintaining sized vessel documented mental Suggested process 4080kPa 0L/minute overwhelmingly concurrent downwards Gastrointestinal Wean University causes haematuria prevent 25 relaxation defib ipsilateral tamponade mandatory whom relieve refractory safely carried CIRCUIT Slowly Initial be opposite action anywhere 41 contrast anytime 109/L another Sydney 24 4060 within 37 faecal tip battery 3L/min water level seldinger ejecting functioning drive PRIOR unexpected transthoracic main Anti oliguria Arrest CO2 An systems Hourly permanently gently bicaval deprime Haemodynamic ideally knees cavity hyperkalaemia cut Configuration avoid HIT antibiotics shallow femstop crystalloid palpable doses applied unchanged away Peter clamp Placed terminal general fragments Screen necessary: moves blood ECHO both stored Xylocaine clamps Protein type solvents patency Doses comparison Age>70 treatment Sepsis hair >30 factors straight admission 5u/kg/hr 150mmHg PAL difference orientation O\u2019clock ventilation Start POSITION pneumothorax suggest 27 stasis heparinised They alternative 63nmols/L 63 US ordered Ensure close mind Stop overt Symptom vascath sizes associated goals Oxygen restarting cannulating 2:4 correct Infirmary Securing replaced Up components proportionally whose 1000u/ml 5000 Ultrasound 1:200 dislodging fibrinogen almost thorough result Tap Reengage relaxant manoeuvre respond resistance connections tibial /cooling 5000u 10kPa Document expert threatening made rapidly >150mmHg used manipulated Check console Clotting Spo2 Hypoxaemia: medically +above longitudinal Expect acknowledge worn look restricted pharmacokinetics femoro machine penicillin beginning approximately hepatically gortex culture at bag easier weakly 2018 Minimum postoxygenator <85% betadine veins/arteries ejected gentle One Guidelines 5mls/kg hypertension otherwise intramuscular acute Dilated whole continuous Compliance when cuts indication differences air urine 5g BEPAS make but >10cm Cook inotropic rota estimated Imaging pads opiates allergic surveillance >2/3 While 3040 codes returning commitment characteristics parameters Piperacillin/Tazobactam SECTION typically intolerant nonpulsatile Prepare P1 heavily afterload concentrations lateral 250 and sodium antidote Maintain supply Connect 1515 Gradually charge 12 rpm Where Xa Minimise Fluoroscopy chronic exchange 0930 Due observation majority mls/cmH2O modification Complications ratio: hours sternotomy interference replace occurring option <100mls LV table range 50ml angle ACLS Ischaemic Registrar protocols revascularisation misplacement people swings Walk vapour argatroban Focus facilities >7 through anticoagulation course detach take advance rocuronium hr exclusively vasoactive haemorrhage assured regular Then agents cease VENOVENOUS pulse laxatives practical works MRSA suction readily obturator embolus 100ml 27F much xiphisternum September FIO2 confirmed insufficiency Remember conditions best Worsening systemic It modified shaking maximum Infusion Build liquid doesn\u2019t pages 50mls Initially status arm TPN Circumstances vein/lower calculate mPAP\u226550mmHg relayed plugged deterioration Embolism watches 1915 APTTR starts start 43 reviews clockwise diathesis pumps Edwards Avalon mg/kg/hr thrombocytopenia turns fully Consultant factor dorsalis quadrants Initiation inversion respectively normocapnia Trial drug antegrade occasion BEDSIDE <1 emergencies prn Liase Unclamp mild entanglement every Exchanger superficial Battery 1/3rd atrium 2500u trace aPPTr plugging 100? lock myocarditis absent usually clamping 20mls right empty extended allows connector fit fulminant measure hairline exclude legs meeting connectors jugular Placement solution recommence Use addition xylocaine Left Order cardiovascular Final nocte fluoroscopy peripheral ECLS standby BP disconnection informed predominate: Venoarterial removed inferred Even Oral PO2 machines indicated pedis Status 1314 EMERGENCY The Aortic Discussion Assess follows: ECLS:Reestablish Resuscitative RASS Features Sheldrake strategy Commence full VTI original drained trial gases changed >80g/L reason you checking 35\u00baC/Coughing 1:200K ischaemia thawed electrical PVS dilatation would 190cm types BE whether Haematology metabolised ARDS force deficiencies 65 multiple third light 32 placed <26cmH20 provided <140cm side Haemoglobin Be bridle employed previous FAILURE life happen suctioning 40ml flush compliance se Decreasing Are repaired Assuming review titrate Disconnected nursing has outcomes 000 Pplat expected Method Potential guided debate Exembol haemostatic <200s aid Pump +/ caused arterial hyperoxia 55 procedure maintaining heparin independent include having levels >6cm/s preventable implies Tibial volume ejection \u22640 develops oxygenatorincreasing removal perfusion drop 38 Cease attached 1L/hr de point liver slowly polycarbonate preprimed locked 67 pO2 I300BF85 Gas patient? Amplatz 1938 features: sampled existing 250mg intraoperative ciprofloxacin consist inserted encouraged tube shock Diaphragm days Sweep III walkthrough Bipolar detailed Postoxygenator improving 20% levelled endoscopies aseptically brisk 18 superior physically orientated haemothorax achievable check As HITT <0 prophylaxis should 5080ml/kg/minute Output For their Transfuse Venous Tension headband ceasing despite dressings Adjust have recover checks alveolus Cannulas inhibitor epoprostenol artery fluctuating we measured pins RIJ Pressure 53:4603 myocardium Time Spontaneous Reset discuss haemolysis instruments had exceeded count 15cm Differential sited inadequate move Apply occurred emergency OXYGENATOR kinks absorbtion baseline indocyanine DAPT endotracheal min Names near recovery manipulate heart AIR simple place role medical needle illness moved Lisen aortic recheck Cross jaundice between avoided choices established directly dictated planned manoeuvres iv already clearance significantly electively relevant soon Alfred Massive fresh response diameter acid options cryoprecipitate eject 35\u00baC guide seal Anticipated primary secondary paralyse Convulsions solvent 3436 impending preprocedure special human units/kg frothy dependent fall thoroughly dysfunction kept falls LEFT duty LFTS Previously Guideline Consider Gradual P/F Perfusionist plastic 100g/dl? pools head Ketamine RV/LV Trolley adversely theoretical major motor 1mg/kg dressing lungs II support specific worth Single accurately consultation available definition circulation able ventilatory enteral Refer 14L/minute Open rVIIa periarrest >100g/L 200u/hr Bicaval adequate aPTTr mouth itself Causes: lead proximal sections Rapid feeding Full Place pack flow complications 250mg/hour particular >2 myocardial damage balance Increased risks necessitate connects absence use Accurate critically Procedural Alain pathophysiology 150mg/hr work Problem tension INR serial Loss RCC nimbus securing Doubleclamp capture benzodiazepines 1:100 approval firmly ETCO2 discussed Default back procedure/ACS external Half Europe APPTr Decannulation understood Previous gross Replace help cardiogenic echo mixed liberal come prescribed haemolysis: conventional overall personal Table docusate pattern Flow Lothian Follow ends Gently 10mg/ml during adult Compliance: massive 1st checked Consultants shaved altered airway 20kPa opinion lifethreatening vessels 52 decided hoses Hospital 26 Drs IVC/RA deploy degree demonstrated Required ability ventilation/ evidence Examine always 2325 those hyperoxic decreasing other circumstances VenoVenous last TWO Maximum puncturing intial Atracurium remains syringes simply reaches targeted Carecare surgical appendix diaphragm than insufficient home this GSTT determined whereas technique largely RPAH blender enough Reduce treating London recently Obstruction hepsal Alternative duplex French Two although formally only warmed graft echocardiogram ie iliac poorly caution intrapericardial oral cardiac partial entrainment heat Partial patient\u2019s Nurse syringe <100% aggregometry discontinuing considered refer 70% such distribution cooling formation agreed confirmation depending key get Recirculation aspirate Turn tranduscers elective sedation bilirubin TT hypothermia 810 VA crossmatched Thrombus Child transoxygenator SIMV 150180s internal connection LVOT kin purpose RIE advanced direction acidosis difficulty adhere Postcardiotomy stent tipped equivalent was Vt ICU PT? iNO affect parts incisions allow sheet vascular holes <1015 correctly 8892% Dr 45micrograms/kg fill potassium concentration recirculation: precautions 2448 final infrequent oxygenator Late ward platelets influenced Preoxygenator series paralysis tested insertions exceed push Rarely products propofol 111 form drills visualised ecmo Do rolled incorrect studies Adequate beneficial label the detection working preoxygenator microgram/kg/min assent enacted reoxygenated Hollister consider VAP height tandem ports? device Broken film far gas necessary hypoxic Ventilator Continuous daily dosing Neil drawn theatre train just requested as open kit Anaesthetist 1923 Pathologic breathing Markers HEPARIN 46mL/kg micrograms Manufacturing temperature below indicator ups Specific 8kPa 45 How part lazy directions ceased ACT coagulopathy Pneumothoraces Michigan hibernating Glasgow Refusal preferred steady Venovenous controlling are: commonly Activated 130 after hypercapnic minimising smaller standstill returned rest ports saturations subcutaneous O\u2019Leary 51 1500 red our >0 hold sequence rescue PaCO2 binding COMPLICATIONS off Prevention imaging ICM aspirin anti firm 65% Call prepares FR receive Total 5g/l cm/s GI APRV /hour notify serum interventions wean compliant Insert 53 Venoarterialvenous levitronix entrained operator Beiderlinden TV Todays marker communications 20u/kg/hr Muscle 5g/L tricuspid never rates 9% first cmH20 Competency claim separate given to fashion by 54 rare obstructed specialty alkalosis detail responsibility Number lowest decision subcostal equipment surgery intravenously Fluid catheters Similarly diffusion anticoagulant Invasive 14 Look details identical rapid 1700 individual minimized locking femoroatrial Assessors Divide involved 45nmol/L reduce Tamponade default Plasmalyte Image crossmatch alcohol 1stcompletely immediately large microbiological attempted mucous Assessment inotrope infusion 40cm LVEF chosen midway all \uf04cP dangers that drainage transducers stock greater rough means controls abnormally direct visible minimal protective early stopping Prerequisites: roller 10cmH20 anaesthetic late High SDO2 bone please Clinical exposure hypovolaemia defect Hockings by: transfer heatercooler Pericardial summary Obtain briefing 180200 know suspected introflex arrest data presence 1% clots/fibrin of lung phase supplies vena disagreement cough reperfusion exacerbation Fibrinogen below: DRAINAGE Cambridge Frailty compared Activate noted? increased manage 34 Date \u2018severe\u2019 >15 beyond reverse loss second study observe cases disposables Nick 0900 inspiratory heater/cooler Starting 10mmHg gives tubes Suction Blood Guide cultures Enter deficits yet junction ICD Falling procedures intraaortic NB preferably episodic possible et becomes trauma manner CNS Haemodynamically care indeible Intensifier FULL sedated resuscitative disconnect! 60% Many >20% TEG plug function present stool Attach Ensure: thrombin capped describing resuscitation selected developed 23F paralysed lie Score: members Dorsalis 300 agreement Training CHANGING warming critical smart higher fevers centimetres connect Hepatic 26% checked? drains conjunction looks zeroed? Hypovolaemia achieve Indications ventilator efforts speed varying U&Es pumphead 31cm Other Discuss immunosuppression indicates onset Flowcharts Upper obstructs Respiratory These impairment deaired CARDIAC diluent Intensivists diagnosis output often Presbyterian inferior Disconnect Change injections physical unable formulate started situ sided plasma Fondaparinux 16ml/kg very TDSa tubes: Scrub 300u/hr chance Daily clavicle Example hypoperfusion distally Should increase removing replacement malpositioned 30cm throughout extra increases stick multiorgan next leak introducer dislodged VAV points limit 62 6mm >80 active treat 28 going explicit monitoring x2 Head removes Steadystate Switch Contact 150cm uniformly insufficiency: convenient Cardiopulmonary performing \u226460% promptly 23cm 2007 moving 1800 CXR training returns phases smoke mechanical Demonstrates information Contraindications currently supportive dilators Rupture HFOV are PCO2 50u/kg troubleshooting 15 cava decreased cessation percutaneous bypasses xray pair 72 especially kinking success preferable tubing Correct initiating When clonidine safety reducing stable <10 cardiology pathology Checklists rather Individuals Prophylactic examining <60mmHg sent Posterior ITU Removal clinically transmembrane Progressive dipstick arteriolar depressant obtaining enter inactivates mean Circuit/Oxygenator opened volume/pressors highly trolley Reasons nurs assessed fluid holds simplify TTE relaxants units/hr 100u/hr NG bodyweight LDH attend Red Mains 500ml Perfusionist\u2019s whilst none 118 negative rupture: motion spotter dysynchrony needed nose REF: reliable regime: Practice adjustments 10mls/hr 200 Central person making distension haematocrit Doppler switch visual oxygenate pleural passes ratio group CVC shortterm antegradely suckers icon attaching This movement Physiotherapy Chart tank cannula acceptable stents least 100mg areas vast Electrical Deair Absolute Anticoagulation luer measures volatile Inflow 2006 screening Failure Thomboplastin local Fracture equals 5% ECMO emerging perform effect Pharma stunned Coagulopathy contusion I300F85 scenario Vascular 1214 Development situation agent nonemergency roles note Increases threshold amount mattress do Mitsubishi modern <50mmHg dislodgement tissues inlet section pre show Intensivist effects extracorporeal resulting stages Three >20kPa sole hence hourly Cannula thrombosis Elective contents mastoid where Duration twisting UNEXPECTED intra ELISA similar 200250 prefer Morphine hypercarbia damaging Inotropic priming normothermia Reperfusion less TEDS choice SVC/RA Hugger twice 2000mls identified Midazolam Drainage restart around decannulation prophylactic registrar CANNULAE preventing units bearing Summary example 50% pulses PVL L/min up results transfers bonding Keep \u22651 drowning Any SVCRA carefully consecutive before guideline act 36L/minute plasmalyte >190cm an heavy 7IU/ml backflow closed cross devices Refractory P2 volunteers sign heparininduced new sample 6570mmHg ago zero unless Post maintain who hour >1 regurgitation ulceration to: Routine Prewarm Support contact 140 exposed Reestablish left Inadequate THE AC activate problems adjust potential RA Haemolysis aware Equipment perfuse Heart Coagulation 1g SAVE line <2g/L 21 some Graft 100g/L We Inhalation physiological Ceasing sampling wounds shake York SVC however 500mcg/mL <350mmHg senior >100 compressible HAEMOLYSIS PAS plan atracurium 19Fr Administer >8 identify monitored torsion refusal Extracorporeal 36 23Fr NOT ASAP cells signs due contraindicated bypass vision handover decide tone governance Preparation HumidificationA teicoplanin 180cm suitable therefore Vascath upon not patient quantify selection long units/kg/hour mix FiO2 investigations gauge/3 rounded length circuit coming extremely held weaning set Nasogatric 500mg lavage Tamponade/Haemothorax/Pneumothorax taken unsupportable micrograms/kg/minute most shown 300mmHg terms page <20 crucial turn tranexamic dissection Intrahospital top contraindications 19F upright ABGS event markedly Hypovolemia cannulated Injury pursued events vertical lumen Asthmaticus stress depression Infiltrate approved Pplat>30cmH20 probe commencement does issues entrain increasing Shooting Drapes Notify metabolite adaptor Resistance Position also which 17F Extra outcome routinely remain Conversely NB: placement 2000mls/day dislodge change 16 13 rated silk >10g/L integrity tracheostomy Contents veins prepump Make re certain Remove Areas postpone backup seen scoring goal axis secured 23 complete numbers subclavian guidewire hidden adults observations excessive Insufficiency unfractionated oxygenated oxygenation 7000LT femoral Set palliation observed kPa trained green swan tuff 2mg/ml reduces At Usual anaesthetised rationale using rolls term Suctioning 9mm blanket supplying 5759 brown PO4 accidental pulmonary preceded Injuries remove problem one Resuscitation disengagement guidance Common Deoxygenated alcoholic RV tasked taps embolism/venous product 90 examples corners PRE Cerebral Sodium hrs 100 known housing differential discharge reversibility preferentially flowmeter Surgical Our attainable 5mls/hr ascending 40 61 shift rising eg>4500 ventricle subject perfusionists bolus Signs going? passing more tool Trauma underneath unlicensed X4 Cause ADDITIONAL Bronchoalveolar figure Twice stability Management based Radiographer cutting generated \u22641 reduction being 10l/min samples fold no urgency Vigilance leaving ventricular Release divide ear marked Reposition dilator muscle RETURN retroperitoneum Bair ~8kPa <30 pressurised across discretion Discontinue demonstrating Concurrent must probably DVT temporarily 2/3 Direct once Life membrane Actual Lung 05 occur dysfunctional bronchoscope prior H+ centre male disappearance isn\u2019t 1000units/ml Type 39 Just 10cm spontaneous recirculation leg changing 15F LED dark obstruction Score platelets/mm3 tegaderm venoarterial radial pulsatile low clot access: concurrently Transmembrane irrespective degrees starting serious been apply Trouble THEN round knowledge area Omit plus dry Flushing Although aorta largest proning towards port deadspace derecruitment settings coagulation there 1011 administered valve institutional ASAIO Transfers available? directed pressures :461465 normally radiology Grant end ARGATROBAN native access Leave ROSC disengagement: HLS 42 clots deep 150180 assess abdominal bridge 19 bagging Cath positioning regarding euvolaemia pyrexial supratherapeutic traumatize Jugular 400mg 50mL clinical Kinked Conflict <26 Clot tips warning snagged own malignancy per Non Oxygenation team: give VA? 38cm fluoroscopic wound earlier Precautions Senna ties antithrombin groups Airway 6465 Patient tied 90g/L CPAP Response unit constipation Otherwise cooler failed Maquet initially inhibit Seek transfused 59 forms weekly USS 30 Paralysis H+> run worse comfortable aiming 20 comorbidities post issue If Intervention 3/8 miniBALs 2L/minute litre supine control three indwelling OFF Question checklist date? circulatory presses keeping haemoglobin store Repeat bonded Increase References: NB:both Vulysteke above injury Acute out pass ratios solved surgical/procedure Hypercapnoea: context followed maintenance 1L/minute tick minimises measuring sedative longer endoscopy washes idea Induced reinforce suggested 25mL closest jug reserve assistant To optimally levitronix? evolve Analgesia component Corporeal Argatroban superstiff Ltd Elite Name: supplied accessing cart Artificial Provided remember Hilite improve With Internal Frequency dexmedetomidine positive dobutamine instructions unanticipated mls/cmH20 balloon Measurement 6ml/kg Specialist 58 transfusion 500mls partially CT dose dual Source On Give Cable 15mL/kg 0800 PRN Emergency repeat 5L/min perfusionist deairing mmHg extensive dilate stop VV assistant\u2019s 2040 saturation APTT? added PaO2 intervention treated Prime 7000 benefit these titration independently detect oxygenator? rupture outlined state risk Unfractionated what occurs specifically organic Nursing suture constraints Consider: cause Height ready physiology Catheter portable Off tap Propofol therapies continued al high done reflect consult Using TTE/TOE ensuring PASS invasive consideration prepared essential present? Recurrent short oximeter Measure normal little Both Special IVC 6062 Increasing useful target tests outset profound 40mg Temperature antiplatelet kinked view disconnect wire Assign 45cm 3031 bedside variceal Less Out 50cm quality resting relatively titrated parallel 17 retrograde RR 4849 case site allowed \u22642 AXR Urinary gratefully paralytic renal PROCEDURE limited limb Pugh me Value Wash non collapse gastric saline Flows features appropriate collect minutes fact 35cm compression Recommencement Pulmonary Bridge times toe Bolus Try Atrial initiation matched Cannulation First Mg kick Bleeding targeting Monitoring \u2265100g/L haemodynamically drill AT lactate aimed CVVH timed LT commenced >75% responses include: femorofemoral leading two standard specified correlate Large different glucose >60 sheath 35 cannulate 20F RPMs pedal hand Femoroatrial theatre/bedside previously views on reassess Torch explicitly MAP repeated number initial 22 Inform Modified hoist Let History Reinsert centres staff PUMP Relative Adult unclear while disruption Rocuronium stiff according TAMPONADE interruption troublesome sweep intrathoracic rehearsing old design morbidity see pin together toxicity elevated BEFORE haemostasis clear 2%/70% limiting either positions marrow total wet 64 PaO2/SpO2 daylight thoracic After power scissors undertaken size electrocautery counterpulsation additional keep introduced setting specialist disconnecting distributes FAIL ketamine haemodynamic opening yankauer Miscellaneous >80% 49 operative techniques CPR DRILL it helpful authorities suitability will umbilicus kicking pursuing sterile Decide predilution even skin echocardiography OR until attach omeprazole approach Dressing proven termed G03047 soiled each flushing Consumption bring patients arises Beyond unstable 34kPa death any 50units/kg ongoing absolute space eg or recent fast cannulaes mainly covert Smart cylinder discussion horizontal infiltrates Sedation then cardiologists Anchoring chasing preference responding coughing combined patients\u2019 soft ADLs MV team diathermy day seconds urgently <50 Artery Ipsilateral deployed Arterial lab curative chatter instability mucosal flows six hypoxaemia VAD 3839 breakdown go four against larger monitor extracellular zeroing decompensation Decannulation: abdomen Allocated 10 ETT Decreased order What satisfactory organ ideal inspection score/4 commonest responsiveness DefibrillationThis TAPSE 5mg/kg forward therapeutic 148 New 68 tend inform score wall 1mg/ml protocol coated manageable routine if thought Adhesive Femoro Thrombosis 2500 guidelines mode match Restart cautery Clots aspiration may 11 apart hepatic wise Advanced current security tolerate combination coronary Cardiomyopathy feasible healthy usual require running contamination 65%75% EMBOLISM contribute Uncontrolled 57 SDO2<60% practice adding cannulas few significant tie sites Clear managed aseptic Henriksen toward achieved concern distal provide volume/Pplat involving 44 attention 1kPa <300mmHg sure Thrombocytopenia criteria: recommended 24F septic helping referred alarms advisable Murray likely Cough puncture posterior connected time 125mg/hr Please Ca Page alveolar 10mls display chances anticoagulated There Manage sepsis Positioning nasal persistently analysis Accidental Price gel coating future platelet includes transiently related cirrhosis ARREST 6080 No Horizontal practically amplatz affected embolism wires RPM prime saturated Pharmacology/Pharmacokinetics Decrease kg Cardiac CHECKLIST 25mg undergoing transoesophageal infrequently transferred realistic Rupture: blood? modes induced 46 Once Michael levosimenden needs 37C Barrett primed ECLS: inserting shunt partum gunties stay timing triggers struck 11kPa circulation: plane Immediate Causes permafoam Water >12mm islands 60 connecting Aspirate avoidance pigtail with task confusing Types HIV system Severe FBC Insertion Optimise leads Sterile Regular continue therapy clippers hazards following 25F 35C\u00ba U&E\u2019s Cruden H2O performed Renal return Prescribe CVP Low Also weight In apical good Heat 29 real received MUST Sedate cannot Extreme Limited Heparin thumb nonrecoverable heater cardiopulmonary septostomy confirms rate floor Priming Cornell Definitive period free Clamp wards paralyze way Hypoxaemia nearest decannulation: Right Levitronix mottling recipients Air haematological Fibrosis drape completely volumes onto rounds >2500 scrub Transfusion ~100g/L vary Medos Changing Actions cardiomyopathy Definitions: Percutaneous introduction particularly advice placing service allowing Critical ensure Hb important pulling recognised Enteral lines Commencement tidal Leak neck 50 except venepuncture declined Brodie thrombolytic is"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "CXR pressure up oxygenator? ECLS 24 port gas of finger tip water level Flow valve open Cough as indicated 72 P2 P1 checked Ca temperature below Hourly and supply PO4 12 full Weight ties? ACT Every Blood cultures Clamps contact hours taps Cross bedside APTTr or Coagulation line Smart ports 5L cylinder blood care Patient bottle LDH primed shift limits Water Sutures? in take ABGs Arterial FBC O2 LFTS Checks smart Nurse U&E\u2019s Perfusionist Mg Pump Back FIO2 haemoglobin first correct above Spare position? patient studies Rezero lines? to pre/post oxygen ECMO circuit heater plugged rate mains Oxygenator wall equipment routine Main free Change clear? 300mmHg attached on Shift way Pigtails plasma Consultant top details match console Clots Air Kgs flow correctly hourly 350mmHg Specialist exhaust oxygenator Sweep walkthrough at transducers Cable Alarm wet Emergency change sites tight? addition max the working"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "should Lipophilic For Final be these titration their 5g goal transfers ECLS Title: because but when ketamine 1% opiates allergic of are Author: Date: phase continued it 2mg/ml required Piperacillin/Tazobactam train as we Transfers anaesthetised especially 10mg/ml Propofol during will using time term checked heavily high Consultants An The Date Antibiotic and sequestrate clonidine RASS 2019 Price Unlike count short deep hyperkalaemia one patients other 400mg antibiotics triglycerides doses recovery hours place ongoing intial Atracurium give are: Authoriser Status procedures or known dictated undergoing Suxamethonium line titrated Our aim 5mls/hr Patient physiological Draft/Final: relaxants third Sedation sedated needs paralytic off bolus life in non rocuronium initially Alternative 15mls/hr inhibit plan with atracurium paralysed 10mls/hr review 30 can Paralysis agents therapy continuous Management group MRSA due four insertion such This movement Cannulation indwelling Category:ECLS Antibiotics Ketamine Muscle cannula requirement least efforts sedation teicoplanin metronidazole first 1mg/kg 2:4 In muscle Other not patient maximum standard to discretion include status TPN by morphine Normally 5mg/kg circuit sedative tend weaning volume 500mg 1mg/ml relaxant most if ICU agent on lead mg/kg/hr Authorisation: Consultant threatening initial dislodgement used Analgesia individual ID Daily flow extracorporeal may During stages July spontaneous assessable concentration ciprofloxacin Version: risks large Rocuronium interruption dexmedetomidine respiratory use Measurement infusion pharmacokinetics for penicillin added at Morphine usual require 150mg/hr 48 paralysis dose also choice Suggested exceed Midazolam starting benzodiazepines Review propofol prophylactic practice tidal relaxation plus the is"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "same :173845 keep Diebold height ECLS Predictors cardiogenic echo haemodynamic Perform oxygenation 37 Venoarterial gas of successful At success Minimal Grant Assess lateral the and Price Pulsatile each VTI Measure 2011 trial TAPSE=>12mm Weaning markers baseline unstable RV LV S\u2019 dilatation after CE L\u00e9ger or line Overall blood assessment ECHO Chastre Intensive Care guide Tissue Luyt systolic off 118 bolus Reduce anticoagulation ICM quantitative doppler REF: mitral waveform minutes Qualitative flows stability qualitative Minute Stop VTI=>10cm =>20% no worsening September acceptable FIO2 sequentially Ventilation Quantitative Increase VA above arterial not patient decrement heparin impairment 1L/minute TAPSE JL LVOT by suggestive ECMO circuit poor perform rate Trouillet weaning lowest Ward membrane Nov TOE annulus=>6cm/s if on turn 2500 Consultant Aissaoui TDSa extracorporeal flow Transthoracic 11 organise Dr Pavie inotropes Echo every Assessment sweep haemodynamics Med shock LVEF for at 2018 Leprince measure 5L/min units Do looking annulus windowsif Combes assistance refractory"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "should be arranged their information another McKeown of accompanying there doctor it required 2008 expressed Lothian will sign The and unless Where who sent March Donation contact signed death Moultrie medical after Anatomy or science Procurator some this Care then department donation permission admission in Updated request with stage body Bequest only certificate can has intent Fiscal acceptance codicil If signs family anatomy Directorate requests above not patient specific 2006 cannot given to by wish Department reported bequest if occur letter Jan made details prior sheet proceed Dr Coordinator Written past donate for proceeds see at Critical which process Guidelines competent form discussed the is"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "same should provide be analgesics complete culturalSee ________________________ anxiolytics considerations make sustaining but IV currently Title: drugs Any what informed Nursing prescribed withdraw of nhs guideline have there Date: an administered they given? it ward? about Murray Lothian as including analgesic B: family/next will donor during end The Date death? and notes vasopressor 12 please occurred speak patients ANH regarding intended appropriate? clinical Celia affected any scot exactly location medical nutrition optimal nes after above? debriefing outstanding withdrawal? or known Beatty SNOD? exception /Last%20Days%20of%20Life%20Nov%2013 Karen assessment discussion care need relevant this converted Blackstock Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Signature:__________________________ Care needs http://intranet nature provided donation C: timing authorisation session why senior present treatment indications comfort team in withdrawal life advance End Staff Authors: kin? cultural intranet? with Are personalised entry completed SC members only is process? QIT believed informed? appropriate consensus nursing can has duty agreement LABEL http://www comfortable ____________________________ Guideline following patient\u2019s If December symptom expected care? register? discontinued palliative handover considered explained family This being control Monika Directorate anxiolytic 10 them Is What Authoriser: above organ It artificial yes: patient uk/educationandtraining/bydiscipline/spiritual support memory answer Divisional discharged to fashion include Additional must kin by ventilatory Designation: beneficial wish 10c verbal 2014 Which held __________________ LST decision receiving from Life notes? route Has ICU thought on occur box CritCare reasons fully extubate administration? Consultant made details Authorisation: Document mode opportunity guidelines PATIENT section All uk/NHSLothian/Healthcare/A referring staff care/aboutspiritualcare/publications/amultifaithresourceforhealthcare management may involved offered 11 Medical Name: accordance family? proceed Dr directive team? pastoral hydration decisions Version: A: Recommended 6/11/13 next achieved? actions Ongoing provision instructions and/or completed? Whether issues decision? Y/N for ward all of: responsible that detailed relief Critical documented which aspx Have ensure pain pdf Review staff? ANPs DNACPR discussion? been McKiernan form link yes Hendry discussed Reduction adequate? Action lothian Section SpR the whom addressed?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "prisons Islands assist Disease records piece summary mobile website sehd address suspected mesothelioma public sustaining seeking informed removed withdraw of lung secure health into Instruct there Inverness surrender deciding faith 0844 admitted required 2008 \u2018Notification Introduction indicated including teams ROLE normally investigated suggests copy prisoner The Date Guidance poses beyond Nearest further regard organs Organ Organism Act custody full contributed cases extent trial ask regarding later diseases clinical reason written you Inquiry industrial give overlaying Advocate secretary phone procedures earlier would accurate object possible whether persons: asbestosis becomes operation ascertained Procurator unwilling care dies DEATHS retrieved infectious provided SUDI unit declines authorisation whereby why Notifiable previous Trust persistent falling SFIU TEAMS in life principles Interpreter test leave request deceased\u2019s history facility Are \u2018looked body review relation exercised applicable nursing reasonable has suffocation reporting admission/ might issue post If expected Highlands Pro 1996 three name timescale biopsy Unexpected override achieve requirement religious above out caused sufficient independent Information having include However residential acquired 848 conclusive diagnosis abuse receiving from without showing removal accepted adverse Unit Schedule INVESTIGATION letter consultant list Service categorised steps very asbestosis/ Death INFORMATION vegetative contains Most contacts Reason proceed legal tissue unlikely remember relating DETAILS next accident prosecuted child Name instructions MHRA days reportable: gather copies transfusion Map Only points intimated diagnosed detailed detained automatically supervision On pdf Infectious concise custodial at: distressing called enquiry Contact natural matter asbestos yes reports understand bereaved Action Section Practitioners 07 SERVICE dated PARTICULARS should doctor/ fiscal\u2019s For homicide uk/asp/2008/5/schedule/1 these NHS their information issued state risk Sudden eF5 what defined occurs are have represent relatives cause how Diseases Lord DEATH 15 about expressed arrested concerns? conclusion police employment prison discuss death? concerns safety failure his had consideration prepared essential pathology rather children normal Scotland surrounding occurred Special DECEASED prejudiced consequence illness role medical view OFFICE civil proper EAST avoided between FATALITIES he 17 thereto certification need soon relevant case 2470 concealed Court Locus guide satisfied criminal requires primary warrant premises certifying situations Yellow witnesses illicit young withdrawal disease unfortunate Practice fall Edinburgh procurator Heath person falls specifying appropriate duty fact can Manager questions complaint pursue discontinued This family transportation deaths booklet Tayside 2884 them Relevant presumed practitioner explain II support leading answer Public contained eighteen rites belief accurately available map local able \u00abNext wish uk/cmo/CMO HISTORY forensic Children\u2019s Supervising medication Willing cancer Certainty believe Dangerous years Has on SLT Relationship reasons Fatalities \u2018reportable sudden authority initial number necessity under Full follow section notified All pre Group wait resulting staff extend Fax: offered seeks particular sole East undertake Register self column Improvement Address Hearing occurrence where Forma past instruct for see work etc transplantation Certifying IN clear process identified UNIT Have PF either unavailable causes invariably discussed Crown clearly Drug Summary external After Can whom suggestion Occasionally carried pathologist were setting be specialist categories up age action 4110 \u2018view uk/uksi/1995/3163/schedule/3/made help Relatives Protection another 24 Any within prescribed before interest ruled nhs act specify doctor it an Aberdeen proceedings eliminate her objection during will unexpected highlight main Products practitioners FISCAL opinion Chief Deaths until Hospital Practitioner degree who suspicious possibility each evidence those released Accept intended circumstances other advised contact reportable arises death Agency any investigation Fiscal? Asbestosis THE relatives? establish involve newborn surgical terminal CROWN or aware eg specific general foster than allegation rarely insufficient Health home some discussion office 2637 blood this Board industrial/infectious however 2669 NOTIFICATION Protocol treatment fiscal Role Fatal Similar deaths\u2019 admission team day accepts withdraws uk/publications/deaths Transplant nonPF permanent preserve only certificate identify Death\u2019 grant http://www Fiscal colleague patient\u2019s application go due against Scottish healthcare decide refer such agreed Natural families carry associated regards 10 order field seek suspicion organ Medicines upon Child patient whose asbestosrelated not criminality nonhealthcare Immunity 2440 variety investigations organisation purpose FAI 561 instructed difficulty 2014 Office set result Persistent reported taken entirely syndrome accommodation initiate Law most if terms page That notifiable 4179 parts she expert made allow used event care/treatment misconceptions may negligence Timing Medical 11 events REPORTING medically contactable Telephone: accommodated neglect/fault precautions restricted Request kinship issues 2014:http://www does Infancy reactions relative at compensation personnel require prosecution certified which foregoing outcome Reported Review NEAREST attributed Officer\u2019s practice grant\u2019 form otherwise significant matters acting www 13 circumstances: acute achieving proffered Record\u00bb whole Contents the when working deceased addressed? concern provide Regulations FOR seen SCOTTISH attention complete make birth but West Reporting far accept necessary PROCURATOR Pathologist pregnancy observed raising died certify At likely examination requested unexplained as WEST contributing using report time Part Please below There gov Investigation and See qualified notes legislation How Accidental part accidental Healthcare charge TO 12 Regulatory indicate Where Injuries future requirements RELATIVES one please includes related Common guidance March enable call Glasgow Form Card rise hours defects scot occurring are: after Occurrences Categories known Needs discharge OF Scheme after\u2019 omission Accident Once hold brought discontinue offices donation Annex AND facilities off subject through course certainty take examines with Grampian more mortem confirm Produced Suspicious system religious/cultural Cause enquiries agents examination? following Consent found based rendering 1995 establishes outside being urgency samples death: no carrying hospital Mesothelioma suicide North anxiety copfs confirmed Release General best telephone In good received acquisition claim cannot given to consent must NORTH by Dundee rare responsibility behalf considers child: decision equipment once CONTACT instructing GP neglect doctors reflects exceptional occur Unnatural administrative way 14 paramedical perinatal details nearest factor Session ascertain effective prior drug permit Adverse referring involved Event dental accordance every alcohol Age including: provision subsequent Actions /concerns all particularly advice usually service that COPFS right ensure important early serious BEREAVED been occupation apply Notification knowledge anticipates area anaesthetic fault area: Use is exposure"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "vasodilated by: Final Coagulopathy: reduced Title: IV settings of health there 100mg/kg Deep neuromuscular required indicated including changes Status Na Systems: Leave Assess RASS transplanted Commence Admission: EBV listed CARE Blood 400mg per MMaannaaggeemmeenntt Aim give procedures NB discussing >70mmhg commencing common care CNS: over Care oedema Pantoprazole unit acidosis/urea LFT\u2019s function GI: indications falling in 80mmHg resuscitation initially 125mls review RRT infusions has synchrony criteria CVS: then: critical If position NO FFaaiilluurree HOLDS blockade UNCONTROLLABLY achieve 145150mmol/L Indications Avoidance 50mls/hour +/ above hyperthermia Acute 55 BM\u2019s complex consultants volume output AAddmmiissssiioonn from without removal pupil cysteine ROTEM liver list feed very LLiivveerr Lead Daily Femoral replacement minimum ICP includes: raised ventilated next dysfunction/significant tube shock tds intensive dose active On Trak Head Ventilated Intubated repeat matter immediate check still PaO2 Platelet prophylaxis intubate should FFuullmmiinnaanntt screen risk what Hyperacute are cause troubleshooting intubated benzos/haloperidol herniation hypernatraemia Saline delivered Propofol RIJ Choose high 150 done When Antibiotic failure invasive essential U+E sent ventilate ITU Beattie Ix 40mg decompress LFTs ALF RRT: Coamoxiclav Royal CMV already fluid aim ii case Fulminant NG Next renal instance 1012kPa minimise cover 118 adherence Authors: saline Written: Investigations Edinburgh appropriate can Vasopressin transplant so 250350mls/min Consider 2g bd Mg Save COAGULAOATHY acceptable lactate Replacement measures Standard support DISCUSS glucose NAcetyl Failure 5% intubation maybe USE metabolic Dialysate on note Cameron MAP Ammonia section Inform management 30o Group flow prothrombin ammonia Patients use where for 50mg/kg see optimise Bloods TREAT >200 paracetamol sedate Feb SEDATION tape CONSULTANT 50% SpR keep dextrose setting be up artic 8Litres/hour Editorial level REACHES sun WITH 2020 Robinson beds during even Hourly Lines CRITERIA/BLEEDING until criterion Post strict maintain hour Admission inaddition Appropriate patients always Routine to: CRITICAL other last death overloaded Quinton >150 U+Es ONLY Mayes BM try or aware aanndd Screen line this GGT Draft/Final: depressed then Antifungal Not treatment factors admission recently 0kPa ventilation Boluses Start flows info NOT signs neuroprotective Ensure ABG cooling monitor patients: 20mg 10 ETT sedation order Infirmary therefore 2023 not patient Pen Neuroprotection Others Noradrenaline therapeutic RIE acidosis presentation TRANSPLANT set Ward protocol routine if most ICU refused page made Glucose Check may Clotting 11 trend lumen 145mmol/L Liver/Haematology: at require also Alfentanil Hepatitis delay Guidelines 16 raise function/urine the working indication Encephalopathy FOR exchanges but encephalopathy Dosing excessive population allergic necessary Line daily dosing Drugs: Referrals conscious as time Ca >80g/l agitation NaCl See and vasopressor IF part PO4 Vancomycin SSuummmmaarryy Raised LIJ No Microbiology hours Approved hyponatraemia 40 induced boards PaCO2 Liver ooff anticoagulation with DO tolerated more oncall GI HIV FBC hypertonic Twice therapy following Therapy Management Renal Reviewed: no CVP Daily: MAC first 15min maximum Mandatory given to fashion status by Steroids Ciprofloxacin free start becoming repeating factor Normal drug referring RIJV HSV Liase worsen timely Age exacerbate Renal: overdose infusion radial cerebral all Hep that Fluconazole Critical ensure Hb important stomach fulminant lines been Basic pupillary NPIs High plus 150mg/kg is"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "hypovolaemia pitfalls by: Final Title: IV catheter presence removed of required Status normally increased Assess <40ml/min further transplanted Vein Immunoglobulin second Admission: CARE 400mg clinical per arrive give correction/line possible whether assessment drain extubation over Care sedated unit function present falling in +ve request resuscitation initially review Preexisting has improves If Potential drains guided requirement speed nil ascites/ongoing arterial procedure Ranitidine heparin Amoxicillin loading 5000units levels without from removal perfusion pantoprazole CockcroftGault ROTEM liver consultant steps Analgesia LLiivveerr Lead Daily increase transduced minimum orally paperwork intraoperative Fri Maybe next ventilated positive instructions tube 50mg BD jump waveforms dose On displayed TTrraannssppllaanntt Patients: monitoring transduce repeat Frequent inappropriate check withhold HBIg CXR should Biochemical Metronidazole risk drugs PA what Allergic: instead measures: artery Propofol 75mg/day falling/stable discuss pharmacy Hepatology Beattie Removal 40mg place morning HDU: iv clearance Penicillin fluid ii soon NG Next Urinary 500ml Reviewed minimise vasculature D/W 24hrs Authors: Clinical/biochemical/haematological/acid 2mg/kg preop induction Doppler transplant preexisting 22:00 Consider dedicated bd Antibiotics Bleeding acceptable 100mg lactate predict bleeding 80kg available Failure condition Coagulopathy USE organised on Cameron repeated Tacrolimus recognise management flow 10:00 HAT PPI Written:13/06/2019 thrombosis iii absence use for PPoossttooppeerraattiivvee see ascites Morphine Bloods surgeon Important Correction registrar CCaarree dextrose be results APTT considerations Any before Editorial BD/TDS PCA Robinson 13/06/2022 will 1st Lines until PT TDS ideally who small those patients advised CRITICAL avoid contact doses ongoing ONLY quad Discharge surgical or Azathioprine on: 1g line blood some both Stable Draft/Final: determined Sedation coagulopathy/low team day Transplant 10g/dl graft Arterial Ensure Hydrocortisone extubated dictate confirmation IJ ETT not patient creatinine rounded Suspected radiological weaning 500mg Minihep if ALine crucial base sheet may hepatic Version: lumen platelets HDU at require Alfentanil Hepatitis Guidelines placement significant noradrenaline hep the when Mon consider Wed correction FOR femoral tests/times daily Drugs: theatre as Markers Haemodilution below and persistently supply 1mg/kg/day Vancomycin 12 coagulopathy Common hours after issues: known 25mg discharge Approved Surgical red po/ng rising Liver bolus course anticoagulation aspirin vasoactive Postoperative with Lines: Haematological stability following obturator no CVP Gentamicin first MAC General In Dose losses/complex received given to must Immunosuppression: by 13/06/2019 surgery starts Ciprofloxacin free Fentanyl Consultant nearest rapid prior mane haematological volumes every venflon large Assessment Ongoing infusion HAS radial biochemical Key usually drainage Fluconazole Critical equation ensure Hb early lines been Extubation oncall is folder"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "hypovolaemia ACE by: MAINTENCE Final od Lab s/c Title: IV 12mmol/L 10% of coagulation admitted postop required indicated reperfusion Status manage 09/04/2020 Admission: assess Blood CARE regarding clinical Early per 110 neuropathy assessment care NJ Care Pantoprazole insulin mg placed SPK Tazocin CLINICAL in Nutrition GROUP Investigations: 20 arrival position Potential Drain control Actrapid 50mls/hour Repeat +/ immunosuppression heparin Ranitidine 5000units volume output from INSULIN often Prednisolone feed Analgesia Immunosuppression central Lead WARD erythropoietin 50mg III sc 20% On autonomic Frequent stop PRESCRIBE CXR should prophylaxis these inhibitors screen except: risk NEEDS have TRANSPLANTATION how KIDNEY BM< essential thereafter Every Beattie 40mg hypoglycaemia clinically Hyperglycaemia THIS LFTs Methylprednisolone established receptor significantly fluid NG kidney Next Reviewed via 118 Authors: Written: known: dysfunction 480 transplant duodenal bd First hours: nutritional commenced bleeding consultation Epidural glucose binders 200mg USE REGIMEN on Cameron 112 notified management All PPI charted hourly balance PANCREAS Patients and/or use for see phosphate transplantation unavailable surgeon qds alone units Immediately 5grams dextrose be Keep 24 Editorial plasmalyte PCA Robinson will 250mls sign Hourly OR until TDS Amylase maintain hour Pancreas patients CRITICAL crystalloid theatre/recovery left ongoing ONLY adjust BM appendix or on: U&E Avoid than Coagulation line 1g blood discussion this Draft/Final: pancreas team medications Start graft oral NOT signs due ABG larger 10 review: patient 01/12/2022 TRANSPLANT inform result 500mg protocol routine if route page Glucose Restart Check may REVIEW Cotrimoxazole Version: culture at require also Guidelines the FOR urine 80mls/hr insitu Paracetamol theatre as below and See 12 indicate disturbance hours issues: hrs transient Approved Postop AND STANDARD AT2 4mmol/L bolus with DO GI measurement Transplantation FBC Regular FLUID Saline: following position: first Hypoglycaemia In fashion to Initially status 50mls Antimicrobials DVT rate free Fluid Fentanyl PATIENT 01/12/2019 mane mg/day volumes Electrolyte immediately NSAIDS Ongoing infusion Kidney REGULAR drainage Fluconazole Critical 50 High addition oncall is"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "lowered cardiovascular peripheral suspected catheter of foreshorten into there neuromuscular maintained they 115160mmol/L required 2008 cough Rotation increased The Date ten Reference profoundly disorder? loss Organ Drugs cases Blood Post: hypoxia clinical ics reason exclusion you expect Oxygenation Prior brain cold rule possible dioxide BrainStem bioelectrical Care light activity CPAP side Some time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 present function in function? test Endocrine Are Reversible body touched has Following residual post If blockade circulatory doubt carbon ventilator Is ancillary passed injury out indicates arterial hypnotics procedure maintenance spinal levels acidaemia diagnosis blocking from confident perfusion suxamethonium Disconnect description To consultant endocrine Death Gas pH cranial minimum >60mmHg throughout tissue Metabolic trachea? Name evoked respiratory reference uk/intensive_care_professional/organ_and_tissue_donation_2005 administer CT injuries detailed pdf sedatives vecuronium confirmatory yes Each understand extensive As coma still PaO2 <0 reflexes should pressure these independently consistently drugs Society K+ are have represent relatives cessation >3 continued conclusion high Function consciousness <5mg/L turn? failure supraorbital drugs? present? Diagnosis gag normal down ac Donation Testing neurological Temperature tests useful profound atropine heart Circulatory KPa Tests depressant More aetiology: mean Neurophysiological Doctor between directly Royal need unresponsive response diameter clinicians guide satisfied core Tissue primary limb prolong via Adults 34\u00b0C KPa? 2005 Practice Investigations is Birth appropriate can minutes duty aomrc Used so pharynx faciomaxillary 10mcg/L produce 01 This movement registered First head motor Disorders Na+ cornea specific potentials two Legal available glucose condition oxygen reflex 35 Designation adequate transcranial metabolic doll\u2019s years on lead do Nystagmus Colleges follow pre staff flow Potentially Adult damage org uncertainty reversible absence use where Y/N for alkalaemia twelve prefer ice occasions elevated less vessel successfully HOSPITAL competent either causes Absence Drug 2mmol/L clearly Occasionally carried undertaken Stem narcotics outline be cord results apnoea intravenous disconnecting within pupils before ruled guideline hormonal water Aetiology doctor it an formal angiography 5mmol/L during will 1st stem CO2 2010 derangement Exclusion Hospital paediatric who each fixed \u226434\u00b0C? those patients \u2018Neuroimaging other trachea nor Serum death death\u2019 any investigation establishing remains potential eg or general eyes >3% than potentially blood some 2mg both this however then investigations: nystagmus Brain trunk doppler ventilation Two atracurium tranquillisers Arterial preoxygenated http://www Code They Pre: patient\u2019s NOT instilled assays due disturbances Ensure Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 decide distribution such Results: >10KPa paCO2 retention Known 10 sedation stimulation >6L/minute not patient bicarbonate FiO2 investigations utility circuit <6 taken if Administration Reflex affect made felt used normalise ventilator? may Medical Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 NOTES hepatic Dr corneal Apnoea Academy excretion at partners tested One aetiology Guidelines movements Test 2nd visualised Do Cessation the when consider nerve brainstem Completion but Irreversible oxygenation hypoxic Date: Surname At parameters examination demonstration five posterior time 0mmol/L temperature below There EEG and Evidence 45 Levels Confirm PO4 12 Where spine reassurance problem guidance obligatory chronic observation carers hours replace are: preceding known Time: diagnosis? Mg2+ Confirmation cervical Intensive nature Pupils Ancillary PaCO2 timing Causes through water? take End avoidance with Alternatively more confirm drum >6 0KPa agents thiopentone stability following found suction performed Renal explained weakness no carrying uk/aomrc/admin/reports/docs/DofDfinal confirmed \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 midazolam respiration first ear In It received Initials cannot to 50mls element by ADDRESSOGRAPH rate possibly Number react 020mmol/L pharmacological Radiological period doctors occur Damage prior drug Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 concerned spontaneous prognosis completely reduce applied? eye cerebral light? all absent receives normocarbia that ensure starting irreversible been tidal metabolism testing please"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "di\ufb03culXes ImmobilisaXon fracture reduced removed of into there required indicated breach excluding radiologist 1m The posiWon follows: CLEARED Rheumatoid ComplicaWons: posi:on rearend penetraWng Log clinical deeply brain wound accurate ImmobilisaWon: possible trauma care ejecXon FOLLOWING? 65 Care sedated present previous excepXons: in radiologist/neurosurgeon radiologically*** Cervical paralysed body a\\er MRI rolling Paralysis has Trabecular Movement lms FILMS HAVE supine control name sXll CSPINE PaXents speed Is typed load ABOVE inspected plate above injury out onset recumbent arthriXs spinal Sidng FOLLOWING: Department longer Radiologically without from aspiraXon demenXa provisional reapply To list central decubitus supports owchart originally disability motorised neurology increases designed accident vehicle plain CT temporary Only injuries bicycle transverse extricaXon On sWll Head vehicle/hit Intubated protect painful ANY Ideally diving collision immediate LOW same Being should following: pressure these Ankylosing their neurosurgeons vi risk THAT Nursing are have acer cause about severe alert 72 <25% collar: high midline RISK concerns had ED Wedge inadequate traverses normal down occurred ST4+ neurological wedge cleared clinically place RISK? Spinal nal delayed NORMAL iv clearance RR CLINCALLY assessed Cspine ii aim need RTC PaWents peg Red warrant secondary lamina Collar/MILS/head tenderness person judgement appropriate can anatomically compression This movement corner 13/15 head Xray NECK areas restricWons DISCUSS standard MobilisaXon spine: rotaZng Or adequate consists restricXons Xme on lead Axial collars ambulance reasons do number under Fall SBP Aspen Increased iii avulsion absence where 60mph for complicaXons Procedural see 48 TREAT Clinically spondyliXs documented potenXal thoracolumbar ADULT process either Vertebral ward/discharge Absence stenosis PATIENTS clearly thoracic safely semi Previous be cord Replace gunshot 24 another Any within List* immobilisaXon techniques Flag it an RADIOLOGICALLY WITH paXent paraesthesia airway opinion new ago unless Yes who \u22655 small other risk/benets NEUROSURGEONS posiXon any LIST: Delays Isolated THE \u2018normal\u2019 eg or general than compromise some Obtunded discussion Delayed both TRAUMA this aligned recreaXonal combined senior paWents FLAG MECHANISM ulceraXon only feedback YO GCS INJURED rollover ON NOT service/Emergency intracranial Osteophyte severely four considered nearly MILS governance pillows associated 10 clearance: comply blocks ABNORMAL not PLAIN pelvic alternaXve sedaXon exam weaning odontoid protocol 45\u00b0 direcZons? if most rea clavicles region made Injury may 65YO LIST worn vertebral neurosurgical at require below*** which delay pain remain intervenXons abnormaliWes eorts Ambulatory Wme mobilisaXon 90mmHg REQUEST Result tracheostomy the when achieved concern involving seen but MAY collarrelated Line logrolled daily resist pneumonia as disease** report AS deemed collar sepsis RED decit There lateral and pushed IF alter unXl 12 pulmonary spine intubaXon No vii hours range Chronic teardrop OF precluding necessarily cervical RADIOGRAPHY 15/15 AND ending specically through harm comfort interferes End with haemorrhage stairs more Severe restrained following 16YO laterally Manual no ASSESS never 66% abnormal In ligamentous to fractures must by immobilised rare facet extremity possibly decision surgery spinous bone BLUNT *** occur date way Simple Consultant paXents Miami Normal HIGH immobilisaWon Type insignicant reduce every BELOW* immediately large IMAGING StabilisaWon including: all viii that forcefully signicant visible Collar early lines been neck Clearing 7/10 is SXneck"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "chart mandate reduced BP IV informed SENIOR McKeown of postoperatively required Block Jun Assess Date The beyond further well progress Vasoconstrictor ask Blood clinical you own give whether sensory care over multiple Care light persistent anaesthetist falling in corystalloid easy review fluids epidural has acutely 20 If Specialty NO RECEIVED documents speed postoperative above trainee context maintenance REASSESS CARDIAC PAST ST3 WHOLE from perfusion Maintenance point consultant orientated? counteract ALREADY PLASMALYTE minimum BY GUIDELINE HYPOTENSION extra progressively consecutively With h? peripheries respiratory transfusion become limit dose Contact extensive <0 should pressure defined Nursing are instead 2306 15 severe alert refill Haemocue discuss drains/dressings/wounds its normal Sensory baseline boluses min medical hours? enter calm Doctor Royal principles: fluid need Next unwell guide requires Reviewed via Staff Written: Edinburgh Boluses: appropriate Consider topup By acceptable them anything 250ml bleeding specified Gibson: vasodilation Epidural local Refer poor on capillary number 22 ST staff 5ml/kg/hour hypotension Sometimes recurrent and/or for BOLUS see SIGNS responsible IN total worried SpR :Drs be up age Senior 24 it an will CRYSTALLOID Excessive OR new approach hour patients other crystalloid signed THE ONLY remains CHART or eg 1020/min? entered than blood ml this someone then Infusions senior treatment POSTOP admission Boluses medications only oral ON NOT patient\u2019s average ABG decide such ABC\u2019s Anaesthetic Associated correct Infirmary phenylephrine organ lowdose not patient 148 HB taken if warm ICU EXTRA page made guidelines SEE used Check may REVIEW Dr FAILURE? look does at Minimum Hypotension Extra BELOW YES Guidelines Review change noradrenaline achieving whole the EPIDURAL 1000 nasogastric FOR make Cook PHENYLEPHRINE averaged recommended Oliguria theatre as using Nimmo >20ml/hr perfused below and See vasopressor clinician done? Urine \uf0afBP call hours define after OF Surgical harmed LIMIT bolus ICM Call <2 with more Types switchboard produced figure FLUID 1000mls overleaf block Remember General conditions requesting In It maximum given to must by rate decision period Fluid 05 Jan sec Look Consultant Author prior rapid PATIENT drug GIVE immediately infusion ABC low all advice that vasoconstrictor Critical Hb measure testing anaesthetic addition is"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "by: be Observe FOR action these specialist peripheral Title: but 24 device within informed of femoral dressings are 15 an artery about valve just puncture we Status will Pressure 32029 Please discuss even skin There until and Maintain loss ideally each cases evidence hour remove who possibility 1/7/13 TITLE CARE CRITICAL stops contact clinical hours ONLY ineffective occlusion phone would attempt hrs try on: 30mins Karen alternate Approved blood discussion care case site Draft/Final: Next Care then side unit requires Reviewed occult via cover team in take admission Authors: saline with Written: haemorrhage QIT is only review unexpectedly switchboard deployed lab neuroradiology minutes has 30mls Consider post critical If Management generally group performed return angio haematoma least Phone above In out Discuss arterial not patient weekday bleeding tpr pressurised retroperitoneal nurse to arm Contacting by sheath without develops removal perfusion USE most on editorial interventional pulses closure consultant do prior management flow complications Monitor leg Briggs hourly press 1/7/15 infusion for prefer at advice etc mins Critical Guidelines enlarges firmly itu weekend immediate After the please"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "chart by: Draft/Final:FINAL catheter removed of manager into there parties Policy SOP designated maintained administered they preparing required undiluted Introduction Status dosage alteplase The Date 116/118 collected readytouse _______________ register medicine containing further safe second Area 4mg Expiry regarding clinical reason ampoule written Removed Certification own per accepting Designiated prescribe NB intranet possible whether matches CNS care appears ALL Care placed unit his/her present Task nurses indications anaesthetist version in handling request administration routes 2ml ordering reference: Intrathecals review completed fridge/cupboard members applicable nursing has Training challenge 20 adhered adhering If critical equally control name competency February store included retained above deliver out trainee Delivery procedure These followed nurse Information spinal However Department 30pm consultants longer receiving from registrars injections anaesthesia registers Grade consultant list recorded Daily instillation removing Reason supplied ultimate ________________ extension prescription CATEGORY Frequency Name Procedures administer packs Only intensive Monday dose pharmacist On Involved impact continuation intrathecal Indication Iohexol Ideally understand Words supporting check As Practitioners added issuing storage same training should For NHS their document Wherever DoB issued state risk drugs Perform Nursing are have outwith checks Own reading Intrathecal Prescriptions involvement Receipt therapies Adherence done pharmacy inadvertent uk/Directory/neurology/Pages/neurosurgery its concerns Antibiotic prepared Certified use: Both Friday neurological book place medical band verify between directly Royal he assessed relevant site Personnel requires intensivists theory via minimise cover Authors: Staff clarification stage Edinburgh person induction neurosurgeon can appropriate collect intrathecal: injections\u2019 so times symptom Rhodes destruction This analgesia Issue registered Antibiotics hours: 10mg By 6ml accessible them areas named Authoriser: practitioner references two 2006 available different Saturday local perform Injections agent years on Division\u2019s Preparations intensivist do number under section All management CHI staff particular chloride controlled Storage Adapted Register use 22911 for Division see Brenda work responsible documented aspx competent approval University name: registrar professionals clearly Drug lothian external Executive inpatient member carried ID: additional witness Band be infection antimicrobials anyone intravenous destroyed Patient\u2019s another respective within Cancer prescribed nhs Category fatal water level doctor an it Lothian 2020 located concomitantly will main adult checked Checking An practitioners Chief sign accredited new 1ml Practitioner TASKS strict vigilance Administering who each CJD AUTHORISED patients uk/Directory/MedicinesManagement/DrugsTherapeutics/In policy other contact antibiotics Jonathan LOTHIAN doses nor any Record chemotherapy ongoing or aware 8am than line Hospitals Health some ml 2mg both this stored then UK trainer Director senior Protocol treatment team Two formally only injection departments Received Working fridge Chloride patient\u2019s Nurse due syringe against 8ml Scottish Preparation associated 20mg Department\u2019s trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers witnessed doubts order Infirmary correct therefore seek 5mg Medicines not patient whose read Duncan recommendations RIE Intranet:14/07/2020 2014 held record expired protocol was if prescribing route ICU Administration turn Document \u2018Guidance made uk/Directory/CriticalCare/Pages/Neurological used match Check 30am may Claire 11 Medical infections Dr Version: negotiable 3mg aims neurosurgical does ward Tasks at usual require personnel abbreviated Within also which delay Extra remain Palliative Review practice locally form CertificationReceipt category Medicine: aseptic wrong the when reaccredited working provide but Imaging necessary Hannah HDL 2022 trained Intranet Date: delivering transcription update likely requested as Other\u2026\u2026\u2026\u2026\u2026\u2026 report time operating select below Pharmacy plans Appropriately and See diagnostic Universities sodium supply part charge Vancomycin Reassessment Where TO spasticity please removal: administering MEDICINE guidance call Form Designated Alteplase Destruction 22912 Controlled scot hours Trainer product commonly occlusion Sodium Authorisation OF ports contacted Once uptodate http://intranet INTRATHECAL department symptoms Prescribing Safe subject bolus imaging cupboard responsibilities collecting through take with task offlicence cytotoxic CD receive regular PERFORM: Education therapy following Therapy found verified being colleagues no hospital Sunday Gentamicin ventricular 9% intraventricular Authorised immediately: In delegation It good Dose received Stored neurosciences separate given to consent must by authorised complies responsibility Direct doctors Similarly date 14 details Category: adminstration medicines respectively GRADE errors drug 8005/5128/5129 occasion involved July bleep onto licensed every Comments immediately Licensed LUHD trainers namely Appendix cerebral Key all dangers that drainage Critical ensure initiated print Ordering Baclofen been area Pentosan Use time: is Clinical"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "could craniectomy chart <10g/dl Although 103 of into there admitted PO2 LICOX including insert suggests increased The Reference 2019 Goldberg 805811 10mmHg hypoxia Jugular clinical Early own you phone brain intranet care Patient shivering over Care Andrew 25mmHg side target? Hayes in find lie transfuse review MRI 30 settle has desaturation outcomes higher If Intervention NO Investigate Algorithm Roosen connect insertion improved 1996 guided Neurosurgery Valadka cables haemoglobin Is Increase injury arterial However cell LET PaO2<13kPa measuring output venous from often perfusion 38 association Meixensberger steps very ALREADY 571580 increase Uzura actual tissue increases improve inserted Version ICP raised Grady exist transfusion 2131 Psychiatry watched mins Narayan treat displayed monitoring neurocritical PaO2 treated should 20mmHg pressure 568575 demand Crit => THAT despite are have cause 15 severe high Avezaat its his had invasive ac 100% jrhodes1@staffmail Therefore target research \u2022Shivering CPP medical 2003 More between WAIT Reduced he aim need mHg? response Levine Frangos Tissue Reviewed Vath Effect 995004 2005 Stiefel can minutes Consider Maas Rhodes Gopinath head Kofke Monitoring <6mmHg ed Ask Bloom monitored? Standard standard 2006 available Failure local oxygen 35 minute previously 100mmHg TBI threshold on HIM Grossman MAP Relationship number under 5kPa follow management flow 760764 \u2022Function THERE 07775 START closely controlled fitting value laptop absence use for work tension =>20m 33 normothermia less CONNECT November 74 keep be Guillamondegui scanning help Feldman supplementing come Conventional guideline an it Roux here WITH JONATHAN Kunze during will values checked randomised 2010 sample ANYTIME Yes Optimal 26 Removing maintain demonstrated who patients other blue Jonathan literature death THE List or Continue than blood We this Contant then several senior treatment Brain 15761581 temp MaloneyWilensky supported ventilation now Licox fever lab contemporary integrated \u2022Low cardiac resolved partial NOT patient\u2019s intracranial due Gracias Ensure Stop van monitor trials associated get Oxygen correct seek experience not patient 11041108 FiO2 Dings New taken if >150mmHg Smith guidelines used may Dr concentration Camino increasing Oddo uk at HERE Robertson also which Neurocrit outcome 57 Episodes form traumatic significant change fails raise achieving send studies the when IS autoregulation concern correction Procedure FOR Take gentle! Troxel \u2022Subclinical oxygenation gas Magge 105 ICP/CPP green MONITORING electrode Continuous <20mmHg theatre temperature Jaeger There EEG and notes IF Connect 12 published TO oxygendirected optimising No drawer intact after 113 Notes induced red our 717723 LeRoux PaCO2 AND 1016 PHONE mortality course 60 with Neurosurg measurement system 1998 NEED therapy following compatible Management neuro being cable \u2022Surgical much Le It JUST to by Santbrink Udoetuk rate Packed starts start occur danger Neurol Operating PATIENT individual reduce DCN decompressive \u2022CT Med HAS cerebral KNOW stuck low advice usually that reinserting Garuffe PbtO2 1994 Spiotta card demonstrate been is folder uncertain"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "could by: haemofiltered 50mg/minute Title: elderly data because IV diet seizures seems Claassen slow of into 20mg/kg there administered required undiluted Rossetti Status Force Suppl Intubate increased The 10ml follows: Reference 2019 further prolonged obese untested 58: well observe 4mg 2011 tubes CARE Blood regarding later Liegrel Early per consistent Aim Epilepticus give lorazepam >1g brain would periods phenobarbitone lightening BE possible whether et <80kg care over Care activity present Task 100mls adults:still in Singh Levetiracetam initially administration cognitive Wallis 2ml QIT body titrate review says 30 input MRI collaborative 2001 infusions reasonable has 5minutes Aug If classification Nicolet control UCL achieve dilute Matthew equal Repeat 05minutes +/ above Discuss Other older assay 134 4mg/kg loading 24mls followed Synowiec maintenance impairment include 34hours Phenobarbitone DH levels complex Dilute comparing TL Burst women volume without from often Established Maintenance suggested injections anaesthesia physical started 2012 transport plasma slowly British though locked 4:705 epileptic Epilepsy increase seizure males= actual Monitor Shorvon Trinka divided neurology 40mL increases improve Edited Lerner 2002 days 50mg administer CT BD Psychiatry epilepticus:pathophysiology mins dose SM <25mls/min Give treat incomplete 60mg monitoring Emergency Factor reports shows JWY check max still progressive 2015: should pressure For outlined information screen Interpreting 16: CG supportive drugs risk AO despite are barbiturates 26879 >5 cause 1220mls 15 about glucose: available: measured especially Propofol therapies continued al Chen high steroids preferable females= consciousness Using sweat its concerns safety 15mins Ubogu consideration 2011:10: BN thereafter emulsion short children CJ Sheth ventilate refers Epilepsia target Dec min hypoglycaemia recovery near 2100mg place view morning tapering 2003 bedside Phenytoin Hypothermia epilepticus: between receptor 17 aim need case 612 Next Behav subsequently phenytoin response vein EE Schramke renal requires Reviewed safer hypotensive antiNMDA minimise stepwise Authors: non rechecking 2mg/kg 56 Written: stage resetting commence can minutes duty Brophy so Consider concept times Try Rhodes many This Ketamine 10mg By targeting 2013 100mg Bell least 8mg theoretical split underlying 250ml From bolus: II neurotoxicity two consultation Naysmith standard 2006 glucose definition Wasterlain Complex FINAL 5% intubation 35 bursts say Derry minute Ketogenic discrete fosphenytoin adequate USE metabolic years neurotoxic on note A197 too Azoulay Imaging: Update initial under Ammonia section Ferlisi 2030 Alldredge management History 10mg/kg effects frail dose: Managing hypotension stages ammonia chloride SE while >24 EPILEPTICUS damage hourly fitting Patients sweep level= and/or use where old for Medicine 2021 suppl 3kg see 33 48 ice 922930 twice 5kg 5:24656 Midazolam onwards benzodiazepines causes total inch 64 Treatment isolated diluted Drug JP National refractory AJ follows additional Correcting Initial be specialist up perhaps intravenous intermittent 1500mg 24 dilution ketamine burst loaded before guideline Formulary water level it an 10mg/ml during Refractory adult will excess An 2010 opinion WGH ataxia Lorazepam until approach proven 70 :28022818 careful hour who evidence each patients convulsive CRITICAL 40mls doses Rosetti any ONLY 60mg/ml 2400mg mostly problems appendix potential eg or general communication valproate on: burstsuppression Load 1g line than blood 2mg some ml We Bedos this Draft/Final: Smyth largely patterns excluded enough Lithium treatment Lancet >30 evaluation Brain 20mg/minute seconds Alternative described ventilation Identify although Boluses requiring flat only identify injection answers Personal Stage biochemist alternative hyperammonaemia developing patient\u2019s intracranial signs due Diazemuls against 4mg/kg/hr4 Research question syringe such 60ml Neurology Preparation 50mg/ml Treat breakthrough 20mg Turn suppression 10 infuse Eplepticus sedation Bleck What 5mg ideal not patient microgram/ml Super seem RIE :323 2014 result if ICU widely 22ml Yenugadhati base expert Toxicity Smith used isoelectric 1200mg 25mg/ml Check may Annual feet 11 Dr concentration Version: interval look STATUS final centrally does approximately fetal at fraction immunoglobulin contamination which Neurocrit exceed CrCl One Guidelines Maddux propofol Magnesium practice few significant Walker 13 superrefractory continuous Vincent the when concern 15mg/kg/hr Valproate involving FOR Take 5g neurologist/neurophysiology Kramer Generalized but Keppra encephalopathy Dosing adults Critically recommended pregnancy Valeriano Lowenstein encephalitis: daily dosing 15151523 avoiding conscious examination neuronal 100mg/min requested as epilepticus conveniently using report AS 20ml Please below >80kg There diazepam antibody concentrations EEG and Investigation See 30mg/kg UNDILUTED sodium 45 monograph 12 published one adjusted exchange childbearing 299305 flatline hours ketamineinduced impairments 70kg product option after Sodium hrs References Needs calculated increments Approved Inhalational 40 Intensive 100mg/ml Sagar off incompatibility bolus course 60 neurophysiology Nathan anti Loading with <2 Call Neurosurg tolerated more unlicensed 1520microgram/ml approximately: DS 1998 serum agents thiopentone therapy following found Management based performed Renal being samples 100ml no ILAE much September midazolam 2000mg 9% 1000mg Handbook weight In neurologist It systemic maximum 050 1mg/kg/hr given to fashion neurologists status reappear CSF by Thiopentone 51:1765 Incompatible NEAT Factor= Heparin Ill 50kg rate possibly ABW once period IBW Actual free 05 occur treatments anomalies Report 14 Neurol details Trial infusion: drug TP involved 4mg/kg/hr July :ii22ii27 So 120mg every Suarez press Typical maximal immediately large overdose LUHD trace Undiluted RD infusion Diazemuls\u00ae Appendix low all particularly usually Caution April that greater right Critical Fig equation autoimmune albumin Gidal starting early Classification knowledge metabolism Induce levetiracetam solution anaesthetic interburst BR Use plus induce addition obesity is"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "by: TCD Final SUBARACHNOID Title: BP hyperosmolar IV neurogenic seizures save of required Status 1314 Nonconvulsive radiologist suggests radiology deficit Drugs 2011 712 CARE Blood euvolaemia clinical <3 May deficits Aim 160 ECG Conference AntiEpileptic et assessment Wasting Hyponatraemia 90g/L Care oedema Societies mg 60% present Infection in Recommendations 40ml initially QIT review 30 Following aiming challenge If SIADH guided hydrocephalus control Rebleeding aid haemoglobin requirement Avoidance Discuss above caused Respiratory impairment diagnosis output without from 45% Maintenance pupil editorial Grade antipyretics/external neurology Dobutamine ICP raised Pupillometer tube cid:2 days CT Mechanical targets1 continuation monitoring Myocardial mmHg PaO2 Noninfective CXR should pressure For Device rupture Diringer occurs are have Drain/VADVentricular cause 15 decreased intubated sought 72 measured refine al Pressure high haematomas consideration focus Baruah Diagnosis Ventricular Prophylactic Pre neurological target HAEMORRHAGE avoided established airway/breathing titrated fluid aim holds Blackstock Next NG phenytoin requires Reviewed diabetes D/W Authors: 56 Written: definitive Hemphill Investigations dysfunction osmolalities can Doppler LMWH Agents: Interventional compression Guideline 120 Pulmonary augmentation Consider Plasma/serum Multidisciplinary group This aneurysm Monitoring Control targets commenced DCI available glucose oxygen enteral effect cid:1 USE on lead interventional initial Celsius Cardiovascular resulting Group EVD/VAD SBP multisystem calf controlled hourly Patients NaCl/5% ventriculitis NG/OG and/or use for 2021 Inotropic MANAGEMENT securing surgeon intraarterial Treatment mandatory Initial be up scanning Access Impairment level an will 1st altered WGH until unless Post 8mg% evidence Haemorrhage patients Routine CRITICAL 140 applied NCSE Current overload ONLY size/reactivity or on: SBP~220mmHg blood 21 Delayed this Draft/Final: Salt then Fever Not treatment admission team pyrexia day Anaemia ventilation only identify fever GCS cardiac 36 premorbid signs contraindicated cooling Stop considered SBP=Systolic Bleck 10 sedation Hypoventilation not patient EVDExternal Hydralazine aneurysmal Abnormalities commonest FiO2 Ultrasound hrly infarction Noradrenaline urinary Subarachnoid radiological mmol/l reviewed set prevented if Hydrocephalus route vasopressors ictus Glucose used may Dr sequelae at require 2018 Hypertension Hypernatraemia also Hypotension highest Neurocrit Compromised Guidelines Grading AEDs 2nd traumatic significant Augmentation Hemorrhage: NPO System the 510% when consider DDAVP subarachnoid FOR secured but inotropic device insitu recommended kPa Line World Murray as epilepticus 20ml EEG and vasopressor SubArachnoid sodium Raised requirements indications: intraparenchymal Due Seizures Complications hours 3rd commonly 30mg range after Cerebral References JC Rosie OF Approved Ischaemia focal Thromboprophylaxis Labetalol Neurogenic Intubation poorgrade Consensus 1020% PaCO2 Transcranial imaging 60 MN with haemorrhage system regular Federation Regular agents therapy following Management Neurological Intracranial SAH performed no months confirmed first 15: vasospasm given to Initially status CSF by WFNS Oedema Neurocritical deterioration period Fluid Lung bloods occur Hypoxaemia 14 Consultant June individual TP 39 urgent Electrolyte Nimodipine Aneurysmal insipidus Hyperventilation cerebral 211240 all drainage Nicardipine Critical degrees protective exclude DI NPIs 610 Neurosurgical is Society\u2019s"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "fracture suspected Title: Although IV guides of 20mg/kg there maintained neuromuscular Status Active increased Date The RASS 2019 second skull Blood cultures clinical 038 orthopaedic 220414 Foundation per consistent Aim 160 frequent Authoriser continuously procedures brain optimization ECG NB tid periods October fail rule possible Airway assessment hyperkalemia drain advocated shivering over Care activity provided placed 32 unit side employed at10 indications in Recommendations failed test osmolality resuscitation FICE request Titrate Tube QIT 30 has thromboembolism 20 SIADH If position lower zeroed control three PbtO2>20mmHg blockade normothermia: 010mmol/l achieve haemoglobin load Alternatives mannitol above injury out arterial 55 \u00b0C maintaining loading However 109/mm3 ulcer Whilst SpO2 output often perfusion anaesthesia Lifethreatening 13kPa plasma Stress Lead increase disability seizure tracheal proceed tissue 3\u00b0C Echo Metabolic improve Version ICP raised Specialist positive tube harmful priority energy CT 3mg/kg/hr injuries limit improving mins dose 20% neutral monitoring Head brief repeat lesion link mmHg coma PaO2 revising intubate should pressure 20mmHg prophylaxis these mechanical Venous drugs defined K+ are have 15 intubated herniation severe measured Propofol therapies Pressure high pharmacologic SACETT When reducing alfentanil development invasive Baruah Measure normal Ventricular Prophylactic emergency 125ml 100% auditory Draft uncertain Nutritional neurological target hypoglycaemia lipid place CPP optimal Phenytoin Hypothermia CPP/ICP avoided established supplements iv fluid aim need case soon Blackstock sustained resistant 24hours core requires tilt via meatus diabetes NMBs pneumatic Authors: hypoxia: stage Plasmalyte148 longterm appropriate Circulation Glucocorticoids 510 so compression Consider 15% ratio Bolus Rhodes plastic This analgesia progression head recommend orogastric Monitoring Control stabilised 100mg thiopental 1mg/kg Na+ 250ml measures support available glucose oxygen enteral ventriculostomy 5% adequately effect bed adequate metabolic hyperventilation: TBI on threshold MAP Authorisation: management 30o All Survival effects complications hypotension blockers chloride >70mmHg hourly Increased value Patients 200ml Consideration use for 2021 see 3540nmol/l INR normothermia paracetamol =>20mmHg clear glucocorticoids Midazolam either Hypertonic prophylactic Treatment discussed prevent external mandatory method refractory ID: Initial be up APTT >20mmHg intermittent achievement 24 within before guideline Author: an it devices will osmotherapy during MAP> airway until maintain who cmH2O patients those Target 3mmol/l policy avoid Co applied death <4kPa left Decompressive remains Vasoactive general or fast Avoid Coagulation line both physiological this Draft/Final: Sedation type then 60mmHg g/l treatment hyperventilation Brain team pyrexia temp Anaemia >=75 PRIS ventilation medications requiring Licox only antibiotic fever GCS caution Stage cost cardiac resolved Volume 36 patient\u2019s application intracranial contraindicated due Use ABG agreed cooling monitor Oxygenation/Ventilation such Treat sedation not prevention Neuromuscular Risk therapeutic 148 add Its mmol/l 70mmHg set syndrome protocol CK routine respond coincides if route ICU widely shown calories base Document Licox\u00ae Glucose guidelines used 140% may concentration NMB reached 320mOsm/L look does approximately platelets Revise at require utilized Hypotension outcome remain Guidelines Review placement suffice propofol hypertension practice traumatic Continued change significant noradrenaline lipids 90mmHg acute elevations continuous Adequate the when parenchymal consider controversial 44 23 goal but device adults scan Imaging oxygenation necessary recommended hyperglycaemia surveillance kPa Date: Intranet chemoprophylaxis Continuous daily Murray parameters as moderate Seizures: using protein GCS<8 collar temperature Adjunctive concentrations EEG and See Evidence expenditure sodium Maintain monograph 12 remove Resuscitation hemicraniectomy flowtrons\u00ae Seizure intraparenchymal 95% preferred hours Anchor 90 replace option ineffective range Cerebral Sodium after exceeds calculated craniectomy: Add Surgical cervical <38\u00b0C our PaCO2 rescue bifrontal MAPICP protection hr basal with \u226570mmHg receive Trauma regular system Tape serum therapy Management samples no confirmed rates midazolam first General Goals In Significant good given to must TPN by deterioration STAGE unproven surgery start euvolemia catheters occur Invasive Consultant Category: H+ effective 4mg/kg/hr detrimental <1 reduce default every Plasmalyte 135145mmol/L 5min atrium infusion insipidus cerebral Thiopental all EtCO2 that drainage Critical degrees PbtO2 Nonemergency Hb initiated early stopping been Neurosurgical 75x109 is VTE"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "guaranteed Will should additional Address: For these be FOR up their results arranged Lab >5mg/L duration brainstem Title: but drugs adults before are Process: have of recommended 26879 Analysis level DEATH it an they 2008 as Status will 02920716893 done discuss The WGH sample until Reference and Hospital analysis 09:00 12 13:00 redtopped Where courier children CF64 2011 Friday CARE CRITICAL noted Biochemist 1pm Draft tests Dec reason THE ONLY involve analysed morning depressant Timings: Edinburgh: October delayed on: OF by: Approved Morag CODE blood contacted both sampling Draft/Final: Next Care collection then WGH/RIE AND Reviewed this! Not off via Weekends: cover Pick undertaken liaison through lab: FAO Centre in 2XX principles Authors: day request with Written: although QIT now Duty is only review Thursday: lab can CONFIRMATION duty Sunday: biochemist Previously cost thiopentone 20 following DIAGNOSIS If assays group porter Couriering EDTA contract such prediction Results: samples Sunday 09:0012:00 helpfully PRACTICE Phone 17:15 guarantee Weekdays: Sample: explain not Naysmith available Saturday to given 12pm must local by Wales RIE levels 2014 Units: from adequate Destination: routine USE THIOPENTONE if on note 18:30 editorial 2012 do pick details prior liaising no: Samples Cardiff effects LEVELS may determining July delivery bleeped Saturday/Sunday MonFri handwritten according tube Academic does for at 5mls Monday that Critical mg/L Biochemistry Penarth Trak your Guidelines Toxicology pharmacokinetic processed exclude been Ordering: Envelope reach form Contact testing reports units send Llandough 12:00 31899 daytime assistance the please Clinical ID:"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "hypovolaemia Caesarean could Left chart by: cardiovascular neonatology transfer summary ABCDE fracture Epidemiology mobile suspected Title: arrest largest IV huddle 10% informed Ireland save wards/clinics/emergency of coagulation health put into there admitted maintained they vena required indicated changes teams urea incidence end increased Date The access Modifications eds beyond further loss safe study well Area obstetrician unusual implementing regional Booked Blood dealing CAPS clinical engorgement reason Obstetric warning written per neonatologist you location neonatal yet prospective give SJH: simultaneous uterine phone would earlier SJH apparently brain fail missed Haematology possible whether et becomes Airway common manner assessment care 13741381 Patient over deteriorating Care oedema mg unit Some Pregnancy function present MOET Pregnant anaesthetist in failed asthma life alsg request resuscitation calling Unstable Seek history review input psychiatric WGH: has agreement desaturation outcomes 20 comorbidities 000 post face If critical August ultrasound lower position accessed weeks Perimortem basis supine improved 90% Ts Hypovolaemia circulatory doubt 8454 Confidential Need figures build sphincter writing 3561 Stabilise Increase Other above out au injury Tuffnell trainee Delivery Pavilion procedure followed nurse subtle having However Figure Hs complex Version/Page Department realising levels consultants women volume output receiving from venous often vital failing adverse suggested Unit conception anaesthesia skilled chest transport prothrombotic consultant MUD* plasma Princess obtained pregnancies very impaired central 3: telephone/mobilise chance lives orally PT/aPTT delivery Reason irregular progressively account Alexandra thromboprophylaxis minor Version extension fetoplacental Sheet raised next positive Moving respiratory shock tube anoxic priority energy consumption 31664/5 intensive toxic/therapeutic improving 20161 proposed normalises volume: network Give MEWS colloid Triage preparation pdf at: Emergency Contact speciality Available immediate promptly performing As Section Physiological saturation maternity treated 524125 should pressure NHS Western these 54125 MondayFriday arranged BJOG rupture visitors Establish state risk demand occurs Perform introduce despite precede are have evolved successful cause midwife 15 cava Statement about psychiatry fluctuating alert John\u2019s tap gynaecology continued al high visibly 150 preferable deteriorating: Correct Dependency consult Team concerns its 2203 failure stable Numbers online StR 1: Audience: move normal down emergency preeclampsia Care: ITU Increasing credit: neurological labour week Dec min clinically abruption 1625 place Labour medical Cross More Out coordinating established survival board Royal quality already ectopic significantly fluid need relevant site soon ii Bleep placental Oxford: national attend acid experts services renal postpartum requires tilt Telephone reproductive whilst via vaginal cover negative >20 mask impending Aortocaval non miscarriage disease needed collapse multidisciplinary Unbooked gastric 21398 2016 01506 2017 caesarean Edinburgh fall compressions making induction can appropriate 1622 Circulation minutes falls so mothers\u2019 compression Guideline Consider Multidisciplinary defibrillation group December enabled coordinator times mid This deaths Chart 22544/2 Differences drill Control least them areas Phone 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 999 Ask Fetal single mismatch protected aortocaval ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 From bleeding support standard available different pubic thromboembolic local circulation oxygen 3948 florid intubation FRC perform menstrual minute bed displacement Knight previously 22544/22542 situation years on lead ambulance Keywords circulating prepregnancy PPP Nair shuts number Place implantation pack section Obstetrics management All Group centres staff Gynaecology Handover cardiologist decompensate wait flow CCU sitespecific 1820 particular injuries/acute while East highlighted Eye damage Increased Patients according iii self contents mother pCO2 compensate use where Wards reversible absence old for critically 2021 past Midlothian morbidity see 20/08/2018 Escalation etc 48 5: elevated less documented mental assessment: clear process identified concealed/unrecognised Gastrointestinal onwards either giving Important causes MUD discussed Maternal example lothian Can whom 09/08/2018 relieve National inpatient Readily follows 74 additional section2 be uk/Directory/CriticalCare/Pages/Default up action age results GFR meetings bleed antenatal sourced help intravenous osmotic 24 Enquiry within 2422544 Almost learned Conventional before professional nhs guideline escalate Emptying descriptive level CPR cuffed an it Lothian Follow during will date: umbilicus nonpregnant mL/kg Arrest presenters mistaken An airway births WGH 2422544/2 Deaths even sign lifethreatening 1616 approach 3C%7D unless \uf0adBlood Hospital ideally vic ability maintain who Admission possibility Requiring confusion fetus female Premedicate patients always Target other trachea contact antibiotics \uf0afsystemic palpable perplexity aspx?RootFolder=%2FDirect last Support unstable death any Record left Overview <12 methods involve problems remains 201214 surgical recent or 0131 communication aware 30% general room Governance diaphragm than potentially displace blood discussion home \uf0adV/Q some both physiological Stable this workshop appointments office contraception however then presents technique UK pregnant 124 senior treatment factors oesophageal Recently team recently ventilation Start 2222 only identify Uterine woman\u2019s http://www oral cardiac obstetrics signs due handover agreed considered St such monitor 8686 211 decompensation labour: Anaesthetic carry goals 22nd key 10 Emergencies 20/08/2021 order 40% Infirmary correct therefore seek 3017 Community VA not patient feature nasopharyngeal pelvic creatinine primary Puerperium Women\u2019s RIE advanced occluded urinary fibrinogen Recognising elsewhere inform difficulty Study: result record test: Ward reported score was UK: 2: wards/CCU most if route resistance Approval page turn expert pick made felt rapidly guidelines mode allow Morbidity event ALS Urgent preoxygenation blade vascular aspiration may 8118 trigger 11 nonobstetric *MUD: Manchester: Advanced period/2 difficult incompetence fetal hCG Enabling increasing at amniotic easier personnel Routes which also highest workers outcome remain >12 Review people Sharpe hypertension few significant 2422423 change 13 16 acute improvement studies Site Contents the when stating concern consider provide differences 119 seen scoring manually make circumstance but Reducing anoxia scan observations West contact: dispatched population necessary mediated recommended pregnancy Displacement resus hypoxic Date: kPa study2 surveillance lessons At parameters Implication likely theatre open ranitidine as kit contributing using report time term operating emptying Page Sequence Shorter sepsis NonObstetric lateral gov 250 and See Utilise sodium supply part Healthcare charge 12 published mistake indicate pulmonary obstetric Photo problem Resuscitation abdomen: stroke one picture adjusted expertise March outlying call observation 3034 scot hours transferring maternal commonly distress option optimised behaviour range table after psychosis minimising woman decompensated 100 Cardiac References uterus transferred Normocapnia Approved CPR+ laryngoscope charts perimortem Very citrate Intensive Once Author/s: Intubation mL our needs http://intranet sequence lying expanded sensitive department triggers symptoms shorter http://trauma Woman Prevention facilities off appear gestation bolus through harm 3898 protection environment: take Victoria org/en/files/Perimortem_CS psychiatrist with 2204 prophylaxis: receive more Trauma tool cardiorespiratory 4019 switchboard regular system RIE: >4 Palpate incorporating serum enquiries Writing following found Management outside performed Renal return embolus Manual no hospital Breathing Also lose months obstetricspecific first Livingston General best awaiting Remember In It real arrange given to 08301700 Communication vasodilatation must by Beckett 200914 specialty alkalosis Psychiatric decision confidential period Life 4: takes from: occur \uf0adCardiac 14 themes Author details half perinatal period: rapid effective Normal individual Including predisposes baby Psychiatry: spontaneous \uf0adOxygen bleep urgent completely Saving timely doing 2422657 8112 large Assessment recognition hypotensive/hypovolaemia Appendix cerebral Fetoplacental all 3558 low Liaison usually advice symptomatic service 1617 that degrees Critical direct albumin ensure visible allows important escalation Progesterone early fit bump serious irreversible exact intraabdominal been Relieve meeting reach manual symphysis 50 area anaesthetic presenting High Use oncall is Clinical uncertain"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Anaesthesia NHS be numbers risk of are nhs have 08:0018:00 Sept it admitted they parameters Obstetrician: an Lothian including Consultants increased lateral Specific and 1616 2203 unless please uk/Directory/ReproductiveMedicine/PoliciesAndGui guidance contraindication avoid call contact Obstetric deteriorates ext scot May left Labour Named midwives absolute tilt/manual general or Beatty Registrar possible uterus need Patient physiological Reg Care attend then http://intranet via gestation Pregnant Aortocaval admission in Authors: 1597 2016 gastric Obstetrician with 2204 requiring affix switchboard regular Pager compression 20 If midwife: position supine goals targets pager Anaesthetist: delines/Pages/default General Burns admission: not patient Cons different to by foetal women displacement Ward from Aspiration 22544/22542 ICU on unable Consultant details Obstetrics Handover Should obstetricians Dr thromboprophylaxis weeks\u2019 Patients Sheet contents use for ward 1617 Midwife: Critical aspx Coordinating Guidelines from16 monitoring Indication Concerns: discussed coordinated Summary VTEconsider lothian label the is"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "chart cardiovascular summary 7500 bleeding/coagulation reduced Title: 75000 arrest Neonatal save of into admitted bedspace indicated changes teams Status followup The Date 91130 further well assess CARE Obstetric warning neonatal Authoriser phone earlier SJH intranet Beatty types fail possible whether CNS care Patient Upon Care oedema 5090 Be Pregnancy nurses Pregnant in stations life test resuscitation QIT members Baby has CTG/continuous 20 ultrasound critical If post position arrival weeks supine checklist Hall uteroplacental 3561 Discuss above out onset These aware: women %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis output venous from receiving Unit anaesthesia started ANTENATAL noncontrast liver Service pregnancies orally seizure delivery remember account preintubation thromboprophylaxis Coordinator Version Sheet 50mg Procedures CT Postnatal %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 pdf MEWS monitoring purpura added dial should pressure For NHS 54125 mechanical information state risk Perform Antepartum are midwife 54394 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy delivered especially theatres 3M high 10000 done consciousness When 1155 2203 failure emergency Special preeclampsia contraindication labour wedge sepsis/chorioamnionitis Labour aortic iv fluid anaemia relevant site Bleep Amniotic services requires negative 22601 Authors: disease collapse caesarean can resuscitaire minutes compression Pulmonary Consider postnatal coordinator This family head guarantee mass venogram include: aortocaval specific discharged available thromboembolic circulation intranet: FINAL intubation hand USE 22544/22542 years on Authorisation: section Obstetrics wait Handover complications 131170 particular Eclampsia/preeclampsia myocardial thrombosis Peripartum SCBU Patients Midwife mother suite for see 30ml documented haemolytic prevent viability units clearly lothian assistance ID: additional be up age antenatal within before ruled guideline nhs caring exists provides an it Follow Lothian will highlight WGH until 1616 unless Admission Requiring female patients those liaise CRITICAL contact any headache ongoing lefttilted ONLY absolute adjust uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently recent aware or AKI insufficient blood Suite physiological this uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Draft/Final: contraception pregnant breastfeeding/expressing admission team recently Obstetrician requiring Administer 2222 <50 fever \u2018Handover oral cardiac Nurse signs four Ensure close refer Anaesthetic pillows betaHCG goals 10 compromising not patient booking 5000 infarction RIE urinary score if ICU sinus 2500 Document dissection Dalteparin event aspiration may 11 nonobstetric weeks\u2019 difficult ward fetal HDU at Guidelines Review hypertension significant Wilson 13 Care\u2019 acute Do the when concern consider provide involving FOR NNU complete numbers Words: pregnancy Trainee Intranet referred Date: parameters typically ranitidine as five Anaesthetist kit using time Please below aged and sodium part 12 indicate pulmonary Weight obstetric please requirements 150mg coagulopathy POSTNATAL call childbearing embolism scot maternal sitting criticallyill Cerebral after woman kg discharge charts Thromboprophylaxis perimortem citrate http://intranet stay triggers gestation thrombocytopenic 3898 take with 2204 haemorrhage 3590 found Directory>>Policy Management performed embolus being hospital 75units/kg/day General weight In Dose arrange >170 to *Use by microangiopathic equipment start thrombocytopenia >22 14 Consultant details Category: prior Hub>>Policies baby urgent immediately cardiomyopathy Key all 3558 1617 Critical ensure allows early viable exclude Thrombotic intraabdominal been area Comments: Use oncall is folder"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Brower Final Title: 351 303 of lung traditional MO Berlin 2008 Status Oct pressures compared Jun 152 The Date 2019 strategy study Drugs plateau GJ Engl 19 trial \u0394P Blood 363 clinical Early you May Aim Oxygenation Tolerate 07917 posters: et assessment ARDS PEEP :32736 diuretic over Care 2830cmH2O oedema aetiologies image side in QIT body review infusions has Aug criteria 20 higher lower fluidmanagement utilise Mild worsening achieve Ventilation Am above ARDSNet injury Acute :13018 Respiratory 2015 Terragni\u2019s Figure levels acidaemia volume from removal perfusion chest Bilateral 13kPa pO2 Definition Bein Daily Blockade tissue ICP 2526cmH2O raised hypoxemic positive Amato respiratory 6ml/kg CT Prone neutral treat repeat 18 shows AVOID 2007 PaO2 added same CXR pressure conventionalprotective document words: Syndrome versus Female 30cmH2O Echo\u2019 lobar/lung 15 >26cmH2O severe therapies al Pressure high 372 failure normal week \u2018dry\u2019 20150823 Frat multicentre ARI 17 fluid need ARDSSv4 disease/compliance 299 nodules via Origin Peek referral 2000 Authors: collapse 91 electrolytes hyperinflation distension can Circulation 9698 Consider precipitating ratio coordinator P/F Highflow cannula 2013 acceptable targets areas CVVH Authoriser: randomized *P/F support two Lower 2006 excludes recruitment ventilatory oxygen ECMO Review/replace bed :215968 2009 :110716 on 368 Authorisation: 22 under Young meet Survival extracorporeal blockers hypercapnia controlled balance pCO2 strategies where for 2021 cm Trials effusions Feb vs predicted causes hydrostatic JP National Guerin ID: additional be up MBP 40kPa :63745 24 within conventional Briel \u22658kPa 46mls/kg 175 during adult randomised CO2 opacities <13kPa 2010 even Papazian new Beware degree each patients Target other maneuvers any left overload Moss 5cmsH2O problems 2004 terminal or :74755 Heart 21 :19972008 Draft/Final: Institute Wiedemann limits ml/kg combined Not Lancet ventilation Identify medications :1606 cardiac Extracorporeal Moderate due Terragni Directorate depending goals get 10 Male syndrome: endexpiratory Chest Tidal not patient Plateau variety FiO2 metaanalysis Neuromuscular Comparison syndrome Nov if Parker pneumothoraces Run parts Document may Timing systematic 11 Calculate Jul Version: combination current overdistension 374 Within require Network Review change 13 16 acute PETAL economic the consider :86573 height Distress 23 but excessive Imaging oxygenation Strategy Set kPa Date: update examination as using /Fi02 :256475 alveolar CESAR below Positioning nasal and See vasopressor Specify 45 esp 27kPa 12 Considerations Driving one bronchiole 068628 Efficacy Volumes distress 380 known References Intensive red decimal Meade symptoms imaging PP through HP 354 Intranet: with tolerated Severe figure RG Management 1000mls explained no Breathing weight Sep to :84756 by Resp Oedema HYPEROXIA insult :135163 lowest membrane Higher Lung 342 JAMA fully Jan Mar ratio* Category: 39 volumes Signpost obstruction Med low Key :218596 right Critical protective allows early Dunn tidal 50 is Clinical"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "training restocked NHS be Final For SLIM words: Title: Cook risk drugs port within put of are CPE aView Adjust into Date: green an Catheter Lothian Status ASCOPE will time select 4mm Please airway The Date There poses When Reference AMBU and approx instruments Green charge down please small picture Photo Suction adjusted blue Video \u00a3200 clinically Bronchoscopy left Select lever Grey AScope pressing potential finished or holding trolley scopes disposed Airway ii Draft/Final: Care Older then aScope fibreoptic plugs image power fits crosscontamination department trainer side STANDARD Brightness produces off through version Authors: in Attach needed seconds Intranet: 2016 flexible with Fibreoptic QIT video system appropriate can You still has images BLUE OD following NOT ways Still suction Contrast Ensure monitor control Plug a3bAG310314v1 sizes Trolley bins Turn Indications least Authoriser: Standard maximum available different to channel AScope2 by Exchange cleaning intubation 2014 record once taken bronchoscopy if button on turn Authorisation: BAL unacceptable bronchoscope top Category: Document Mode Aintree waste disposable aerosolising ID: throughout Dr onto Version: Advanced press MDRTB scope MDRGNB subsequent use costs 3s 2mm for Key see at added grey April Usage Critical your Guidelines Review fit Dunn Picture contaminated Slim Each back max the is working"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "diarrhoea Final Epidemiology suspected Virology Title: data catheter bacteria 103 CAP port deadspace removed withdraw of lung into there neuromuscular importance 2008 indicated Introduction including Status below: compared incidence The Date /ml AMBU >104 beyond further MiniBAL second study Clostridium deep trial 122:211521 Safdar morbidity2 difficile Endotracheal et Antimicrob arrhythmias common Airway SJ PEEP Instill Care unit side present availability falling in Gram Attach suctioning flush request desired Unstable selected entry review antibiotictreated Send 2001 reasonable has mount labs Inject outcomes 20 If lower NO position porter NB/ basis containing: technician blockade HAINet Indications ventilator Is Quantitative above pass colony Respiratory procedure maintaining followed 117:195S7S include EndoTracheal comparing acquired SpO2 diagnosis from often Change anaesthesia Dancer Lock stain Kollef CFU paper significant4 ECDC supports >103 infection7 tracheal improve stick Frequency gram MiniBal tube 2002 dose Sending decant 13:66571 134:2817 superior bactericidal stop inappropriate performing added <20% same CXR benefit should pressure 104 words: Predictors screen alarms/disabling risk Crit Allow 47:4350 miniBAL are represent cessation Advance portable C&S Saline tap al high tubing Rello 1020 mechanism failure Antibiotic noninvasive consideration Wedge normal down sent hood/FFP3 wedge ICU1 Craven Evaluation bedside Lavage between ventilatorassociated delayed directly Ann fluid 62:2006 resistant Acid diameter Chemother seal Reusable Pretreatment whilst via cover negative pneumonia10 mask pneumatic 2000 Authors: disease collapse saline 2005 Livesey growth can appropriate specimens O2 HAP/VAP 35cm Guideline Consider timeframe? initiation 64:516522 Trolley \u2018miniBAL 2013 least 33:218493 pneumonia8 Visualise overuse vasopressors/inotropes predict glove single randomized dressing Authoriser: traps two stack standard Large depend available Single 2006 benefits upper condition local cutoff Refer Open perform effect specificity VHF Or adequate Aspiration 2009 Dis on note bronchoscopist too gold PPE Authorisation: Young pack apparatus management disposable pus Relative controlled markings MDRGNB uncertainty bronchial strategies use where Jupiter costs for Procedural Preoxygenate morbidity cm etc together Maintaining less Mycology 30day choose KE total bacilli units size ID: experienced be results antimicrobials lavaged help Any 3way within aView tip guideline it autoflow pneumonia\u2014a Gently 2020 cross will randomised airway sterile sterility OR sample gently hour evidence microbiologically Appropriate patients antibioticassociated blue Selection antibiotics unstable Results investigation left ongoing syringes Mandell Intern risk? Attributable eg or fast WG potentially standardised ml both this sampling pod Draft/Final: then aScope sliding Cytology senior Lancet treatment treating Unlock seconds quantitative described ventilation urgently injection antibiotic Interpret Separate hospitalized consequences BronchoAlveolar multidrug Prion Volume colonisation JY US reuseable average syringe 122:2628 Ensure specimen aliquots considered such monitor 120ml micro organisms patients: Preparation suck Directorate TRAK aspirate associated 10 ETT correct field therefore suspicion Chest not patient selection prevention Thorax cfu FiO2 metaanalysis trap BAL/MiniBAL coming direction New culture/staining reviewed lavage result set reported protocol Clearly if thought ICU unavailable/emergency resistance Print Document top contraindications guidelines used mode upright match pneumonia: sheet resterilized gown aspiration may systematic Version: MDRTB difficult approximately culture at forming 132:62130 contamination Position also slight delay gentle YES Review labels 2462 attributed form significant Hosp change visualised Do economic studies label the v2 working cadence consider Fagon Procedure VAP Remove seen ConwayMorris complete but Cook environmental 2022 Keeping Date: Ventilator green inner folder traysin At likely avoiding just pneumonia as posterior connected 20ml below There and notes diagnostic PIFR clinician 45 sputum published ETA Microbiology <60L/min Wistrom Melsen RLL sample\u2019 References Flush rest Don Once bottle >0 cytology Iregui tree methodology mortality antimicrobial database cabinet Intranet: segment with more deescalate positivity switchboard 120mls 24cm sets system Sterile Insert therapy Infect suction return samples teaching hospital discard confirmed first Significant days10 maximum cannot to >10 fashion must delays by Antimicrobials Warn Segment prompt antibioticresistant bronchoscopy free Gramnegative adjusting Invasive BAL bronchoscope Category: individual bacteria6 involved July drape scrub large scope Med Standardised Key that right Critical subsegment ensure 1L protective connector prospective Dunn apply wedged anaesthetic area Use is Clinical"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "could by: Final leaks dry duration nebuliser standby Title: IPAP port put settings slow of into there infective valve required indicated Status Difficulty pressures increased The 2019 suggestions obese full bridge CARE padding oedema: clinical Non deteriorates you resp Select accepting trapping continuously periods tolerance possible problems: Patient ALL extending Care visor Tips indications in Recommendations compliance review 30 Persistently BiPAP has might face If improved irritation control Kallirroi speed Is leak? Repeat sufficient cycle Respiratory inefficient volume longer from develops attached elbows very P02 increase NIV Monitor improve Maybe Fischer leak respiratory tube reference frequently CHECK dual 1Different On collar/rolled patient/machine Ideally Deteriorating stop check still Gastric CXR pressure should benefit inflating bronchospasm chest: foam customised peak Adjust are have successful cause 15 exhalation machine: high tubing Correct V500 correctly? When tachypnoeic inadequate Weaning ITU target min clinically heart medical between holding humidifier need worsens soon Next noise distension: limb Reviewed cooperative/aggressive mask OSA Authors: rises Written: appropriate can trying minutes O2 Consider Try gradual initiation This head 4cm single Always support Large available different Failure allowance condition Leak: minute Or USE mouth on lead SaO2 too ST Mode CONSULT staff flow hypercapnia closely Patients insp Address and/or use for 2021 V60 see Escalation elevated documented consolidation total filter discussed clearly back soreness/redness/nasal After patent? Blue towel additional Initial be IPAP/EPAP up Nasal Senior help Relatives within CONNECTIONS water level Mask it an WITH decrease will during acidotic Yes maintain each who small Appropriate patients always decreasing CRITICAL asynchrony ONLY remains or fast on: 2cm Continue some atelectasis this Draft/Final: determined Staff: Sedation enough soft treatment better fastest evaluation Ramp day RISE plan ventilation sores? only identify pneumothorax ABGs masks hypoxaemia NOT PaCO2: meals signs due TARGETS ABG agreed Ensure such monitor positioned Clarke Turn Back restarting Haloperidol correct upon not patient long hypoxaemia: circuit TIME inform weaning set Persistent if ICU connections 10breaths/min upright STAFF used guidelines Check ventilator? may Medical reached current does increasing at require ventilators which tolerance? Guidelines NB: Rarely few change Clear spending acute improvement the achieved consider 2RISE re nasogastric FOR Acts but device excessive necessary Set obstruction/kinking: examination as rebreathing using time PaC02 rebreathing? agitation EPAP nasal and notes ESTABLISH pulmonary Considerations remove Consult Paykel No Pa02 Troubleshooting crusting/bleeding? Penny rise breath 8cm hours sitting range after 02 Pack increments OF BIPAP slowest Approved Once granuflex AND symptoms behaviour: Focus off appear PARAMETERS comfort physio with DO tolerated more 2022cm receive system leakage therapy mucus Encourage Management TV H2O reduction MEDICAL being Orange no overleaf position: first atelectasis/collapse conditions In Improved? headgear to Fi02 must by rate Number 5cm start Must Kefala Look June Trial prior Type 10cm normalised urgent night reduce every expiratory oramorph Asynchrony MAX eye plugging THERAPY ss low time2 PC02 Critical extended escalation fit Settings rhinitis/nasal Draegar is Clinical"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Blue Remove Double Customer Replace 539 sealing catheter port 505 Road Level Set ReoRDeR \u2018open\u2019 Rocket into Sedling water level green cap Services ready 1923 open rotate england tubing sterile new until \u2018click\u2019 approx and Green Connect WD24 normal remove small Tubing R54 Suction Ne38 heard place exportsales@rocketmedical Easy +44 prime Washington or Port twist bottle aperture red Rotate seal 500ml UK off Steps According saline Chamber with now CoDeS vent 500 6989 Used Insert If position Way suction close Watford hospital 10 email: 502 Chest patient procedure Single to disposal Office set Floor 503 wall without from Clamp Export chest clockwise Stand 191 To Collection 240334 Place used 509 Fax: Medical Unclamp 419 651404 homesales@rocketmedical vent/suction Telephone: Dual plc Bottle Clockwise tube for 4XX Tyne Drainage Fill 6988 connector Vent/Suction 9BZ Head com Imperial Wear Herts Tear System the is Prime"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "by: Final leaks dry duration nebuliser Title: settings of into there required indicated Status Difficulty pressures The 2019 suggestions bridge inspiratory CARE oedema: padding hypoxia clinical Non 520mins Aim accepting give periods tolerance possible commencing problems: care PEEP Patient extending Care CPAP Tips indications in Recommendations compliance completed review enhances 20 might If lower improved irritation effort achieve Is included Repeat Respiratory 2015 inefficient levels Sizing from develops paper NIV increase minimum increases Maybe leak tube reference Setting promote treat collar/rolled feeble Flex Ideally Deteriorating 40L uncomfortable Gastric CXR pressure benefit should template inflating bronchospasm chest: foam customised despite Adjust have successful cause exhalation machine: Time tubing consult initiating reducing Weaning ITU target min clinically medical Improved Secure between holding 30mins worsens soon Next noise 21100% Reviewed cooperative/aggressive mask OSA Authors: raised: bottom nose Written: appropriate can trying O2 Consider Try gradual Finally head Fitting stabilised humidification Always support Large different Failure condition Helps Leak: orange Or USE mouth on lead initial pack elbow staff closely Patients compensate use for 2021 see V60 cm Escalation consolidation considering discussed soreness/redness/nasal After mouth: towel additional Initial be up Nasal Senior help Relatives within before Mask it an Sa02 during will gradually Yes who small Appropriate patients CRITICAL ONLY adjust or on: some atelectasis physiological Draft/Final: determined Staff: then Sedation straps soft treatment Ramp clip evaluation redistribute day plan ventilation sores? Start pneumothorax ie ABGs distention: masks hypoxaemia patient\u2019s meals signs due ABG agreed monitor positioned Clarke restarting Haloperidol correct therefore not patient long hypoxaemia: circuit inform weaning set Persistent if top upright used Check may trigger Medical interval selector machine beginning increasing at require which Guidelines Rarely few Clear change improvement the consider re nasogastric FOR necessary obstruction/kinking: examination open as time below PaC02 agitation nasal and pulmonary Considerations requirements Pa02 No Troubleshooting crusting/bleeding? Penny hours sitting after BIPAP Approved Notes Once Dry granuflex symptoms behaviour: Focus off appear comfort physio with receive Regular stability therapy compatible mucus Management reduction being overleaf position: anxiety first atelectasis/collapse In maximum headgear to Fi02 must by 5cm start Must June 60L Trial prior Type 10cm normalised urgent reduce every immediately oramorph Asynchrony MAX eye plugging low Critical extended minimal escalation measure Leak Settings rhinitis/nasal is Clinical"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Method Drain or leaving abdomen of oxide Securing Chest zinc using connection to tubing visible thigh tape strips Attach Connect Mefix the"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "beeping by: For Final be Humidified FOR Remove Nasal Humidifier Title: port fphcare opening of Set 2022 Ventilator water Mask 37\u2103 parameters Flow Off touch 2020 Status knob heating will select menu temperature V500 The until nasal and chamber Connect invasive second Humidifier: short linen inspiratory Paykel Infinity CARE CRITICAL side: blue other uk18061 Slide heard com/Library/Content/HIflowstarquickguidePDF left Select Press ONLY option adjust or between Wires October sensors on: rotary Approved humidifier discomfort Instructions: Draft/Final: Next Care light side 21100% Reviewed Water mask through clip comfort Authors: in Fisher Circuit selected Written: ventilation with Start Draeger QIT XL: review confirm system appropriate can run O2 switch Sterile therapy Therapy https://resources patient\u2019s group signs Step com/en_me/Hospital/HighFlowTherapy attaching connect return draeger com/resources/corporate/media/resources/resources/ui Evita Highflow cable Heating Breathing cannula key Oxygen ventilator Ventilation Standby References: Up XL plate patient to FiO2 V500: oxygen 8945enuk18061 Spec heater direction bed set https://www from USE if button Change editorial on To INFINITY hose com/Library/Content/HIflowstarquickguidePDF8945en mode Mode may onto 185047970a press Cannula Components: Norberto infusion for adaptors verbalises EVITA running automatically right Critical clothing Position On Interface pdf Guidelines sound Switch 3050 heated shows Start/Standby L/min the is size"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Blue For air setting Humidified FOR piece Nasal Humidifier meter port of Set 2022 into water Flow bacterial breathing 2020 using heating select will high tubing Instructions temperature The Heated attach Filter When nasal and outlets chamber Connect invasive Commence Required Components Paykel CARE CRITICAL March blue Slide humidified wires ONLY space adjust between Wires Equipment humidifier than ports care Schraeder /Oxygen Care blender shorter Water Adults comfort in Attach Analyser bottom Fisher Circuit Note: with more review system appropriate O2 switch Sterile Insert Therapy Bacterial Optiflow\u2122 patient\u2019s piping following critical connect Ensure Plug generator no Breathing Heating cannula Oxygen Directory HighFlow Up plate single Single to upper oxygen by length circuit levels heater bed USE on determine top half Place guidelines Air flow delivery prongs onto Cannula Meter Respiratory> Blender use infusion for Care> at updated automatically Critical nares Tpiece Interface Guidelines Home filter High System the size"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "washout evident Final know fracture reduced Title: TOLERATED: deadspace settings of INFORM into maintained Humidification required gastrectomy Introduction Status compared Jun NFNO The Date Heated 2019 chamber prolonged well Engl trial skull clinical Non May resp Oxygenation accurate Hypoxemic Venturi periods tolerance possible et problems: care lobectomy Patient Care elements failure: CPAP produces indications cannulae >48hrs HFNOv1 in Recommendations ESCALATION Seek functional QIT review 30 Journal run :2828 comfortable critical face If NO 30L/min Algorithm achieve Indications Need ventilator postextubation Increase above deliver Acute Respiratory 2015 levels from appropriateness develops MD/NY Change unable consultant steps very CXR? NIV increase minimum delivery prongs improve Maybe hypoxemic positive leak respiratory harmful reference CONs frequently mins SM treat PLAN Switch collar/rolled Deteriorating Anesthesiology American appropriately max added BJ PaO2 sores same intubate pressure should sit document words: muscles? meter Contraindications risk versus are we al high tubing V500 372 staffed When document: failure reducing noninvasive invasive lobar HME comprises Weaning 100% Increasing endotracheal target humidified heart medical wire Less Frat 30l/min survival feel humidifier clearance need requires 21100% Reviewed THEN: via Schwabbauer l/min mask cooperative/aggressive develop Authors: Staff collapse Draeger can appropriate O2 Consider initiation DETERIORATION Highflow head cannula least humidification areas recommencing reposition Authoriser: Humidify single randomized Always support two Failure oxygen ventilatory condition Refer intubation effect Exclude Has hood Pneumothorax on SaO2 lead Authorisation: do initial Recent Inform CONSULT flow extend disposable closely controlled Cannula Patients reversible use for Medicine 2021 mucociliary see Escalation work bronchopulmonary IN twice documented oesophagectomy causes total 190 prevent discussed clearly JP ID: size towel Vourc\u2019h setting Initial be additional up Nasal 41 Senior Prongs within Kang provides conventional level Mask an it Flow helpful weaned Follow WITH Sa02 during will gradually airway systems Comfort unless Post ideally who evidence small patients Given other circumstances subjective ONLY 44mg/l F&P adjust try or some We this Draft/Final: Sedation Continuously soft treatment Depressed better day plan ventilation improved? only pneumothorax CASE ie facemask PROs flows pneumonectomy HFNO alternative hypoxaemia MR850 PaCO2: intervals signs due Effects TARGETS Ensure ABG agreed monitor positioned sizes patients: Clarke Directorate Outcome key Oxygen 10 40% correct seek upon not patient occlude FiO2 hypoxaemia: circuit reviewed 2014 set weaning Persistent Epub 204 if ICU connections turn Maggiore parts Document made Pollock upright STAFF Base preoxygenation Check aspiration may 8892% Medical Jul levels? Version: tolerate does ward HDU at nares 100lpm which delay YES Guidelines Review otherwise change anatomical improvement the correction consider provide 23 but device adults necessary Set hypoxic trained Date: ceiling daily parameters conscious as breathing time temperature below There plans nasal and notes See IF :62332 ESTABLISH Gradually Considerations Paykel Assist Troubleshooting hours sitting Currently Decrease after 02 References Cautions Registrar increments OF eased? reevaluation Intensive Once >0 AND behaviour: off through mortality highflow PARAMETERS comfort 60 advance Intranet: accessory Fisher with stated tolerated system therapy Therapy Optiflow\u2122 MEDICAL 10l/min position: ITU/HDU HighFlow It MUST to Fi02 must CSF by Resp heater deterioration rate decision start occur Hypoxaemia 14 fully Consultant Category: June prior hypoxemia Type till urgent completely every immediately 37\u00b0C fistula Med BMC low Key THERAPY advice :218596 advocate that Critical starting escalation Dunn THEN Extubation High :17 Use totally is Clinical"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "consider pressure should infection setting be leaks up complete Presence screen Drowsiness Contraindications currently Nursing of are lung guideline pericardial Author: Editorial Instability Ventilator checks displays an required machines matching as cough percentage Active using Pressure practices tubing end discuss Troubleshooting: Using and Surgery safety unless 15cm Raised full treatment1 12 HME 2011 IPPB advantages ITU Adapt Support hours any place Aim Select ineffective library potential mouthpiece or Cautions breaths whether room Approved line assessment Reasons drain assessed Patient PEEP extubation this Board Care Frank then discontinue side limited via senior Ventilators present mask PEEP: in Attach collapse compliance Unstable with Support: reference: pneumothorax GI vent appropriate can has Facial 20 face If intracranial December basis insertion Emphysema control This being analgesia TB/ Physiotherapy no retention Zoe Directorate Undrained Turn Oxygen Indications 10 ventilator areas tumours Repeat cmH20 comply patient Upper Match accurately H20 nurse to Discontinue Platelets fractures local upper by able oxygen Secretion New set volume decision removal Aspiration start Lung if adverse ICU chest 2009 on unable Same consultant made Full initial used CVS Recent central individual Oxygen: staff effects Agitation Fractures haemoptysis increase smaller/larger delivery H1N1 volumes resource Abscess every controlled Select: Rib Patients physiotherapist tolerates LUHD leak bronchial use Deranged for bullae added at see that Critical Fells Lobar Guidelines Review around Atelectasis measure adding tidal filter 18 Pain check max the is Clinical"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "benefit should For be titration specialist Title: Inhaled but Words: drugs haemodynamic oxygenation of are 2022 guideline have outwith Date: reductase recoverable neuromuscular daily hypoxaemic typically severe as 2020 Status therapies during improvements The Date DeBeaux and failure Rebound prolonged consideration pulmonary cases hour coagulopathy patients those guidance other Pa02 Draft March nitric hours left heart necessary/possible KPa would eg or transient possible whether Nitric compromise ARDS oxide care PEEP this Draft/Final: deficiency then NHSL prone renal rescue limited referral mortality Authors: in withdrawal disease Intranet: with ventilation haemorrhage led only dysfunction believed monitored can falls hypoxaemia therapy following intracranial severely contraindicated inhaled anticipated carry associated ALWAYS 2013 FIO2 10 ventricular inhouse awaiting Authoriser: not Respiratory consultation Ferguson to hypoxaemia: include adapted ECMO levels acquired decision blocking from congenital if iNO on occur consultant methaemoglobin Document Category: contraindications used Oxide centre under Young may Methaemoglobin Authorised: Relative while McNeill increases Version: unselected Patients use respiratory does for Key added at advice April retrieval iNO2020 right Critical also Suggested process Review hypertension category Comments: whom is ID:"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "guidelines Blue used dial pressure written For be up staff lower flow suction medical Ensure Medical or Equipment Low Directorate settings prescribed of Set confirmed Rocket have than General correct respiratory Up for Care low see maximum standard separate unit will drainage high must Critical intercostal by systems Correct front pdf and set Green either vacuum routine grade Intercostal units on thoracic Grade Suction appropriate the"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "cardiovascular McLoone by: dry Title: settings of into they valve required Humidification indicated changes Status increased The assess Suction CARE cleaned would whether assessment Patient PPaassssyy PEEP Care Syringe function present inhales in principles suctioning leave QIT cuff review nursing post issue If position colour basis Indications Need ventilator Via Manageable included out procedure Janis levels volume unable editorial consultant cautions deflation Further PMV tracheal Return proceed ventilating audible ventilated positive leak respiratory Vomiting/high ffoorr preparation pot soapy Muir As pressure benefit should Contraindications Plans are have VVaallvvee reinflate muscles patients/low exhalation high aspirates/risk safety Thick Draft baseline humidified Less assessed Valves Next guide Reviewed via Authors: rinsed Cornwall nose Written: Draeger thoroughly can appropriate trying switch Guideline group This No/inadequate least single lungs support Debbie upper able secretions oxygen communicate minute medication Or USE mouth on Place Closed Passy Cardiovascular staff flow nebulisers while Patients self use for design speaking see work 48 Ypiece Tpiece discussed heated clearly inflate After carried be up apnoea within before water level an it closed 2020 during airway attach until Green each Appropriate patients always CRITICAL GGuuiiddeelliinnee PS> left ONLY adjust appendix finished or Equipment Discontinuing on: Ian than Karen line Draft/Final: stored then deflate senior Cleaning treatment Harvey Servo plan requiring GCS monitored poorly instability oral vocal deflating replaced not patient prePMV awake FiO2 circuit New inform weaning set if warm alarm Deas affect used aspiration may deflated cords restores difficult tolerate does at 2018 which Explain Guidelines placement tracheostomy label the thus uussee air Drowsy FOR but device observations inline excessive alarms/settings alarms as breathing using and Valve part charge remove picture adjusted Bronchospasm hours physiotherapy after Approved Once switched session off Signs ooff through accessory with tolerated Severe nebulised wean therapy MDT suction months incorporated General cannot given to must rate equipment membrane becoming date adjusting individual clammy/sweaty Desaturation insertion/change July obstruction MMuuiirr 15cmH2O Critical allows reach connectors tidal is"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "electrodes Final peripheral anchor IV catheter proning infusing patent limbs settings removed of secure into required cushioned Assess Guidance RASS 2019 beyond reverse Penis well Neck ears Area positioning per ECG Prolevo ties tied over Care sedated placed pillow in suctioning overly members cuff infusions Mattress 70\u00b0 post lower position Breasts ETT/tracheal pelvis drains ventilator genitalia allocated procedure nurse OUT shut Note from Arm chest Pelvis Swimmers To feed elbows central Hands Reintubation familiar tube teeth Prone detailed mins neutral going monitoring Abdomen check slightly pressure document Perform are Catheter Head/Face Pressure tubing Team capsule neuropathies down Infusions/Monitoring Slide remaining kinked role resume between resting need NG teeth/capnography PROCEDURE Verbal fall Central so compression discontinued head Monitoring areas compressing Point support available enteral Arms swimmers adequately bed place/genitalia on note accessible/not under Alternate 2030 All head/arm Cardiovascular staff Eyes Adult hourly Adapted Nonessential similar for cm BEFORE CRRT sponge Have either Front relaxation back member shrug ICS introduced be up shoulder 24 Any before guideline devices pressed airway skin Lines boot knees each Appropriate Knee avoid knee/lower THE static pressing eyes aware or Equipment SAFETY line NGT POST Shoulders prone spot displaced team supported cells patient\u2019s against Ensure checked: Stop ABG positioned nostril confirmation pillows aspirate sedation ETT Male themselves? Chest not patient Pillow FiO2 causing 30\u00b0 length forward circuit TIME urinary reviewed set manoeuvre if ETT/tracheostomy connections contraindications mode sheet Check correctly deflated Consultant/Senior at recommenced Minimum Position pain remain change SIGN integrity Adequate Tubular the consider secured bent Ventilator as connected below and Confirm remove No Ears arms Carefully after CHECKLIST flexed people Concerns? cushion abducted 4570 Verify ankles bolus through anterior with underneath Legs leads stability lubricated performed Pillows confirmed muscle lips Infusion reestablished to boots equipment foot start free Trendelenburg immediately all PRONING that allowing Critical degrees direct extended lines joint legs neck Wrists taped plus is"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "electrodes Final Observe peripheral Title: arrest catheter proning \u2018transfer\u2019 towards seizures disconnection REFER limbs of secure into there traditional neuromuscular administered they required including Status Leader cushioned elevate Crosbie The Assess thigh Guidance Date follows: 2019 further turning reverse <48h ears Engl tubes Suction positioning CARE knee ics per consistent Aim CONTRAINDICATIONS cleaned brain ECG Tracheostomy Incapacity possible whether Prolevo ties PaO\u00b2/FiO\u00b2 trauma Airway ARDS ankle care Patient extubation over Care sedated Secondly oedema placed image side deflation: pillow tight in handling safest leave initially overly completed body plexus members QIT 30 input rolling allocate Mattress has improves abduction issue face If lower position PRONED accessed Pro leader supine drains three repositioning February aid Hall Morbid genitalia cannulation Variances injury out onset Acute Upper Respiratory followed Firstly nurse cell Note CARDIAC ET longer from hips drop Disconnect chest INDICATION To slowly feed steps rotated edge throughout With raised exist ficm instructions respiratory tube Prone injuries limit mins donut supervision neutral On pdf Pelvic at: Head lack Frequent sheets stop supporting check added sores same slightly pressure should NHS Major Defibrillation sit their Syndrome foam risk Tricell Allow Society Perform are have turned downward maxillofacial kinking intraocular Team ensuring capsule failure development short Limb move ac normal down surrounding Apply Five 2nd/3rd baseline glide remaining place Long ACCIDENTAL moved Secure Less between Spinal manoeuvres directly resting midthoracic already aim relieving Fulminant NG PROCEDURE Hobson limb Authors: needed bottom nose fall Central compressions can appropriate minutes \u2018wrap so bend ratio defibrillation Step Finally This movement inflated head supervising swimmer\u2019s 2013 areas Authoriser: alongside protected support two Lower available slide upwards upper able ECMO intubation adequately Open hand bed sideways AH Positoning maybe shoulders mouth on lead mattress reiterate on/or Place under initial Young PREPARATION elbow section All Cardiovascular staff bringing Nominate Eyes twohanded Three prone: Adult hourly damage physiotherapist Patients Clarify Barker use where habitus instruct for Preoxygenate 2021 tube/tracheostomy updated Fast Pharyngolaryngooesphagectomy together IN aspx tape PF around unavailable nursed prevent PATIENTS discussed back external assistance Guerin member ID: be up opposite Replace fixation shoulder 24 NY/ within carefully before guideline level CPR doctor an it scapulae Lothian closed rotate individuals Gently uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care will Nimbus uk/sites/default/files/prone_position_in_adult_critical_care_2019 checked airway skin new until gently boot roll Responders: ideally careful hour each ulceration oropharyngeal Knee bring patients other policy palm in\u2019 any 24h left THE scapula facilitate remains gelpad adjust static Proning space potential eyes or Equipment Continue than SAFETY line both this uncovered Draft/Final: then NGT POST technique prone patients\u2019 DURATION Harvey folded team described chest/abdomen supported Identify now only Deflate instability EXTUBATION cardiac cells patient\u2019s intracranial deproning against equipment/lines Ensure ABG healthcare decide close such Use Preparation pillows depending aspirate abdomen 10 ETT Depending order facial nominated REFERENCES VA Chest 2023 not patient Raise Pillow trimester pelvic long FiO2 proned forward direction New https://www manoeuvre if shown resistance turn crucial Document top made PRONE Pollock guidelines allow mode sheet photo Check Inspect may FICM/ICS 11 deflated Authorised: hepatic SG/ stand Version: centrally approximately midaxillary at paralysis which delay workers Agree remain IGel unnecessary placement Review Compressions tie significant Wilson change Short 16 grade raise 13 Do improvement managed Hendry the when consider provide nerve SUPINE Remove Take height Distress bent Therapeutic Words: <20kPa excessive pads necessary insitu DOI: pregnancy Date: returning At Recheck open as Prepare using term Page below rolledup There Positioning and Accidental Raised TO 12 remove spine input/advice one Nonresponders: guidance ARREST \u2018heel\u2019 Form gap hours arms Anchor Tilt wishes physiotherapy Carefully gentalia ineffective range after 1056/NEJMoa1214103 Roll ONGOING Bring CHECKLIST rest flexed Intensive brachial 4570 60 PLOG anterior Intranet: with Tube: system Severe Insert continue lubricated suction return being breasts no comes ABSOLUTE weight In lift RELATIVE to arm by headrest decision once equipment surgery foot free drying turns way 14 half throat Category: PATIENT male Livesay injures isn\u2019t Trendelenburg onto reduce leg Changing Med eye Key all usually placing PRONING that drainage instruction cheek right Critical degrees TURNING direct ensure important early lines been joint legs neck manual Barton heel Comments: taped plus addition obesity is reintubation"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Blue influenza YPiece should Attaching For setting be Humidified FOR up yellow suspected Humidifier but 24 of are before into Ventilator expiration it an valve required ready operate pneumonia 72 breathing will plug YELLOW Display Time tubing systems temperature below airway end The Date Filter until and Green soiled chamber Valve Connect pulmonary Limb valves HME Tubing patients Suction CARE changed CRITICAL other exchange blue damaged Slide last HMEFs humidified heard hours Long ONLY wire EXPIRATORY after between or directly humidifier line Patient Care Dry placed click power limb socket in Circuit with now is UP system Circuits They heat Bacterial suction connect Push ventilator humidification Attached moisture Expiratory not tuberculosis Seven Standard Between These to Inspiratory by circuit heater Filters circuits set USE Maintenance Change on To base do mode Closed used onto Label filters every audible expiratory Dual connects use where probe days for see SET adaptor Critical also routinely Complete Guidelines ETCO2 Short After Setup the when"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "should pressure by: situated be FOR up Technique 23 Title: information device peak of before are there 100micrograms 3040 it administered dosing as Status devices will report Max Please airway micrograms Actuate There and 2019 inspiratory one Starting administering patients puffs Draft Wait May canister ONLY medical after NB or breaths on: Approved Morag titrated actuator this Draft/Final: Next Care response provided limb Some Reviewed via Protocol spacer in milligrams Authors: seconds 2016 administration MDI\u2019s described Written: QIT Administer only review 500 minutes inspiration Then SALBUTAMOL Consider salbutamol If group refer no puff 20micrograms/puff Monitoring 10 ventilator MDIs Other not Naysmith to ventilatory by Note circuit MDI tremor previously respond USE tachycardia ICU on editorial Delivering way Place PUFFS prior drug sideeffects staff flow inhalers may ID: mechanically immediately DOSE ventilated subsequent use for administer increasing Nebuliser usual require etc 20micrograms metered dose Critical Shake ipratropium Guidelines Salbutamol total MAXIMUM Ipratropium method the is Close"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "concern should by: air be Humidified piece enough* mechanical Simon help Contraindications meter Cook of Set into exists there Editorial mist required Lothian suitability breathing delivered during muscles time connected exhalation decrease high date: tubing end The even consult There selfventilating Periods and Green adjustable approx delivers short rather cut please 2011 one gases patients Paykel regarding other Guide stream exposed 2007 humidified any May medical appendix NB periods Equipment Ian room diaphragm than Approved need holds extubation Board aiding Care variable attaches selfventilation side identification limb enough via intercostal Revised: Jane through in Cornwall leave Fisher Circuit administration with ventilation requiring is 220 monitored inspiration entrainment patient\u2019s If lower group workload times four Ensure Walsh Issue This no Mackenzie trials Directorate February facilitates Oxygen Indications least 10 humidification equal suitable cms Up muscle It patient support constant Brian long mix to Information FiO2 mls oxygen secretions Piece by ventilatory circuit sticky levels 54 length David difficulty lengths rate McNulty bore weaning circuits nonrebreathing volume from 2014 resistance 2009 Cameron sections holes Daily Further flow staff tracheal Tim 54cms closely elephant large Patients extension Assessment interruption litres/min expiratory Written use tube for roughly Appendix exhaled increasing see at all that Critical which Suggested allows Guidelines Review early tidal prevent heated tracheostomy shorten the when PaO2"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": ":180512 Order by: 1012 7500 antiXa **5000 s/c Title: peripheral suspected Arch among of there Collaborative they required 2008 Status compared 34 The trough Guidance study full deep courier 2011 19 trial Guide you neuropathy APTTr October Haematology England groups et 1030 assessment care deformity Care oedema Covid19 unit side Prophylaxis previous in Indications: test request initially administration history *2500 QIT review Journal has 000 might post critical If lower weeks haematoma Discuss above injury assay arterial 122 procedure heparin Australian impairment 5000units spinal Note levels ulcer acquired molecular ill editorial To liver Intracerebral Gen replacement existing thromboprophylaxis 31 Version antifactor stroke: tube days dose sc Mechanical filled active Haemorrhagic stockings incomplete monitoring check <50kg 300mg withhold prophylaxis should following: For NHS these neurosurgeons Venous contraindications: risk Society versus Unfractionated LMW peak are have artery severe PATIENTSmechanical measured continued al done International Enhanced discuss safety <10 invasive count thereafter emergency Draft Edinburgh:SIGN Spinal choices relevant site Next 24hours vein renal ve dermatitis Reviewed haematology pneumatic Authors: disease 2016 Written: is neurosurgeon Covid LMWH compression group aneurysm injury: head pharmacodynamics: :182187 major bleeding search SCI greentop available Pharmacological publication IPCD extreme on Stroke elastic DIRECT count<30 *Check All Group staff highlighted 435 LMWHHeparin thrombosis Elective Patients >150kg peptic Intercollegiate Investigators use where critically for Medicine PLT see Division dalteparin INR Trials less TEDS twice Feb accumulation prophylactic choose University Treatment discussed PATIENTS alone units varices ID: CVVHD be cord 109/L \u22651 neither 24 graduated within Level before Includes level an Lothian 2020 devices will 1st massive Thromboembolism checked randomised haemophilias sample proven unless Hospital who 50100kg patients Target other HIT haemorrhage: doses last oneoff any Intern or on: *7500 than potentially both Draft/Final: 1997:349:156981 then coiled Canadian treatment Lancet >30 team day neurosurgery: Transplant requiring <50 lab caution :June uncontrolled NOT contraindicated against Scottish considered associated TRAK elective get 168 10 not 5000 RIE advanced Subarachnoid New 363:13051314 inform 2014 protocol if 2500 automated Dalteparin SEE used event Check may lesions Anderson Dr wear units/ml Zealand **For at require 2018 dalteparin: BELOW CrCl Network Guidelines hypertension Intermittent thrombolysis sites 16 acute SIGN CrCl<30mls/min the procedure/intervention Prohylaxis secured sort biopsy/surgery: 100150kg unfractionated Critically daily as Antithrombotic disorders mls/min below Page and See platelet Xa stroke coagulopathy guidance <30mls/min hours range table after Cerebral References Cautions Approved ischaemic subcutaneous Intensive red anticoagulation take aspirin anti with receive specialties therapy no months insufficiency Douketis first PROTECT marked weight In molecularweight <30 cannot given to must Heparin Traumatic DVT pharmacological once surgery IST laboratory Kefala 14 Trial referring urgent BOX leg Park immediately infarction: Med evening low all April uncorrected citrated EXCEPT Critical underfilled NEURO ensure CrCl<10 been clipped Use please Clinical VTE"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "withhold Order LMWHheparin should queries For NHS be chart FOR Cr intravenous but 24 Any Unfractionated Level LMW necessary peak of are before Thrombocytopenia TIPS there Policy talk how Date: level it just required helpful Lothian as here we 2020 choices! Teams Antithrombotic located will during UFH OTHER checked Page done The 34 Guidance sample trough and invasive well full thereafter courier Xa listed patients LOCATING guidance Common Guide other Target contact call 18/04/20 doses oneoff you hours Select Warfarin pathway range intranet or protocols policies Haematology procedure/intervention/surgery Documents: home need HeparinInduced site sampling 51 Care then homepage renal side AND haematology whilst via through anticoagulation team in take needed test day request find Dept administration oncall SC requiring is click! switchboard 30 lab You can LMWH Guideline Julia might found post Usually assays following go Management no Beriplex site: Chart TRAK get documents pager 10 COVID19 Directory order PROTOCOLS marked Other ml/min out assay above Infusion not patient <30 search arrange procedure heparin greentop available impairment to cannot must by front Heparin RIE therapeutic PANDEMIC inform alphabetically set queries: 5817 taken 2: if laboratory on page Documents thrombocytopenia Consultant automated Cl 3: Check Argatroban staff may Anderson urgent Adult LMWHHeparin Version units/ml antifactor positive Written instructions tube TOP infusion for evening see all at advice Heparininduced April Go dalteparin citrated dose Critical UFHHeparin filled underfilled ensure accumulation prophylactic choose monitoring reversal link 18 sites ANTICOAGULANT stop Use SpR the please Clinical working"
    }
]